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Abstract
This thesis systematically investigates the performance of a novel high retention (HR) –
enzymatic membrane bioreactor (EMBR) for effective degradation of a broad spectrum of trace
organic contaminants (TrOCs) commonly detected either in sewage-impacted water or in
wastewater treatment plant effluent. In the last decade, laccase (EC 1.10.3.2), a coppercontaining oxidoreductase enzyme, has been studied extensively for the degradation of
recalcitrant pollutants. Laccase-catalysed degradation of TrOCs such as pharmaceuticals,
pesticides, personal care products, industrial chemicals and steroid hormones has gained
significant attention. These TrOCs occur ubiquitously in municipal wastewater and sewageimpacted water bodies. This can potentially be harmful to aquatic ecosystems and human
health.
Initially, performance of laccase was assessed in batch enzymatic bioreactors due to the
concern of enzyme washout in a continuous-flow treatment system. In an attempt to prevent
enzyme washout, an enzymatic membrane bioreactor (EMBR) was developed by coupling an
ultrafiltration (UF) membrane to an enzymatic bioreactor. Interestingly, during the operation
of the EMBR, adsorption of some hydrophobic TrOCs (log D >3) onto the enzyme gel layer
over the membrane surface resulted in enhanced degradation of the adsorbed compounds. This
observation indicates the complementarity of simultaneous laccase and TrOC retention within
EMBR. Hence, in this thesis, a novel high retention enzymatic membrane bioreactor (HREMBR) system was developed for enhanced TrOC degradation by coupling an enzymatic
bioreactor with a high retention membrane separation process such as nanofiltration (NF) or
membrane distillation (MD).
To serve as the proof of concept, the first step of this research compared the performance of a
conventional UF- and high retention NF- EMBRs for the degradation of a broad spectrum of
29 TrOCs under identical operating conditions such as TrOC-loading rate and hydraulic
retention time. The results revealed that the overall removal (i.e., biodegradation + membrane
retention) of TrOCs in NF-EMBR was better as compared to that achieved by UF-EMBR. This
is because the NF membrane achieved TrOC rejection ranging from 90 to 99%. Furthermore,
mass balance analysis shows that, as compared to the UF-EMBR, significantly better
degradation (up to 65%) was achieved by laccase in NF-EMBR. Improved degradation
following simultaneous TrOC and laccase retention was mainly due to the prolonged contact
time. Formation of secondary radicals or coupling agents, which are formed following laccasecatalysed degradation of phenolic TrOCs, are highly reactive and could directly oxidize or
polymerize other TrOCs. Notably, the results of this study suggest that UF membrane can
contribute to the removal of TrOCs depending on their hydrophobicity and charge, thereby
improving the overall performance of UF-EMBR. The overall removal by the NF-EMBR was
considerably better due to enhanced TrOC degradation as well as effective TrOC removal.
vi

Permeate flux of UF/NF membranes reduced gradually, this can be attributed to: (i) membrane
fouling due to the adsorption of laccase on membrane surface forming an enzyme gel-layer;
and/or (ii) concentration polarization due to the accumulation of TrOCs and transformation
products on membrane surface. Membrane cleaning with water was suitable for effective flux
recovery.
In vitro treatment with laccase mainly depends on two factors: (i) redox-potential; and (ii)
availability of electron donating (EDG) or withdrawing (EWG) functional groups in the
chemical structure of TrOCs. Depending on its source, the catalytic potential of laccase for
TrOC removal may significantly vary. In the next part of this research work, efficacy of two
different laccases from genetically modified Aspergillus oryzae and Trametes versicolor was
analysed in by coupling an enzymatic bioreactor with the MD process, which is another format
of high retention membrane. Following effective TrOC retention (>99%) by the MD
membrane, enhanced laccase-catalysed degradation of the selected TrOCs was achieved in
MD-EMBR as compared to previously developed UF-EMBRs. Importantly, although
degradation by both laccases was TrOC-specific, performance of laccase from A. oryzae was
superior to that obtained by laccase from T. versicolor. This could be attributed to the higher
redox-potential (up to 15%) of laccase from A. oryzae than laccase from T. versicolor.
Although MD-EMBR can produce TrOC-free permeate, enzymatic degradation of certain
groups of TrOCs (e.g., those containing strong EWGs) was incomplete. The spectrum of
efficiently degraded TrOCs can be extended by introducing a naturally occurring or synthetic
redox-mediator that acts as an electron shuttle between the TrOCs and laccase. Hence, the
performance of three redox-mediators, namely syringaldehyde, violuric acid and 1hydroxybenzotriazole was assessed for improving the degradation of TrOCs in MD-EMBR.
Each redox-mediator achieved TrOC-specific improvement in degradation, but violuric acid
was the most efficient and versatile redox-mediator. However, when a mixture of
syringaldehyde and violuric acid was tested, instead of inducing a synergistic effect,
degradation of at least six pharmaceutically active TrOCs reduced. Despite the improved TrOC
degradation, a mediator-specific increase in toxicity of bioreactor media as well as rapid
laccase inactivation was observed following their addition in the enzymatic bioreactor of MDEMBR. Nevertheless, the effluent of the MD-EMBR (i.e., membrane permeate) was non-toxic.
This is because the high retention MD membrane could retain all the constituents of enzymatic
bioreactor.
To address the issue of laccase inactivation in presence of redox-mediators, an integrated
persulfate- and laccase- based oxidation process was envisioned. Based on the results achieved
in batch tests, effect of persulfate concentration (1-10 mM) and incubation time (up to 24 h) as
well as persulfate activation pathways were elucidated. The results revealed that the combined
laccase/persulfate-assisted oxidation process achieved improved degradation of TrOCs
resistant to laccase only. The developed process was also effective for estrogenicity reduction
vii

without causing significant laccase inhibition. A NF membrane when coupled with the
laccase/persulfate-assisted oxidation process allowed continuous-flow operation. This is
because NF membrane effectively retained both persulfate and laccase. Importantly,
degradation of non-phenolics further improved by 10 to 65% in laccase/persulfate-NF system
as compared to laccase only. This could be attributed to the prolonged contact time between
laccase/PS and TrOCs; as well as the contribution of oxidative coupling agents in degradation.
The toxicity and estrogenicity bioassays confirmed that membrane permeate was non-toxic and
safe for disposal.
Physicochemical properties of raw water collected from surface water and groundwater are
diverse. Raw water matrix contains different dissolved organic and inorganic (e.g., metal ions)
impurities. The freshwater bodies may contain both TrOCs and metal ions (e.g., iron) due to
sewage contamination as well as acid mine drainage (AMD) intrusion. Different treatment
options including the stand-alone and integrated MD system were examined for efficient
treatment of sewage- and AMD-impacted water. The stand-alone MD system successfully
retained (85-100%) bulk organics, TrOCs and metal ions (iron, magnesium, calcium and
lithium). However, accumulation of organics and metal ions caused severe membrane fouling,
consequently reducing the permeate flux by up to 75% within 5 d of operation. Based on the
performance of laccase and persulfate in batch tests, a PS-assisted oxidation process was
selected to be coupled with the MD system. The PS-MD system reduced the accumulation of
bulk organics and TrOCs, but membrane scaling mainly caused by iron still affected permeate
flux. Nevertheless, the MD membrane effectively retained all impurities, and consistently
produced pollutant-free permeate (i.e., treated effluent).
Keywords: Biodegradation; Effluent toxicity; Enzymatic membrane bioreactor; Estrogenicity;
High retention membranes; Laccase; Membrane distillation; Membrane fouling;
Nanofiltration; Trace organic contaminants (TrOCs)
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Chapter 1: Introduction
1.1. Background
Due to the rapid population increase and urbanization, water demand for domestic, industrial and
agricultural activities is increasing at an alarming rate [7, 8]. Less than 3% of all the water on earth
is categorized as freshwater, most of it frozen in glaciers, ice and snow, and less than 1% present
as fresh groundwater and soil moisture. Less than 0.01% of it is present as surface water in lakes,
swamps and rivers. The situation is exacerbated by erratic rainfall patterns due to climate change,
which impose new challenges to the already water-stressed areas [8-10]. In addition to effective
water resource management, wastewater treatment and reuse are important strategies because
wastewater can serve as an alternative non-conventional source of water for diverse end-user
applications (e.g., irrigation and non-potable reuse), particularly in water scarce regions. The
concept of water reuse dates back the 1920s [11-13]. Given the ever-increasing water demand and
uncertain freshwater supply, the importance of water reuse cannot be overstated [14, 15]. Many
countries around the world either have established stringent regulations to ensure water reuse or
have initiated programs to promote water reuse. For instance, a few states of USA such as
California, Florida and Washington have adopted regulations for mandatory connection to the
reclaimed water network, if available [16], thus creating opportunities for investment in future
water reuse projects. Importantly, the financial model of water reuse projects continue to evolve
for attracting investments [17]. These projects are also eligible for subsidies [16]. For example,
water recycling projects in Australia has received approximately $800 million in funding/subsidies
from Water Smart Australia program initiated by Australian Government [18]. The market for
advanced water reuse (i.e., direct and indirect potable) is growing rapidly in USA, Australia,
Mexico, China, Spain and Saudi Arabia [14], and the total market is expected to reach $12 billion
by 2025 [8, 19].
In the last decade, water reclamation and reuse have received particular attention to meet water
demand during long term droughts and to improve and strengthen water supply portfolio. For safe
water reuse applications, effective removal of a wide range of pollutants including bulk organics,
salts, nutrients and trace organic contaminants (TrOCs) is essential. Among these pollutants, the
effective removal of TrOCs is one of the most challenging aspects of wastewater treatment and
reuse as conventional activated sludge (CAS)-based wastewater treatment plants were not
designed for their removal [20, 21].
TrOCs include a diverse group of chemicals such as pharmaceuticals, ingredients of personal care
products, endocrine disrupting chemicals (EDCs), pesticides and industrial chemicals. Most
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groups of TrOCs such as pharmaceuticals and ingredients of personal care products are of
municipal origin and are used in homes and workplaces on daily basis, leading to their widespread
occurrence in municipal wastewater [22-24]. A few other groups of TrOCs such as pesticides can
contaminate municipal wastewater and freshwater bodies via leaching from roads and
parks/gardens during rainfall events [23, 25]. According to a thorough literature survey,
wastewater is the main source of TrOC occurrence in freshwater, hence, their removal in
conventional wastewater treatment plants (WWTPs) is of prime significance [24, 26].
Conventional WWTPs cannot efficiently remove certain groups of TrOCs such as antibiotics,
pesticides and some industrial chemicals [21, 27]. Presence of TrOCs in the treated effluent could
cause severe ecological health concerns even at a trace concentration, i.e., in the range of hundreds
of nanogram per lire to tens of microgram per lire [28-31]. Due to their potentially harmful effect
on aquatic ecosystem and human health, development of a treatment process for effective removal
of TrOCs has gained significant interest in the recent years.
Different physicochemical and biological treatment technologies have been investigated for the
removal of TrOCs from water and wastewater over the last decade, showing promising results [3235]. However, each treatment process has its own advantages and disadvantages. For instance, the
use of physicochemical processes (e.g., coagulation and adsorption) may lead to the production of
toxic sludge, and the disposal of the toxic sludge can be problematic [24]. Similarly, high retention
membrane separation processes such as nanofiltration (NF), forward osmosis (FO) and membrane
distillation (MD) can effectively retain TrOC but without their mineralization into non-toxic
compounds [36-38]. Despite being the environmentally friendly and potentially cost-effective
techniques, biological treatment processes (e.g., CAS process) are only effective for certain groups
of TrOCs such as hydrophobic compounds and/or compounds with strong electron donating
groups (EDGs) [39, 40]. For effective removal of TrOCs, high retention membrane separation
processes such as nanofiltration (NF)/reverse osmosis [41, 42] and membrane distillation [38, 43,
44] have been combined with membrane bioreactors (MBR) as a post-treatment step, providing
effective removal to produce TrOC-free effluent stream. To avoid an additional high retention
membrane separation process, the high retention (HR)-MBRs have been developed, which can
achieve TrOC retention by membrane and subsequent biodegradation in a single step for the
production of high quality effluent suitable for water reuse applications [40].
HR-MBR combines the high retention membranes such as nanofiltration (NF), forward osmosis
(FO) or membrane distillation (MD) with a CAS process. Available studies report that HR-MBR
provides effective removal of a wide range of TrOCs [45, 46]. One of the underlying rationales for
the development of HR-MBR was that the effective retention of pollutants within the bioreactor
may facilitate biodegradation due to the prolonged contact time between the activated sludge and
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TrOCs. Despite the effective TrOC retention achieved by the high retention membranes [45],
degradation of TrOCs by the activated sludge within the bioreactor has not been reported to
consistently improve [45, 46]. This is because the degradation of TrOCs by the activated sludge
depends on their intrinsic biodegradability that is governed by their physicochemical properties
such as chemical structure and hydrophobicity [47]. Poor degradation of resistant TrOCs HR-MBR
leads to their accumulation within the bioreactor of HR-MBR. To improve the degradation of
TrOCs in HR-MBR, other microbes with better TrOC degradation capacity than the conventional
activated sludge can be introduced. In this context, white-rot fungi (WRF) and their ligninolytic
extracellular enzymes [48] are worth-noting.
Depending on growth medium and culture conditions as well as on the type of WRF
species/strains, WRF can secrete four different ligninolytic enzymes namely laccase, lignin
peroxidase (LiP), manganese peroxidase (MnP) and versatile peroxidase (VP). In addition,
cytochrome P450 monooxygenases, a group of intracellular enzymes, have also been reported to
play a vital role in the degradation of TrOCs via hydroxylation, dehalogenation and heteroatom
oxygenation mechanisms [49-51]. Whole-cell WRF and their ligninolytic enzymes have been
reported to efficiently remove a wide range of TrOCs such as pharmaceuticals (e.g., ibuprofen,
ketoprofen and diclofenac), ingredients of personal care products (e.g., triclosan and oxybenzone)
and steroid hormones [52-55]. The capacity of WRF for TrOC removal has been commonly
investigated under sterile conditions to avoid bacterial contamination. However, several studies
have cast light on the aspect of bacterial contamination by operating bioreactors under non-sterile
environment using either synthetic [55, 56] or real wastewater [57-62]. For example, Yang et al.
[55] investigated the performance of whole-cell Trametes versicolor for the removal of bisphenol
A and diclofenac in a membrane bioreactor under non-sterile conditions using a malt-based
synthetic wastewater. They observed that the removal of diclofenac was reduced by 40-50% under
non-sterile conditions as compared to its 99% removal achieved in sterile batch experiments. In
that study, bacterial contamination was evident from microbial analysis. A few recent studies have
investigated the removal of pharmaceuticals and endocrine disrupting compounds from municipal
and hospital wastewater by whole-cell Phanerochaete chrysosporium or Trametes versicolor [5763]. In all these studies, bacterial contamination restricted long term operation of the bioreactors
as the overall removal of the TrOCs gradually reduced as compared to that obtained under sterile
conditions.
Use of the harvested enzyme instead of a live whole-cell preparation allows decoupling of fungal
growth and pollutant degradation steps, and this can be a suitable strategy to avoid bacterial
contamination issues. Importantly, harvested enzymes can achieve TrOC degradation under mild
conditions, while realizing higher rates and reaction specificity [64]. Degradation of TrOCs,
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particularly by laccase has been extensively investigated in recent years [53, 65, 66]. Despite the
promising performance of laccase for TrOC degradation, a few research gaps need to be addressed
for improving the efficacy of enzymatic bioreactors. These research gaps are explained in section
1.2, and are addressed in Chapter 3-7 of this thesis (see Section 1.4).”

1.2. Knowledge gaps
Initial studies have assessed the performance of laccase-catalyzed TrOC degradation in batch
enzymatic bioreactors due to the concern of enzyme washout in a continuous-flow system. In an
attempt to prevent enzyme washout, an enzymatic membrane bioreactor (EMBR) was developed
by coupling an ultrafiltration (UF) membrane to an enzymatic bioreactor [53, 67]. Membrane
coupling to an enzymatic bioreactor offers several advantages over other alternatives such as: (i)
more effective enzyme retention compared to packed bed reactors; (ii) avoid mass transfer
limitation linked with enzyme immobilization; and (iii) easy to replenish enzyme for prolonged
operations [64, 68]. Notably, during the operation of a UF-EMBR, adsorption of some
hydrophobic TrOCs (e.g., amitriptyline, oxybenzone and octocrylene) onto the enzyme gel layer
over the membrane surface resulted in enhanced degradation of the adsorbed compounds [53]. In
another study, removal of four non-phenolic TrOCs, namely atrazine, sulfamethoxazole,
diclofenac and carbamazepine was improved by 15–25% following the addition of granular
activated carbon (GAC) in a UF-EMBR. This was probably because simultaneous adsorption of
laccase and TrOCs on GAC promoted the interaction of TrOCs with the active sites of laccase
[69]. Results from these studies indicate the complementarity of simultaneous laccase and TrOC
retention within an EMBR in contrast to only laccase retention by UF membranes utilized in the
previously developed UF-EMBRs. However, the impact of simultaneous retention of both laccase
and TrOCs by integrating an enzymatic bioreactor with a high retention membrane separation
process (e.g., NF and MD) has not been systematically assessed, and performance governing
factors have not been elucidated.
Degradation of TrOCs in an enzymatic bioreactor can be improved by adding different natural and
synthetic redox-mediators that are low molecular weight compounds capable of exchanging
electrons between laccase and TrOCs [66, 70, 71]. Studied report that the addition of redoxmediators can extend the spectrum of efficiently degraded TrOCs [53, 72]. However, inhibition of
laccase activity following the addition of redox-mediators has been observed. For instance, Hata
et al. [73] observed 90% reduction in laccase activity within fist 8 h of incubation in the presence
of 1-hydroxibenzotriazole (HBT). Rapid decline in laccase activity was also observed following
the addition of HBT, syringaldehyde (SA) and 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfnoic
acid (ABTS) separately [74]. Rate of laccase inactivation depends on the relative stability of the
radicals generated by redox-mediators. Despite rapid inactivation of enzymes, redox-mediators
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can compensate by enhancing the rate of reaction, eventually achieving rapid and enhanced
removal of TrOCs. Hence, it is worthwhile to assess the effect of redox-mediator types and
concentration on TrOC removal and laccase stability in a high retention (HR)-EMBR capable of
retaining both laccase and TrOCs. The conventional UF-EMBRs requires continuous mediator
dosing for achieving stable TrOC removal because redox-mediator pass through the UF membrane
during filtration of bioreactor media. A high retention membrane processes integrated with an
EMBR is expected to retain redox-mediators and may allow long-term operation of EMBR without
mediator re-injection.
Advanced oxidation processes (AOPs) such as photolysis and persulfate oxidation produce highly
reactive radicals (e.g., hydroxyl and sulfate radicals) that can directly oxidize a wide range of
TrOCs [75]. A combination of an AOP and laccase-catalyzed degradation process may act
synergistically and could achieve effective TrOC degradation. Because an integrated AOP-laccase
assisted membrane bioreactor system for TrOC removal has not been assessed previously, it will
contribute to the body of knowledge on the fate of TrOCs in integrated treatment processes. It will
also help to elucidate the role of a high retention membrane separation process during continuous
treatment.
Laccase-catalyzed degradation of TrOCs, particularly in the presence of mediators, produces
reactive radicals and transformation products that may increase the toxicity of the treated effluent
[76, 77]. In addition, estrogenic activity is another important parameter to evaluate the safety of
treated effluent for disposal and reuse [78, 79]. To predict the risk associated with the disposal of
treated effluent, bioassays have been developed and reported for quantifying the toxicity and
estrogenicity [80, 81]. However, studies on TrOC degradation do not always report the toxicity
and estrogenic activity, particularly when treating a mixture of a broad spectrum of TrOCs at an
environmentally relevant concentration.
Physicochemical properties of raw water collected from surface water and groundwater are
diverse. Raw water matrix contains different dissolved organic (e.g., humic substances) and
inorganic (e.g., heavy metals) impurities. A treatment process capable of effectively removing both
heavy metals and TrOCs from wastewater should be critically assessed. A few lab-scale studies
on the removal of TrOCs and heavy metals are available [84, 85], but the impact of impurities such
as metal salts on pollutant retention and membrane fouling remains largely unexplored.

1.3. Research objectives
The primary objective of this thesis is to develop and assess a high retention (HR)- enzymatic
membrane bioreactor (EMBR) system for achieving enhanced TrOC removal. The main idea was
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to gain an in-depth understanding of removal mechanisms and the factors affecting the
performance of HR-EMBR. The specific research objectives are as follows:
i.

To elucidate the impact of simultaneous laccase and TrOC retention on degradation by
comparing the performance of a nanofiltration (NF)-EMBR with a ‘control’ ultrafiltration
(UF)-EMBR under identical operating conditions.

ii.

To systematically assess the performance of two high retention membranes including
membrane distillation (MD) and nanofiltration (NF) coupled to an EMBR separately for
understanding the role of membrane in TrOC and heavy metal removal as well as for
analyzing the hydraulic performance and stability of the developed treatment systems.

iii.

To critically assess the impact of redox-mediator (both natural and synthetic) type,
concentration and mixture on TrOC degradation, laccase stability and effluent toxicity in
both NF- and MD-EMBRs.

iv.

To elucidate the factors affecting the performance of an integrated laccase/persulfate
assisted oxidation process on TrOC degradation, laccase stability, effluent toxicity and
estrogenicity.

1.4. Thesis outline
This thesis is divided into eight chapters (Figure 1.1), and the research objectives outlined above
in Section 1.2 has been addressed in Chapters 3-7.
Chapter 1 describes the background, research gaps and research objectives of this study.
In Chapters 2, a comprehensive literature review of the occurrence of TrOCs in wastewater,
freshwater bodies and seawater. In addition, status and evolution of current activated sludge-based
biological processes such as MBR and HR-MBR are critically explained to understand the fate of
TrOCs during wastewater treatment. The current knowledge related to the application of WRF and
their ligninolytic enzymes (particularly laccase) for TrOC degradation is provided, and the
performance governing factors along with research gaps are identified.
Chapter 3 is arguably the most critical chapter of this thesis because it serves as a proof of the
concept – simultaneous retention of TrOC and laccase within enzymatic bioreactor facilitate
degradation. This is achieved by comparing the performance of a NF-EMBR and a ‘control’ UFEMBR under identical operating conditions.
In Chapter 4, another configuration of HR-EMBR (i.e., MD-EMBR) is assessed for enhanced
TrOC degradation, and the impact of laccase source on the extent of degradation are elucidated.
The purpose of this chapter is to demonstrate that other high retention membrane separation
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processes, in addition to NF membrane, can be integrated with an enzymatic bioreactor for
achieving improved TrOC degradation.
In Chapter 5, long-term performance of MD-EMBR for the removal of 30 TrOCs having diverse
physicochemical properties (e.g., EDGs/EWGs, hydrophobicity and phenolic/non-phenolic
moieties) is examined. The effect of dosing redox-mediators, separately and as a mixture, on TrOC
degradation, laccase stability and effluent toxicity is elucidated.
In Chapter 6, a novel integrated laccase/persulfate oxidation process is examined for the first time.
The effect of persulfate concentration and incubation time on TrOC degradation, toxicity and
estrogenicity is elucidated in both batch bioreactor and continuous-flow NF-EMBR.
In Chapter 7, simultaneous removal of both TrOCs and the selected heavy metals by MD process
is assessed. The effect of metal ions and organic impurities on membrane retention and fouling is
systematically studied. The MD process was selected for simultaneous TrOC and heavy metal
removal because the literature suggests better performance of MD process as compared to the NF
membrane.
Finally, the Chapter 8 summarizes the key findings of this study and outlines recommendations
for the future research.
In this thesis, Chapters 3-7 are structured as a scientific publication, with their own introduction,
materials and methods, conclusion and reference sections; and its own supplementary information
placed at the end of the thesis. However, where suitable, reference to a section in a previous chapter
is made to avoid repetition in materials and methods section.
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Chapter 1: Introduction

Chapter 2: Literature review

Results and discussion

Nanofiltration (NF) membranebased high retention EMBR

Membrane distillation (MD) based high retention EMBR

Chapter 3: Impact of simultaneous
TrOC and laccase retention on
degradation

Chapter 4: Impact of laccase
source on TrOC degradation

Chapter 6: Synergistic effects of
combining laccase and persulfate
oxidation on degradation, toxicity
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Chapter 5: Impact of redoxmediator types, concentrations and
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toxicity

Chapter 7: Simultaneous removal
of TrOCs and heavy metals

Chapter 8: Conclusion and Recommendations

Figure 1.1. A schematic representation of thesis structure and outline

1.5. Contribution to knowledge
Overall aim of this thesis is to develop an integrated process for improving the degradation of
TrOCs, which is a significant addition in the existing literature. The integrated treatment process
that is developed and studied for the first time in this thesis could be applicable to other studies
dealing with bioremediation of hazardous pollutants such as phenols. Since a high retention
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enzymatic membrane bioreactor (HR-EMBR) has not been studied previously, the findings of this
thesis contribute significantly by identifying the performance governing factors as well as by
providing an in-depth understanding of the fate of TrOCs during laccase catalyzed degradation in
EMBR.

1.6. References
[1] H. Hoff, Understanding the Nexus, Background paper for the Bonn Conference 2011: the WaterEnergy-Food Security Nexus, Stockholm, Stockholm Environment Institute, (2011).
[2] C.A. Scott, M. Kurian, J.L. Wescoat, The water-energy-food nexus: Enhancing adaptive capacity to
complex global challenges, in: M. Kurian, R. Ardakanian (Eds.) Governing the nexus: Water, Soil and
Waste Resources Considering Global Change, Springer, Basel, Switzerland, 2015, pp. 15-38.
[3] M. Kurian, The water-energy-food nexus: trade-offs, thresholds and transdisciplinary approaches to
sustainable development, Environmental Science & Policy, 68 (2017) 97-106.
[4] E.M. Biggs, E. Bruce, B. Boruff, J.M. Duncan, J. Horsley, N. Pauli, K. McNeill, A. Neef, F. Van Ogtrop,
J. Curnow, Sustainable development and the water–energy–food nexus: A perspective on livelihoods,
Environmental Science & Policy, 54 (2015) 389-397.
[5] C. Ringler, A. Bhaduri, R. Lawford, The nexus across water, energy, land and food (WELF): potential
for improved resource use efficiency?, Current Opinion in Environmental Sustainability, 5 (2013) 617-624.
[6] M. Howells, S. Hermann, M. Welsch, M. Bazilian, R. Segerström, T. Alfstad, D. Gielen, H. Rogner, G.
Fischer, H. Van Velthuizen, Integrated analysis of climate change, land-use, energy and water strategies,
Nature Climate Change, 3 (2013) 621.
[7] C.Y. Tang, Z. Yang, H. Guo, J.J. Wen, L.D. Nghiem, E. Cornelissen, Potable water reuse through
advanced membrane technology, Environmental Science & Technology, 52 (2018) 10215-10223.
[8] M.B. Asif, F.I. Hai, Wastewater reuse applications and MBR, in: F.I. Hai, K. Yamamoto, C. Lee (Eds.)
Membrane Biological Reactors: Theory, Modeling, Design, Management and Applications to Wastewater
Reuse (2nd Edition), IWA publishing, London, United Kingdom 2019, pp. 183-206. (ISBN:
9781780409177).
[9] J.B. Zimmerman, J.R. Mihelcic, J. Smith, Global stressors on water quality and quantity, Environmental
Science and Technology, 42 (2008) 4247-4254.
[10] N. Mancosu, R. Snyder, G. Kyriakakis, D. Spano, Water scarcity and future challenges for food
production, Water, 7 (2015) 975-992.
[11] J. Wilcox, F. Nasiri, S. Bell, M.S. Rahaman, Urban water reuse: A triple bottom line assessment
framework and review, Sustainable Cities and Society, 27 (2016) 448-456.
[12] T. Asano, M. Maeda, M. Takaki, Wastewater reclamation and reuse in Japan: overview and
implementation examples, Water Science and Technology, 34 (1996) 219-226.
[13] Z. Chen, H.H. Ngo, W. Guo, A critical review on the end uses of recycled water, Critical reviews in
environmental science and technology, 43 (2013) 1446-1516.
[14] P.T. Vo, H.H. Ngo, W. Guo, J.L. Zhou, P.D. Nguyen, A. Listowski, X.C. Wang, A mini-review on the
impacts of climate change on wastewater reclamation and reuse, Science of the Total Environment, 494
(2014) 9-17.
[15] D.R. Marlow, M. Moglia, S. Cook, D.J. Beale, Towards sustainable urban water management: A
critical reassessment, Water research, 47 (2013) 7150-7161.
[16] USEPA, Guidelines for water reuse. Washington DC. United States Agency for International
Development, (2012).
[17] P. Szyplinska, Design–build–operate a sustainable global model, Water World, 26 (2012).
9

[18] J. Radcliffe, Evolution of water recycling in Australian cities since 2003, Water Science and
Technology, 62 (2010) 792-802.
[19] GWI, Industrial desalination and water reuse: ultrapure water, challenging waste streams and improved
efficiency, Media Analytics Ltd, Washington DC, United States, 2012.
[20] J. Radjenović, M. Petrović, D. Barceló, Fate and distribution of pharmaceuticals in wastewater and
sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR)
treatment, Water Research, 43 (2009) 831-841.
[21] F.I. Hai, L.D. Nghiem, S.J. Khan, W.E. Price, K. Yamamoto, Removal of emerging trace organic
contaminants (TrOC) by MBR, in: F.I. Hai, K. Yamamoto, C. Lee (Eds.) Membrane Biological Reactors,
IWA publishing, London, United Kingdom, 2019, pp. 413-468. (ISBN: 9781780409177).
[22] D. Lapworth, N. Baran, M. Stuart, R. Ward, Emerging organic contaminants in groundwater: a review
of sources, fate and occurrence, Environmental pollution, 163 (2012) 287-303.
[23] A. Pal, K.Y.-H. Gin, A.Y.-C. Lin, M. Reinhard, Impacts of emerging organic contaminants on
freshwater resources: review of recent occurrences, sources, fate and effects, Science of the Total
Environment, 408 (2010) 6062-6069.
[24] Y. Luo, W. Guo, H.H. Ngo, L.D. Nghiem, F.I. Hai, J. Zhang, S. Liang, X.C. Wang, A review on the
occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater
treatment, Science of the Total Environment, 473 (2014) 619-641.
[25] C. Postigo, D. Barceló, Synthetic organic compounds and their transformation products in
groundwater: occurrence, fate and mitigation, Science of the Total Environment, 503 (2015) 32-47.
[26] M. Gavrilescu, K. Demnerová, J. Aamand, S. Agathos, F. Fava, Emerging pollutants in the
environment: present and future challenges in biomonitoring, ecological risks and bioremediation, New
Biotechnology, 32 (2015) 147-156.
[27] A. Jelić, M. Gros, M. Petrović, A. Ginebreda, D. Barceló, Occurrence and elimination of
pharmaceuticals during conventional wastewater treatment, in: Emerging and priority pollutants in rivers,
Springer, 2012, pp. 1-23.
[28] F.I. Hai, S. Yang, M.B. Asif, V. Sencadas, S. Shawkat, M. Sanderson-Smith, J. Gorman, Z.-Q. Xu, K.
Yamamoto, Carbamazepine as a Possible Anthropogenic Marker in Water: Occurrences, Toxicological
Effects, Regulations and Removal by Wastewater Treatment Technologies, Water, 10 (2018) 107.
[29] R.P. Schwarzenbach, B.I. Escher, K. Fenner, T.B. Hofstetter, C.A. Johnson, U. von Gunten, B. Wehrli,
The Challenge of Micropollutants in Aquatic Systems, Science, 313 (2006) 1072-1077.
[30] M.B. Asif, F.I. Hai, W.E. Price, L.D. Nghiem, Impact of Pharmaceutically Active Compounds in
Marine Environment on Aquaculture, in: F.I. Hai, C. Visvanathan, R. Boopathy (Eds.) Sustainable
Aquaculture, Springer, Berlin, Germany, 2018, pp. 265-299. (ISBN: 9783319732565).
[31] J.T. Alexander, F.I. Hai, T.M. Al-aboud, Chemical coagulation-based processes for trace organic
contaminant removal: Current state and future potential, Journal of Environmental Management, 111
(2012) 195-207.
[32] A. Garcia-Rodríguez, V. Matamoros, C. Fontàs, V. Salvadó, The ability of biologically based
wastewater treatment systems to remove emerging organic contaminants—a review, Environmental
Science and Pollution Research, 21 (2014) 11708-11728.
[33] Z.-h. Liu, Y. Kanjo, S. Mizutani, Removal mechanisms for endocrine disrupting compounds (EDCs)
in wastewater treatment—physical means, biodegradation, and chemical advanced oxidation: a review,
Science of the Total Environment, 407 (2009) 731-748.
[34] J. Margot, L. Rossi, D.A. Barry, C. Holliger, A review of the fate of micropollutants in wastewater
treatment plants, Wiley Interdisciplinary Reviews: Water, 2 (2015) 457-487.

10

[35] B.J. Richardson, P.K. Lam, M. Martin, Emerging chemicals of concern: pharmaceuticals and personal
care products (PPCPs) in Asia, with particular reference to Southern China, Marine Pollution Bulletin, 50
(2005) 913-920.
[36] A.A. Alturki, J.A. McDonald, S.J. Khan, W.E. Price, L.D. Nghiem, M. Elimelech, Removal of trace
organic contaminants by the forward osmosis process, Separation and Purification Technology, 103 (2013)
258-266.
[37] S.O. Ganiyu, E.D. van Hullebusch, M. Cretin, G. Esposito, M.A. Oturan, Coupling of membrane
filtration and advanced oxidation processes for removal of pharmaceutical residues: a critical review,
Separation and Purification Technology, 156 (2015) 891-914.
[38] K.C. Wijekoon, F.I. Hai, J. Kang, W.E. Price, T.Y. Cath, L.D. Nghiem, Rejection and fate of trace
organic compounds (TrOCs) during membrane distillation, Journal of Membrane Science, 453 (2014) 636642.
[39] K.C. Wijekoon, F.I. Hai, J. Kang, W.E. Price, W. Guo, H.H. Ngo, L.D. Nghiem, The fate of
pharmaceuticals, steroid hormones, phytoestrogens, UV-filters and pesticides during MBR treatment,
Bioresource technology, 144 (2013) 247-254.
[40] W. Luo, F.I. Hai, W.E. Price, W. Guo, H.H. Ngo, K. Yamamoto, L.D. Nghiem, High retention
membrane bioreactors: Challenges and opportunities, Bioresource Technology, 167 (2014) 539-546.
[41] A.A. Alturki, N. Tadkaew, J.A. McDonald, S.J. Khan, W.E. Price, L.D. Nghiem, Combining MBR
and NF/RO membrane filtration for the removal of trace organics in indirect potable water reuse
applications, Journal of Membrane Science, 365 (2010) 206-215.
[42] J. Wang, K. Li, Y. Wei, Y. Cheng, D. Wei, M. Li, Performance and fate of organics in a pilot MBR–
NF for treating antibiotic production wastewater with recycling NF concentrate, Chemosphere, 121 (2015)
92-100.
[43] P. Jacob, P. Phungsai, K. Fukushi, C. Visvanathan, Direct contact membrane distillation for anaerobic
effluent treatment, Journal of Membrane Science, 475 (2015) 330-339.
[44] X. Song, W. Luo, J. McDonald, S.J. Khan, F.I. Hai, W.E. Price, L.D. Nghiem, An anaerobic membrane
bioreactor–membrane distillation hybrid system for energy recovery and water reuse: Removal
performance of organic carbon, nutrients, and trace organic contaminants, Science of The Total
Environment, 628 (2018) 358-365.
[45] W. Luo, H.V. Phan, M. Xie, F.I. Hai, W.E. Price, M. Elimelech, L.D. Nghiem, Osmotic versus
conventional membrane bioreactors integrated with reverse osmosis for water reuse: Biological stability,
membrane fouling, and contaminant removal, Water Research, 109 (2017) 122-134.
[46] K.C. Wijekoon, F.I. Hai, J. Kang, W.E. Price, W. Guo, H.H. Ngo, T.Y. Cath, L.D. Nghiem, A novel
membrane distillation–thermophilic bioreactor system: Biological stability and trace organic compound
removal, Bioresource Technology, 159 (2014) 334-341.
[47] F.I. Hai, L.D. Nghiem, S.J. Khan, W.E. Price, K. Yamamoto, Wastewater reuse: Removal of emerging
trace organic contaminants, in: F.I. Hai, K. Yamamoto, C.H. Lee (Eds.) Membrane Biological Reactors,
IWA publishing, London, United Kingdom 2014.
[48] F.I. Hai, K. Yamamoto, K. Fukushi, Development of a submerged membrane fungi reactor for textile
wastewater treatment, Desalination, 192 (2006) 315-322.
[49] S. Yang, F.I. Hai, L.D. Nghiem, W.E. Price, F. Roddick, M.T. Moreira, S.F. Magram, Understanding
the factors controlling the removal of trace organic contaminants by white-rot fungi and their lignin
modifying enzymes: a critical review, Bioresource Technology, 141 (2013) 97-108.
[50] M. Dashtban, H. Schraft, T.A. Syed, W. Qin, Fungal biodegradation and enzymatic modification of
lignin, Int. J. Biochem. Mol. Biol., 1 (2010) 36-50.

11

[51] N. Golan-Rozen, B. Chefetz, J. Ben-Ari, J. Geva, Y. Hadar, Transformation of the recalcitrant
pharmaceutical compound carbamazepine by Pleurotus ostreatus: role of cytochrome P450 monooxygenase
and manganese peroxidase, Environmental Science & Technology, 45 (2011) 6800-6805.
[52] L.N. Nguyen, F.I. Hai, J. Kang, F.D. Leusch, F. Roddick, S.F. Magram, W.E. Price, L.D. Nghiem,
Enhancement of trace organic contaminant degradation by crude enzyme extract from Trametes versicolor
culture: Effect of mediator type and concentration, J. Taiwan Inst. Chem. Eng., 45 (2014) 1855-1862.
[53] L.N. Nguyen, F.I. Hai, W.E. Price, J. Kang, F.D. Leusch, F. Roddick, J.P. van de Merwe, S.F. Magram,
L.D. Nghiem, Degradation of a broad spectrum of trace organic contaminants by an enzymatic membrane
reactor: complementary role of membrane retention and enzymatic degradation, International
Biodeterioration & Biodegradation, 99 (2015) 115-122.
[54] E. Marco-Urrea, M. Pérez-Trujillo, C. Cruz-Morató, G. Caminal, T. Vicent, White-rot fungusmediated degradation of the analgesic ketoprofen and identification of intermediates by HPLC–DAD–MS
and NMR, Chemosphere, 78 (2010) 474-481.
[55] S. Yang, F.I. Hai, L.D. Nghiem, L.N. Nguyen, F. Roddick, W.E. Price, Removal of bisphenol A and
diclofenac by a novel fungal membrane bioreactor operated under non-sterile conditions, International
Biodeterioration & Biodegradation, 85 (2013) 483-490.
[56] L.N. Nguyen, F.I. Hai, S. Yang, J. Kang, F.D. Leusch, F. Roddick, W.E. Price, L.D. Nghiem, Removal
of trace organic contaminants by an MBR comprising a mixed culture of bacteria and white-rot fungi,
Bioresource Technology, 148 (2013) 234-241.
[57] A. Jelic, C. Cruz-Morató, E. Marco-Urrea, M. Sarrà, S. Perez, T. Vicent, M. Petrović, D. Barcelo,
Degradation of carbamazepine by Trametes versicolor in an air pulsed fluidized bed bioreactor and
identification of intermediates, Water Research, 46 (2012) 955-964.
[58] Y. Zhang, S.-U. Geißen, Elimination of carbamazepine in a non-sterile fungal bioreactor, Bioresource
Technology, 112 (2012) 221-227.
[59] L. Ferrando-Climent, C. Cruz-Morató, E. Marco-Urrea, T. Vicent, M. Sarrà, S. Rodriguez-Mozaz, D.
Barceló, Non conventional biological treatment based on Trametes versicolor for the elimination of
recalcitrant anticancer drugs in hospital wastewater, Chemosphere, 136 (2015) 9-19.
[60] C. Cruz-Morató, L. Ferrando-Climent, S. Rodriguez-Mozaz, D. Barceló, E. Marco-Urrea, T. Vicent,
M. Sarrà, Degradation of pharmaceuticals in non-sterile urban wastewater by Trametes versicolor in a
fluidized bed bioreactor, Water Research, 47 (2013) 5200-5210.
[61] C. Cruz-Morató, D. Lucas, M. Llorca, S. Rodriguez-Mozaz, M. Gorga, M. Petrovic, D. Barceló, T.
Vicent, M. Sarrà, E. Marco-Urrea, Hospital wastewater treatment by fungal bioreactor: removal efficiency
for pharmaceuticals and endocrine disruptor compounds, Science of The Total Environment, 493 (2014)
365-376.
[62] M. Badia-Fabregat, D. Lucas, T. Tuomivirta, H. Fritze, T. Pennanen, S. Rodríguez-Mozaz, D. Barceló,
G. Caminal, T. Vicent, Study of the effect of the bacterial and fungal communities present in real
wastewater effluents on the performance of fungal treatments, Science of The Total Environment, 579
(2017) 366–377.
[63] J.A. Mir-Tutusaus, M. Sarrà, G. Caminal, Continuous treatment of non-sterile hospital wastewater by
Trametes versicolor: How to increase fungal viability by means of operational strategies and pretreatments,
Journal of Hazardous Materials, 318 (2016) 561-570.
[64] F.I. Hai, L.D. Nghiem, O. Modin, Biocatalytic membrane reactors for the removal of recalcitrant and
emerging pollutants from wastewater, (2013).
[65] F. Spina, C. Cordero, T. Schilirò, B. Sgorbini, C. Pignata, G. Gilli, C. Bicchi, G.C. Varese, Removal
of micropollutants by fungal laccases in model solution and municipal wastewater: evaluation of estrogenic
activity and ecotoxicity, Journal of Cleaner Production, 100 (2015) 185-194.

12

[66] N.H. Tran, T. Urase, O. Kusakabe, Biodegradation characteristics of pharmaceutical substances by
whole fungal culture Trametes versicolor and its laccase, Journal of Water and Environment Technology,
8 (2010) 125-140.
[67] L. Lloret, G. Eibes, G. Feijoo, M.T. Moreira, J.M. Lema, Degradation of estrogens by laccase from
Myceliophthora thermophila in fed-batch and enzymatic membrane reactors, Journal of Hazardous
Materials, 213–214 (2012) 175-183.
[68] O. Modin, F.I. Hai, L.D. Nghiem, A. Basile, K. Fukushi, Gas-diffusion, extractive, biocatalytic and
electrochemical membrane biological reactors, (2014).
[69] L.N. Nguyen, F.I. Hai, W.E. Price, F.D. Leusch, F. Roddick, H.H. Ngo, W. Guo, S.F. Magram, L.D.
Nghiem, The effects of mediator and granular activated carbon addition on degradation of trace organic
contaminants by an enzymatic membrane reactor, Bioresource technology, 167 (2014) 169-177.
[70] A.I. Cañas, S. Camarero, Laccases and their natural mediators: biotechnological tools for sustainable
eco-friendly processes, Biotechnology advances, 28 (2010) 694-705.
[71] D.L. Purich, Enzyme kinetics: catalysis & control: a reference of theory and best-practice methods,
Elsevier, Amsterdam, Netherlands, 2010; pp. 759; ISBN: 9780123809247.
[72] L.N. Nguyen, F.I. Hai, W.E. Price, F.D. Leusch, F. Roddick, E.J. McAdam, S.F. Magram, L.D.
Nghiem, Continuous biotransformation of bisphenol A and diclofenac by laccase in an enzymatic
membrane reactor, International Biodeterioration & Biodegradation, 95 (2014) 25-32.
[73] T. Hata, H. Shintate, S. Kawai, H. Okamura, T. Nishida, Elimination of carbamazepine by repeated
treatment with laccase in the presence of 1-hydroxybenzotriazole, Journal of Hazardous Materials, 181
(2010) 1175-1178.
[74] B. Ashe, L.N. Nguyen, F.I. Hai, D.-J. Lee, J.P. van de Merwe, F.D. Leusch, W.E. Price, L.D. Nghiem,
Impacts of redox-mediator type on trace organic contaminants degradation by laccase: Degradation
efficiency, laccase stability and effluent toxicity, International Biodeterioration & Biodegradation, (2016).
[75] M.B. Ahmed, J.L. Zhou, H.H. Ngo, W. Guo, N.S. Thomaidis, J. Xu, Progress in the biological and
chemical treatment technologies for emerging contaminant removal from wastewater: a critical review,
Journal of hazardous materials, 323 (2017) 274-298.
[76] E. Marco-Urrea, M. Pérez-Trujillo, T. Vicent, G. Caminal, Ability of white-rot fungi to remove
selected pharmaceuticals and identification of degradation products of ibuprofen by Trametes versicolor,
Chemosphere, 74 (2009) 765-772.
[77] L.N. Nguyen, J.P. van de Merwe, F.I. Hai, F.D. Leusch, J. Kang, W.E. Price, F. Roddick, S.F. Magram,
L.D. Nghiem, Laccase–syringaldehyde-mediated degradation of trace organic contaminants in an
enzymatic membrane reactor: Removal efficiency and effluent toxicity, Bioresource technology, 200
(2016) 477-484.
[78] S.D. Richardson, C. Postigo, Safe drinking water? Effect of wastewater inputs and source water
impairment and implications for water reuse, in: Wastewater Reuse and Current Challenges, Springer,
2015, pp. 155-182.
[79] H.V. Phan, F.I. Hai, J.A. McDonald, S.J. Khan, J.P. van de Merwe, F.D.L. Leusch, R. Zhang, W.E.
Price, A. Broeckmann, L.D. Nghiem, Impact of hazardous events on the removal of nutrients and trace
organic contaminants by an anoxic–aerobic membrane bioreactor receiving real wastewater, Bioresource
Technology, 192 (2015) 192-201.
[80] F. Spina, C. Cordero, T. Schilirò, B. Sgorbini, C. Pignata, G. Gilli, C. Bicchi, G.C. Varese, Removal
of micropollutants by fungal laccases in model solution and municipal wastewater: evaluation of estrogenic
activity and ecotoxicity, J. Clean. Prod., 100 (2015) 185-194.
[81] B. Ashe, L.N. Nguyen, F.I. Hai, D.-J. Lee, J.P. van de Merwe, F.D. Leusch, W.E. Price, L.D. Nghiem,
Impacts of redox-mediator type on trace organic contaminants degradation by laccase: Degradation

13

efficiency, laccase stability and effluent toxicity, International Biodeterioration & Biodegradation, 113
(2016) 169–176.
[82] M.A. Caraballo, F. Macías, J.M. Nieto, C. Ayora, Long term fluctuations of groundwater mine
pollution in a sulfide mining district with dry Mediterranean climate: Implications for water resources
management and remediation, Science of The Total Environment, 539 (2016) 427-435.
[83] K.K. Kefeni, T.A. Msagati, B.B. Mamba, Acid mine drainage: prevention, treatment options, and
resource recovery: a review, Journal of Cleaner Production, 151 (2017) 475-493.
[84] L. Han, T. Xiao, Y.Z. Tan, A.G. Fane, J.W. Chew, Contaminant rejection in the presence of humic
acid by membrane distillation for surface water treatment, Journal of Membrane Science, 541 (2017) 291299.
[85] P. Pal, A.K. Manna, Removal of arsenic from contaminated groundwater by solar-driven membrane
distillation using three different commercial membranes, Water research, 44 (2010) 5750-5760.

14

Chapter 2: Literature Review

This chapter is based on the following publications:
Journal articles:
Asif, M.B., Hai, F.I., Singh, L., Price, W.E., Nghiem, L.D. 2017. Degradation of pharmaceuticals and
personal care products by white-rot fungi—A critical review. Current Pollution Reports, 3(2), 88-103.
Asif, M.B., Ansari, A.J., Chen, S.-S., Nghiem, L.D., Price, W.E., Hai, F.I. 2018. Understanding the
mechanisms of trace organic contaminant removal by high retention membrane bioreactors: a critical
review. Environmental Science and Pollution Research, 1-16. DOI: https://doi.org/10.1007/s11356018-3256-8
Book chapters:
Asif, M.B., Hai, F.I. 2019. Degradation of pharmaceutically active compounds by white-rot fungi and
their ligninolytic enzymes. in: Pharmaceutical Biocatalysis, (Eds.) P. Grunwald, Pan Stanford
Publishing, Singapore. (in press)
Asif, M.B., Hai, F.I., Jegatheesan, V., Price, W.E., Nghiem, L.D., Yamamoto, K. 2019. Applications of
Membrane Bioreactors in Biotechnology Processes. in: Current Trends and Future Developments on
(Bio-) Membranes: Membrane processes in the pharmaceutical and biotechnological field, (Eds.) A.
Basile, C. Charcosset, Elsevier. Amsterdam, Netherlands, pp. 223-257. (ISBN: 9780128136065)

15

2.1. Introduction
In this section, rationale for carrying out this research is outlined, and the arrangement of the
literature review is explained. Due to their ineffective removal by conventional wastewater
treatment plants (WWTPs), widespread occurrence of trace organic contaminants (TrOCs) has
been reported in freshwater bodies (See Section 2.2 and 2.3). For their effective removal, a high
retention membrane bioreactor (HR-MBR) was developed, which combines the high retention
membranes such as nanofiltration (NF) or membrane distillation (MD) with an activated sludge.
Activated sludge-based HR-MBR provides effective removal of a wide range of trace organic
contaminants (TrOCs), via membrane retention and biodegradation, and can produce high quality
TrOC-free effluent stream for safe disposal and reuse. One of the underlying rationales for the
development of activated sludge- based HR-MBR was that the effective retention of pollutants
within the bioreactor may facilitate biodegradation due to the prolonged contact time between the
activated sludge and TrOCs. Despite the effective TrOC retention by the high retention
membranes, degradation of TrOCs by activated sludge within the bioreactor has not been reported
to consistently improve (see Section 2.3.3.4). This is because the degradation of TrOCs by the
activated sludge depends on their intrinsic biodegradability. To improve the degradation of TrOCs
in HR-MBR, other microbes with better TrOC degradation capacity than conventional activated
sludge can be introduced. In this context, white-rot fungi (WRF) and their extracellular ligninolytic
enzymes (such as laccase) are worth-noting. They can achieve effective degradation of TrOCs that
are resistant to an activated sludge-based treatment process (see Section 2.4.2). However, bacterial
contamination may hamper the growth and enzymatic activity of whole-cell WRF in any reactor
configuration. Use of the harvested enzymes, particularly laccase instead of a whole-cell
preparation allows decoupling of fungal growth and pollutant degradation steps, and this can be a
suitable strategy to avoid bacterial contamination issues. Initially, only batch enzymatic
bioreactors were assessed for the degradation of TrOCs to prevent enzyme washout with the treated
effluent (see Section 2.4.2). This led to the development of a laccase-based EMBR that couples
an enzymatic bioreactor with an ultrafiltration (UF) membrane having a suitable molecular cutoff
for effective enzyme retention (see Section 2.4.4). UF membranes in practice cannot effectively
retain TrOCs. Thus, TrOCs that are not readily degraded by laccase can still pass through the UF
membrane, consequently requiring an additional post-treatment process (e.g., high retention
membrane separation processes) for their effective removal.
It is important to note that the formation of an enzyme gel-layer on the surface of the membrane
in previously developed UF-EMBR effectively adsorbed a few significantly hydrophobic TrOCs
(log D >3). This resulted in improved degradation of the adsorbed TrOC following their retention
by the enzyme gel-layer (see Section 2.4.4). Hence, it was envisaged that the use of high retention
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membranes, which will retain both laccase and TrOCs, can facilitate the degradation of resistant
TrOCs in HR-EMBR. Importantly, HR-EMBR will produce high quality TrOC-free effluent
without an additional post-treatment process. In light of the discussion above, literature review is
structured accordingly in four different sections. In Section 2.2, recent occurrences and fate of
TrOCs in surface water, groundwater and seawater are systematically presented and discussed. In
addition, the factors influencing the occurrence of TrOCs in different environmental systems are
elucidated. Section 2.3 discusses the performance of biological processes (such as conventionaland HR-MBRs), and critically analyses the factors governing the removal of TrOCs. Section 2.3
is critical to understand the fate of TrOCs during biological treatment, and it facilitates in
identifying the research gaps that led to the development of enzymatic-MBRs. In Section 2.4,
performance of WRF and their ligninolytic enzymes for TrOC removal is critically evaluated.
TrOC removal by enzymatic membrane bioreactor (EMBR) is particularly discussed, and the role
of membrane in removal is elucidated. In addition to exploring the efficiency of enzymatic
degradation, this thesis explores the combined application of enzymatic and emerging advanced
oxidation processes (AOPs). In line with this, performance of emerging AOPs such as persulfate
oxidation process is reviewed and presented in Section 2.5.

2.2. Trace organic contaminants (TrOCs)
A broad spectrum of organic compounds has become an integral part of our daily life. These
compounds are used in immense quantities for a variety of purposes including industrial processes,
food production and preservation as well as for the healthcare of human and animals [1-3].
Occurrence of these compounds in environmental systems has become a topic of growing interest
over the last decade due to their potential detrimental impacts on both aquatic life and human
health [4, 5]. Among these compounds, TrOCs, also known as emerging organic pollutants, are of
particular interest due to their widespread occurrence in wastewater as well as in different
environmental systems such as groundwater, surface water and seawater. TrOCs from both natural
and anthropogenic sources can be divided into different categories including pharmaceuticals,
personal care products, pesticides, industrial chemicals, steroid hormones and food preservatives
[6, 7]. Concentration of TrOCs in environmental system could be very low (i.e., in the range of a
few µg/L to ng/L). This not only affects the analytical procedures associated with their detection
[8], but may also influence the efficacy of water and wastewater treatment processes.
Conventional wastewater treatment plants (WWTPs) have not been designed for effective TrOC
removal [9]. Following the discharge of the treated effluent, TrOCs may induce ecotoxicity and
endocrine disrupting effects in an aquatic ecosystem [10-14]. Although occurrence, fate and
impacts of TrOCs have been extensively studied in last 15 years, their environmental significance
is still not fully understood. Different organizations including the World Health Organization
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(WHO), the European Union (EU), the International Program of Chemical Safety (IPCS) or the
North American Environmental Protection Agency (EPA) have realized these issues and are
developing legal frameworks to protect environmental systems, particularly freshwater sources
[15]. A wealth of studies have been published in the last decade on the occurrence of TrOCs in
surface water [8, 16, 17] and groundwater [18], as well as their fate in biological and
physicochemical treatment processes [6, 9, 16]. In this section, recent occurrences and fate of
TrOCs in surface water, groundwater and seawater are systematically presented and discussed. In
addition, the factors influencing the occurrence of TrOCs in different environmental systems are
elucidated.

2.2.1. Occurrence of TrOCs in environmental systems
With ever growing population, pharmaceutical production for human use has increased many folds
in recent years [19, 20]. According to one estimate, thousands of new pharmaceuticals are being
invented every year [21]. Per capita consumption of pharmaceuticals in developing countries
varies from 50-150 g/year. However, worldwide average of pharmaceutical consumption is on the
lower side (15 g/capita.year) due to their less consumption in developed countries [22]. Upon
consumption, pharmaceuticals and animal medicines are excreted into the wastewater, making it
the most significant source of TrOC in environmental systems [23]. Similarly, other sources of a
broad spectrum of TrOCs and their intermediates in different environmental systems include but
are not limited to hospital wastewater, industrial effluents, aquaculture and livestock activities,
solid waste dumping and agricultural runoff [18, 24, 25]. Notably, domestic use of pharmaceuticals
and personal care products remains the largest contributor of TrOC contamination in wastewater
and subsequently in environmental systems. Sources and pathways of TrOCs in the surface water,
groundwater and seawater are shown in Figure 2.1. Domestic, industrial and hospital wastewater
in addition to the effluent from combined sewage treatment plant are the examples of point source,
and TrOC loading from these sources can be measured and monitored. On the other hand, diffuse
sources such as urban/agriculture/livestock runoff, biosolids, artificial recharge and leachate
originating from a large geographical area cannot be quantified accurately (Figure 2.1).
Uncertainty of TrOC loading in the freshwater and seawater sources originating from diffuse
sources is the major challenge to measure, assess, control and monitor their detrimental impacts
[1, 18, 26].
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Figure 2.1. Sources and pathways of TrOC contamination in freshwater and seawater. Data
source: [1, 18, 26]. “AR”: artificial recharge

2.2.2. Wastewater
Reported concentrations of TrOCs in the influent and effluent of WWTPs summarized in Table
2.1 indicate significant variations among the selected compounds. Variations in the influent
concentration of TrOCs can be attributed to several factors such as the production rate, annual
sales, excretion rate, agricultural practices and average daily water consumption per person. On
the other hand, effluent concentration of TrOCs may vary, depending on the relevant
environmental regulations and effectiveness of WWTPs. Since most of the operational WWTP
were not designed for effective TrOC removal, poor TrOC removal is not entirely unexpected [27,
28]. According to Table 2.1, influent concentration of TrOCs varies between 1 and 10 µg/L, while
the concentration of some pharmaceuticals such as atenolol, caffeine, naproxen and diclofenac,
one industrial chemical (DEHP), one pesticide (triclosan) and one surfactant (nonylphenol) is
relatively high (up to 1 mg/L) in raw wastewater. TrOCs with high concentration in raw wastewater
are mostly pharmaceuticals, probably because of their elevated production amounts and
use/consumption in our daily life. It is important to note that the prescription may not be required
for a few pharmaceuticals such as ibuprofen and caffeine. Thus, their occurrence at high
concentration can be attributed to the ease of accessibility.
Concentration of steroid hormones has been reported to be generally low (<1 µg/L) in raw
wastewater (Table 2.1). Average excretion rate for steroid hormones ranges between 0.4 and 81
µg/capita.day (Table 2.1). Effluent concentration of most TrOCs in WWTP varies from 1 to 10
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µg/L and governed by the efficacy of WWTPs. However, a few TrOCs such as acetaminophen,
caffeine, DEHP, atenolol and triclosan are discharge into water bodies at high concentrations (up
to 40 µg/L) due to their abundance in wastewater and/or their persistence to conventional
wastewater treatment process. Steroid hormones are generally well removed in conventional
WWTPs, but their very low concentration (up to 1 ng/L) is enough to induce estrogenic effects in
aquatic life [29].
In general, production of TrOCs and their use/consumption pattern in a country govern the level
TrOC contamination in wastewater. Many studies have correlated the concentration of
pharmaceuticals in wastewater with their production as well as with the population of a country.
For instance, Kasprzyk-Hordern et al. [23] and Choi et al. [30] studied the occurrence of
pharmaceuticals such as acetaminophen, carbamazepine, sulfamethoxazole, codeine in the
wastewater of UK and Korea, respectively. They observed that the concentration of
pharmaceuticals in wastewater followed the production rate of these TrOCs in their respective
countries. However, a few studies reported that the concentration of some TrOC in wastewater did
not correlate well with population and their production rates [31, 32], possibly because TrOCs can
find their way into wastewater steams from other sources such as storm water runoff a (Figure
2.1). Since pharmaceuticals require oral ingestion, their occurrence in domestic wastewater also
depends on their excretion through urine and feces. Excretion rate of ibuprofen, carbamazepine,
naproxen, clofibric acid and gemfibrozil is generally low (1-10%). On the other hand, the highest
excretion rate (>70%) has been reported for paracetamol and atenolol (Table 2.1). However, it is
important to note that high or low excretion rate does not necessarily mean high or low
concentration of these TrOCs in wastewater. In addition to the ambient environmental conditions,
outbreak of a certain disease in a community could also influence the concentration of
pharmaceuticals and personal care products in raw wastewater. Moreover, concentration of
pesticides in wastewater could be influenced by seasonal variations [16, 33]. Similarly, rainfall
effects the flow pattern of wastewater in combined sewerage system, resulting in the change of
wastewater composition containing TrOCs. For instance, Kasprzyk-Hordern et al. [23] observed
an increase (up to 2 folds) in the concentration of pharmaceuticals in domestic wastewater during
dry weather conditions, as compared to rainy season.
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Table 2.1. Occurrence of a wide range of TrOCs in wastewater. The range of influent
concentration, effluent concentration and removal efficiency of TrOCs is presented. Excretion
rates of pharmaceuticals and steroid hormones are also given. Data is extracted from [16, 17, 29,
34].
Category

Pharmaceuticals
β-blocker

Compounds

Atenolol
Metoprolol
Propranolol
Sotalol

Analgesic and
anti-inflammatory

Acetaminophen

Anticonvulsant
Lipid regulator

Diclofenac
Ibuprofen
Ketoprofen
Mefenamic acid
Naproxen
Salicylic acid
Carbamazepine
Bezafibrate
Clofibric acid
Gemfibrozil
Erythromycin
Sulfamethoxazole
Trimethoprim
Caffeine

Antibiotic

Nervous stimulant
Personal care
products
Musk fragrance
Disinfectant
Insect repellant
UV filter
Steroid hormone

Galaxolide
Tonalide
Triclosan
DEET
Benzophenone
Estrone (E1)
Estradiol (E2)
17αEthynylestradiol
(EE2)
Estriol (E3)

Excretion
rate

Concentration (µg/L)

Removal
efficiency

(%)

Influent

Effluent

(%)

50-95
5-30
2.5-10
0-17.5

0.14-35.1
0.019-1.48
0-0.5
0.320-0.711

0.33-7.60
0.003-0.30
0.30-0.71
0.21-0.24

0-80
3-56
40-45
25-35

≤5

5.64-44

21-70

0-0.03

0.5-39
5-10
≤0.5
3-5
40-69
≤6
≤1
5-25
20
≤39
1-5

0.001-90.5
0.004-590
0.004-9.01
0.015-1.15
<0.01-50.7
0.58-65.4
0.035-3.8
0.05-1.39
0-0.74
0.10-17.1
0.14-10.0
<0.01-0.98
0.06-6.80
0.22-209

<0.001-0.69
0-55
<0.001-3.42
0.005-0.40
0.002-5.1
0-0.54
<0.01-4.50
0.03-0.67
ND-0.33
<0.01-5.24
0.02-2.84
<0.01-1
<0.01-3.05
0-43.50

0-81
70-100
10-100
0-75
43-99
90-100
0-65
10-70
0-93
0-90
0-82.
15-90
0-80
50->99

-

0.03-25
0.05-1.93
0.03-23.9
2.56-3.19
0.079-0.90

0.06-2.77
0.05-0.32
0.01-6.88
0.61-15.8
0.079-0.23

85-88
80-85
71->99
66-80
64-98

19 a
7.7 a

0.01-0.17
0.002-0.05

0.001-0.08
0.001-0.007

75-90
93-100

0.41 a

0.001-0.003

81 a

0.125-0.80
21

0.001-0.002
0

45-100
100

Category

Compounds

Excretion
rate

Nonylphenol
Octylphenol

-

0.03-101.6
0.2-8.7

0.03-7.8
0.004-1.3

25-99
0-95

Bisphenol A
DBP
DEHP
DMP
TCEP
TCPP

-

0.013-2.14
0-11.8
0.003-70.0
0-6.49
0.06-0.50
0.18-40.

0.03-1.10
0-4.13
0.0001-54.0
0-1.52
0.06-2.40
10-21

65-99
75-80
25-97
85-95
0
0

-

0.02-28
0.03-1.96
0-0.684
0.012-0.08
0-1.89

0.004-0.73
0.002-2.53
0.0007-4.16
ND-0.005
0.0005-0.69

0-25
25-70
0
85-95
0-60

Concentration (µg/L)

Removal
efficiency

Surfactants

Industrial
Chemicals
Plasticizers

Fire retardant
Pesticides
Herbicide

Atrazine
Diuron
Diazinon
Fungicide
Clotrimazole
Insecticide
Tebuconazole
“–“: not available; ND: not detected
a
µg/capita.day

2.2.3. Surface water
Compared to other sources (Figure 2.1), major source of TrOCs in surface water has been reported
to be the discharge of the treated effluent from WWTPs [17, 35]. After the discharge of TrOCs
into freshwater bodies, different natural attenuation processes such as photolysis, aerobic
biodegradation, sorption onto sediments and dilution play an important role. However, in-stream
attenuation rate varies for each process, and is dependent on the physicochemical characteristics
of TrOCs and local environmental conditions. For instance, Kunkel and Radke [36] observed
different attenuation rates for 10 pharmaceuticals in a river, and the physicochemical properties
were credited for these variations. Similarly, while investigating the relationship between natural
attenuation rates and physicochemical properties of 225 TrOCs [37], high attenuation rates were
obtained for: (i) compound having medium to low volatility (−4<log Kaw<−2); and (ii) hydrophilic
compounds (0<Kow<4.5). By contrast, Acuñaet al. [38] did not observe any meaningful correlation
between attenuation rate and physicochemical properties of TrOCs. Hence, more studies are
needed to understand the factor affecting the natural attenuation of TrOCs in environmental
systems.
Photolysis is an important natural attenuation process for TrOCs in surface water bodies. However,
Kunkel and Radke [36] found that some TrOCs such as bezafibrate, metoprolol and naproxen
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could not be attenuated via photolysis. Despite the efficacy and rapidness of photolysis process,
resultant transformation byproducts could be toxic and resistant to further photolysis or
biodegradation. For instance, Donner et al. [39] showed that the transformation byproducts formed
during photolysis were more toxic than their parent compound (i.e., carbamazepine). Water
dilution and sorption onto sediments also contribute in attenuating a wide range of TrOCs.
Significance of water dilution can be realized from the fact that high concentration of TrOCs in
surface water bodies has been reported during dry weather [40, 41]. Concentration of TrOCs in
surface water was less in samples collected during summer season than those collected during
winter season [42]. Enhanced biodegradation rate due to high temperature in summer and/or
elevated wetter summer season could be another reason of relatively lower TrOC concentration in
summer than winter [42]. Rainfall, in some cases, can also contribute as a source of TrOCs in
surface water bodies. This is because they can leach from municipal solid waste dumping sites
during the rainfall and ends up in either combined sewerage system or surface water bodies [43,
44].
Contamination of surface water bodies with pesticides may depend on the characteristic of
receiving water body such as: flows rate and depth; distance from land; soil characteristics; and
crop type [45]. While studying the pathways of TrOCs for Swist river basin (Germany),
Christoffels et al. [44] detected the presence of pharmaceuticals in combined sewer overflows, and
they also observed the presence of fungicides and insecticides in the runoff originating from an
orchard, thus, highlighting the significance of diffuse sources for TrOCs. Figure 2.2 illustrates the
variations in the concentration (ng/L) of each class of TrOCs from recent studies. Pharmaceuticals
are the most commonly detected class of TrOCs followed by industrial chemicals. Nonsteroidal
anti-inflammatory drugs (NSAIDs) such as acetaminophen, diclofenac and ibuprofen are the most
frequently detected subclass of pharmaceuticals in surface water.
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Figure 2.2. Variations in the concentration (ng/L) of TrOCs in surface water bodies. Box plots
represents interquartile range, median (horizontal line), min and max (whiskers), and average
(black and white square box). Number of data points for each class/subclass is given in brackets
on the x-axis. NSAIDs: Nonsteroidal anti-inflammatory drug; ALR: Anticonvulsant and Lipid
regulator; and PCPs: Personal care products. Data is extracted from [46-54].
Average concentration of pharmaceuticals varies from 75 to 140 ng/L (Figure 2.2) and the highest
average concentration (140 ng/L) is observed for NSAIDs possibly due to their abundance in
domestic wastewater (Table 2.1). On the other hand, average concentration of industrial chemicals
(1150 ng/L) and personal care products (410 ng/L) in surface water is alarmingly high.
Concentration of steroid hormones ranges from 1 to 10 ng/L, and is high enough to induce
estrogenic effects [50].

2.2.4. Groundwater
Groundwater is the major source of freshwater for domestic and industrial use in many countries.
It constitutes approximately 30% of total freshwater resources in this world. Since 70% of
freshwater resources are frozen, groundwater represents 97% of freshwater available for human
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use [55]. It also suggests that groundwater is key for sustainable water supplies in the world.
Despite the high attenuation of some TrOCs in soil strata, some studies confirmed the presence of
TrOCs in groundwater, making it an issue of significant concern [18, 56-58]. Currently, the
occurrence of TrOCs in groundwater has been well documented only for Europe and America [56,
58-61]. Concentration of TrOCs may not be as high as in surface water bodies but still more
emphasis is needed to characterize them better in other parts of the world.
TrOCs can contaminate groundwater from variety of sources such as wastewater, contaminated
surface water, landfill leachate, artificial recharge, percolation of agriculture/storm water runoff
and leakages from sewers and septic tanks (Figure 2.1). Concentration of TrOCs from septic
tank/sewer leakage and landfill leachate generally varies from 10 to 104 and 10 to 103 ng/L,
respectively, making them the major sources of groundwater contamination. Application of
pesticides in agriculture lands may contaminate groundwater because they can percolate down
with irrigation water [62]. After the discharge of WWTP effluent containing TrOCs in surface
water bodies, TrOCs can also find their way into groundwater due to lateral and vertical hydraulic
exchange [63]. For instance, Gasser et al. [64] reported the transfer of TrOCs from surface water
to groundwater by using carbamazepine as a marker. Artificial recharge (AR) using surface and
reclaimed water is another source of TrOCs in groundwater, especially when the reclaimed water
has poor quality and residence time in soil is short. Common AR processes include but are not
limited to well injection and river bank filtration [65]. TrOCs during the river bank filtration of
WWTP effluent could find their way into shallow groundwater aquifer, and the concentrations of
a few compounds such as carbamazepine and sulfamethoxazole were reported to be above 20 ng/L
in groundwater along the bank of the stream [66].
TrOCs pass through subsurface and unsaturated zone before reaching the groundwater. During the
transfer of TrOCs in soil, natural attenuation helps to reduce their concentration [67]. Attenuation
of TrOCs in underground environment is possible via: (i) adsorption; and (ii) biodegradation.
Physicochemical properties of TrOCs such as hydrophobicity, molecular weight and chemical
structure governs their adsorption on soil strata. TrOCs with octanol–water partition coefficient
(KOW) of less than 1.5 tend to be highly mobile and are more likely to be detected in groundwater
[68]. For instance, sulfamethoxazole (log KOW=0.9) and caffeine (log KOW=-0.07) have been
commonly detected in groundwater due to their poor adsorption on soil [18]. A few TrOCs such
as triclosan (log KOW= 4.76) are only adsorbed by both silt loam and sandy loam soil, while a few
TrOCs such as caffeine (log KOW=-0.07) are only adsorbed by sandy loam soil. These results
suggest that caffeine is more likely to reach groundwater than triclosan. Teijón et al. [69] found
that low sorption potential of naproxen on sandy loam material with low organic content resulted
in its ubiquitous occurrence in sandy loam aquifer. It also suggests that properties of TrOCs and
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soil characteristics both govern the mobility of compounds in soil. Occurrence of TrOCs such as
pharmaceuticals and personal care products in the soil of different countries along with their
physicochemical properties is presented in Table 2.2. Concentration of a few TrOCs such as
triclosan and ibuprofen is up to 35.5 µg/Kg due to high sorption capacity (log Kow > 3). Despite
having poor sorption coefficient (log Kow > -0.9), concentration of oxytetracycline was 9.6 µg/Kg
in the soils of China. It validates that other factors such as soil properties may also influence the
occurrence of TrOCs in soil. Moreover, oxytetracycline, ibuprofen and triclosan in soil exceeds
the predicted no effect concentration (PNEC) of these TrOCs in the soil of China and Mexico. In
Europe, TrOCs with a log Kow value of greater than 4 are considered an environmental risk [70].
It is believed that degradation of TrOCs is faster in aerobic conditions than anaerobic conditions,
probably due to the difference in aerobic and anaerobic microbial communities [71]. Degradation
of TrOCs in groundwater is generally poor and/or incomplete due to the unavailability of diverse
microbial species in groundwater. However, while investigating the degradation of 27
pharmaceuticals under oxic and anoxic conditions, Burke et al. [72] reported effective degradation
of some TrOCs such as propyphenazone, doxycycline and phenazone only in oxic conditions. On
the other hand, some TrOCs including clindamycin, roxithromycin and clarithromycin were only
degraded in anoxic conditions. Increase in temperature during summer season could facilitate the
removal of a few TrOCs such as iopromide, metoprolol, and diclofenac in the hyporheic zone [73].
These observations presented here suggests that environmental parameters and redox conditions
influence the degradation of TrOCs.
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Table 2.2. Occurrence (µg/Kg) of some TrOCs in the soil of different countries. Data is extracted from [18, 74-79]
Compounds

Class/Use

Concentration (µg/Kg)
USAa

Chinab

Mexicoc

Malaysiad

Indiae

Log Kow

PNEC (µg/Kg)

Carbamazepine

Anticonvulsant

ND-1.4

0.02-0.06

0.1-16.4

-

-

2.45

48.6

Trimethoprim

Antibiotic

ND-0.64

0.64-2.15

-

3.1-60.1

-

-

-

Ibuprofen

NSAID

-

1.51-5.03

ND-0.3

-

-

3.97

3

Diclofenac

NSAID

-

0.35-1.16

<0.1

-

-

4.51

735

Sulfadiazine

Antibiotic

-

1.15-16

ND

-

-

0.28

-

Triclosan

Personal care product

ND

n.d-16.7

0.4-35.5

-

-

4.8

3.74

Oxytetracycline

Antibiotic

-

ND-9.6

-

-

-

-0.9

0.3

Norfloxacin

Antibiotic

-

61.9

-

-

0.011

1.03

47-12611

Salicylic acid

NSAID

-

4.5

-

-

-

2.26

2079

Ciprofloxacin

Antibiotic

-

-

-

0.014

3.1

248915

Ofloxacin

Antibiotic

-

-

-

0.019

-0.39

569

Naproxen

NSAID

3.18

2357

-

-

0.20-2.40

-

-

ND: not detected; NSAID: Nonsteroidal anti-inflammatory drug; Kow: Octanol-water portioning coefficient; PNEC: Predicted no-effect
concentration; and “–“: not reported

27

Box and whisker plot (Figure 2.3) for the five classes of TrOC shows that pharmaceuticals are
most commonly detected in groundwater, followed by the ingredients of personal care
products. Average concentration of pharmaceuticals ranged from 100 to 1000 ng/L.
Pharmaceuticals are of particular interest because of their widespread occurrence in wastewater
and surface water (see Table 2.1 and Figure 2.2). Concentration of pesticides and personal
care products is on the higher side (above 100 ng/L) in groundwater (Figure 2.3) as compared
compared to surface water. This difference is because some studies reported the occurrence of
TrOCs in the vicinity of a landfill site and septic tank [56, 80]. Concentration of steroid
hormones is generally low (less than 10 ng/L) except for one study that reported a 17αethynylestradiol concentration of 1500 ng/L [32].
100000

10000

Concentration (ng/L)

1000

100

10

1

0.1

Pesticides (5)

Industrial chemicals (8)

Steriod hormone (9)

PCPs (13)

Nervous stimulant (9)

Antibiotic (36)

NSAIDs (44)

ß Blockers (6)

ALR (38)

Pharmaceuticals

0.01

Figure 2.3. Variations in the concentration (ng/L) of TrOCs in groundwater. Box plots
represents interquartile range, median (horizontal line), min and max (whiskers), and average
(black and white square box). Number of data points for each class/subclass is given in brackets
on the x-axis. NSAIDs: Nonsteroidal anti-inflammatory drug; ALR: Anticonvulsant and Lipid
regulator; and PCPs: Personal care products. Data is extracted from [56, 57, 81-87].

2.2.5. Seawater
According to one estimate, one fifth of the world population lives in coastal areas. 21 out of 33
megacities of the world such as Mumbai (India), Guangzhou (China) and New York (USA)
are situated in coastal areas [88]. Corcoran [89] estimated that above 80% untreated wastewater
in coastal areas is discharged in to oceans without any treatment. Septic tanks are used for
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wastewater collection in many Asian countries, and wastewater is subsequently released to
coastal waters without any treatment [90]. A few cities such as Los Angeles discharge their
treated effluent into oceans via marine outfalls [91, 92]. Following disposal in freshwaters,
treated effluent also ends up in oceans, thereby putting an additional load of TrOC in seawater.
According to one estimate, 150 tons of pharmaceuticals are received by the ocean via Yangtze
River in China [93]. Ships, cruise liners and boats discharge their treated effluent in oceans
[94]. Moreover, leachate from the landfill sites in coastal areas could also contaminate oceans.
For instance, Rodríguez-Navas et al. [95] reported that the leachate from a landfill site situated
in Mallorca Island (Spain) is adding 27 µg/L of pharmaceuticals in ocean on daily basis.
Aquaculture is one of the largest industry of the world, and more than 500 million people are
associated with this industry [96]. A range of pharmaceuticals are used in aquaculture activities
to prevent the outbreak of diseases. According to one estimate, more than 75% of the
pharmaceuticals used during aquaculture find their way into oceans via food pellets and
excretion [97]. Like surface water and groundwater, other sources of TrOCs in oceans include
surface runoff, agriculture runoff and leaching from domestic/hospital waste [98, 99].
Unlike freshwater, occurrence and fate of TrOCs in oceans has been investigated only recently
as >70% of the studies dealing with this topic are published in last ten years. However, more
investigations are required for many parts of the world, especially South America, Asia and
Africa. Interestingly, there is only one study reporting the occurrence of TrOCs in India, the
2nd largest population of the world [100]. Pharmaceuticals have been the most commonly
reported class of TrOCs, while data availability is very limited for other classes such as personal
care products, industrial chemical and pesticides. Scope of the studies included in this section
varies significantly. Some studies deal with a particular class of TrOCs [101], while others
focus on the development of detection methods and validation [102]. Occurrence of TrOCs in
oceans is presented in Figure 2.4, which shows that pharmaceuticals have been commonly
detected. Among pharmaceuticals, NSAIDs are ubiquitously detected followed by ALR.
Concentration of pharmaceuticals ranged from 1 to 1000 ng/L, while the concentration for
other classes ranged from 0.1 to 1000 ng/L. It is also observed that the concentration of TrOCs
is usually greater than the predicted no-effect concentration (PNEC) of 10 ng/L.
Dilution and adsorption are the two natural attenuation process in oceans. However,
concentration of a few TrOCs such as ketoprofen, gemfibrozil and caffeine can be higher than
PNEC, suggesting that dilution could not reduce the concentration of TrOCs to acceptable
levels. For instance, concentration of gemfibrozil (77–758 ng/L) and ketoprofen (185–805
ng/L) was higher than their PNEC value of 10 ng/L in the coastal waters of Costa Rica.
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Figure 2.4. Average concentration (ng/L) of the five major classes of TrOCs in sea and coastal
waters. Box plots represents interquartile range, median (horizontal line), min and max
(whiskers), and average (black and white square box). Number of data points for each
class/subclass is given in brackets on the x-axis. NSAIDs: Nonsteroidal anti-inflammatory
drug; ALR: Anticonvulsant and Lipid regulator; and PCPs: Personal care products. Data is
extracted from [103-108].
Adsorption of TrOCs in marine environment is influenced by acid dissociation constant (pKa)
and pH of the seawater because these factors can change the octanol-water partition coefficient
(log Kow) of TrOCs. For instance, log Kow of propranolol and fluoxetine was observed to
increase linearly with pH [109, 110]. Similarly, typical pH=8 of seawater facilitates the
lipophilicity of ionisable TrOCs onto marine sediments and marine organisms. For instance,
McEneff et al. [111] reported incomplete dissociation of trimethoprim (pKa= 6.6) in marine
environment. In some studies, log D has been used to predict the adsorption/sorption of TrOCs
onto marine sediments/biota. For example, Fu et al. [112] observed that TrOCs with high log
D (>3) are more likely to adsorb onto marine sediments. Occurrence of a few commonly
detected TrOCs onto marine sediments and marine biota is presented in Table 2.3.
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Table 2.3. Occurrence of commonly detected TrOCs in marine sediments and marine biota
[113].
Compounds
17β – estradiol
17α – ethinylestradiol
Trimethoprim
Tetracycline
Sulfamethoxazole
Diclofenac
Naproxen
Ibuprofen
Acetaminophen
Atenolol
Propranolol
Clofibric Acid
Gemfibrozil
Caffeine
Simvastatin
Triamterene
Carbamazepine
“-“: not reported

Marine sediments
(ng/g)
11–63
0.15–130
0.1–734000
0.6–7.1
0.4–820000
0.1–10
0.6–15.8
98–100
0.1–25.5
0.1–0.3
0.1–0.9
0.1–0.1
0.1–0.9
1.9–12.2
2–4
0.3–10.8
0.1–88.8

Marine biota
(ng/g)
2.9–11.4
3– 38
0.6
1.9–9.5
2.3-20
1.3–5.3
0.3–13
-

2.3. TrOC removal by biological treatment processes
As discussed above in Section 2.2, TrOCs are ubiquitously detected in municipal wastewater,
industrial wastewater, hospital wastewater and landfill leachate. Due to their ineffective
removal by WWTPs (Table 2.1), widespread occurrence of TrOCs has been reported in
freshwater bodies [46-54]. Concentrations of TrOCs in the effluent of WWTPs and sewageimpacted waterbodies range between hundreds of nanogram per litre (ng/L) and tens of
microgram per litre (μg/L) [114, 115]. Even at the reported trace concentrations, several
categories of TrOCs (e.g., pharmaceuticals) are biologically active compounds, and cause acute
and/or chronic ecological risks such as: (i) interference with the endocrine systems of the
aquatic life; and (ii) accumulation in plants and animals. Thus, effective removal of TrOCs,
particularly from municipal wastewater is essential for safe disposal of WWTP effluents.
Among different physicochemical and biological treatment processes investigated over the last
few decades [116, 117], biological treatment processes, particularly conventional activated
sludge (CAS) and membrane bioreactor (MBR) have been by far the most commonly
investigated processes. Physicochemical treatment processes such as coagulation-flocculation,
advanced oxidation processes (AOPs) and membrane separation processes (e.g., nanofiltration,
forward osmosis, and membrane distillation) have also been assessed for TrOC removal [16,
118].
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Biodegradation is the dominant mechanism of TrOC removal in CAS-based biological process.
During biological treatment, microorganisms convert and/or biomineralize TrOCs into simple
organic and/or inorganic molecules (carbon dioxide and water). Microorganisms generate
energy by utilizing organic compounds as a primary source of food. A part of this energy is
used by the microorganisms for their cell growth, and the remaining energy is used for cell
maintenance [119]. Since some TrOCs such as antibiotics and pesticides can be toxic to
microorganisms, an additional growth substrate may be required to maintain microbial growth
and diversity for adequate biodegradation. This process of adding an additional substrate is
known as ‘cometabolism’ [120, 121]. In this section, performance of biological processes (such
as conventional- and HR-MBRs) are discussed, and the factors governing the removal of
TrOCs is critically analysed. This section is critical to understand the fate of TrOCs during
biological treatment, and it facilitates in identifying the research gaps that led to the
development of enzymatic-MBRs

2.3.1. TrOC removal by CAS process
In the CAS process, growth of microorganism takes place in an aeration tank under aerobic
conditions. Among other conventional biological processes, the CAS process is the most
widely applied treatment process for the treatment of municipal wastewater [122]. Although
CAS-based WWTPs have not been designed for effective TrOC removal, it can achieve above
80% removal for some specific groups TrOCs such as bisphenol A, caffeine and surfactants.
Several different mechanisms such as photolysis, volatilization, biodegradation and sorption
onto activated sludge have been reported to contribute in TrOC removal, but major portion of
these compounds are removed via biodegradation. The extent of TrOC removal depends on
their physicochemical properties of TrOCs and operational parameters of the CAS process
[123, 124]. This aspect is comprehensively discussed in Section 2.3.3.4. Performance of the
CAS process for the removal of 86 TrOCs categorized based on their use/class is presented in
Figure 2.5, indicating a wide range of variation.
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Figure 2.5. Removal of different categories of TrOCs by an CAS-based treatment process. Data presented as average ±standard deviation. Data is
extracted from [125, 126].
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The CAS process can achieve greater than 95% removal for all the selected surfactants.
Effective removal of surfactant by the CAS process has been attributed to both sorption onto
the activated sludge and biodegradation [122]. Margot et al. [127] reported that biodegradation
remained the dominant mechanism of removal for surfactants. However, notably, they
observed that sorption is mainly responsible for the removal of a cationic surfactant, namely
dialkyldimethylammonium chloride [127].
All the EDCs are shown separately in Figure 2.5, because they can be harmful even a very low
concentration. Of the 23 EDCs, complete elimination of four EDCs, namely 2-OHE1, a-OHE1,
androstenedione and androsterone has been reported following treatment with the CAS
process. Average removal of the remaining EDCs ranges from 75 to 90% except for the one
syenthetic estrogen D-equilin (less than 5%) [128]. Due to their simple chemical structure, high
sorption potential and biodegradability, EDCs are either adsorbed onto activated sludge or
biodegraded by the activated sludge [123, 129]. According to the available literature,
availability of dissolved oxygen is one of the key factors for effective EDC removal. For
instance, Furuichi et al. [130] reported better removal of EDCs under aerobic conditions as
compared to anaerobic conditions.
The CAS process has been reported to achieve significant removal (70-95%) for several PCPs
such as methyl dihydrojasmonate, methylparaben, oxybenzone, galaxolide, tonalide and
salicylic acid. Although removal of DEET, cashmeran, celestolide and 2,4-D is not as high as
others TrOCs in this category, the CAS process can still achieve up to 60% removal. Notably,
sorption was reported to be the dominant mechanism for PCPs with above 70% removal in the
CAS process. Indeed, Margot et al. [127] estimated that the contribution of sorption in the
overall removal of two PCPs (galaxolide and tonalide) can be as high as 80%. Removal of
pesticides in the CAS process has been reported to range between 50 and 60% (Figure 2.5).
Among the selected pesticides, atrazine is the most recalcitrant pesticide and was poorly
removed (25%) by the CAS process (Figure 2.5).
Reported removals for different classes of pharmaceuticals such as beta-blockers, NSAIDs and
antibiotics indicate that there is no apparent correlation in their removal. Beta-blockers such as
atenolol and propranolol were poorly removed (<25 %) by the CAS process. Although atenolol
and propranolol contain an electron donating group (EDG), their hydrophilic nature and poor
affinity for biosolids could be the reason of their poor biodegradation in CAS process [124].
Among analgesics and anticonvulsants pharmaceuticals (Figure 2.5), ibuprofen, naproxen, and
paracetamol were well removed (>70%) by the CAS process, probably because their chemical
structure contains strong EDGs. Similarly, removal of a few antibiotics, namely ciprofloxacine,
norfloxacin and ofloxacin as well as a few NSAIDs such as gemfibrozil and clofebric acid has
been reported to be ranged between 50-60% in the CAS process. All nervous simulants and
metabolites were observed to be completely removed (95-99 %) in the CAS process (Figure
2.5). In general, highly polar pharmaceuticals containing EWGs such as carbamazepine,
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diclofenac, primidone and erythromycin are resistant to the biodegradation by the activated
sludge in the CAS process and cannot be biodegraded by microorganisms. In addition, these
TrOCs have the tendency to inhibit microbial activity [122, 131, 132]. Although it is difficult
to classify the TrOC removal based on different categories, removal trends (Figure 2.5) can be
written as follows: surfactants > nervous stimulants > metabolites > EDCs > personal care
products > pesticides > pharmaceuticals except metabolites and stimulants.

2.3.2. TrOC removal by MBR
Membrane bioreactor (MBR) is considered as an effective improvement of the CAS process
due to its robust and compact design as well as excellent effluent quality [133-135]. In
conventional MBR, activated sludge is responsible for the degradation of the pollutants such
as bulk organics, nutrients and TrOCs, while micro- or ultra-filtration (MF/UF) based
membrane separation process effectively retains the activated sludge within the bioreactor
[136-138]. Conventional MBR can achieve efficient aqueous phase removal of bulk organics
from wastewater [139-141]. As far as TrOC removal is concerned, MBR may achieve better
removal for certain groups of TrOCs as compared to the CAS process, possibly due to high
concentration of the mixed liquor suspended solids (MLSS) and long solids retention time
(SRT) [16, 124, 142]. MBR has been investigated extensively for the removal of TrOCs in the
last decade, and its performance for the removal of TrOCs is shown in Figure 2.6. TrOCs are
arranged in their respective class such as EDCs, pesticides and antibiotics. It is interesting to
note that removal of some TrOCs such as fenoprop, triclosan, atenolol and carbamazepine
varies from one study to another possibly due to different operating and environmental
conditions.
Like the CAS process (Figure 2.5), average removal efficiency for EDCs is generally high and
ranges from 80 to 99% in MBR. Above 90% removal has been observed to be achieved by
MBR for two PCPs namely salicylic acid and octocrylene, while the removal for other personal
care products range between 50 and 70%. As expected, pesticides have not been effectively
removed by MBR except for triclosan and 2, 4-D. Atrazine was the most poorly removed
compound with removal of less than 25% among all pesticides, while triclosan removal could
be as high as 99% (Figure 2.6). Although different classes of pharmaceuticals showed TrOCspecific removal, removal of beta blockers and NSAIDs range from 70 and 90%. Some
pharmaceuticals such as carbamazepine, trimethoprim and roxithromycin are poorly removed
(<50%) in MBR. Compared to the CAS process (Figure 2.5), approximately 10-20%
improvement in the removal of pharmaceuticals could be achieved in MBR.
Similar to other biological processes, removal of TrOCs in biological systems is also influenced
by operational parameters and physicochemical properties of TrOCs such as chemical structure
and hydrophobicity [124] as explained in Section 2.3.3.4. General trend in MBR based on
different TrOC categories is as follows: EDCs > stimulants > NSAIDs > Analgesics > PCPs >
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Antibiotics > beta-blokers > pesticides. Despite the effectiveness of MBR for the removal of a
broad spectrum of TrOCs, knowledge is limited to understand the compound specific removal
mechanisms and degradation pathways in addition to the fate of byproducts and their impacts
on microbial communities [122, 124, 143, 144].
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Figure 2.6. Removal of different categories of TrOCs by MBR. Data presented as average
±standard deviation. Data is extracted from [125, 126].

2.3.3. TrOC removal by high retention (HR)-MBR
Ineffectiveness of the CAS process and conventional MBR for the removal of certain groups
of TrOCs is a significant concern. For effective removal of TrOCs, high retention membrane
separation processes such as nanofiltration (NF)/reverse osmosis [145, 146] and membrane
distillation [147-149] have been combined with conventional MBRs as a post-treatment step.
To avoid an additional high retention membrane separation process, the high retention (HR)MBRs have been developed, which can achieve TrOC retention by membrane and subsequent
biodegradation in a single step for the production of high quality effluent suitable for water
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reuse applications [150]. HR-MBR combines the high retention membranes such as
nanofiltration (NF), forward osmosis (FO) or membrane distillation (MD) with an activated
sludge process. Available studies report that HR-MBR provides effective removal of a wide
range of TrOCs and can produce high quality TrOC-free effluent stream [151, 152]. One of the
underlying rationales for the development of HR-MBR was that the effective retention of
pollutants within the bioreactor may facilitate biodegradation due to the prolonged contact time
between the activated sludge and TrOCs. Despite the effective TrOC retention by the high
retention membranes [151, 153], degradation of TrOCs by activated sludge within the
bioreactor has not been reported to consistently improve [151, 152]. This is because the
degradation of TrOCs by the activated sludge depends on their intrinsic biodegradability that
is governed by their physicochemical properties such as chemical structure and hydrophobicity
[6].
A few excellent reviews on the main features, overall performance and technological
constraints of HR-MBR have been published recently [150, 154-156]. However, removal of
TrOCs by HR-MBR and factors affecting the removal of TrOCs by the activated sludge,
particularly in HR-MBR have not been critically reviewed and discussed. This section aims to
critically analyze the removal of TrOCs by the high retention membranes and activated sludge
in HR-MBR. In addition, mechanisms of TrOC removal by HR-MBR are systematically
elucidated. Based on the contribution of each mechanism of TrOC removal, a qualitative
predictive framework is proposed.
2.3.3.1. HR-MBR configurations
In addition to the use of high retention membranes that allows effective retention of pollutants
including TrOCs, HR-MBRs may have different features compared to the conventional MBR
configuration (Figure 2.7a). Three configurations of HR-MBR, namely membrane distillation
(MD)-MBR (Figure 2.7b), forward osmosis (FO)-MBR (Figure 2.7c) and nanofiltration (NF)MBR (Figure 2.7d) have been investigated to-date [151, 152, 157].
Mechanisms of TrOC removal by HR-MBR include: (i) membrane retention; (ii)
biodegradation; (iii) sorption; (iv) air stripping/volatilization; and (v) photolysis [6, 21, 158].
Removal of TrOCs by volatilization depends on the Henry’s constant (H), which is the ratio of
the concentration of a target pollutant in air to its concentration in wastewater. It has been
reported that the removal of target pollutants via volatilization can be significant (5-10%) if
their H values are higher than 0.005 [159-161]. Since the values of H for TrOCs generally fall
in the range of 10-6 to 10-10, TrOC removal in HR-MBR via volatilization is insignificant.
Similarly, contribution of photolysis is negligible due to the high mixed liquor suspended solids
(MLSS) concentration in the bioreactor [152, 162]. Hence, biodegradation, sorption and
membrane retention mechanisms primarily contribute in varying extent for TrOC removal by
HR-MBR as discussed in the following sub-sections.
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(a) Conventional MBR

(b) MDBR

(c) FO-MBR

(d) NF/RO-MBR

Figure 2.7. Schematics of (a) Conventional membrane bioreactor (MBR); (b) membrane
distillation bioreactor (MDBR); (c); forward osmosis- membrane bioreactor (FO-MBR); and
(d) nanofiltration- membrane bioreactor (NF-MBR)
2.3.3.2. Mechanisms of TrOC removal by high retention membranes
Retention by high retention membrane appears to be the most dominant mechanism for removal
of TrOCs that are resistant to degradation by the activated sludge. Therefore, understanding
the mechanisms of TrOC removal by MD, NF and FO membranes is vital. TrOC
retention/removal by high retention membranes depends on: (i) the type of high retention
membrane; (ii) influent characteristics; and (iii) operating conditions (Table 2.4). TrOC
retention by NF and FO membranes has been reported to be influenced by a number of factors
(Table 2.4) such as physicochemical properties (e.g., hydrophobicity, charge and molecular
weight) of TrOCs, operating parameters and membrane properties as explained below [163166]. On the other hand, TrOC retention by MD membranes depends on the volatility (pKH)
and hydrophobicity (log D) of pollutants [147, 150], thereby making TrOC retention by MD
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membrane simpler as compared to NF and FO membranes. In a stand-alone MD process,
‘pKH/log D’ ratio of less than 2.5 corresponds to ineffective TrOCs retention (50-70%), while
TrOCs with a high pKH/log D ratio (>2.5) are effectively retained (90-99%) by MD membranes
[147]
Table 2.4. Factors affecting the retention of TrOCs by high retention membranes
MD
Factors
FO membrane
NF membrane
membrane
Fouling
*
*
*
Diffusion of solute

-

*

*

Hydrophobicity

*

*

*

Membrane MWCO

-

*

*

Charge on TrOCs

-

*

*

Membrane
charge

-

*

*

Polarity

-

*

*

Molecular width

-

*

*

Volatility of TrOCs

*

*

*

Temperature and pH

*

*

*

surface

“ –” : no effect according to available reports
Mechanisms of TrOC retention by NF and FO membrane consist of: (i) the net sorption of a
solute on the membrane surface; (ii) the transport of solute inside the membrane; and (iii) the
sieving property of the membrane [150, 167, 168]. Influence of other factors including
hydrophobicity and charge repulsion on sorption and solute transport has also been observed
[169, 170]. In general, size exclusion mechanism is responsible for the retention of non-ionic
and hydrophilic (log D <3) TrOCs, and the extent of retention depends on the molecular weight
cut-off (MWCO) of membranes. For example, a tight NF membrane (MWCO <200 g/mole)
achieved 97% retention of carbamazepine (log D = 1.89) from a filtered lake water containing
a mixture of 22 TrOCs, while only 50% removal was observed by a loose NF membrane
(MWCO >300 g/mole) [171]. In another study by Xie et al. [172], retention of carbamazepine
by a cellulose triacetate FO membrane remained in between 80 and 90% at different pH values
(i.e., 3.5-7.5). Similarly, carbamazepine retention by cellulose triacetate and thin film
composite polyamide FO membranes was reported to be 90-95% [173]. Effective retention
(80-99%) of other hydrophilic TrOCs such as metronidazole (log D = -0.14), clofibric acid (log
D = -1.06) and N, N-Diethyl-meta-toluamide (DEET, log D = 2.42) by NF and FO membranes
has been reported [145, 174-177]. Hydrophobic TrOCs (log D >3) such as steroid hormones,
bisphenol A and 4-tert-octylphenol have also been reported to be effectively retained (>80%)
by both NF and FO membranes [164, 177, 178]. Notably, hydrophobicity of TrOCs can
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influence their retention because hydrophobic TrOCs can adsorb onto the membrane surface,
thus initially resulting in their effective retention. However, as the filtration continues, their
retention may reduce due to their subsequent diffusion into the permeate [164, 177]. Compared
to hydrophilic TrOCs, hydrophobic TrOCs, regardless of their size, can diffuse into the
permeate to attain an equilibrium between the concentration of hydrophobic TrOCs on/near the
membrane surface and the permeate. This gradually reduces the extent of TrOC retention by
the NF and the FO membranes [179-181]. Once an equilibrium between the concentration of
TrOCs on/near membrane surface and permeate is established, the role of adsorption in TrOC
retention diminishes, and charge repulsion and size exclusion mechanisms govern the retention
of TrOCs by NF and FO membranes [168, 182].
NF and FO membranes are negatively charged at pH=7 owing to the protonation of their
functional groups [168, 171]. Hence, membrane surface charge and its interaction with charged
TrOCs such as diclofenac, naproxen and ibuprofen will govern the extent of their retention.
Poor rejection of positively charged hydrophobic TrOCs such as steroid hormones by NF/FO
membrane can be attributed to the attraction between positively charged TrOCs and negatively
charged membrane surface. This consequently increases the concentration of solute at the
surface of membrane, thus increasing their diffusion into permeate. On the other hand, effective
retention of negatively charged hydrophilic TrOCs is due to the charge repulsion mechanism,
which keeps TrOCs away from the membrane surface [179, 183, 184]. Notably, the
transformation of neutral TrOCs to negatively charged TrOCs at pH>pKa can improve their
retention by NF and the FO membranes. For example, an increase of 50 and 65% in the
retention of sulfamethoxazole (pKa = 5.6) and ibuprofen (pKa = 4.47), respectively, by a thin
film composite NF membrane was observed when the feed pH was changed from 5 to 10 [167].
In another study, retention of ibuprofen (pKa = 4.47) and naproxen (pKa = 4.2) by an FO
membrane was observed to be increased by 10-15% due to the increase in the pH of feed from
6 to 8 (i.e., pH>pKa) [173]. Based on the discussion regarding the factors affecting the retention
of TrOCs by NF and FO membrane, a qualitative predictive framework is presented in Figure
2.8.
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Figure 2.8. Qualitative predictive framework for the retention of TrOCs by NF or FO
membrane. The case of an acidic compound is depicted here. A basic compound will become
positively charged at pH<pk b. The transformation of neutral TrOCs to negatively charged at
pH > pKa or positively charged at pH < pK b can improve their retention by NF and the FO
membranes. Modified from [166, 170]
2.3.3.3. Aqueous phase removal of TrOCs by HR-MBR
As mentioned before, three configurations of HR-MBR, namely membrane distillation
bioreactor (MDBR), forward osmosis (FO-MBR) and nanofiltration (NF-MBR) have been
investigated to-date [151, 152, 157, 185]. Depending on the physicochemical properties of
TrOCs and the type of HR-MBR configuration, removal of TrOCs by HR-MBRs can range
between 90-99% (Table 2.5).
The advantage of an integrated biodegradation and membrane separation process is that HRMBR can achieve better TrOC removal as compared to the standalone HR-membrane. For
instance, Wijekoon et al. [147] studied the rejection of a mixture of 30 TrOCs by a standalone
MD process, and observed partial retention (50-70%) of a few volatile TrOCs (pKH <9) such
as 4-tert-octylphenol (pKH= 5.06), benzophenone (pKH= 5.88) and amitriptyline (pKH= 8.18).
On other hand, when the performance of MDBR was studied for the removal of a mixture of
30 TrOCs, effective removal (95-99%) was achieved by MDBR for all the selected 30 TrOCs
including those partially removed by the standalone MD process [147, 152].
Compared to ineffective or unstable removal of a few hydrophobic TrOCs such as bisphenol
A (40-80%), oxybenzone (70-75%), estrone (80%), and 17α – ethynylestradiol (70-90%) by a
standalone FO process [168], FO-MBR has been reported to achieve above 99% removal for
hydrophobic TrOCs [151, 186]. Better performance of MDBR and FO-MBR for TrOC removal
as compared to the standalone MD and FO process can be attributed to the efficient degradation
of volatile and hydrophobic TrOCs such as 4-tert-octylphenol, benzophenone, triclosan,
bisphenol A and oxybenzone by the activated sludge [152, 186, 187].
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Table 2.5. Physicochemical properties of TrOCs and their aqueous phase removal by HR-MBR
TrOCs

Primidone
Ketoprofen
Naproxen
Gemfibrozil
Metronidazole
Diclofenac
Fenoprop
Ibuprofen
Ametryn
Clofibric acid
Carbamazepine
Octocrylene
Amitriptyline
Atrazine
Propoxur
Benzophenone
N, N-Diethyl-meta-toluamide (DEET)
Estriol
17α – Ethynylestradiol
Oxybenzone
Estrone
17β – Estradiol
17β – Estradiol-17-acetate
Bisphenol A
Salicylic acid
Triclosan
4-tert-Butylphenol
4-tert-Octylphenol

Dissociation
coefficient
(pKa) a

Chemical
formula a

Molecular
Weight a

C12H14N2O
C16H14O3

g/mole
218.25
254.28

12.26 ± 0.40
4.23 ± 0.10

C14H14O3

230.26

C15H22O3
C6H9N3O3
C14H11Cl2NO2
C9H7Cl3O3
C13H18O2
C9H17N5S
C10H11ClO3
C15H12N2O
C24H27N
C20H23N
C8H14ClN5
C11H15NO3
C13H10O
C12H17NO
C18H24O3
C20H24O2
C14H12O3
C18H22O2
C18H24O2
C20H26O3
C15H16O2
C7H6O3
C12H7Cl3O2
C10H14O
C14H22O

250.33
171.15
296.15
269.51
206.28
27.33
214.65
236.27
361.48
277.40
215.68
209.24
182.22
191.3
298.33
269.40
228.24
270.37
272.38
314.42
228.29
138.12
289.54
150.22
206.32

Henry
constant
(H) b

pKH b

Log D at
pH=7 a

13.93
13.70

0.83
0.19

4.84 ± 0.30

1.164E-14
2.005E-14
2.096E-13

12.68

0.73

4.75
14.44 ± 0.10
4.18 ± 0.10
2.93
4.41 ± 0.10
3.71±0.41
3.18 ±0.10
13.94 ± 0.20
9.18 ± 0.28
2.27 ± 0.10
1.49 ± 0.70
10.25 ± 0.70
10.24 ± 0.60
7.56±0.35
10.25 ± 0.40
10.27
10.26 ± 0.60
10.29 ± 0.10
3.01 ± 0.10
7.80 ± 0.35
10.13 ± 0.13
10.15 ± 0.15

7.677E-13
2.073E-12
3.098E-12
3.284E-12
4.066E-11
4.418E-10
2.909E-10
8.168E-10
3.382E-09
6.596E-09
5.223E-08
5.265E-07
1.316E-06
1.410E-06
1.644E-11
3.399E-10
5.851E-10
9.286E-10
1.173E-09
2.151E-09
2.197E-09
6.653E-09
6.537E-07
7.136E-06
8.670E-06

12.11
11.68
11.51
11.48
10.39
9.35
9.54
9.09
8.47
8.18
7.28
6.28
5.88
5.85
10.78
9.47
9.23
9.03
8.93
8.67
8.66
8.18
6.18
5.15
5.06

2.07
-0.14
1.77
-0.13
0.94
2.97
-1.06
1.89
6.89
2.28
2.64
1.54
3.21
2.42
1.89
4.11
3.89
3.62
4.15
5.11
3.64
-1.13
5.28
3.40
5.18

a

Removal efficiency (%)
FO-MBR c
>99
>99
>99

MDBR d
>99
>99
>99

NF-MBR e
94
98

>95
>95
>95
83-99
>99
>99
>99

>99
>99
90
95
>99
>99
>99

50-99

95

80-90
>99
75-90
>99
>99
40-90
>99
>99
>99
>99
>99
>99
>99
>99
>99
>99
>99

90
>99
>99
>99
95
>99
>99
>99
>99
>99
>99
>99
95
>99
>99
>99

99
99
45-95
100
75
18-75
95
83-100
16-80
>99
60
95
95-97
70
82
88
-

Data extracted from SciFinder Scholar; b Henry’s law constant (H) = Vapour pressure × molecular weight/water solubility; and pKH = - log10 H. c Wijekoon, Hai, Kang, Price, Guo, Ngo, Cath and Nghiem
[152]; d Alturki, McDonald, Khan, Hai, Price and Nghiem [188]; Holloway, Regnery, Nghiem and Cath [187]; Lay, Zhang, Zhang, McDougald, Tang, Wang, Liu and Fane [189] Luo, Hai, Kang, Price, Nghiem
and Elimelech [186]; and Luo, Phan, Xie, Hai, Price, Elimelech and Nghiem [151]; e Phan, McDonald, Hai, Price, Khan, Fujioka and Nghiem [157]; and Wang [153]
“–”: not available
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Removal efficiency (%)

Both MDBR and FO-MBR was reported to achieve effective removal of a range of TrOCs (Table
2) [150, 190]. Indeed, a comparison of the aqueous phase removal of TrOCs by CAS, conventional
MBR and HR-MBR reveals that median TrOC removal by HR-MBR is almost 90%, while median
values for CAS and MBR are approximately 60 and 65%, respectively (Figure 2.9).
100
90
80
70
60
50
40
30
20
10
0
-10

CAS (n=364)

MBR (n=297)

HR-MBR (n=64)

Figure 2.9. Aqueous phase removal of TrOCs by CAS, MBR and HR-MBR. Box-and-whisker
plot is showing information about: the interquartile range; median (horizontal line in the box); min
and max (whiskers); and average (block square in the box). Adapted from [126].
2.3.3.4. Factors affecting TrOC removal by activated sludge in HR-MBR
2.2.3.4.1. Effect of TrOC molecular structure

Degradation of TrOCs by activated sludge depends on their intrinsic biodegradability and sorption
potential. The extent of TrOC degradation can vary depending on the chemical structure of the
target compound [186, 191]. In general, simple structured TrOCs without branched/multi chain
alkyl groups are readily biodegraded compared to structurally complex TrOCs due to their
resistance to microbial degradation. Similar to conventional MBR, TrOCs containing strong
electron withdrawing functional groups (EWG) such as carboxyl, halogen and amide are resistant
to biodegradation, and their degradation is also poor and/or unstable in HR-MBR [152, 157]. For
instance, atrazine, carbamazepine and diclofenac are resistant to biodegradation due to the
presence of EWGs (i.e., halogen and amide) in their structures [191, 192].
Based on their biodegradation, TrOCs can be divided into three categories: (i) low or unstable
removal (5-30%) for TrOCs containing strong EWGs such as atrazine, carbamazepine and
primidone; (ii) consistently high removal (80-90%) of hydrophobic TrOCs containing electron
donating groups (EDGs) such as steroid hormones; and (iii) poor to moderate removal (30-80%)
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of hydrophilic TrOC containing both EWGs and EDGs [152, 157, 193]. Limited degradation of
some TrOCs by the activated sludge highlights the significance of high retention membranes in
effective TrOC removal for producing a high-quality effluent. Specific groups of TrOCs that are
poorly degraded by the activated sludge accumulate within the bioreactor of HR-MBR. Thus, there
is a need to introduce microbes such as fungi with strong degradation capacity.
2.2.3.4.2. Effect of TrOC sorption on activated sludge

Hydrophobic TrOCs (log D>3) can adsorb onto the activated sludge by following mechanisms: (i)
chemical binding to bacterial proteins and nucleic acids; (ii) sorption onto polysaccharide
structures outside the bacterial cell; (iii) adsorption onto bacterial lipid structure [129]. With a few
exceptions, HR-MBR can achieve as high as 99% removal of hydrophobic TrOCs via
biodegradation and sorption [152, 187]. Additionally, non-hydrophobic interactions such as
hydrogen bonding, electrostatic interactions and ion exchange can also instigate sorption of
hydrophilic TrOCs onto activated sludge. For instance, Wijekoon et al. [152] observed that
sorption significantly contributed to the removal of a hydrophilic TrOC salicylic acid (log D = 1.22).
Sorption on activated sludge contributes to improvement of overall aqueous phase removal of
TrOCs in conventional MBRs [160, 189, 194-196]. For instance, halogenated TrOCs are widely
reported to be persistent to microbial degradation. However, the increase in halogen-content
increases the hydrophobicity of halogenated TrOCs [197]. Thus, efficient removal of halogenated
TrOCs, particularly of triclosan, have been reported to be achieved by even conventional MBRs
due to its sorption onto activated sludge [6, 191, 198]. Although sorption also contributes to the
removal of TrOCs within the bioreactor of HR-MBRs, the overall TrOC removal by HR-MBR is
less dependent on sorption because of the high retention membranes, which can retain even the
TrOCs demonstrating low sorption on sludge.
Following sorption onto the activated sludge, the extent of TrOCs degradation depends on their
intrinsic biodegradability [6]. For instance, Wijekoon et al. [152] observed higher concentrations
of two highly hydrophobic TrOCs, namely triclosan and octocrylene in the sludge samples of an
MDBR as compared to other hydrophobic TrOCs such as bisphenol A and steroid hormones. This
is because of the presence of strong EWGs in the molecular structure of triclosan and octocrylene
i.e., halogen and carbonyl, respectively [6, 191].
2.2.3.4.3. Effect of mixed liquor suspended solids concentration

Conceptually, mixed liquor suspended solid (MLSS) concentration may affect the removal of
TrOCs in a biological process by influencing the rate of biodegradation. However, biodegradation
also depends on TrOC physicochemical properties and diversity of microbial communities [19944

201]. Indeed biodegradation of TrOCs containing EDGs in their molecular structure (i.e., easily
biodegradable) has been reported to be 80-99% in conventional MBRs at the tested MLSS
concentrations ranging from 2-15 g/L [202-205]. Similarly, effective degradation (90-99%) of
TrOCs containing EDGs such as naproxen, ketoprofen, bisphenol A and t-octylphenol has been
achieved in NF-MBR, FO-MBR and MDBR over MLSS concentrations of 2-5 g/L [151, 152,
157]. Holloway et al. [187] also achieved 95-99% degradation of TrOCs containing strong EDGs
such as naproxen, oxybenzone, ibuprofen and caffeine by operating an FO-MBR at a MLSS
concentration of 3-4 g/L.
Degradation of hydrophilic TrOCs containing EWGs in conventional MBR has been reported to
be poor irrespective of operating MLSS concentrations [199, 206-209]. Similarly, poor and
unstable degradation (15-40%) by the activated sludge in HR-MBR has been reported for
hydrophilic TrOCs containing EWGs such as carbamazepine, DEET and atrazine [157, 186].
2.2.3.4.4. Effect of solids retention time

Solids retention time (SRT) governs the microbial makeup of a bioreactor. Conceptually, long
SRT may improve the extent of TrOC removal by providing adequate time for the development of
special TrOC degrading microbial communities [200, 210, 211]. Indeed, biodegradation of a few
resistant TrOCs such as sulfamethoxazole, diclofenac, mefenamic acid and carbamazepine
improved significantly following an increase in the SRT of conventional MBR (Figure 2.10). The
biodegradation of resistant TrOCs containing strong EWGs varied depending on the type of HRMBR configuration. For instance, FO-MBR (SRT = 20 days) achieved better degradation of
carbamazepine, atrazine, clofibric acid, fenoprop and diclofenac as compared to MDBR (SRT =
88 days) [151, 152, 157]. Disrupted metabolic activities associated with the treatment in
thermophilic conditions may have resulted in less effective degradation of resistant TrOCs by
MDBR [120, 152]. However, a systematic study is necessary to determine the actual reasons of
these observations.
As expected, no improvement was observed in the degradation of easily biodegradable TrOCs
containing EDGs such as naproxen, ketoprofen and ibuprofen by increasing the SRT of a
conventional MBR beyond 15 days [198, 204, 212, 213]. Similarly, no observable effect of SRT
on the degradation of TrOCs such as naproxen, ketoprofen, ibuprofen, bisphenol A and 4-tertoctylphenol has been reported in HR-MBRs over a wide range of SRTs [152, 157, 187, 214].
2.2.3.4.5. Effect of operating temperature

To date lab-scale FO- and NF-MBRs have been operated at the room temperature i.e., 18-21 ºC,
while the operating temperature of MDBR falls in the thermophilic range i.e., 40-60 ºC [152, 157,
215, 216]. As noted in the previous section, relatively less degradation of a few hydrophilic TrOCs
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such as carbamazepine, atrazine, clofibric acid, fenoprop and diclofenac has been observed in
MDBR as compared to FO-MBR [151, 152]. This can be attributed to the higher operating
temperature of MDBR, which can disrupt microbial activities. Particularly, high operating
temperature (>35 ºC) can affect TrOC degradation by reducing the abundance of nitrifying bacteria
[217-219]. In conventional MBR, improvement in TrOC removal has been reported to concur with
the achievement of efficient nitrification [220]. To provide further insight into this aspect, the
effect of thermophilic conditions on the microbial diversity and TrOC removal in various formats
of HR-MBR should be further investigated.

(b) Insignificant
effect of SRT

Figure 2.10. Effect of SRT on the aqueous phase removal of selected TrOCs by conventional
MBR. (a) Significant SRT dependent improvement in TrOC removal; and (b) insignificant
dependence of TrOC removal on SRT. Adapted from [126].
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2.3.3.5. Fate of TrOCs in HR-MBR
Effective retention of TrOCs (90-99%) within the bioreactor of HR-MBR by the high retention
membranes may facilitate their biodegradation due to the prolonged contact time between the
activated sludge and TrOCs. Indeed, comparing data from independent studies, degradation of
some TrOCs seems to be more stable in HR-MBR as compared to conventional MBR and CAS
(Figure 2.11).

(a) CAS

100
80
60
40
20

(c) HR-MBR

Removal efficiency (%)

(b) MBR

0
100
80
60
40
20
0
100
80
60
40
20

Salicylic acid (3+9+10)
Ketoprofen (4+16+25)
Fenoprop (3+8+0)
Naproxen (4+18+34)
Ibuprofen (3+19+39)
Gemfibrozil (4+10+17)
Amitriptyline (4+10+5)
Trimethoprim (2+10+26)
Omeprazole (2+4+1)
Sulfamethoxazole (2+20+24)
Atenolol (2+10+15)
Caffeine (3+8+23)
Paracetamol (3+15+11)
Fluoxetine (3+4+7)
Primidone (4+12+7)
Diclofenac (4+27+28)
Carbamazepine (4+20+48)
Atrazine (4+11+0)
DEET (3+8+17)
Bisphenol A (4+14+22)
Triclosan (4+15+14)
4- tert-octylphenol (4+13+10)
Octocrylene (4+5+13)
Estriol (4+6+23)
Estrone (4+11+37)
17 -Ethynylestradiol (4+8+24)
17ß-Estradiol (4+8+29)

0

Hydrophilic TrOCs Hydrophobic TrOCs
with EWGs
with both EWGs and EDGs

Hydrophilic TrOCs
with both EDGs and EWGs

Figure 2.11. Variations in the biodegradation of TrOCs in CAS (a), MBR (b) and HR-MBR (c).
Box-and-whisker plot is showing information about: the interquartile range; median (horizontal
line in the box); min and max (whiskers); and average (block square in the box). Numbers in the
parenthesis on the x-axis represent the no. of data points (no. of data points: HRMBR+MBR+CAS). Adapted from [126].
The degradation improvement for these TrOCs in HR-MBR is discernible, however, not very high.
An assessment of the relative contribution of different mechanisms of TrOC removal suggests that
membrane retention and biodegradation govern the effectiveness of treatment by HR-MBR
(Figure 2.12). According to the available literature, TrOC removal in HR-MBR via sorption onto
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activated sludge ranges between 1-10% and 2-30% for hydrophilic and hydrophobic TrOCs,
respectively.

Figure 2.12. Contribution of different mechanisms for TrOC removal in HR-MBR and
conventional MBR. HR-MBR. Adapted from [126].
The fate of TrOCs during wastewater treatment by HR-MBR is governed by the TrOC
physicochemical properties (e.g., chemical structure and hydrophobicity), which influence their
biodegradation. The hardly biodegradable TrOCs will not appear in the treated effluent because of
the extra barrier provided by the high retention membranes. However, when not subsequently
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biodegraded, their accumulation on sludge would complicate sludge disposal and reuse. Based on
the contribution of each mechanism of TrOC removal, a qualitative framework for the removal of
TrOCs in HR-MBR is proposed in Figure 2.13.

Figure 2.13. A qualitative framework to predict the contribution of different mechanisms of TrOC
removal in HR-MBR categorized based on their physicochemical properties.
An in-depth assessment of the available literature on HR-MBR performance suggests that, as
compared to CAS and conventional MBRs (using micro- or ultrafiltration membrane), aqueous
phase removal of TrOCs in HR-MBR is significantly better. However, a strong evidence of
improvement in TrOC degradation in HR-MBR is not available. In fact, poor degradation of
resistant TrOCs HR-MBR leads to their accumulation within the bioreactor of HR-MBR. To
improve the degradation of TrOCs in HR-MBR, other microbes with better TrOC degradation
capacity than the conventional activated sludge can be introduced. In this context, white-rot fungi
and their extracellular enzymes [221] are worth-noting. White-rot fungi (WRF) and their enzymes
have been reported to achieve effective degradation of TrOCs that are resistant to activated sludgebased treatment process [222-224]. Performance of white-rot fungi and their enzymes for the
degradation of a wide range of TrOCs is elucidated in the next section.
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2.4. TrOC degradation by white-rot fungi (WRF)
White-rot fungi (WRF) are a type of fungus that can degrade lignin, a class of complex natural
organic polymers found in the cell wall of plants, by using their extracellular enzymatic system,
called as ligninolytic enzymes [225, 226]. WRF and their ligninolytic enzymes have also been
studied for the treatment of a variety of recalcitrant compounds such as polycyclic aromatic
hydrocarbons, dyes, and chlorophenols [222, 227, 228]. In particular, removal of TrOCs using
WRF or their extracellular enzymes has gained much attention over the last decade [229-231].
TrOCs such as pharmaceuticals, personal care products, industrial chemicals and steroid hormones
have been commonly detected in municipal wastewater and surface water bodies as discussed in
Section 2.2. Their occurrence in environmental systems can be harmful to aquatic ecosystem and
human health even at trace concentrations [5, 16].
Whole-cell WRF and their ligninolytic enzymes have been reported to efficiently remove a wide
range of TrOCs such as pharmaceuticals (e.g., ibuprofen, ketoprofen and diclofenac), personal
care products (e.g., triclosan and oxybenzone) and steroid hormones [229, 232-234]. Moreover, a
number of influencing factors for such treatment systems have been identified. These factors
include physicochemical properties of TrOCs, type of WRF species and their individual
ligninolytic extracellular enzymes as well as culture medium and environmental conditions [222,
235]. The potential of WRF for the removal of TrOCs has been investigated mostly in batch mode.
There are only a few studies on continuous-flow reactor configurations [234, 236-239]. Despite a
significant research effort, efficient removal of TrOCs by WRF mediated treatment, their removal
mechanisms and degradation pathways remain largely to be elucidated. There have been a few
excellent reviews on bioremediation of recalcitrant compounds by WRF and their enzymes [222,
235, 240-242]. In this section, performance of WRF and their ligninolytic enzymes as well as the
performance governing factors is critically analysed and discussed. In addition, the performance
of conventional enzymatic membrane bioreactor (EMBR) is elucidated. The key research gaps are
identified, indicating the need of high retention (HR)-EMBR.

2.4.1. Properties of WRF and their ligninolytic enzymes
WRF species degrade recalcitrant compounds including TrOCs by using their intracellular or
extracellular enzymes [222, 243]. The key features of WRF that make them an attractive treatment
option for TrOC removal include but are not limited to (i) the non-specificity and non-selectivity
of their enzyme systems, enabling them to degrade complex individual and mixture of pollutants;
(ii) the secretion of extracellular enzymes, enabling them to degrade pollutants with low water
solubility; (iii) the ability of their plasma membrane-dependent redox system to degrade pollutants
in a nutrient deficient reaction mixture over a wide range of pH; and (iv) the ability of intracellular
enzyme to degrade some pollutants [225, 244, 245]. Depending on growth medium and culture
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conditions as well as on the type of WRF species/strains, WRF can secrete four different
ligninolytic enzymes namely laccase, lignin peroxidase (LiP), manganese peroxidase (MnP) and
versatile peroxidase (VP). In addition, cytochrome P450 monooxygenases, a group of intracellular
enzymes, have also been reported to play a vital role in the degradation of TrOCs via
hydroxylation, dehalogenation and heteroatom oxygenation mechanisms [222, 246, 247].
Characteristics of ligninolytic extracellular enzymes such as molecular mass, isoelectric point and
redox potential are outlined in Table 2.6. Stability and catalytic potential of ligninolytic enzymes
may vary due to difference in their redox-potential as well as due to the extent of glycosylation. In
general, enzymes having high redox-potential are favorable for enzyme catalyzed reactions [246,
248, 249]. Redox-potential of ligninolytic enzymes is as follows: LiP>MnP=VP>laccase (Table
2.6).
Table 2.6. Characteristics of extracellular ligninolytic enzymes [250, 251]
Molecular
mass (kDa)

Redox
potential
(mV)

Laccase

50 – 80

0.3 – 0.8

Lignin peroxidase

35 – 48

1 – 1.2

Manganese
peroxidase
Versatile
peroxidase
“N.A.”: not available

38 – 62

0.8 – 1

40 – 47

>1

Ligninolytic
enzymes

Glycosylation
(%)

Isoelectric
point

Cofactor

10 – 20 (NGlycosylated)
20 – 30 (NGlycosylated)
5 – 15 (NGlycosylated)

3–4

O2

3.1 – 4.5

H2O2

3 – 7.2

H2O2

N.A.

3.4 – 4.9

H2O2

Glycosylation, a complex enzymatic process, is responsible for the formation of biopolymers such
as polynucleotides at the cellular level [252, 253]. Glycosylation in extracellular enzymes can
influence their shape, structure, composition and the formation of substrate binding sites as well
as their properties such as redox-potential, enzymatic activity and catalytic potential [254, 255].
Stability of enzymes tends to improve with the increase of glycosylation but it may not always
improve the catalytic potential of an enzyme [256, 257]. Deglycosylation of extracellular enzymes
has been observed to adversely affect the enzymatic activity, stability and catalytic potential of
enzymes [255, 258, 259]. Notably, the catalytic potential or redox-potential of LiP is higher than
other ligninolytic enzymes, possibly because the level of glycosylation in LiP is greater than other
ligninolytic enzymes [246, 250]. Isoelectric point is important to estimate the charge on fungal
enzymes at different pH [260]. Isoelectric point of ligninolytic enzymes mostly falls in acidic pH
range i.e. 3-7, indicating that ligninolytic enzymes are negatively charged at pH ≥7.0 [261].
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2.4.2. Modes of TrOC degradation by WRF
Different WRF and their ligninolytic enzymes have been investigated under different experimental
conditions for the removal of TrOCs - either by whole-cell WRF culture or by using the crude
and/or purified enzyme extracts. Different modes of TrOC degradation via WRF and their
ligninolytic enzymes are critically discussed as follows.
2.4.2.1. Removal by Whole-cell WRF
Although whole-cell WRF cultures, either in submerged or solid media, have been used for the
removal of TrOCs, submerged whole-cell WRF cultures have been more commonly reported.
Since WRF species harbor different enzyme systems, the extent of TrOC removal achieved by
different WRF species also varies. TrOC removal performance by different WRF species is
presented in Table 2.7. Notably, temperature and pH for these studies were in the range of 2530oC and 4.5-5, respectively, with glucose used as the common electron donor.
T. versicolor, also known as Coriolus versicolor [262, 263], has been investigated in several
studies for the removal of TrOCs both in batch and continuous-flow bioreactors [234, 237, 264268]. Depending on the strain, T. versicolor may contain laccase, LiP and MnP, with laccase being
the predominant enzyme in some strains. It can be observed from Table 2.7 that T. versicolor
achieved significant removal (>70%) for most of the tested TrOCs. TrOCs such as steroid
hormones, nonylphenol and octocrylene can induce endocrine disrupting effects [269, 270]. Their
removal by T. versicolor in literature ranges from 80 to 99% regardless of the operating conditions.
Conversely, poor and unstable removal was reported for particular pharmaceuticals, namely
ciprofloxacine (35%), salicylic acid (0-5%), azithromycin (26%), tetracyclin (0-5%) and
carbamazepine (negligible to 90%). Low and/or unstable removal of these compounds can be
attributed to the presence of strong electron withdrawing functional groups (EWGs) in their
chemical structure [222]. Compared to the pharmaceuticals, the removal of personal care products
has been communicated in only a limited number of studies [266, 267]. However, T. versicolor
has been shown to achieve high removal of ingredients of personal care products such as triclosan,
oxybenzone, octocrylene and nonylphenol (Table 2.7).
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Table 2.7. Removal (%) of TrOCs by different species of WRF (whole-cell) under different operating conditions
WRF Specie

Bioreactor
Type
Stirred tank
(Batch-fed)

P. chrysosporium
(LiP, MnP)

Stirred tank
(Continuous)

Fixed bed
(Continuous)

Fluidized bed
(Batch-fed)
T. versicolor
(Laccase, LiP, MnP)

Fluidized bed
(Batch-fed)

Fluidized bed
(Continuous)

Operating conditions
Inoculum= 1.2 g/L
Reactor volume = 2 L, HRT= 24 h
Mixing speed = 200 rpm
pH = 4.5; Temperature= 30oC
Electron donor= glucose
Operating time= 30 days
Reactor volume = 1.5 L
HRT= 24 h
pH = 4.5; Temperature= 30oC
Electron donor= glucose
Operating time= 50 days
Inoculum= 3.2 g/L
Reactor volume = 0.13 L
HRT= 120 days
pH = 4.5; Temperature= 22oC
Electron donor= glucose
Operating time= 26 days
Inoculum= 3.8 g
Reactor volume = 1.5 L
pH = 4.5; Temperature= 25oC
Electron donor= glucose
Operating time= 15 days
Inoculum= 1.5 g/L
Reactor volume = 10 L
pH = 4.5; Temperature= 25oC
Electron donor= glucose
Operating time= 8 days
Real hospital wastewater
Non sterile conditions
Inoculum= 1.4 g/L
Reactor volume = 10 L
pH = 4.5; Temperature= 25oC
Electron donor= glucose

TrOCs
Diclofenac
Ibuprofen
Naproxen

Diclofenac
Ibuprofen
Naproxen
Carbamazepine
Diazepam
17β-estradiol (E1)
17αethynylestradiol

Carbamazepine

Initial
concentration
(mg/L)
0.8
0.8
0.8

Removal
efficiency (%)
>99
75-99
>99

1
1
1
0.5
0.25-0.5

92
95
95
25-60
0

3-18.8

>95

7.3

>95

0.05-9

61-94

References

[271]

[272]

[264]

[268]

Ibuprofen
Acetaminophen
Ketoprofen
Ciprofloxacine
Azithromycin
Propranolol
Carbamazepine
Acetaminophen
Naproxen
Ibuprofen
Ketoprofen
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2.34
1.56
0.08
84.71
4.31
0.06
0
109
1.62
35.5
2.17

100
100
100
35
100
100
-50
100
100
100
95

[237]

[273]

WRF Specie

Bioreactor
Type

Operating conditions
Operating time= 8 days
Real hospital wastewater
Non sterile conditions

Membrane
bioreactor
(Continuous)

Membrane
bioreactor
(Continuous)

Inoculum= 3.5 g/L
Reactor volume = 5.5 L, HRT= 1
day
pH = 5.4; Temperature= 27oC
Operating time= 90 days
Non sterile conditions
Inoculum= 3 g/L
Reactor volume = 5.5 L, HRT= 2
day
pH = 4.5; Temperature= 27oC
Operating time= 110 days
Non sterile conditions

TrOCs
Diclofenac
Codeine
Phenazone
Salicylic Acid
Ofloxacin
Ciprofloxacine
Sulfamethoxazole
Trimethoprim
Metronidazole
Azithromycin
Clarithromycin
Erithromycin
Tetracyclin
Caffeine
Carbamazepine
Atenolol
Metoprolol
Diclofenac

Initial
concentration
(mg/L)
0.477
0.606
0.497
0.606
3.34
13.0
1.41
0.853
0.912
1.37
2.20
0.008
0.011
149
0.056
2.99
0.019
0.3-1.5

Removal
efficiency (%)

References

100
100
96
0
98
99
100
100
85
26
80
100
0
39
0
75
95
55
[234]

Ibuprofen
Naproxen
Ketoprofen
Diclofenac
Carbamazepine
Metronidazole
Gemfibrozil
Amitriptyline
Estriol (E3)
17-β-estradiol
54

0.005

95

0.005

95

0.005
0.005
0.005
0.005
0.005
0.005
0.005
0.005

90
50
20
40
95
85
>95
>95

[266]

WRF Specie

Bioreactor
Type

Erlenmeyer
flask
(Batch-fed)

P. ostreatus
(Laccase, MnP)

D. squalens
(Laccase, MnP)

B. adusta
(Laccase, LiP, MnP)

Erlenmeyer
flask
(Batch-fed)

Erlenmeyer
flask
(Batch-fed)

Erlenmeyer
flask
(Batch-fed)

Operating conditions

17-β-estradiol –
acetate
17-α
ethinylestradiol
Triclosan
Benzophenone
Oxybenzone
Octocrylene
Triclosan

Inoculum= 2-3 mg/test
pH = 4.5; Temperature= 28oC
Operating time= 14 days
Electron donor: glucose
Inoculum= 2-3 mg

17-α
ethinylestradiol
Nonylphenol
Triclosan

pH = 4.5; Temperature= 28oC
Operating time= 14 days
Electron donor: glucose
Inoculum= 2-3 mg

17-α
ethinylestradiol
Nonylphenol
Triclosan

pH = 4.5; Temperature= 28oC
Operating time= 14 days
Inoculum= 2-3 mg
o

pH = 4.5; Temperature= 28 C
Operating time= 14 days

TrOCs

17-α
ethinylestradiol
Nonylphenol
Triclosan
17-α
ethinylestradiol
Nonylphenol
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Initial
concentration
(mg/L)

Removal
efficiency (%)

0.005

>95

0.005

>95

0.005
0.005
0.005
0.005

95
80
92
94

10

98

10

94

10

90

10

98

10

62

10

93

10

98

10

78

10

85

10

98

10

78

10

85

References

[267]

[267]

[267]

[267]

Other WRF species such as P. chrysosporium [271, 272], B. adusta , D. squalens and P. ostreatus
containing different combinations of ligninolytic enzymes have also been investigated for the
removal of TrOCs (Table 2.7). However, these studies reported the removal of only a few TrOCs
such as ibuprofen, diclofenac and triclosan. Despite the difference in enzyme secretion pattern of
these WRF, efficient removal (in the range of 70 to 99%) was achieved for most tested TrOCs,
with uncertain/unstable removal reported for carbamazepine, which is a known persistent
pharmaceutical. It is important to note that a direct comparison of TrOC removal data from
different studies may not be valid due to the differences in operating conditions and bioreactor
configurations as well as difference in their enzymatic systems. However, Table 2.7 serves the
purpose of providing a general overview.
2.4.2.2. WRF bioreactor configurations
Different bioreactor configurations have been explored for the continuous treatment of TrOCs in
WRF-based systems (Table 2.7). Since whole-cell WRF based treatment systems are still in their
development phase, the bioreactor design and configurations are of significant importance. Hence,
the salient features of the bioreactor configurations studied to-date for the removal of TrOCs,
namely, stirred tank bioreactors [271, 272], bubble column bioreactors, fluidized or packed bed
bioreactors [274-276] and membrane bioreactors [277-280] are briefly discussed here to provide
a general overview.
Among all the bioreactor configurations, stirred tank bioreactor has been the most common type
of bioreactor used for the treatment of TrOCs in WRF based treatment systems. This bioreactor
type has been explored mostly in batch and sterile modes [271, 272]. In this bioreactor, aeration is
provided usually at the bottom of the bioreactor, which is dispersed via mechanical agitation.
Mechanical mixing also ensures the uniform mixing of the growth medium and wastewater in the
bioreactor [274]. Enhanced production of ligninolytic enzymes could be achieved in stirred tank
bioreactors as compared to other bioreactor configurations. For instance, Babič and Pavko [281]
investigated the production of laccase and MnP from D. squalens in stirred tank bioreactor and
bubble column bioreactor under different operating conditions such as incubation time and
agitation speed: they observed that laccase production was as much as 70% higher in the former,
although the production of MnP was comparable [281]. Agitation speed and high shear rate may
influence the morphology of the fungal biomass. In a study by Cao et al. [282], impact of two
bioreactor configurations, namely stirred tank bioreactor and airlift bioreactor, on the morphology
of P. sanguineus was investigated. They found that the morphology of the fungal biomass was
adversely impacted in the stirred tank bioreactor, which uses strong mechanical mixing. Consistent
with the finding of Cao et al. [282], it has been reported that excessive agitation may lead to the
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rupturing of fungal hyphae [274, 283, 284]. Therefore, agitation/mixing speed in bioreactors is an
important parameter governing fungal morphology and enzymatic activity.
Fluidized bed bioreactor is another type that has been used for the removal of TrOCs from
municipal and synthetic wastewater [237, 273]. In this type of bioreactor, fungal biomass rapidly
moves around the solid carrier (‘bed’), allowing uniform mixing of the reaction media [285].
However, aggregation of fungal biomass may cause poor fluidization, resulting in spouting of bed.
Biomass aggregation can be avoided by intermittent and partial purging of the biomass [286].
A bubble column bioreactor coupled with a microfiltration membrane has been recently explored
for the removal of TrOCs [234, 266]. Such fungal membrane bioreactor was expected to offer
some additional advantages over bubble column reactors [227, 287, 288] such as: (i) formation of
biofilm on the membrane surface that may enhance the removal of recalcitrant TrOCs; (ii)
maintenance of high fungal biomass concentration improving biodegradation rate; and (iii)
effective prevention of enzyme washout. Nevertheless, bacterial contamination may hamper the
growth and enzymatic activity of whole-cell WRF in any bioreactor configuration. Impacts of
bacterial contamination on WRF are discussed in the next section.
2.4.2.3. Performance under non-sterile environment and bottlenecks
The capacity of WRF for TrOC removal has been commonly investigated under sterile conditions
to avoid bacterial contamination. However, several studies have cast light on the aspect of bacterial
contamination by operating bioreactors under non-sterile environment using either synthetic [234,
266] or real wastewater [237, 268, 273, 289-291]. For example, Yang et al. [234] investigated the
performance of whole-cell Trametes versicolor for the removal of bisphenol A and diclofenac in
a membrane bioreactor under non-sterile conditions using a malt-based synthetic wastewater. They
observed that the removal of diclofenac was reduced by 40-50% under non-sterile conditions as
compared to its 99% removal achieved in sterile batch experiments. In that study, bacterial
contamination was evident from microbial analysis. A few recent studies have investigated the
removal of pharmaceuticals and endocrine disrupting compounds from municipal and hospital
wastewater by whole-cell Phanerochaete chrysosporium or Trametes versicolor [237, 268, 273,
289-292]. In all these studies, bacterial contamination restricted long term operation of the
bioreactors as the overall removal of the TrOCs gradually reduced as compared to that obtained
under sterile conditions. Two probable modes of bacterial interruption to fungal enzymatic
expression can be perceived: (i) loss of enzyme secretion capacity of fungi owing to the growth
disruption under competition for substrate and bacterial colonization of the mycelia, and (ii)
destabilization or consumption of secreted enzyme by bacteria [234, 285, 293]. Bacteria are fast
growing prokaryotes as compared to eukaryotic WRF and can easily outperform WRF in substrate
utilization [293, 294].
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In addition to bacteria, other species of fungi can interrupt WRF growth and enzymatic activity.
For instance, Badia-Fabregat et al. [291] analyzed the composition of microbial communities in a
fluidized bed bioreactor treating hospital wastewater. They observed other fungal species (e.g.
Trichoderma asperellum and Trichoderma spp.) to overtake the originally inoculated fungi
(Trametes versicolor) in the bioreactor. This is the only study demonstrating the dominance of
fungal species other than the inoculated fungi in the bioreactor. Therefore, more research is needed
to analyze the presence of different competing species that can suppress the growth of inoculated
WRF to formulate strategies to control their proliferation in the bioreactor. A number of strategies
for the control of microbial contaminations have been reviewed previously [295]. However, these
strategies could only extend the operation of fungal bioreactors without bacterial contamination
for a few weeks. Some of the strategies to avoid bacterial contamination are outlined below:
(i)

(ii)

(iii)

(iv)

(v)

Operation under acidic pH: Optimum pH for the growth and reproduction of fungi ranges
from 4.5-5. Conversely, bacteria grow at or near neutral pH. Bacterial growth can be
suppressed by maintaining the pH in the range of 4.5-5. However, this is a temporary
solution to the problem of bacterial contamination because some bacteria can eventually
adapt to acidic environment [293].
Immobilization or attached growth of fungi: Immobilization of fungal strains onto different
carriers under non-sterile conditions shows promising results. For instance, by
immobilizing C. versicolor onto a plastic support, Hai et al. [287] was able to prevent
bacterial contamination for an extended period of time while operating the reactor under
non-sterile conditions for the treatment of an azo dye.
Nitrogen limited feed: Bacterial contamination can be avoided by using a media deficient
of nitrogen. However, this strategy can only help during the startup of the bioreactor.
Bacterial contamination would occur with the passage of operating time as bacteria would
start consuming carbon and nitrogen available in fungal mycelium [293].
Coupling of bioreactor with micro-screen: Bioreactors can be coupled with a micro-screen
which would retain fungal biomass but allow the washout of bacteria with effluent.
Moreover, this strategy will benefit from using shorter hydraulic retention times, which
will enhance the washout of bacteria from the reactor [296].
Use of disinfecting agents: Inactivation of bacteria without imposing any harmful effects
on fungal biomass can be a promising strategy. Depending on the wastewater
characteristics, it is important to carefully select the type, dose and contact time of the
disinfectant. Disinfection of wastewater using ozone has been used successfully to
selectively inactivate bacteria [297, 298].
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(vi)

(vii)

Biomass replacement: Periodic biomass replacement and purging strategy can be used to
carry out long term operation of fungal bioreactors. In this strategy, biomass in the
bioreactor is purged and renewed in different fractions (e.g., ½ or ¼th of the initial biomass
volume) at different frequencies [292, 299].
Pretreatment of wastewater: Coagulation-flocculation pretreatment of non-sterile
wastewater can help to reduce the initial bacterial count which would allow an extended
operation of the fungal bioreactor [292].

2.4.2.4. Removal by crude ligninolytic enzymes
Individual extracellular ligninolytic enzyme has been tested for the removal of a wide range of
pollutants. Use of the harvested enzyme instead of a whole-cell preparation allows decoupling of
fungal growth and pollutant degradation steps, and this can be a suitable strategy to avoid bacterial
contamination issues. The capacity of both crude and purified/commercially available extracellular
enzymes for TrOC removal has been reported previously [229, 266, 300-307]. However, wholecell fungi may achieve relatively better removal of a broader spectrum of pollutants than
extracellular enzymes due to the availability of extracellular, intracellular and/or mycelium bound
enzymes in addition to sorption of pollutants onto fungal biomass.
Crude extracellular enzymes have been investigated for the degradation of TrOCs in both batch
and continuous-flow mode. For instance, Wen et al. [308] achieved significant degradation of two
pharmaceuticals, oxytetracycline (84%) and tetracycline (72%), by using crude MnP (40 U/L)
extracted from P. chrysosporium. Similarly, crude enzyme solution extracted from T. versicolor
containing MnP (30 U/L) and laccase (1500 U/L) was tested for the degradation of 10
pharmaceuticals at an initial concentration of 10 µg/L each [301]. They achieved complete
degradation of five pharmaceuticals, viz diclofenac, ibuprofen, naproxen, indomethacin and
fenoprofen, while the rest were partially removed. LiP extracted from P. chrysosporium was tested
for the degradation of diclofenac and carbamazepine at different pH [309]. It was observed that
degradation of carbamazepine was mostly less than 10%, while a complete degradation was
achieved for diclofenac at pH 3-4.5. Similarly, crude extract from T. versicolor was used for the
removal of 30 TrOCs [302]. The results revealed that all steroid hormones were almost completely
removed (>95%), while removal of two TrOCs namely diclofenac and triclosan ranged from 50 to
60% with poor removal of the remaining TrOCs (<20%). In another study [310], crude enzyme
extract from P. ostreatus achieved low removal (<20 %) for two TrOCs, namely oxybenzone and
naproxen.
Since WRF also secretes natural mediators along with extracellular enzymes, crude enzyme may
achieve better removal as compared to purified and/or commercially available enzymes. For
instance, Tran et al. [301] highlighted that complete removal (>99%) of some pharmaceuticals
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such as diclofenac, indomethacin and ibuprofen was due to the presence of some natural mediators
in crude laccase solution. Removal of selected TrOCs by individual crude enzymes has been
systematically presented in Table 2.8. It can be seen that the extent of TrOC removal is different
for each type of extracellular enzyme. Moreover, crude enzyme extract from different fungi may
perform differently. For instance, Weng et al. [311] collected crude LiP from two WRF species,
namely, P. sordida and P. chrysosporium for the treatment of EDCs and found that LiP from P.
sordida was more effective than LiP from P. chrysosporium. Similarly, removal of DEET, an
insect repellent, by T. versicolor was 55% in real wastewater as compared to its 20% removal in
acetate buffer. High removal of DEET in real wastewater was attributed to the presence of other
compounds (such as phenolic compounds) that may act as redox-mediators [312], as further
discussed in Section 2.4.5.
2.4.2.5. Removal by purified ligninolytic enzymes
Purified or commercially available extracellular ligninolytic enzymes, mostly laccase from
different WRF, has been used for the treatment of TrOCs in both batch and continuous bioreactors.
Average removal of the selected TrOCs by purified laccase reported in recent studies is presented
in Figure 2.14. Purified laccases are more effective for the removal of phenolic compounds such
as oxybenzone, triclosan and steroid hormones. Removal of non-phenolic compounds such as
carbamazepine, naproxen and ketoprofen is generally poor/unstable. Their degradation depends
on their physicochemical properties such as hydrophobicity and chemical structure as well as the
oxidation reduction potential (ORP) of the enzyme [222, 313]. Indeed, based on the results of the
recent studies incorporated in Figure 2.14, removal of phenolic compounds ranges from 70 to
99%, while the removal of non-phenolics is generally less than 20%. However, relatively higher
removal of some non-phenolic compounds, namely, diclofenac (40-50%), octocrylene (>80%) and
ibuprofen (30-45%) has been reported because these compounds contain both electron donating
and electron withdrawing functional groups. Although both crude and purified enzymes
demonstrated degradation of a range of pollutants, crude enzymes achieved better removal of some
TrOCs such as diclofenac and naproxen as compared to purified enzymes [229, 266, 300, 302,
303, 306], possibly due to the presence of natural mediators in crude enzyme solution secreted by
WRF. For instance, Tran et al. [301] achieved almost complete removal of three pharmaceuticals
namely diclofenac, ibuprofen and naproxen after treatment with crude enzyme extracted from T.
versicolor, whereas purified laccase from T. versicolor and A. oryzae achieved 20-50% removal
of these compounds [229, 303, 304, 314].
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Table 2.8. Performance of crude enzymes for the removal (%) of the selected TrOCs
TrOCs
Non-phenolic compounds
Carbamazepine
Ibuprofen
Naproxen
Diclofenac
Gemfibrozil
ketoprofen
Clofebric acid
Benzophenone
DEET
Octocrylene
Phenolic compounds
Estrone
17β-Estradiol
17α-Ethynylestradiol
Oxybenzone
Nonylphenol
Triclosan
“-”: not reported

Laccase [231, 301, 302, 310, 312, 315-321]
Initial
Removal
Incubation
concentration
(%)
time (h)
(mg/L)
5 – 37
0.01-0.1
24-48
<5 – 38
0.01-0.1
24-48
20-100
0.01-0.5
24-48
60-100
0.01-0.1
3-48
20-25
0.01-0.1
24-48
<5 -12
0.01-0.1
24-48
10-20
0.01-0.1
24-48
<5
0.1
24
20-55
0.01
4
20
0.1
24
70-100
>99
>99
10-25
100
70-90

0.1-27
0.01-5
0.1-2.96
0.1-0.5
22
0.1-144

1-24
1-24
1-24
24
1
24

Removal
(%)
<10
>99
60
40, 85
20, 82
-
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LiP [309, 311, 322]
Initial
Incubation
concentration
time (h)
(mg/L)
5
2
5
2
27
0.6, 27
6.6, 30
-

24
1, 24
8, 24
-

MnP [301, 317, 318, 323]
Initial
Removal
Incubation
concentration
(%)
time (h)
(mg/L)
14-20
0.01-4.7
24-48
20
0.01
48
95
0.01
48
100
0.01
48
30
0.01
48
22
0.01
48
<10
0.01
48
>99
>99
>99
-

5
2.96
2.96
-

8
1
1
-

Utilization of crude enzymes for the treatment of TrOCs may considerably reduce the cost of the
treatment process. However, extracellular extract i.e., the crude enzyme solution also contains
significant amount of the unspent growth media, and dosing crude enzyme means additional
organic loading from this.
100

Removal efficiency (%)

80

60

40

20

Phenolic TrOCs

Amitriptyline (3)

Benzophenone (3)

Octocrylene (2)

Sulfamethoxazole (2)

Carbamazapine (3)

Clofibric acid (2)

Ibuprofen (2)

Fenoprop (3)

Diclofenac (7)

Metronidazole (3)

Gemifibrozil (3)

Naproxen (3)

Ketoprofen (2)

Primidone (2)

Formononetin (2)

Enterolactone (3)

Pentachlorophenol (3)

Salicylic acid (2)

Triclosan (2)

Estrone (6)

Estradiol (6)

Oxybenzone (2)

Ethinylestradiol (6)

Estriol (3)

0

Non-phenolic TrOCs

Figure 2.14. Average removal of phenolic and non-phenolic TrOCs after treatment with
purified/commercially available laccase. Error bar indicates average±standard deviation. Numbers
within parenthesis indicates number of data points. Data was collected from the following studies:
[229, 303, 304, 306, 314, 324-328].
2.4.2.6. Mechanisms of TrOC removal
Removal mechanisms during treatment with WRF whole-culture include: (i) sorption onto the
fungal biomass; (ii) degradation by extracellular enzymes; and (iii) degradation by mycelium
bound or intercellular enzymes. A schematic of fungal mediated treatment process with possible
removal mechanisms is presented as Figure 2.15. Hydrophobicity (log D) of TrOCs is a key
property that governs biosorption onto fungal biomass and could facilitate enhanced removal of
some compounds. For instance, a batch study to investigate the contribution of biosorption and
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degradation by extracellular enzymes confirmed that hydrophobic TrOCs (log D>4) were highly
removed by both mechanisms [300]. Moreover, they also confirmed that biosorption of
significantly hydrophobic compounds facilitated the biodegradation of these compounds. On the
other hand, a few studies have reported that removal of some TrOCs such as 17β-Estradiol, 17αethynylestradiol, triclosan and nonylphenol by whole-cell WRF and extracellular enzymes is
comparable (see Table 2.7 and 2.8), indicating a negligible impact of biosorption on their removal.

Figure 2.15. TrOC removal mechanisms by WRF-based treatment processes. Adapted from [329].
Biodegradation by whole-cell can be due to intracellular, extracellular and mycelium-associated
enzymes. This can lead to significant differences in removal by whole-cell WRF and harvested
enzyme. For instance, carbamazepine, containing a strong EWG, was significantly removed by
some WRF species, namely P. ostreatus (100%) [247] and T. versicolor ATCC 42530 (76%)
[301], while crude [247, 301, 302] and purified laccase [229, 306] could only achieve 5-15%
carbamazepine removal. Similarly, ibuprofen and naproxen were almost completely removed by
whole-cell WRF [237, 265, 273]. In contrast, their removal by crude and purified laccase was in
the range of 10 to 40% [229, 266, 306, 314]. Since both naproxen and ibuprofen are hydrophilic
compounds (log D <3), role of biosorption in their removal would be limited. However, almost
complete removal of these compounds by whole-cell WRF substantiates the role of mycelium
bound and/or or intercellular enzymes. Indeed, the role of intercellular enzyme (i.e., cytochrome
P450) in the degradation of naproxen, diclofenac and carbamazepine has been demonstrated [247,
265, 330]. These studies showed that naproxen, diclofenac and carbamazepine were partially
removal (15-50%) in the presence of cytochrome P450 inhibitor during whole-cell WRF treatment.
63

Therefore, it can be concluded that high removal of some TrOCs in whole-cell WRF treatment is
due to the synergetic effects of extracellular, intercellular and/or mycelium bound enzymes.
Moreover, secretion of natural mediators may also help in enhancing the removal of these
compounds.
2.4.2.7. Degradation pathways, identification of intermediates and toxicity
TrOCs degradation pathways and their intermediate products have been identified for some
compounds such as carbamazepine, diclofenac, triclosan and ibuprofen. However, each WRF
species may follow a different degradation pathway.
Fungal mediated treatment of diclofenac starts with the conversion of the hydroxyl group in its
structure into an intermediate product, namely, hydroxy diclofenac. Hydroxy diclofenac can be
amenable to further fungal biodegradation [330, 331]. In vivo and in vitro experiments for the
degradation of diclofenac showed that laccase (T. versicolor)-catalyzed degradation leads to the
formation of biodegradable compounds such as: (i) hydroxelated metabolites (appeared in both in
vivo and in vitro experiments); and (ii) 4-(2,6 dichlorophenylamino)-1,3-benzenedimethanol
metabolite (appeared only in in vivo experiments) [331]. Diclofenac and its metabolites both
disappeared after 24 h of incubation, reducing the ecotoxicity of the treated effluent. Degradation
of ketoprofen was reported to initiate by the intercellular cytochrome P450 that converts
ketoprofen into (2-[3-(4-hydroxybenzoyl)phenyl]-propanoic acid) and (2-[(3-hydroxy(phenyl)methyl)phenyl]-propanoic acid) via hydroxylation and reduction of the ketone group, respectively
[331]. Moreover, it was also observed that the role of extracellular enzyme (laccase) in the
degradation of ketoprofen was insignificant.
Both laccase and cytochrome P450 can catalyze the degradation of naproxen in WRF based
treatment. Formation of two intermediates, namely 6-desmethylnaproxen and 1-(6methoxynaphthalen-2-yl)ethanone), was observed possibly via P450-mediated desmethylation and
laccase catalysis, respectively [265, 272]. Moreover, naproxen and associated intermediates were
completely removed from the reaction media and the treated effluent was non-toxic [265].
Ibuprofen conversion predominantly starts with the formation of hydroxy-ibuprofen via
hydroxylation. Marco-Urrea et al. [332] investigated the degradation pathways of ibuprofen by
WRF T. versicolor. They observed that oxidation of isopropyl chain resulted in the formation of
1-hydroxy ibuprofen and 2-hydroxy ibuprofen. These intermediates were then degraded by T.
versicolor to 1,2-dihydroxy ibuprofen, which was not further degraded. Hence, the ecotoxicity of
treated effluent was higher than that of the initial solution [332].
Degradation pathways for carbamazepine by different whole-cell WRF including T. versicolor and
P. ostreatus have also been studied. These have identified several stable intermediate products
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namely, 10,11-dihydro-10,11-dihydroxy-carbamazepine, acridine, acridone and 10,11-epoxycarbamazepine. Interestingly, the treated effluent showed less toxicity [247, 268].
Intermediates or metabolites of triclosan during whole-cell treatment depends on WRF species.
Major intermediates of triclosan during the treatment with C. polyzona WRF were dimer, trimer
and tetramer [333], while 2-O-(2,4,4-trichlorodiphenyl ether)-b-D-xylopyranoside, 2-O-(2,4,4trichlorodiphenyl ether)-b-D-glucopyranoside and 2,4-dichlorophenol were identified as major
intermediates following its treatment with T. versicolor [334].

2.4.3. Impacts of physicochemical characteristics of wastewater on TrOC removal
Performance of WRF in wastewater treatment depends on several factors such as environmental
conditions and physiochemical properties of the wastewater as well as the properties of TrOCs.
Influence of TrOC properties on their overall removal in a WRF mediated treatment process has
been comprehensively reviewed previously by Asif et al. [329]. Briefly, physicochemical
properties of water/wastewater such as pH, temperature and the presence of dissolved organic
and/or inorganic compounds may influence the performance of both WRF and their ligninolytic
enzymes. Because information about these properties are vital to design and optimize WRF- and
enzyme-based treatment systems, these are discussed in this section.
The operating temperature not only affects the stability of WRF/enzymatic systems but also the
rate of reaction. It is believed that the rate of reaction increases with increase in temperature [309].
However, depending on the WRF strain, rapid thermal inactivation of ligninolytic enzymes has
been observed at temperature above 40oC [335, 336]. Only a few studies have investigated the
impact of temperature on enzymatic activity and removal efficiency in a reaction media. For
instance, increase in temperature of the reaction media from 20 to 25oC enhanced the removal
efficiency of chlorophenols in laccase-mediated treatment system [337]. Similarly, Ullah et al.
[338] investigated the removal of pentachlorophenol by varying the temperature from 10 to 45 oC
and found that the optimal temperature was 25oC to achieve maximum laccase activity and
pentachlorophenol removal. Temperature range of 37-40 oC has been reported to achieve optimal
activity of MnP and LiP [308, 339].
The pH for optimum activity can vary depending on the source of enzyme. For instance, laccases
extracted from Pleurotus ostreatus [340], Trametes versicolor [341], and Albatrella dispansus
[342] have been reported to show maximum laccase activity at a temperature of 35, 50 and 70 oC,
respectively. However, in general, the optimum temperature for most fungal laccases and
peroxidases ranges from 25-30oC and 35-40oC, respectively [308, 337, 339]. Depending on the
source fungus, the optimum pH for high and stable laccase activity ranges from 3.5 – 6.0 [343].
For example, the optimum pH for activity of laccase from Trametes versicolor [344, 345],
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Physisporinus rivulosus [346] and Agaricus blazei [347] was 3.0-4.5, 4.0 and 5.5, respectively.
Best removal of TrOCs ubiquitously detected in wastewater such as triclosan, diclofenac,
ketoprofen and bisphenol A was achieved at pH range of 4.0-6.0 [233, 303, 311, 315, 348, 349].
The optimum pH varies for different types of TrOCs due to the difference between the redoxpotential of the TrOC and enzymes [350, 351]. In general, removal of TrOCs at varying pH results
in a bell-shaped curve because TrOC removal reduces with the increase in the pH of the reaction
mixture [303, 348]. Reduction in the removal of TrOCs with the increase in pH can be attributed
to: (i) the change in the redox-potential of enzymatic reactions; and (ii) the binding of hydroxide
ions to Type II and Type III copper sites of laccase at alkaline pH, thereby blocking the internal
electron transfer [352, 353].
Fungal/enzymatic bioreactors have mostly been studied for the treatment of synthetic wastewater
spiked with TrOCs in absence of potential inhibiting compounds prevalent in real wastewater [222,
324]. However, wastewater derived interfering compounds can affect the stability and catalytic
efficiency of WRF and ligninolytic enzymes [354, 355]. Many compounds such as sulphides,
halides [350, 356], natural/synthetic organics [357-362] and heavy metals [231, 363] can inhibit
the catalytic activity of laccases [364]. Moreover, each compound may have different mode of
laccase inhibition. For instance, fatty acids inhibit laccase catalytic potential by blocking the
binding sites for phenolic substrates [365-367]. On the other hand, spectrophotometric assays,
electron spin resonance spectroscopy and catalytic voltammetry analysis confirmed that anionic
inhibitors such as halides and sulphides could block the access to the active copper sites in laccase
[368-370]. Among anionic inhibitors, fluoride and azide are the most effective and can rapidly
reduce the catalytic activity of laccase by 50% even at µM concentrations [371]. Although
inhibition of laccases by halides can proceed in the following order: fluoride > chloride > bromide,
the concentration of halides required to inhibit laccases varies, with no fixed correlation with their
inhibition potential. For instance, chloride concentration ranging from 100 µM – 100 mM may
cause a 50% drop in activity of laccase from different species [242, 372].

2.4.4. TrOC removal by enzymatic membrane bioreactor (EMBR)
Enzyme washout had been the major limitation of enzyme applications in continuous-flow
reactors. These limitation can be solved by immobilizing enzyme onto a support material [319,
373] or by coupling the enzymatic bioreactor with a membrane [229, 374]. Compared to enzyme
immobilization, an EMBR offers several benefits over immobilized enzyme including ease of
operation and maintenance as well as limited mass transfer limitation.
Lloret et al. [243] investigated the removal of two estrogens (estrone and 17β-estradiol) by using
a suspension of a commercially available laccase from M. thermophila in the EMBR. The UF
membrane (MWCO of 10 kDa), which was submerged in the enzymatic bioreactor, effectively
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retained the enzyme. The EMBR effectively removed to (64 – 100%) estrone and 17β-estradiol at
an enzymatic activity of 500 U/L. In addition to the high removal efficiency, the EMBR effectively
reduced estrogenic activity to 97%. Similarly, Nguyen et al. [229] investigated the removal of 30
TrOCs in UF-EMBR using purified laccase from A. oryzae. They observed that the removal of
phenolic TrOCs with EDGs ranged from 70 to 99%, while the removal of phenolic TrOCs with
EWGs was in the range of 25 to 50%. On the other hand, removal of tested non-phenolic
compounds were generally poor (i.e. 5-20%) expect for a few non-phenolic TrOCs namely,
benzophenone (75%), amitriptyline (95%), octocrylene (99%) and diclofenac (45%) [229]. A list
of EMBR studies for the removal of TrOCs is presented in Table 2.9.
Denaturation of enzyme (i.e., loss of enzymatic activity) has been observed during the operation
of EMBR. Denaturation of enzyme may be due to various factors including physicochemical and
biological inhibitors. Denaturation of enzyme can lead to the reduction in the removal of TrOCs
by the EMBR system. Reduction in enzymatic activity has been observed in several studies [229,
303, 375]. Thus, periodic enzyme addition may be necessary to maintain stable enzymatic activity
and TrOC removal. Hata et al. [375] re-injected laccase every 8 h to the bioreactor to enhance the
performance of the laccase-catalyzed treatment system. Similarly, Nguyen et al. [229] re-injected
laccase every 12 h to maintain laccase activity in an UF-EMBR.
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Table 2.9. Details of the selected studies for the removal of TrOCs by EMBR
Laccase
(µM/min)

Reactor
volume (L)

HRT
(h)

pH

Temperature
(oC)

UF Polyethersulfone
(10 kDa)

500, 100

0.25

1, 4

7

26

UF Polyethersulfone
(10 kDa)

500

0.25

2, 4

4, 7

25

90

1.5

8

6.8

28

TrOCs (0.5 mg/L each) in Milli-Q water

[303]

180

1.5

8

6.8

28

TrOCs (0.005 mg/L each) in Milli-Q water

[229]

90

1.5

8

6.8

28

TrOCs (0.25 and 0.5 mg/L each) in Milli-Q
water

[306]

NA

2

24

7

25

TrOCs (20 mg/L each) in deionized water

[377]

0.42

0.04

24

5.5

22

TrOCs (35 mg/L each) in water buffered with
100 mM acetate

[378]

Membrane type (MWCO)

UF Polyacrylonitrile
(6 kDa)
UF Polyacrylonitrile
(6 kDa)
UF Polyacrylonitrile
(6 kDa)
Laccase-grafted ceramic
membrane (0.2 and 1.4 µm)
Laccase on TiO2 coated on
PVDF membrane
“NA”: not available
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Wastewater composition
TrOCs (4 mg/L each) in water buffered with
100 mM sodium phosphate
TrOCs (4 mg/L each) in water buffered with
100 mM sodium acetate at pH 4 and with 100
mM sodium phosphate at pH 7

References
[243]
[376]

Interestingly, during the operation of UF-EMBR, removal of some TrOCs such as naproxen,
oxybenzone and pentachlorophenol was better as compared to batch experiments as explained
here [306, 374]. Although a direct comparison between batch and continuous experiments may
not be valid, TrOC removal data obtained from batch enzymatic bioreactor and UF-EMBR
(Figure 2.16) indicates two distinct pattern: (i) significant improvement (40-90%) in the
removal of some phenolic TrOCs such as amitriptyline, benzophenone and octocrylene and
some phenolic TrOCs such as oxybenzone, pentachlorophenol, and salicylic acid during the
operation of UF-EMBR, and (ii) 5-20% reduction in the removal of some phenolic compounds
such as estrone, 17β – estradiol and bisphenol A.
Improvement in the removal of some non-phenolic and phenolic compounds was attributed to
retention of these compounds on enzyme gel-layers formed on the surface of the membrane
during EMBR operation [229]. Since laccase is negatively charged at pH ≥6, formation of an
enzyme gel-layer may have converted the membrane surface from an uncharged to a partially
charged membrane. Although ultrafiltration membrane used by Nguyen et al. [229] was not
expected to retain TrOCs via size exclusion mechanism, enhanced removal of some TrOCs can
be attributed to: (i) adsorption of hydrophobic TrOCs (log D>3) onto enzyme gel-layers; and
(ii) non-hydrophobic interaction (e.g., electrostatic interaction) between ionizable TrOCs and
negatively charged membrane surface. For instance, removal of the significantly hydrophobic
nonphenolic TrOCs such as benzophenone (log D=3.46), octocrylene (log D=5.18) and
oxybenzone (log D=3.21) in EMBR improved, possibly due to their adsorption onto enzyme
gel-layer (Figure 2.16). However, significantly hydrophobic solutes adsorbed on membrane
surface could diffuse in permeate to attain the equilibrium. This phenomenon has commonly
been reported for nanofiltration and forward osmosis membranes [379, 380] but could be
possible in ultrafiltration membranes as well [381, 382]. The evidence (Figure 2.16) suggests
that diffusion in to permeate can be the reason of reduction in the removal of a few hydrophobic
phenolic TrOCs such as estrone, 17β – estradiol and bisphenol A. Moreover, reduction in their
removal can also be attributed to the continuous loading of TrOCs in EMBR [229, 243].
Electrostatic interactions between charged membrane and ionizable TrOCs are strongly
influenced by solution pH and dissociation constant (pKa) of compounds [383]. For instance,
Nghiem et al. [167, 384] observed that the rejection rate of hydrophilic pharmaceuticals (log
<3) via charge repulsion by a negatively charged loose NF membrane was increased at pH>pka
due to the transformation of compounds from neutral to negatively charged species. Since
EMBR was operated near neutral pH i.e., 6.8-7 [229, 306], removal of hydrophilic compounds
such as ibuprofen (pKa=4.41), naproxen (pKa =4.84), ketoprofen (pKa =4.23) was possibly
improved due to their conversion from neutral to negatively charged species. It was also
confirmed that the retained TrOCs were subsequently degraded in EMBR [229], indicating that
retention of both enzyme and TrOCs is important to enhance the removal of TrOCs in EMBR.
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Despite all the possible explanations, change in membrane properties and impacts on TrOC
removal due to the formation of enzyme gel layer need focused and thorough investigations.
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Figure 2.16. Removal of TrOCs in batch enzymatic bioreactor and continuous-flow EMBR.
Numbers within parenthesis indicates number of data point (nEMBR +nbatch laccase). Error bars
represent standard deviation among data points. E1: Estrone; E2: 17β – Estradiol; EE2: 17α –
ethinylestradiol. The data is extracted from the studies listed in Table 2.9.
As noted in section 2.3, activated sludge-based HR-MBR provides excellent removal of TrOC
based on the effluent quality, however the biodegradation of TrOC in the bioreactor is
comparable to that achieved by CAS process and/or MBR, leading to the accumulation of
TrOCs in the bioreactor of HR-MBR. Therefore, WRF or their ligninolytic enzymes having
stronger biodegradation capacity than the activated sludge should be investigated for the
biodegradation of TrOCs. Based on the impact of membrane retention in conventional UFEMBR, it can be postulated that that the coupling of an enzymatic bioreactor with a high
retention membrane process may facilitate the degradation of recalcitrant compounds by
retaining both enzyme and TrOCs.

2.4.5. Improvement in the performance of EMBR with redox-mediators
Laccase catalyzes mono-electronic oxidation of TrOCs. However, the extent of removal
depends on the ORP of the enzyme and individual TrOCs. Poor removal of non-phenolic
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TrOCs can be attributed to: (i) presence of a strong EWG in the structure of non-phenolic
compounds, causing steric hindrance; and (ii) higher ORP of non-phenolic compounds than
laccase [313]. Removal of non-phenolic compounds can be enhanced by introducing a lowmolecular weight redox-mediator. In a redox-mediator catalyzed system, highly reactive
radicals are formed due to the oxidation of a mediator by laccase, and these radicals then serve
as an electron transfer shuttle between TrOCs and laccase, facilitating enhanced removal of
recalcitrant compounds. Three oxidation mechanisms, namely hydrogen atom transfer (HAT),
ionic mechanisms and electron transfer have been reported for mediators. For instance, 1hydroxybenzotriazole (HBT) and syringaldehyde (SA) follow HAT mechanism, while 2,2azino-bis(3-ethylbenzothiazoline)-6-sulfnoic
acid
(ABTS)
and
2,2,6,6tetramethylpiperidinyloxyl (TEMPO) follow electron transfer and ionic mechanisms,
respectively [310, 385].
Properties of different redox-mediators used to enhance the removal of different TrOCs are
summarized in Table 2.10. Although the mediators perform differently, two mediators namely
HBT and SA have been commonly used to broaden the spectrum of compounds significantly
degraded by laccase. Studies involving these mediators confirmed that they not only improved
the ORP of reaction media but also the extent of removal. Only a few studies elucidated the
performance of different mediators based on the type of substrate (i.e., phenolic vs. nonphenolic). For instance, N=OH type mediators (VA and HBT) were found to achieve the best
removal of non-phenolic TrOCs such as clofibric acid, naproxen and carbamazepine, while SA
and ABTS performed better for phenolic compounds such as salicylic acid and steroid
hormones [229, 303, 306].
Table 2.10. Properties of redox-mediators used to improve the performance of laccase-based
treatment of TrOCs. Adapted from [295].
Redox-mediator

Type of mediator

Free radicals

Oxidation
mechanism

1-hydroxibenzotriazole
(HBT)

N-OH/ synthetic

aminoxyl

HAT

Violuric acid (VA)

N-OH/ natural

aminoxyl

HAT

N-hydroxyphthalimide
(HPI)

N-OH/ synthetic

aminoxyl

HAT

Syringaldehyde (SA)

C6H4(OH)(OCH3)/
phenoxyl
natural

HAT

Vanillin (VAN)

C6H4(OH)(OCH3)/
phenoxyl
synthetic

HAT

2,2,6,6tetramethylpiperidinyloxyl N – O / synthetic
(TEMPO)

Oxoammonium
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Ionic

Application for
TrOC removal
PPCPs,
EDCs,
pesticides
and
industrial chemicals
PPCPs,
pesticides
and
industrial
chemicals
PPCPs and pesticides
PPCPs,
EDCs,
pesticides
and
industrial chemicals
PPCPs,
EDCs,
pesticides
and
industrial chemicals
PPCPs,
EDCs,
pesticides
and
industrial chemicals

Redox-mediator
2,2-azino-bis(3ethylbenzothiazoline-6sulfnoic acid (ABTS)

Type of mediator
ABTS/ synthetic

Free radicals
ABTS+
ABTS++

Oxidation
mechanism

and Electron
transfer

Application for
TrOC removal
PPCPs,
EDCs,
pesticides
and
industrial chemicals

Mediator type, concentration and compound properties influence the performance of a redoxmediator. For instance, removal of diclofenac improved from 40 to 80% by increasing the
concentration of SA from 0.1 to 0.5 mM [314]. Similarly, Nguyen et al. [306] achieved an
improvement of 35% in the removal of diclofenac in an EMBR by increasing the dose of SA
from 0.01 mM to 0.1 mM. However, beyond a threshold concentration increasing redoxmediator dose may not improve the removal of TrOCs. For instance, Ashe et al. [310] observed
that increasing the concentration of VA and ABTS from 0.5 to 1 mM could not enhance the
removal of oxybenzone and naproxen. They also observed that removal of atrazine was reduced
by 15-25 % when the concentration of VA and HBT was increased from 0.1 to 0.25 mM. This
may be attributed to the complex interactions between laccase and the radicals generated due
to degradation of the mediator by laccase, as discussed below.
It has been observed in almost all the studies that enzymatic activity significantly drops with
the addition of mediators. For instance, Hata et al. [375] observed 90% decline in enzymatic
activity within fist 8 h of incubation in the presence of HBT. Similarly, rapid decline in
enzymatic activity was also observed with the addition of VA, HBT or ABTS [310]. Rate of
enzyme inactivation depends on the relative stability of the radicals generated by mediators. In
the absence of any known enzyme inhibitor, rapid enzyme inactivation in mediator catalyzed
system can be attributed to: (i) the blockage of active sites of the enzyme by charged radicals
and metabolites; and (ii) the reaction of metabolites with enzyme-active sites to convert them
into non-productive complexes [386, 387].
Despite rapid inactivation of enzymes, redox-mediators can compensate by enhancing the rate
of reaction, eventually achieving rapid and enhanced removal of TrOCs. However, periodic
replenishment of enzyme is needed to maintain the removal efficiency of TrOCs, constraining
the long-term operation of mediator-enzyme based wastewater treatment processes. Therefore,
selection of mediator type and its concentration is vital for effective and long-term operation
of such systems.

2.5. Performance of emerging advanced oxidation process
In addition to exploring the efficiency of enzymatic degradation, this thesis has explored
combined application of enzymatic and emerging advanced oxidation processes (AOPs). In
line with this, performance of emerging AOPs such as persulfate (PS) oxidation process is
reviewed and is briefly presented in this section.
Due to their molecular properties, conventional biological processes are not effective for a wide
range of TrOCs (see Section 2.3). On the other hand, despite the effective removal of TrOCs
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by NF/RO membrane filtration, an additional step is required for the treatment of the produced
concentrate. In this context, it is noteworthy that advanced oxidation processes (AOP) may
achieve effective degradation of TrOCs, and may degrade pollutants causing membrane
fouling. Notably, post treatment of biologically treated wastewater by AOPs may
simultaneously achieve disinfection and TrOC removal [388]. Among the advanced oxidation
processes, ozonation has been mostly investigated for TrOC removal [389, 390]. However,
ozone residuals may interact with membrane material, and can reduce the membrane lifetime
[391]. Activated PS is an emerging advanced oxidation process that can degrade both natural
organic matter and recalcitrant TrOCs [392, 393].
PS is stable at room temperature, but can be activated by various agents such as transition
metals (e.g., iron), heat, and ultraviolet (UV) light to form one or more sulphate radicals (SO4–
•
), which are highly reactive [392]. PS activation by heat and UV light produce two SO4– •
radicals (Equation 1), while only one SO4– • radical is generated following activation by
transition metals such as Fe2+ (Equation 2). This indicates that activation by heat or UV light
may provide more efficient treatment compared to activation by a transition metal [392, 394].
𝑆2 𝑂8 2− + ℎ𝑒𝑎𝑡 𝑜𝑟 𝑈𝑉 𝑙𝑖𝑔ℎ𝑡 → 2 𝑆𝑂4 2−.

Eq. (1)

𝑆2 𝑂8 2− + 𝐹𝑒 +2 → 𝐹𝑒 +3 + 𝑆𝑂4 2−.

Eq. (2)

Depending on wastewater characteristics, persulfate or SO4–• radicals may react with water
and/or organics to form secondary radicals that can also contribute to degradation of organic
impurities [392, 395]. SO4–• radicals can react with water to form hydroxyl (OH–•) radicals, but
the abundance of the SO4–• and OH–• radicals is governed by the pH of reaction media. Under
acidic conditions (pH<7), SO4–• radicals are the dominant species, while OH–• is the primary
reactive species under basic conditions (pH>7). At neutral pH, both SO4–• and OH–• radicals
contribute equally to pollutant degradation [396].
Literature on the degradation of TrOCs by activated PS is scarce, and to date has been generally
focused on PS activation routes in the presence of a single TrOC. Previously, the combined
peroxymonosulfate (50 µM) – Fe2+ (50 µM) process achieved above 99% degradation of
atrazine, outperforming atrazine removal by coagulation [397]. Heat activated PS has been also
reported to achieve 40-100% removal of a few investigated TrOCs such as atrazine, aniline,
monochlorobenzene and 2,4-dichlorophenol [392]. Deng et al. [398] reported only 12%
degradation of carbamazepine following 2 h treatment with heat-activated PS at a PS
concentration and operating temperature of 1 mM and 40ºC, respectively. In a study by Ji et al.
[399], PS (1 mM) activated by heat at 40ºC achieved 20% atrazine degradation after an
incubation time of 120 h. Ji et al. [400] observed complete degradation of the antibiotic
sulfamethoxazole within 8 h at 50ºC. These previous experiments were done in batch mode.
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Instead of a single TrOC, performance of activated PS for the degradation of a wide range of
TrOCs in their mixture should be assessed. In addition to TrOC degradation, PS activated by
UV light was reported to control fouling during the treatment of surface water by an
ultrafiltration membrane [401]. In another study by Chen et al. [397], fouling of an
ultrafiltration membrane caused by humic substances and sodium alginate was significantly
reduced by peroxymonosulfate activated by Fe2+.
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Chapter 3: TrOC removal by a high retention
nanofiltration vs. ultrafiltration enzymatic
membrane bioreactor (UF- vs. NF-EMBR)
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3.1. Introduction
Trace organic contaminants (TrOCs) such as pharmaceuticals, pesticides, steroid hormones and
industrial chemicals are commonly detected in different environmental systems including
surface water and groundwater due to the discharge of secondary treated wastewater [1, 2]. In
addition, agricultural run-off, combined sewer overflow and stormwater run-off can
significantly increase the concentration of TrOCs in freshwater bodies [2, 3]. Since TrOCs can
be potentially harmful to the aquatic ecosystem and human health [4], an efficient treatment
system is required for effective TrOC removal.
Conventional activated sludge process and membrane bioreactors (using micro- or
ultrafiltration membranes) have been reported to be ineffective for the removal of TrOCs [5,
6]. Bioreactors equipped with high retention membranes (e.g., nanofiltration or membrane
distillation) can be a promising alternative. Among different types of high retention membrane
separation processes, nanofiltration (NF) membranes have been studied extensively for the
removal of TrOCs from secondary treated wastewater and freshwater [7-10]. Following
membrane separation, an additional process is required for the treatment of the membraneconcentrate containing high concentrations of TrOCs. Instead of providing a separate treatment
process for the degradation of TrOCs, it is a sensible approach to integrate a TrOC degradation
process with the NF membrane. In this context, an enzymatic bioreactor can be combined with
an NF membrane, which will provide complete retention and TrOC biodegradation in a single
step. TrOC degradation by fungal enzymes in enzymatic bioreactors is a promising eco-friendly
technique. Enzyme-catalyzed degradation of TrOCs by fungal enzymes does not produce
secondary toxic sludge, which is a key attribute of physicochemical treatment processes [11,
12]. Among different fungal enzymes (e.g., lignin peroxidases and manganese peroxidase),
laccase is interesting as it does not require an external co-factor such as hydrogen peroxide
(H2O2) to catalyze the degradation or oxidation of TrOCs [13]. Laccase-catalyzed degradation
process typically involves the transfer of an electron from a substrate to the active sites of
laccase followed by conversion of dissolved oxygen to water [14, 15]. The characteristics of
active sites of laccase have been studied by using a combination of spectroscopic and
crystallography techniques [16, 17]. Briefly, laccase active sites consist of four copper atoms,
and can be classified into following categories: (i) Type 1 containing one copper atom; (ii)
Type II containing one copper atom; and (iii) Type III containing a pair of copper atoms.
During the degradation process, reduction of Type I copper site occurs due to the transfer of an
electron from a substrate to the laccase. This promotes the transfer of an electron to Type II
and Type III active sites where dissolved oxygen is reduced, and release of water takes place
[15, 17].
Performance of laccase is governed by the operating conditions (e.g., pH and temperature) and
molecular properties of pollutants (e.g., molecule structure and hydrophobicity). Typically,
laccase can efficiently catalyze the degradation of TrOCs containing strong electron donating
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functional groups (EDGs) such as hydroxyl (–OH) and amine (–NH) functional groups. By
contrast, degradation of TrOCs containing strong electron withdrawing functional groups
(EWGs) such as amide (–NH2) and halogen (–X) is incomplete [11, 18, 19]. To improve the
degradation of resistant TrOCs, a low molecular weight redox-mediator can be introduced in
the enzymatic bioreactor. Redox-mediators are readily oxidized by laccase and produce highly
reactive radicals that can either directly degrade or polymerize resistant TrOCs [20].
Performance of laccase for TrOC removal has been predominantly studied by operating the
enzymatic bioreactor in batch mode to avoid enzyme washout. This issue has been addressed
by coupling an ultrafiltration (UF) membrane to an enzymatic bioreactor to effectively retain
the enzyme [21, 22]. Notably, the UF membrane integrated with an enzymatic membrane
bioreactor (EMBR) can effectively retain laccase but are not expected to retain TrOCs via size
exclusion. During the filtration of bioreactor media, an enzyme gel-layer was reported to be
formed on the membrane surface, which partially retained the resistant TrOCs. Due to the
prolonged contact time between TrOCs and laccase, the retained TrOCs were demonstrated to
be degraded by laccase. This improved the overall performance of UF-EMBR [23]. Based on
this observation, it can be envisaged that the simultaneous retention of laccase and TrOCs could
facilitate degradation. However, this has not been systematically investigated by integrating an
enzymatic bioreactor with a high retention NF membrane, which will retain both laccase and
TrOCs, or a conventional UF membrane, which will only retain laccase but not TrOCs.
To-date, the performance of the NF based enzymatic membrane bioreactor (NF-EMBR) has
been reported only once in available literature [24]. In the first study by Escalona et al. [24],
removal of an industrial chemical (bisphenol A) by NF-EMBR was studied over a short
duration of only 5 h by operating the NF-EMBR in full batch or recirculation mode [24].
Because the available studies focused on only one compounds, it is imperative to investigate
the degradation of a broad spectrum of pollutants at the environmentally relevant concentration
for elucidating the role of simultaneous TrOC and laccase retention on the performance of an
EMBR.
In this chapter, the degradation of a set of 29 chemically diverse TrOCs in an enzymatic
bioreactor coupled to the NF membrane (NF-EMBR) was assessed. To demonstrate the impact
of effective TrOC retention on degradation, the performance of a “control” UF based EMBR
that can only retain laccase but not TrOCs, was investigated and compared to that achieved by
NF-EMBR. Importantly, the factors governing the performance of NF and UF membranes as
well as laccase were studied. This facilitated in elucidating the mechanism responsible for
better TrOC degradation in the NF-EMBR. To further improve the degradation of TrOCs,
impact of a naturally occurring redox-mediator (violuric acid) at different concentrations was
systematically studied. Finally, variations in membrane flux and changes in membrane
properties were assessed and explained.
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3.2. Hypothesis
▪
▪

Simultaneous retention of laccase and TrOCs by the high retention NF membrane will
facilitate degradation
Physciochemical properties, particularly chemical structure may govern TrOC removal
by laccase and membranes

3.3. Materials and methods
3.3.1. Enzyme solution, redox-mediator and trace organic contaminants
Laccase from genetically modified Aspergillus oryzae supplied by Novozymes Australia Pty.
Ltd. (Sydney, NSW, Australia) was used. According to the supplier, w/w composition of
enzyme solution was as follows: 66% water, 25% propylene glycol, 4% glucose, 3% laccase
and 2% glycine. The purpose of adding propylene glycol, glucose and glycine is to stabilize
the enzyme solution. The enzyme solution had an enzymatic activity of 190,000 µM(DMP)/min,
which was measured before the commencement of this experiment by using 2,6-dimethoxy
phenol (DMP) as substrate at room temperature and pH =4.5 (see Section 3.3.4.2).
A naturally occurring redox-mediator, namely violuric acid (VA), was used because it has been
reported to significantly improve degradation of TrOCs that are resistant to laccase-catalyzed
degradation [25, 26]. Analytical grade VA was purchased from Sigma Aldrich (Sydney, NSW,
Australia). A stock solution of VA was prepared in Milli-Q water and stored at -4 ºC in dark.
Various categories of TrOCs such as pharmaceuticals, personal care products, pesticides,
steroid hormones and industrial chemicals are ubiquitously detected in freshwater bodies [2].
Therefore, synthetic wastewater was prepared by adding a mixture of 29 TrOCs in Milli-Q
water at a concentration of 5 µg/L to stimulate the composition of TrOCs in environmental
systems. These TrOCs include ten pharmaceuticals, seven pesticides, five naturally-occurring
steroid hormones, three industrial chemicals, three ingredients of personal care products and
one phytoestrogen (see Appendix Table 3-1). Relevant physicochemical properties of TrOCs
are given in Table 3.1. Analytical grade TrOCs (purity >98%) were purchased from Sigma
Aldrich (Sydney, NSW, Australia), and a stock solution containing the mixture of 29 TrOCs
was prepared in methanol. The stock solution was stored at – 18 ºC in dark for use within one
month.
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Table 3.1. Physicochemical properties of the selected 29 TrOCs
TrOCs

Chemical
formula

Molecular
weight (g/mol)

Log D
at
pH=7

pKa

Charge at
pH=7

214.65
171.15
269.51
254.28
230.26
218.25
206.28
209.24
296.15
236.27
250.33
277.4

-1.06
-0.14
-0.13
0.19
0.73
0.83
0.94
1.54
1.77
1.89
2.07
2.28

3.18
14.44
2.93
4.23
4.84
12.26
4.14
12.28
4.18
13.94
4.75
9.18

-ve
Neutral
-ve
-ve
-ve
Neutral
-ve
Neutral
-ve
Neutral
-ve
Neutral

191.3

2.42

1.37

-ve

215.68
227.33
182.22
361.48

2.64
2.97
3.21
6.89

2.27
3.71
7.5
-

-ve
-ve
Neutral
-

138.12
298.33
288.38
266.34
150.22
270.37
228.29
269.4
272.38
314.42
206.32
289.54

-1.13
1.89
2.53
2.85
3.4
3.62
3.64
4.11
4.15
5.11
5.18
5.28

3.01
10.25
9.93
4.68
10.13
10.25
10.29
10.24
10.27
10.26
10.15
7.8

-ve
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral
Neutral

Non-phenolic TrOCs
Clofibric acid
C10H11ClO3
Metronidazole
C6H9N3O3
Fenoprop
C9H7Cl3O3
Ketoprofen
C16H14O3
Naproxen
C14H14O3
Primidone
C12H14N2O
Ibuprofen
C13H18O2
Propoxur
C11H15NO3
Diclofenac
C14H11Cl2NO2
Carbamazepine
C15H12N2O
Gemfibrozil
C15H22O3
Amitriptyline
C20H23N
N, N-Diethyl-meta-toluamide
C12H17NO
(DEET)
Atrazine
C8H14ClN5
Ametryn
C9H17N5S
Benzophenone
C13H10O
Octocrylene
C24H27N
Phenolic TrOCs
Salicylic acid
C7H6O3
Estriol
C18H24O3
Enterolactone
C18H18O4
Pentachlorophenol
C6HCl5O
4-tert-Butylphenol
C10H14O
Estrone
C18H22O2
Bisphenol A
C15H16O2
17α– Ethinylestradiol
C20H24O2
17β–Estradiol
C18H24O2
17β-Estradiol-17-acetate
C20H26O3
4-tert-Octylphenol
C14H22O
Triclosan
C12H7Cl3O2

Note: Data collected from SciFinder database, Taheran et al. [9]; and Fujioka et al. [27]

3.3.2. Experimental setup
A laboratory-scale cross-flow filtration system coupled to an enzymatic bioreactor (3 L) was
used in this experiment (Figure 3.1). A detailed description of the filtration system is given
elsewhere [27]. Briefly, this system mainly consists of a stainless-steel enzymatic bioreactor,
high-pressure pump (Hydra-Cell, Wanner Engineering Inc., Minneapolis, MN, USA), stainless
steel membrane cell, and bypass and back-pressure valves (Swagelok, Solon, OH, USA). The
membrane cell with a channel height of 2 mm holds the flat-sheet NF or UF membrane with a
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surface area of 40 cm2. A digital flow meter (FlowCal, GJC Instruments Ltd, Chester, CH, UK)
was connected to the permeate line for monitoring the permeate flux. The cross-flow velocity
and temperature were maintained at 40.2 cm/s and 25 °C, respectively in all experiments.

Figure 3.1. Schematics of the lab-scale cross-flow filtration system attached to an enzymatic
bioreactor operated in full recirculation mode (a) and continuous-flow mode (b). Arrows show
the direction of flow. Laccase retention was first confirmed with a short term (i.e., 24 h) study
in full recirculation mode. Further operation of EMBRs were conducted in continuous-flow
mode for assessing the impact of TrOC retention on their degradation. Cf, CEBR and Cp are the
concentration (µg/L) of a specific TrOC in the feed, enzymatic bioreactor and permeate,
respectively. Vf, VEBR and Vp represent the volume of feed, enzymatic bioreactor and permeate,
respectively. A picture of lab-scale EMBR is shown in Appendix Figure 3-2.
Commercially available flat-sheet UF and NF membranes were used in this experiment. The
UF membrane was purchased from Sterlitech (WA, USA). The active layer of the UF
membrane is made of polyvinylidene fluoride (PVDF), and its molecular weight cut-off
(MWCO) is 30,000 Da. The UF membrane was not expected to retain TrOCs by size exclusion,
because the molecular weight of the selected TrOCs ranged between 138-361 Da (Table 3.1).
On the other hand, the NF membrane (NF90, Dow chemicals, MI, USA) had an MWCO of 200
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Da. It was a polyamide thin film composite (TFC) membrane that has been studied extensively
for the rejection of recalcitrant pollutants from surface water and secondary treated wastewater
[9]. However, the performance of the polyamide-TFC NF membrane has not been studied for
the removal of TrOCs following its integration with an enzymatic bioreactor.

3.3.3. Enzymatic membrane bioreactor operation and experimental protocols
Each experiment was initiated with membrane compaction. The NF membrane was compacted
at a pressure and cross-flow velocity of 10 bar and 40.2 cm/s, respectively, using Milli-Q water
until the permeate flux stabilized at around 7 L/m2 h. Similarly, the UF membrane was also
compacted but without applying any pressure. This is because the cross-flow velocity of 40.2
cm/s was enough to generate a permeate flux equivalent to that achieved by the NF membrane.
A series of experiments were conducted by operating UF/NF-EMBR separately to assess:
TrOC degradation by laccase; and TrOC removal by the UF and NF membrane. This exeriment
has two parts – (i) proof of the concept preliminary run: the performance of NF vs. UF coupled
EMBRs for the degradation of only five TrOCs; and (ii) comprehensive run: the performance
of NF vs. UF coupled EMBRs for the degradation of a broad spectrum of TrOCs. Experimental
protocoals for both runs are explained separately in the following sections.
3.3.3.1. Preliminary assessment of NF vs. UF coupled EMBRs
The working volume of the enzymatic bioreactor was kept at 3 L in all experiments. In full
recirculation mode, UF/NF-EMBRs were operated for a period of 24 h, and the membrane
permeate was continuously returned back to the enzymatic bioreactor. The NF-EMBR was
operated at a pressure of 8 bar and cross-flow velocity of 40.2 cm/s, which corresponds to an
initial permeate flux of 6.9 L/m2 h bar. Laccase was directly added to the enzymatic bioreactor
to achieve an initial laccase activity of 180-185 µM(DMP)/min. This laccase activity was selected
based on that reported for previously developed UF-EMBRs [22, 28]. Stock solution containing
the TrOC mixture was added to the enzymatic bioreactor to obtain a concentration of 1000
µg/L of each TrOC. However, the actual initial measured concentrations of atrazine,
carbamazepine, sulfamethoxazole, diclofenac and oxybenzone were 1100±20, 1050±40,
1120±80, 1070±40 and 1000±30 μg/L (n=4), respectively.
All operating parameters for UF-EMBR were identical to that of NF-EMBR except the applied
pressure as explained above. The EMBRs were first operated to confirm retention of laccase
and TrOCs by the membrane and check the stability of laccase during EMBR operation.
Duplicate samples were collected from the membrane permeate at 2, 4, 8 and 24 h for
measuring laccase activity and TrOC removal.
All the operating conditions in continuous-flow mode were same as described above for full
recirculation mode, except that the synthetic wastewater containing the mixture of TrOCs was
continuously fed into the enzymatic bioreactors at a loading rate of 1.44 mg/L.d for each TrOC.
A peristaltic pump (Masterflex, Vernon Hills, IL, USA) was used for continuous feeding.
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Based on the initial permeate flux of the membranes (i.e., 6.9 L/m2 h bar), the hydraulic
retention time (HRT) of the EMBRs was 16 h. The EMBRs were each operated continuously
for a period of 48 h (i.e., 3×HRT). During each run, duplicate samples were collected from the
enzymatic bioreactor and membrane permeate at specific intervals (i.e., 6, 12, 16, 24, 32, 38
and 48 h) for measuring laccase activity and TrOC removal. At the end of UF/NF-EMBR
operation, the clean water flux was measured for 1 h using Milli-Q water to assess membrane
fouling and flux recovery.
3.3.3.2. Assessment of NF vs. UF coupled EMBRs for broad spectrum of TrOCs
The NF-EMBR and UF-EMBR (“control”) were operated under continuous mode to
systematically investigate the effect of TrOC retention on their degradation. Under continuous
mode, the synthetic wastewater containing the mixture of TrOC in ultrapure Milli-Q water was
continuously fed to UF/NF-EMBR separately for a period of 68 h using peristaltic pumps
(Masterflex, Vernon Hills, IL, USA). Based on the initial permeate flux of the membranes, the
HRT for both EMBRs was approximately 16 h. Duplicate samples from enzymatic bioreactor
were collected at 32 and 68 h for analysis to assess TrOC degradation by laccase. At same
intervals (i.e., 32 and 68 h), duplicate samples from permeate were also collected to analyze
the overall removal of TrOCs (i.e., biodegradation+membrane retention). At the end of each
experiment, UF and NF membranes were backwashed with ultrapure Milli-Q water for 1 h,
and the clean water flux of the membranes was measured to assess flux recovery.
Redox-mediators are low molecular weight phenolic compounds that can facilitate the
degradation of TrOC by acting as an electron shuttle between laccase and target pollutant [20].
In this experiment, the NF-EMBR was operated with and without mediator dosing to
investigate the influence of mediator dosing on TrOC degradation. A single dose of violuric
acid (VA) was introduced at different concentrations (i.e., 10, 25, 50 and 100 µM) separately
to the NF-EMBR. Duplicate samples from enzymatic bioreactor and permeate were collected
at 32 and 68 h for TrOC analysis.
3.3.3.2.4. Laccase stability and maintenance in EMBRs
During the operation of EMBRs, laccase activity may diminish due to various physical,
chemical and biological inhibitors such as shear stress caused by membrane filtration [13, 29].
Moreover, the transformation products formed following TrOC degradation in an EMBR can
also inhibit laccase by blocking the active sites of enzymes [30]. Therefore, laccase activity
was regularly monitored during the operation of EMBRs. Based on laccase activity drop (see
Appendix Figure 3-3), a protocol of re-injecting a small dose of laccase (250 µL per litre of
bioreactor media) was developed to maintain a laccase activity of 170-185 µM(DMP)/min for
stable TrOC degradation.
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3.3.4. Analytical methods
3.3.4.1. TrOC analysis
During prelimnary assessment with five compounds, quantification of TrOCs was carried out
by using High-performance liquid chromatography (HPLC) (Shimadzu, Kyoto, Japan) at the
detection wavelength of 280 nm using a method reported previously [31]. Briefly, the HPLC
system was equipped with a UV-Vis detector and C-18 column (300×4.6 mm) having a pore
size of 5 μm (Supelco Drug Discovery, Sigma Aldrich, Sydney, NSW, Australia). Milli-Q
water buffered with 25 mM KH2PO4 and HPLC grade acetonitrile were used as the mobile
phase for TrOC quantification. Two eluents, namely eluent A (20% acetonitrile + 80% buffer,
v/v) and eluent B (80% acetonitrile + 20% buffer, v/v), were passed through the C-18 column
at a flow rate of 0.7 mL/min for 30 min in time dependent gradients as follows: [Time (min),
A (%)]: [0, 85], [8, 40], [10, 0], [22, 0], [24, 85]. The gradient of eluent B was then
automatically adjusted as follows: [Time (min), B (%)]: [0, 15], [8, 60], [10, 100], [22, 100],
[24, 15]. The limit of detection (LOD) for this method was approximately 10 µg/L.
During experiment with as broad spectrum of 29 compounds, TrOC concentration was
measured using a method previously described by Hai et al. [32]. This method involves the
extraction of TrOC by solid-phase extraction technique followed by their quantification using
a GC/MS system (QP5000, Shimadzu, Japan). TrOCs present in the feed, supernatant and
permeate samples were extracted using 6 mL 200 mg Oasis HLB cartridges (Waters, Milford,
MA, USA). The TrOC extraction procedure was as follows: (i) pre-conditioning of HLB
cartridge with 5 mL dichloromethane and methanol solution (1:1 v/v), 5 mL methanol and 5
mL Milli-Q water; (ii) loading of acidified (pH 2-2.5) samples onto the cartridges at a flow rate
of 1–4 mL/min; and (iii) drying of cartridges with nitrogen for 30 min. The TrOCs were
subsequently eluted from the cartridge using 5 mL of methanol followed by dichloromethane
and methanol mixture (1:1 v/v) at a flow rate of 1–4 mL/min. The effluent was subsequently
evaporated at 40 oC under a gentle stream of nitrogen. The residual after evaporation was redissolved in 200 µL methanol containing an internal standard (5 mg bisphenol A-d16) before
its transfer into 1.5 mL vials. The mixture present in 1.5 mL vials was again evaporated under
gentle stream of nitrogen. Finally, the extracts were derivatized by adding 100 µL of N,Obis(trimethylsilyl)trifluoroacetamide (1% trimethylchlorosilane) and pyridine (dried with KOH
solid), then heated on a heating block (60–70 oC) for 30 min. The derivatives were cooled to
room temperature and analyzed using the Shimadzu QP5000 GC–MS (Shimadzu, Kyoto,
Japan). The limit of detection (LOD) for this method is compound specific and ranged from 120 ng/L as listed in Appendix Table 3-1. Removal efficiency by laccase (Rdegradation) and the
membrane (Rmembrane) was measured as:
Rdegradation = 100 × (1 – CEBR/Cf)
Rmembrane+degradation = 100 × (1 – Cp/Cf)
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(1)
(2)

where, Cf, CEBR and Cp are the concentration (ng/L) of a specific TrOC in feed, enzymatic
bioreactor and permeate, respectively. The mass of TrOCs degraded by laccase was calculated
as follows:
Cf × Vf = (CEBR × VEBR) + (Cp × Vp) + biodegradation/biotransformation
(3)
where, Vf, VEBR and Vp represents the volume of feed, enzymatic bioreactor and permeate,
respectively.
3.3.4.2. Laccase activity assay and ORP
Laccase activity was measured by using a method previously reported by Paszczynski et al.
[33]. Briefly, the change in absorbance of 2,6-dimethoxyl phenol (DMP) in sodium citrate
buffer (pH = 4.5) was recorded over a duration of 2 min at room temperature using a UV-Vis
spectrometer (DR3900, HACH, Loveland, Colorado, USA). A molar extinction coefficient of
49.6/mM cm was used to calculate laccase activity. Oxidation-reduction potential (ORP) of
laccase with and without the addition of redox-mediator was measured using an ORP meter
(WP-80D dual pH-mV meter, Thermo Fisher Scientific, Australia).
3.3.4.3. Analysis of membrane properties and surface morphology
Surface charge and hydrophobicity was analyzed to assess the effect of laccase on membrane
properties. Membrane hydrophobicity in terms of contact angle was measured by the standard
sessile drop method using a Rame-Hart Goniometer (Model 250, Rame-Hart, Netcong, New
Jersey, USA) as previously described [34].
For assessing the change in surface charge of the membranes, the zeta potential was measured
at room temperature using a SurPASS elctrokinetic analyzer (Anton Par GmbH, Graz, Austria).
Analytical grade potassium hydroxide and hydrochloric acid were used to adjust the pH of the
electrolyte solution. The zeta potential was calculated from the steaming potential using the
Fairbrother-Mastin approach [34].
NF and UF membranes collected at the end of experiments were air-dried in a desiccator. After
coating the membranes with a gold layer by using a sputter coater (SPI Module, West Chester,
PA, USA), the surface morphology of the membranes was characterized with scanning electron
microscopy (SEM) (JCM-600, JEOL, Tokyo, Japan).

3.4. Results and discussion
3.4.1. Laccase and TrOC retention by the membranes
Coupling a membrane to the enzymatic bioreactor can prevent washout of the enzyme along
with treated effluent. The flat-sheet UF and NF membranes used in this experiment have not
been tested before for laccase retention. Hence, effective retention of laccase was studied by
operating UF/NF-EMBRs in full recirculation mode. Laccase activity in NF-EMBR permeate
remained undetected throughout operation as shown in Figure 3.2, thus confirming effective
106

retention of laccase by the NF membrane. On the other hand, no laccase activity was detected
in the permeate during the first 4 h of UF-EMBR operation in full recirculation mode, but a
small laccase activity of 5-7 µM(DMP)/min (i.e., still above 95% laccase retention) was measured
in UF-permeate samples for the rest of the experiment. In previously developed UF-EMBR,
hollow fiber UF membranes with molecular weight cutoff (MWCO) of 6-10 kDa effectively
retained laccase in the enzymatic bioreactor [21, 22]. Although the MWCO of the flat-sheet
UF membrane (30 kDa) used in this experiment was smaller than the size of laccase (56 kDa),
slight passage of laccase through the UF membrane can be attributed to its diffusion into the
permeate following the formation of a laccase gel-layer on the active side of membrane that
was visible to the naked eye. The enzyme gel-layer formed on the UF membrane can be seen
in the picture given in Appendix Figure 3-4. In addition, membrane pore size may be nonuniform, and presence of pores with diameter greater than the average pore size can increase
the effective MWCO of a membrane. Furthermore, depending on water matrix (e.g., ionic
strength and pH) and membrane properties (e.g., surface charge, hydrophobicity and pore size),
chemicals may permeate even through the membrane with a smaller MWCO. Similar
observations were made when two enzymes, namely, lysozyme and protease were concentrated
using polysulfone and polyethersulfone ultrafiltration membranes, respectively [35, 36].
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Figure 3.2. Laccase activity in the enzymatic bioreactor and permeate of UF-EMBR and NFEMBR during their operation in full recirculation mode for 24 h. The standard deviation of
duplicate samples was less than 2%.
The results of NF-EMBR operation in full recirculation mode confirmed above 95% retention
of the TrOCs by the NF membrane. Conversely, TrOC rejection by the UF membrane varied
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between 1% (Sulfamethoxazole) and 5% (diclofenac). The rejections of TrOCs by both
membranes are shown in Appendix Figure 3-5.
3.4.2. Preliminary assessment of TrOC removal in UF vs. NF-EMBRs
In this experiment, NF-EMBR achieved 92 to over 99% removal of the TrOCs (Figure 3.3).
In general, NF membranes can remove TrOCs via the following mechanisms: (i) size
exclusion; (ii) adsorption; and (iii) electrostatic interaction [9, 37]. TrOCs having a molecular
weight higher than 200 g/mol have been reported to be effectively rejected by the NF90
membrane [38]. Because the molecular weight of the selected TrOCs during preliminary
assessment was above 200 g/mole, effective rejection (92-99%) could be attributed to size
exclusion mechanism. Moreover, charge repulsion between the negatively charged NF
membrane (Table 3.1) and negatively charged TrOCs (i.e., diclofenac, sulfamethoxazole and
atrazine) could be responsible for their rejection by the NF membrane in the NF-EMBR.
Adsorption of hydrophobic TrOCs (log D>3.2), which are generally neutral at pH=7, on
membrane surface has been reported to result in effective rejection by the NF membrane at the
initial stage of operation. However, their rejection could reduce gradually with time due to the
diffusion of hydrophobic TrOCs into permeate [9, 39]. In this experiment, the NF-EMBR
achieved above 99% removal of a hydrophobic TrOC, namely oxybenzone (log D = 3.99),
because it was highly degraded (~99%) by laccase (Figure 3.4).
UF-EMBR

NF-EMBR

80
60
40

Oxybenzone

Sulfamethoxazole

Carbamazepine

0

Diclofenac

20

Atrazine

Removal efficiency (%)

100

Figure 3.3. Overall removal (i.e., degradation + membrane retention) of TrOCs in UF- and
NF-EMBRs operated separately at an HRT of 16 h and TrOC loading rate of 1.44 mg/L d.
Data presented as average ± standard deviation (n = 6).
The overall removal of the TrOCs by the NF-EMBR (as indicated by TrOC concentration in
the membrane permeate) was 10-80% higher than that by the UF-EMBR (Figure 3.3). UF
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membranes are not expected to remove TrOCs via size exclusion. However, it was observed
that TrOCs were partially retained by the UF membrane. This aspect has been comprehensively
discussed in Section 3.4.3.3.
During preliminary assessment of TrOC degradation by laccase in EMBRs, remaining TrOCs
following degradation will mostly pass through the membrane (for UF membrane) or be
significantly retained (for NF membrane). The NF membrane is expected to retain TrOCs more
effectively than the UF membrane, but the current experiment seeks to assess if the application
of NF can also enhance degradation. The UF/NF-EMBRs were continuously operated for a
duration of 3×HRT under identical conditions to provide a common basis for comparing the
degradation of TrOCs in UF- and NF-EMBRs. The degradation of TrOCs by laccase in UF/NFEMBR was calculated using Equation (1). Among the selected TrOCs, efficient degradation
(80-99%) of oxybenzone was achieved by laccase in both UF- and NF-EMBRs (Figure 3.4).
In addition, its degradation was observed to be above 50% within the first 6 h of EMBR
operation, which suggested that oxybenzone was easily amenable to degradation by laccase.
Since phenols are typical substrates of laccase [11, 13], high removal of oxybenzone by laccase
could be attributed to the presence of a phenolic moiety in its molecule. Indeed, oxybenzone
removal by batch and continuous-flow enzymatic bioreactors has been reported to range from
60-99% [40, 41]. Gago-Ferrero et al. [42] reported the formation of three degradation products,
namely benzophenone-1, 4-hydroxybenzophenone and 4,4′-dihydroxybenzophenone,
following laccase-mediated degradation of oxybenzone. Interestingly, despite being inherently
amenable to laccase-catalyzed degradation, its degradation was 19% better in NF-EMBR as
compared to UF-EMBR (Figure 3.4). This could be attributed to the effective retention of
oxybenzone by the NF membrane, which resulted in its prolonged interaction with laccase.
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Figure 3.4. Degradation of TrOCs in UF- and NF-EMBRs operated separately at an HRT of
16 h and TrOC loading rate of 1.44 mg/L d. Data presented as average ± standard deviation (n
= 6).
During preliminary assessment, compared to the UF-EMBR, better degradation (15-30%) of
the non-phenolic TrOCs was achieved by the NF-EMBR (Figure 3.4). For example,
degradation of atrazine and carbamazepine was 29 and 35%, respectively, by the NF-EMBR,
while their degradation was approximately 10% in UF-EMBR. Similarly, degradation of
sulfamethoxazole and diclofenac was 10-30% better as compared to that achieved by UFEMBR (Figure 3.4).
Literature on the performance of an NF based enzymatic membrane bioreactor for TrOC
removal is scarce. To date, only one study [24] has reported the performance of laccase in an
NF-EMBR in the recirculation mode (rather than the continuous flow, which is required for
scaling up) for a period of only 5 h and targeting only one TrOC (i.e., bisphenol A). To improve
from the previous study by Escalona [24], in this chapter, degradation of a mixture of TrOCs
by laccase was assessed by operating the NF-EMBR in continuous-flow mode for a longer
duration of 3 × HRT (i.e., 48 h). Indeed, long term operation of a bioreactor is critical to achieve
steady state TrOC degradation (Figure 3.5). The results of the preliminary assessment suggest
that a NF membrane-coupled enzymatic bioreactor cannot only produce high quality effluent
due to effective TrOC retention, but also achieve improved TrOC biodegradation (i.e., reduced
concentrate disposal). However, it is imperative to investigate the degradation of a broad
spectrum of pollutants in NF-EMBR as demonstrated in next section.
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Figure 3.5. Time course of TrOC degradation by laccase in continuous-flow UF- and NFEMBRs. Each data point denotes average of two samples with a variation of less than 5%.

3.4.3 Laccase-catalyzed degradation of a broad set of TrOCs by NF-EMBR
During assessment of EMBRs for the degradation of a broad spectrum of TrOC, laccase was
again effectively retained (>95%) by both the membranes (Appendix Figure 3-6). TrOCs were
retained effectively only by the NF membrane, and this was confirmed by filtering a TrOC
mixture in Milli Q water through the membrane (Appendix Figure 3-7). Hence, the operating
conditions of the UF/NF-EMBRs were suitable to systematically investigate the impacts of
effective TrOC retention within the enzymatic bioreactor on their laccase-catalyzed
degradation.
Laccase-catalyzed degradation occurs due to the transfer of a single electron from a substrate
to laccase [20]. With some exceptions, phenolic TrOCs have been reported to be effectively
degraded by laccase [13, 43]. On the other hand, degradation of non-phenolic TrOCs by laccase
can be highly variable and may depend on the difference of ORP between laccase and the nonphenolic TrOCs as well as the TrOC molecular properties such as the presence of an EWGs or
EDGs [11, 44]. Therefore, here the degradation of the phenolic and non-phenolic TrOCs is
discussed separately.
3.4.3.1. Degradation of phenolic TrOCs
In this experiment, laccase achieved efficient degradation (>80%) for four out of 12 phenolic
TrOCs, namely 17ß–estradiol-17-acetate, 4-tert-octylphenol, triclosan and salicylic acid in
both UF- and NF-EMBRs (Figure 3.6). Efficient degradation of these TrOCs by laccase has
been reported previously in both batch and continuous-flow enzymatic bioreactors [23, 45, 46].

111

UF-EMBR

NF-EMBR

Phenolic TrOCs

Non-phenolic TrOCs

Enzymatic degradation (%)

100
80
60
40
20

Enterolactone
Pentachlorophenol
Bisphenol A
Estriol
Estrone
17ß – Estradiol
4-tert-Butylphenol
17 – Ethinylestradiol
17ß–Estradiol-17-acetate
Salicylic acid
Triclosan
4-tert-Octylphenol
-Carbamazapine
Diclofenac
Atrazine
Primidone
Ibuprofen
Ametryn
Fenoprop
Naproxen
Ketoprofen
Gemifibrozil
Clofibric acid
Propoxur
DEET
Metronidazole
Amitriptyline
Benzophenone
Octocrylene

0

Figure 3.6. Degradation of TrOCs in enzymatic bioreactor coupled to the UF or NF membrane
for showing the effect of effective TrOC retention on degradation. Both enzymatic membrane
bioreactors were operated at an initial laccase activity of 180 µM(DMP)/min, TrOC concentration
of 5 µg/L, HRT of 16 h and cross-flow velocity of 40.2 cm/s. The temperature of the enzymatic
bioreactor was kept at 25 ºC. Data is presented as average ± standard deviation (n=4).
As mentioned above, phenolic pollutants are typical substrates of laccase. However, the
concomitant presence of EWGs in the molecule of phenolic TrOCs can cause steric hindrance,
thereby delaying the access of a pollutant to the active sites of laccase for effective degradation
[44]. For phenolic TrOCs containing EWG(s), the extent of degradation by laccase in NFEMBR was observed to vary depending on the type of EWGs. For example, NF-EMBR
achieved 80% degradation of estrone that contains the carbonyl (=O) functional group as an
EWG in its molecular structure. On the other hand, degradation of pentachlorophenol,
containing a halogen (–X) functional group as an EWG, was observed to be 60% in NF-EMBR.
Notwithstanding the above-mentioned variations in the degradation of the phenolic TrOCs
containing EWG(s), NF-EMBR achieved from 5 up to 60% better degradation for eight out of
the 12 investigated phenolic TrOCs as compared to the UF-EMBR (Figure 3.6). When an NF
membrane is attached to an enzymatic bioreactor, the HRT of the bioreactor can be decoupled
from the organic retention time due to effective TrOC retention. This leads to increased contact
time between laccase and TrOC and can thus facilitate TrOC degradation. Indeed, in a study
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by Lloret et al. [21], enhanced removal (33-37%) of two phenolic TrOCs, namely estrone and
17ß–estradiol, was achieved by increasing the HRT of an enzymatic bioreactor coupled to a
UF membrane by 2 h. It is important to note that prolonged contact time might not be the only
reason for improved degradation of TrOCs in the NF-EMBR: phenolic TrOCs (e.g., bisphenol
A), which could act as a redox-mediator, can also improve the degradation of TrOCs in NFEMBR. This aspect is discussed further in Section 3.4.3.2.
Degradation of six phenolic TrOCs including four steroid hormones (17ß–estradiol and 17α–
ethinylestradiol and estriol) and two industrial chemicals (4-tert-butylphenol and bisphenol A)
by laccase was 70-90% in NF-EMBR, while UF-EMBR achieved 10-40% degradation (Figure
3.6). Although these TrOCs have been generally reported to be well removed by laccase in
batch enzymatic bioreactors [46, 47], the lower performance of UF-EMBR in this experiment
can be attributed to the continuous TrOC loading that has been reported to affect the extent of
TrOC degradation [21, 23]. Continuous TrOC loading in UF-EMBR could affect the extent of
TrOC degradation due to kinetic limitations. Under sustained TrOC loading, TrOCs occupy all
the active sites of laccase, eventually reducing the percent degradation [23, 44]. Notably, the
NF-EMBR was better suited to withstand the continuous loading of the phenolic TrOCs to the
enzymatic bioreactor.
3.4.3.2. Degradation of non-phenolic TrOCs
In this experiment, the following three trends were observed in the degradation profile of 17
non-phenolic TrOCs (Figure 3.6): (i) From 5 up to 65% better degradation of six
pharmaceuticals (i.e., ketoprofen, naproxen, primidone, gemfibrozil, amitriptyline and
metronidazole) and five pesticides, namely fenoprop, clofibric acid, propoxur,
pentachlorophenol, N, N-diethyl-meta-toluamide (DEET) and ametryn, in NF-EMBR as
compared to UF-EMBR; (ii) efficient degradation (>80%) of two ingredients of personal care
products (i.e., benzophenone and octocrylene) in both UF- and NF-EMBR; and (iii) poor
removal (5-15%) of a pesticide (i.e., atrazine) and three pharmaceuticals (i.e., carbamazepine,
diclofenac and ibuprofen) in both UF- and NF-EMBR.
Only around 5-15% degradation of atrazine, carbamazepine, diclofenac and ibuprofen by the
EMBRs can be attributed to the presence of strong EWGs such as amide (–NH2), carboxylic
(–COOH) and halogen (–X) functional groups (see Appendix Table 3-1), which makes them
resistant to laccase-catalyzed degradation [11, 19, 47]. On the other hand, benzophenone and
octocrylene, which were well removed by laccase in this experiment, were also reported to be
efficiently degraded by laccase in a continuous-flow enzymatic bioreactor [23].
The significantly better degradation of 11 non-phenolic TrOCs following their retention within
the NF-EMBR can be attributed to the increased reaction time between laccase and the
pollutants. Asif et al. [26] reported high TrOCs degradation in membrane distillation (MD)EMBR, where the studied TrOCs and laccase were retained by MD membrane. However, in
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that experiment the performance of the MD-EMBR was not compared to a suitable “control”
i.e., an EMBR that will retain laccase but not the TrOCs [26]. By comparing UF- vs. NFEMBR, this experiment demonstrates that effective TrOC retention within the bioreactor
facilitates their degradation.
It is important to note that TrOCs containing hydroxyl and amine functional groups such as
bisphenol A and steroid hormones can also play an important role in the degradation of nonphenolic TrOCs by acting as redox-mediators [46, 48]. The secondary radicals or coupling
agents, which are formed following the oxidation of TrOCs containing hydroxyl and amine
functional groups, are highly reactive and could directly oxidize or polymerize other TrOCs.
For instance, lignin is a plant polymer with a highly complex chemical structure. The
degradation pathway for lignin reveals that laccase directly oxidizes the phenolic components
of lignin, and produces highly reactive phenoxyl radicals, which then oxidize the non-phenolic
components of lignin [44, 49]. Similarly, Hachi et al. [48] demonstrated that the degradation
of acetaminophen by laccase formed a coupling agent (i.e., dimer). This coupling agent reacted
with carbamazepine to form oligomers, thereby improving carbamazepine removal from 10 to
40% [48]. In another study by Jahangiri et al. [50], removal of triclosan was reported to improve
in a batch enzymatic bioreactor following the addition of the phenolic compound
acetaminophen. Enhanced removal of triclosan was attributed to the formation of
acetaminophen-triclosan cross-coupling products [50]. In the current experiment, the synthetic
wastewater that was continuously fed to the UF/NF-EMBR contained a mixture of 29 TrOCs
including 12 phenolic and 17 non-phenolic TrOCs. Since these TrOCs were effectively retained
by the NF membrane but not by the UF membrane (see Section 3.4.3.3), it is possible that the
radicals or coupling agents formed after the oxidation of some phenolic TrOCs by laccase
contributed to better degradation of the non-phenolic TrOCs in NF-EMBR as compared to UFEMBR. A close look at the trend of laccase-catalyzed degradation in both UF- and NF-EMBR
indicates that the improvement in degradation could be correlated with the molecular weight
of TrOCs. In the current experiment, the extent of improvement in degradation was
significantly higher for TrOCs with a molecular weight above 200 g/mol (Figure 3.7). This is
probably because the presence of more branches and/or functional groups in TrOCs with high
molecular weight would create more opportunities of their interaction with laccase, secondary
radicals and coupling agent [51].
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Figure 3.7. Enzymatic degradation in both UF- and NF-EMBR as function of TrOC molecular
weight, showing that the extent of degradation was significantly higher for TrOCs with a
molecular weight above 200 g/mol.
3.4.3.3. Overall removal of TrOCs in EMBRs
TrOC degradation in the enzymatic bioreactor ranged between 10-99% (Figure 3.6). However,
the overall TrOC removal (calculated based on TrOC concentration in membrane permeate) by
the NF-EMBR was 90-99%, demonstrating the significant contribution of the NF membrane
to the overall removal.
As explained in Section 3.4.2, NF membranes can reject TrOCs via following mechanisms: (i)
size exclusion; (ii) electrostatic interaction; and (iii) adsorption. In general, the NF membrane
used in this experiment has been reported to effectively retain TrOCs with a molecular weight
of greater than 200 g/mol (i.e., MW > MWCO) via size exclusion mechanism [38]. With a few
exceptions, the molecular weight of the TrOCs investigated was greater than 200 g/mol, and
indeed they were effectively removed (>90%) by the NF-EMBR (Figure 3.8). The exceptions
include salicylic acid (138.12 g/mol), metronidazole (171.15 g/mol), benzophenone (182.22
g/mol), DEET (191.27 g/mol) and 4-tert-butylphenol (150.22 g/mol). Removal of these TrOCs
also ranged between 95-99% in NF-EMBR (Figure 3.8). Since salicylic acid, atrazine and
DEET are negatively charged (pKa < pH) at the operating pH of the NF-EMBR (i.e., 6.7-6.9),
charge repulsion between the negatively charged NF membrane and anionic TrOCs is likely
responsible for their removal by the NF membrane [9, 27, 52].
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Figure 3.8. Overall TrOC removal in enzymatic bioreactor coupled to the UF or NF membrane.
Data is presented as the average ± standard deviation (n=4).
TrOC adsorption on the membrane surface is also a mechanism of removal by NF membranes.
Hydrophobic TrOCs (log D > 3) can adsorb on the membrane surface, thereby resulting in their
high initial rejection by the NF membrane [9, 53], but this may reduce with time due to their
diffusion into membrane permeate [9, 54]. Nevertheless, in this experiment, the hydrophobic
TrOCs were efficiently degraded by laccase in the enzymatic bioreactor (80-99%, Figure 3.6).
Thus, the overall removal of hydrophobic TrOCs (log D > 3) was above 99%. Previous studies
reported that a combination of activated sludge [55] or enzymatic bioreactor [26] with a high
retention membrane (e.g., MD membrane) can improve the overall removal of TrOCs
compared to a stand-alone high retention membrane system. However, this is the first study
that demonstrates the performance of an NF-based EMBR for a set of 29 TrOCs.
UF membranes cannot reject TrOCs via size exclusion. Thus, as expected, the overall TrOC
removal by the NF-EMBR was 10-80% higher than the UF-EMBR (Figure 3.8). However, it
is noteworthy that, for the UF-EMBR, the overall removal efficiency of a few TrOCs was
significantly better than that suggested by biodegradation efficiency (Figure 3.6). This
indicates that the UF membrane provided partial retention of those TrOCs. To facilitate the
discussion on TrOC removal by the UF membrane, the ratio of the concentration of selected
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TrOCs in membrane permeate and bioreactor (i.e., permeate/bioreactor ratio) is shown in
Figure 3.9.
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Figure 3.9. Permeate to supernatant (P/S) ratio of the selected TrOCs to show their partial
retention by the UF membrane in UF-EMBR. Data is presented as average ± standard deviation
(n=4).
Indeed, the permeate/bioreactor concentration ratio for significantly hydrophobic TrOCs (log
D>3) including 17ß–estradiol-17-acetate, triclosan and 17α-ethinylestradiol was significantly
below 1 and ranged between 0.3-0.6 (Figure 3.9). Previously, Nguyen et al. [23] observed
adsorption of TrOCs on the enzyme gel-layer formed on the surface of a polyacrylonitrile
hollow fiber UF membrane following the filtration of media within an EMBR. They also
reported that the adsorbed TrOC was subsequently degraded by laccase in UF-EMBR, and this
prevented the accumulation of TrOCs on the membrane surface. In this experiment, the
formation of enzyme gel-layer on membranes surface during EMBR operation was confirmed
by characterizing the surface morphology of both the UF and NF membranes by SEM (Figure
3.10).
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Figure 3.10. SEM images of the NF and UF membranes, confirming the formation of enzyme
gel-layer on the surface of membranes. The spiral formations on the SEM images with the
annotation ‘NF- and UF- used’ represents enzyme gel-layer. These spiral formations are not
present on the clean NF and UF membrane. The formation of an enzyme gel-layer on the
surface of membranes could improve overall performance of EMBRs via TrOC adsorption
In a study by Garcia-Ivars et al. [56], partial retention of anionic pharmaceuticals such as
naproxen, diclofenac and ibuprofen by a flat-sheet ceramic UF membrane was attributed to
charge repulsion mechanism. Similarly, in this experiment, despite being hydrophilic (log D
<3), the partial retention of a few anionic TrOCs by the UF membrane was observed. These
hydrophilic anionic TrOCs include naproxen (permeate/bioreactor ratio= 0.8), primidone
(permeate/bioreactor ratio= 0.86), ibuprofen (permeate/bioreactor ratio= 0.9), propoxur
(permeate/bioreactor ratio= 0.88) and diclofenac (permeate/bioreactor ratio= 0.94). Despite the
higher MWCO of the UF membrane than the MW of TrOCs, data from the current experiment
confirms that the flat-sheet PVDF UF membrane along with the enzyme layer on it can retain
anionic TrOCs to some extent via charge repulsion mechanism.
The discussion here suggests that UF membrane can contribute to the removal of TrOCs
depending on their hydrophobicity and charge, thereby improving the overall performance of
UF-EMBR. However, the overall removal by the NF-EMBR was considerably better due to
enhanced TrOC degradation (Figure 3.6) as well as effective TrOC removal (Figure 3.8) in a
single step.
Laccase-catalysed degradation of the target pollutants may produce degradation products or
metabolites that could be more toxic than the parent pollutants. However, the previous studies
suggest that toxicity of EMBR permeate after the enzymatic treatment of a mixture of TrOCs
does not increase, particularly when a high retention membrane separation process, e.g.,
membrane distillation, is integrated with an enzymatic bioreactor [23, 26]. In the current
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experiment, a high retention NF membrane combined with the enzymatic bioreactors
effectively retained TrOCs (Figure 3.8). Thus, the permeate of NF-EMBR was expected to be
non-toxic.

3.4.5. Effect of redox-mediator addition on TrOC degradation by NF-EMBR
3.4.5.1. Overall improvement in TrOC degradation
As noted in section 3.4.3.1, efficient degradation (>80%) of three non-phenolic and eight
phenolic TrOCs was observed during operation of the NF-EMBR (Figure 3.6). To improve
the spectrum of efficiently degraded TrOCs, redox-mediators can be introduced to the reaction
mixture. In a laccase-mediator system, laccase oxidizes the mediator to produce highly reactive
radicals. Due to high redox-potential of these radicals, they can directly degrade or polymerize
TrOCs, particularly those resistant to laccase-catalyzed degradation [20].
In this experiment, a naturally occurring redox-mediator (violuric acid, VA) was studied for
improving the degradation of TrOCs by NF-EMBR.Laccase can readily oxidize VA to form
highly reactive aminoxyl (=N–O) radicals. The aminoxyl radicals degrade the target pollutants
by following hydrogen atom transfer (HAT) mechanism [25, 57]. The driving force of HAT
mechanism is the enthalpy balance between the forming bond (H–ON) and the dissociated C–
H bond [20].
Improvement in the degradation of TrOCs following the addition of a single dose of VA at a
concentration of 10 µM is presented in Figure 3.11. Redox-mediators capable of degrading a
substrate following the HAT mechanism has been reported to be particularly effective for nonphenolic compounds, which are originally poorly removed by laccase [25, 58]. In this
experiment, VA improved the degradation of six non-phenolic compounds by 10-50% (Figure
3.11). For example, diclofenac degradation increased from 13% in NF-EMBR to 42% in
laccase-VA mediated NF-EMBR. Similarly, VA addition improved the degradation of the
pesticide atrazine by 40%. The highest improvement (50%) was observed for ametryn (Figure
3.11). Laccase cannot efficiently degrade non-phenolic TrOCs with higher redox-potential [11,
44]. The redox-potential of the media in enzymatic bioreactor increased from 300 to 390 mV
following the addition of VA at a concentration of 10 μM (Appendix Figure 3-8), which is
one of the reasons of the improved degradation in NF-EMBR. The concentration of redoxmediators is another influencing factor as explained in Section 3.4.5.2.
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Figure 3.11. Effect of adding a naturally occurring redox-mediator, violuric acid VA, on the
degradation of TrOCs in NF-EMBR. VA was added at a concentration of 10 µM at the start of
the experiment. Data is presented as the average ± standard deviation (n=4).
Laccase achieved almost complete (>99%) degradation of three phenolic TrOCs viz 4-tertoctylphenol, triclosan and salicylic acid in NF-EMBR. However, biodegradation of some
phenolic compounds by laccase-only was incomplete. Six steroid hormones (estrone, 17βestradiol, estriol 17α–ethinylestradiol and 17β-estradiol-17–acetate, enterolactone), two
industrial chemicals (4-tert-octylphenol and bisphenol A) and a pesticide (pentachlorophenol)
were degraded by laccase with an efficiency between 20 and 90%, and their degradation did
not improve at a VA dose of 10 μM (Figure 3.11). Our observation is consistent with that by
Nguyen et al. [23] who reported that the degradation of phenolic TrOCs such as estrone, estriol,
17β-estradiol 17–acetate, 4-tert-butylphenol and bisphenol A did not improve in UF-EMBR
following the addition of another aminoxyl radical producing redox-mediator (i.e., 1hydroxybenzotriazole, HBT) at a concentration of 10 μM. This is probably because the laccaseVA system did not produce enough reactive aminoxyl radicals at such a trace concentration
(i.e., 10 μM) that would improve the degradation of the phenolic TrOCs tested here. Indeed,
increasing the concentration of VA from 10 to 25 μM in NF-EMBR resulted in enhanced
degradation for six phenolic TrOCs (see Section 3.4.5.2).
It is noteworthy that redox-mediators have been reported to exhibit substrate specificity [26,
59]. In this experiment, VA (10 μM) was more effective in improving the degradation of the
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non-phenolic TrOCs, although it should be noted that the overall degradation of the phenolic
compounds within the bioreactor was still significantly better than the non-phenolic TrOCs.
3.4.5.2. Effect of mediator concentration on TrOC degradation
The concentration of redox-mediators can influence the performance of the laccase-mediator
system because TrOC degradation is affected by the abundance of highly reactive radicals.
Hence, a single dose of VA at different concentrations (i.e., 10, 25, 50 and 100 µM) was added
separately to the NF-EMBR. To show different trends of improvement, degradation of 10
selected TrOCs at different VA concentrations is presented in Figure 3.12.
Increasing the concentration of VA from 10 to 25 µM further improved the degradation of
TrOCs by up to 10-25% (Figure 3.12). Although VA did not improve the degradation of
phenolic TrOCs at 10 µM, an improvement of 10-25% was observed in the degradation of
estrone, estriol, 17β-estradiol 17–acetate, 17β-estradiol, 4-tert-butylphenol and bisphenol A
after adding VA at 25 µM concentration in NF-EMBR (Figure 3.12). Improvements were also
noted in the case of non-phenolic compounds such as propoxur, ibuprofen, diclofenac, ametryn
and atrazine. Despite a discernable increase in ORP (see Appendix Figure 3-8), no further
degradation improvement was observed by increasing the concentration of VA from 25 to 100
µM (Figure 3.12). Depending on mediator type, laccase source and the target pollutant, the
improvement in TrOC degradation may reach a plateau beyond a certain mediator
concentration [60, 61]. For instance, Ashe et al. [25] observed no improvement in atrazine and
naproxen removal beyond 500 μM of VA in a batch enzymatic bioreactor. In another study,
increasing VA concentration from 250 to 500 μM provided similar degradation for a few
phenolic TrOCs such as bisphenol A and 4-tert-butylphenol [62]. The current experiment
confirms that TrOC degradation would not significantly improve i.e., reach a plateau beyond a
certain mediator concentration in a high retention enzymatic bioreactor.
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Figure 3.12. Effect of different mediator concentration on the degradation of selected TrOCs
in NF-EMBR. Data is presented as the average ± standard deviation (n=4).
Although addiation a redox-mediator improved TrOC degradation, the radicals formed
following the oxidation of redox-medaitors can cause toxicity. In prvious studies, addition of
syringaldehyde [61] and 2,2'-azino-bis-3-ethylbenzothiazoline-6-sulphonic acid [25] has been
reported to increase the toxicity treated effluent. Notably, following VA addition at
concentration ranging from 0.5–1 mM, toxicity of the treated effluent has been reported to not
increase significantly [25, 62]. For instance, Asif et al. [62] studied the improvement in TrOC
degradation by adding a single dose of 0.5 mM VA in an membrane distillation (MD) – EMBR,
and observed that the toxicity of reaction media with and without VA was up to 1.8 and 3.9
rTU, respectivley. Despite the increase in toxicity following the addition of 0.5 mM VA, they
reported that the toxicity of MD-EMBR permeate was below the limit of detection [62].
Because a high retention NF membrane that can effectively retained TrOCs and their
metabolities was combined with an enzymatic bioreactor in this experiment, permeate of NFEMBR with and without VA addition was expected to be non-toxic.
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In light of mediator performance at different concentrations, VA at a concentration of 25 µM
was the best for achieving improved TrOC degradation by the NF-EMBR. Three phenolic and
14 non-phenolic TrOCs were not completely degraded even with redox-mediator dosing.
However, the final treated effluent, i.e, NF-permeate achieved over 95% removal of all TrOCs
(Figure 3.13).
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Figure 3.13. Improvement in TrOC degradation by adding single dose VA at different
concentration separately at the start of NF-EMBR operation. VA showed compound-specific
and concentration dependent improvement. The overall removal of TrOCs in NF-EMBR was
>95%. The NF-EMBR were operated for a period of 68 h in continuous mode at an initial HRT
of 16 h.

3.4.6. Hydraulic performance of membranes
Variations in permeate flux during the operation of the laccase based EMBRs are presented as
normalized permeate flux in Figure 3.14. Typically, a steep fall in the permeate flux of the NF
and UF membranes has been observed at the initial stage of their operation [24, 56]. Indeed,
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the permeate flux reduced rapidly in the first few hours of UF/NF-EMBR runs in this
experiment (Figure 3.14). Given the MWCO of the membranes, i.e., 200 Da for the NF and
30,000 Da for the UF, the reduction in permeate flux for the NF membrane was steeper. The
initial permeate flux of the UF membrane decreased by approximately 15%, and stabilized after
10 h of UF-EMBR operation. On the other hand, a progressive fall in the flux of the NF
membrane was observed during the first 30 h of NF-EMBR operation. Despite this, the
permeate flux at the end of NF-EMBR operation was still 65% of the initial flux (Figure 3.14).
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Figure 3.14. Variations in the permeate flux presented as a normalized flux as a function of
operating time. The reduction in the permeate flux was attributed to: (i) membrane fouling
following the adsorption of laccase on membrane surface forming an enzyme gel-layer (see
Figure 3.10), and/or (ii) concentration polarization due to the accumulation of TrOCs and
transformation products on membrane surface. Cleaning the membranes with clean water for
one hour was enough to recover the permeate flux by more than 90%.
The reduction in permeate flux in UF/NF-EMBR can be attributed to: (i) membrane fouling
due to the adsorption of laccase on membrane surface forming an enzyme gel-layer (Figure
3.10); and/or (ii) concentration polarization due to the accumulation of TrOCs and
transformation products on membrane surface [24, 63]. To assess whether the reduction in
permeate was reversible or irreversible, permeate flux was measured after backwashing the UF
and NF membranes with Milli-Q water for 1 h. Membrane cleaning recovered the permeate
flux of the NF and UF membranes by 92 and 96%, respectively. The flux recovery was not
100% probably due to the irreversible adsorption of laccase on the membrane surface. This is
also evident from changes in membrane properties, i.e., contact angle and zeta potential as
discussed in the following section.
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3.5. Effect on membrane surface charge and hydrophobicity
The UF and NF membranes were negatively charged at the operating pH of the UF/NF-EMBRs
(i.e., approximately 7) as shown in Figure 3.15. The virgin NF membrane is negatively charged
due to the protonation of carboxylic and amino functional groups of the active membrane layer
[34]. On the other hand, the virgin PVDF UF membrane is usually not charged but it becomes
negatively charged due to the adsorption of hydroxyl ions that originates from the selfionization of water [64, 65].
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Figure 3.15. Effect of laccase on the properties of the NF and UF membranes. Error bars
represent the standard deviation among triplicate measurements. Although change in properties
of the NF membrane did not affect TrOC removal by NF-EMBR, the formation of an enzymegel layer on the surface of the UF membrane following laccase adsorption can improve the
overall performance of UF-EMBR by adsorbing hydrophobic TrOCs (see Figure 3.9).
The negative charge on the surface of UF and UF membranes in response to their operation
with enzyme solution reduced as compared to the virgin membranes (Figure 3.15). These
changes in membrane surface charge can be attributed to the adsorption of laccase on the
membrane surface as shown in Figure 3.10. It was reported that adsorption of solutes on the
membrane surface can change the surface roughness and chemistry of membrane active layer,
thereby altering their streaming potential [66].
Hydrophobicity of a membrane depends on its surface properties and water associating
chemical groups [34]. Based on the contact angle, the UF membrane was significantly
hydrophobic, while the NF membrane was moderately hydrophobic (Figure 3.15). However,
hydrophobicity of both the UF and NF membrane reduced, which again confirms the
adsorption of laccase on the membrane surface. Results of this experiment indicate that laccase
adsorption can alter the properties of the membranes to some extent although above 90% flux
recovery can be achieved by flushing the membrane with ultrapure Milli Q water. While no
effect of change in properties of the NF membrane was observed on TrOC removal, the
formation of an enzyme-gel layer on the surface of the UF membrane following laccase
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adsorption can improve the overall performance of UF-EMBR by adsorbing hydrophobic
TrOCs (see Section 3.4.3.3).

3.5. Conclusion
Enzymatic degradation of a broad spectrum of TrOCs including 12 phenolic and 17 nonphenolic compounds was compared by operating ultrafiltration (UF)- and nanofiltration (NF)based enzymatic membrane bioreactors (EMBR). This helped to assess the effect of effective
TrOCs retention within enzymatic bioreactor on their degradation by laccase. Initially,
comparative performance of UF- and NF-EMBRs were assessed for five TrOCs to prove the
concept. Overall removal of TrOCs by UF-EMBR varied from 20-85%, while NF-EMBR
achieved 92-99.9% TrOC removal. Notably, the effective retention of the TrOCs within the
enzymatic bioreactor by the NF membrane improved (15-30%) their degradation as compared
to UF-EMBR. This observation confirmed the hypothesis that simultaneous retention of
laccase and TrOCs by the high retention NF membrane facilitates degradation During the
assessment of EMBRs for a broad spectrum of TrOCs, the overall removal of TrOCs in NFEMBR was better because the NF membrane achieved TrOC rejection ranging from 90-99%.
Furthermore, mass balance analysis shows that compared to the UF-EMBR, significantly better
degradation (up to 65%) was achieved by laccase in NF-EMBR. However, physciochemical
properties, particularly chemical structure governed TrOC removal by laccase and membranes.
Laccase achieved efficient degradation of TrOC containing strong electron donating functional
groups (such as bisphenol A and natural hormones), while those containing strong EWGs (such
as carbamazepine and diclofenac) remained resistant to laccase-catalysed degradation. A
redox-mediator (violuric acid, VA) was dosed to NF-EMBR for further improving the
degradation of TrOCs. VA achieved improved degradation for four phenolic and six nonphenolic TrOCs in NF-EMBR, at a concentration of 25 µM, beyond which the extent of
degradation did not improve significantly. Change in membrane properties due to laccase
adsorption along with concentration polarization can reduce the permeate flux of the UF and
NF membrane, although flux can be recovered effectively by cleaning the membrane with
water.
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Chapter 4: TrOC removal by a membrane
distillation – enzymatic membrane bioreactor (MDEMBR): Impact of laccase source

This chapter is based on the following publication:

Asif, M.B., Nguyen, L.N., Hai, F.I., Price, W.E., Nghiem, L.D. 2017. Integration of an
enzymatic bioreactor with membrane distillation for enhanced biodegradation of trace
organic contaminants. International Biodeterioration & Biodegradation, 124, 73-81.
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4.1. Introduction
Trace organic contaminants (TrOCs) include a wide array of natural or anthropogenic
chemicals including pesticides, pharmaceuticals and personal care products. Recent studies
have confirmed the potentially harmful effects of TrOCs on the growth and reproduction
patterns of aquatic flora and fauna as well as on human health due to prolonged ingestion [1,
2]. Conventional wastewater treatment processes cannot effectively remove certain groups of
TrOCs, resulting in their widespread occurrence in freshwater sources [3, 4]. Therefore, the
scientific community is in constant pursuit of an effective wastewater treatment process for
TrOC removal.
Different physicochemical and biological wastewater treatment processes have been
investigated over the years for TrOC removal [5-8]. TrOC degradation by biocatalysts such as
laccase, peroxidase and proteases is a promising eco-friendly technique [9, 10]. Enzymatic
transformation of TrOCs is governed by a number of factors such as pH, temperature, TrOC
properties and characteristics of enzymes [11]. Laccase is an oxidase enzyme that can degrade
a broad spectrum of TrOCs over a wide range of pH by utilizing the dissolved oxygen in water
[12, 13]. Particularly mention worthy is the ability of laccase to oxidize the phenolic TrOCs
including aromatic/aliphatic amines, diphenols and methoxy-substituted monophenols [11].
Molecular structure, namely distribution of the functional groups, i.e., electron withdrawing
functional group (EWGs) and electron donating functional groups (EDGs), governs the extent
of TrOC removal by laccase. The oxidation of TrOCs containing EWGs such as amide (–NH2),
halogen (–X) and nitro groups (– NO2) is slower as compared to those containing EDGs [11,
14]. TrOC oxidation can be enhanced by introducing a redox-mediator, which can act as an
electron shuttle between the target compounds and enzyme. Depending on the type of redoxmediator, laccase source and TrOC structure, laccase-mediator systems can achieve significant
improvement in the removal of target compounds [15, 16]. However, literature on the impact
of laccase source and their combination with redox-mediators is limited and require further
attention.
Enzyme washout is a major constraint in the large-scale application of an enzymatic bioreactor.
To mitigate this problem, laccase can be immobilized onto or entrapped within different
supports [11, 17]. Alternatively, enzymatic bioreactor can be coupled with a membrane having
a suitable molecular cutoff. For example, Nguyen et al. [13] and Lloret et al. [18] achieved
complete retention of laccase with ultrafiltration (UF) membranes. The use of enzymatic
membrane bioreactor (EMBR) can avoid the mass transfer limitations associated with laccase
immobilization onto support media. Although TrOCs are not expected to be retained by UF
membranes, Nguyen et al. [13] observed the formation of an enzyme gel layer on the surface
of the membrane that effectively adsorbed non-phenolic hydrophobic TrOCs such as
octocrylene, amitriptyline and benzophenone. This resulted in enhanced degradation of these
compounds. However, enzyme gel layer could not adsorb hydrophilic non-phenolic TrOCs
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such as atrazine and carbamazepine, and their overall removal was less than 10% [13]. Hence,
it was postulated that the use of high retention membranes, which will retain both laccase and
TrOCs, can facilitate the degradation of resistant TrOCs.
In recent years, high retention membranes, namely membrane distillation [19], nanofiltration
[20] and forward osmosis [21-23], have been integrated with the conventional activated sludge
bioreactors to achieve complete TrOC retention, resulting in their high aqueous phase removal.
However, these short-term studies have revealed accumulation of membrane-retained
recalcitrant compounds in the bioreactor, indicating the need for enhancement of
biodegradation. Although laccase has been reported to achieve better biodegradation than
conventional activated sludge, more efforts are required to explore the performance of high
retention membrane – enzymatic bioreactor.
In Chapter 3, performance of ultrafiltration (UF) – and nanofiltration (NF) – enzymatic
membrane bioreactor (EMBR) operated under identical operating conditions (e.g., hydraulic
retention time and TrOC loading rate) is demonstrated. As compared to UF-EMBR, NF-EMBR
achieved better degradation of TrOCs. Membrane distillation (MD) is another format of high
retention membrane separation process with a completely different working principle and can
potentially be integrated with an enzymatic bioreactor for enhanced TrOC degradation. In MD,
a vapor-liquid interface is developed around a hydrophobic micro-porous membrane that
allows the water to pass through the membrane via diffusion due to vapor pressure gradient. A
simplified schematic of MD is presented in Figure 4.1. Compared to conventional distillation
processes such as fractional distillation, the MD process requires low temperature and could
be operated by using low grade heat or solar energy [24, 25]. Since the mass transfer in the MD
process occurs in gaseous phase, it can theoretically achieve 100% retention of all non-volatile
compounds [26]. Previously, the standalone MD process has been investigated for seawater
desalination [27], industrial wastewater treatment [28], municipal wastewater treatment [29]
and TrOC removal [26].

Figure 4.1. A simplified schematic of an MD process. The TrOC wastewater recirculation loop
is kept at higher temperature as compared to cold water circulation loop. This creates a vapor
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pressure gradient across the MD membrane surface and allows water to diffuse from hot side
to cold side.
This chapter is based on the experiment conducted to investigate the performance of a
membrane distillation – enzymatic membrane bioreactor (MD-EMBR) for enhanced
degradation of five hardly degradable TrOCs. A series of experiments were performed to
elucidate the performance of two commercially available laccases – one from genetically
modified Aspergillus oryzae (A. oryzae) and the other from Trametes versicolor (T. versicolor).
In addition, impacts of two N=OH type redox-mediators, namely 1-hydrozybenzotriazole
(HBT) and violuric acid (VA) on TrOC degradation as well as on enzyme stability were also
studied.

4.2. Hypothesis
▪
▪

The high retention membrane distillation – enzymatic membrane bioreactor may
achieve enhanced TrOC degradation
Depending on the source of commercially available laccases, the extent of TrOC
degradation may be different

4.3. Materials and methods
4.3.1. Trace organic contaminants
Four pharmaceutical and personal care products, namely sulfamethoxazole, carbamazepine,
diclofenac and oxybenzone, and one pesticide (atrazine) were selected for this experiment due
to their widespread occurrence in environmental systems [4]. Analytical grade (>98% purity)
standards of these TrOCs were purchased from Sigma–Aldrich (Australia). The
physicochemical properties including molecular weight, chemical structure, hydrophobicity
(log D) and volatility (pKH) of the tested TrOCs are given in Table 4.1. A stock solution (2
g/L) of these compounds was prepared and stored at -18 oC in the dark.

4.3.2. Enzyme solutions and redox-mediators
Commercially available laccase purified from T. versicolor (CAS No. 80498-15-3) purchased
from Sigma–Aldrich (Australia) was used in this experiment. Laccase from genetically
modified A. oryzae (Novozym 51030) was the second source of laccase, and it was supplied
by Novozymes Pty. Ltd, Australia. These laccases have been investigated recently for the
removal of a broad spectrum of TrOCs, showing promising results [13, 15, 30]. Properties of
laccase from A. Oryzae are already presented in Section 3.3.1 (Chapter 3). Laccase from T.
versicolor was received in powdered form. After dissolving 10 mg of T. versicolor laccase in
1 L Milli-Q water, T. versicolor laccase showed an activity of 8.5 µM(DMP)/min at pH 4.5 and
20°C.
Two N=OH type mediators, namely HBT and VA were selected for this experiment. HBT and
VA are particularly effective for improving the degradation of non-phenolic compounds. Both
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HBT and VA follow hydrogen atom transfer (HAT) mechanism, producing highly stable and
reactive aminoxyl radicals [14]. Mediators were also purchased from Sigma–Aldrich
(Australia), and separate stock solutions (50 mM) for HBT and VA were kept at 4 oC before
use.
Table 4.1. Physicochemical properties of selected TrOCs
H

Molecular
weight
(g/mol)

Log D at
pH 7

Sulfamethoxazole

253.28

-0.22

1.52×10-12

11.81

Carbamazepine

236.27

1.89

8.17×10-10

9.08

Diclofenac

296.15

1.77

2.06×10-09

8.68

Oxybenzone

228.24

3.99

1.58×10-08

7.80

Atrazine

215.68

2.64

5.22×10-08

7.28

Compounds

Molecular structure

(atm
m3/mol)

pKH at pH
7

Note: Henry’s law constant (H) at 25oC (atm m3/mol) = Vapor pressure × molecular weight/water solubility.
The pKH value is defined as pKH= -log10H. Chemical structure, molecular weight (MW), log D, vapor pressure
and water solubility values were taken from SciFinder Scholar.

4.3.3. MD-EMBR experimental setup
A laboratory scale MD-EMBR setup consisting of a glass enzymatic bioreactor (1.5 L) and an
external direct contact membrane distillation (DCMD) module was used (Figure 4.2). The
enzymatic bioreactor was covered with aluminum foil to avoid TrOC photolysis. An immersion
heating unit (Julabo, Germany) was immersed in the water bath to maintain the temperature at
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30±0.2 oC. Moreover, air diffuser connected with an air pump (ACO-002, Zhejiang Sensen
Industry Co. Ltd., Zhejiang, China) was placed at the bottom of the bioreactor to maintain
homogeneity, and to keep dissolved oxygen (DO) above 3 mg/L.
To minimize heat losses, acrylic glass material was used to prepare the DCMD module. The
feed and distillate flow channels (Dimensions: 145 mm×95 mm×3 mm) were engraved on each
acrylic block. Water from the enzymatic bioreactor and the distillate container was
continuously passed from the DCMD module and then recirculated back to the enzymatic
bioreactor and distillate container, respectively. A temperature sensor was placed at the inlet
of the DCMD module to monitor the temperature of the feed. Distillate temperature was
maintained at 10±0.1 oC using a chiller (SC100-A10, Thermo Scientific, USA). A stainlesssteel heat exchanging coil connected with the chiller was immersed in the distillate container
placed on a precision balance (Mettler Toledo Inc, USA) to monitor permeate flux. The
recirculation flow rate of both feed and the distillate was kept at 1 L/min (corresponding to the
cross-flow velocity of 9 cm/s) using two rotameters.
Hydrophobic microporous polytetrafloroethylene (PTFE) membranes (GE, Minnetonka, MN)
were used during all experiments. Properties of PTFE membrane are given elsewhere [19, 31].
Briefly, nominal pore size, thickness, active layer thickness and porosity of the PTFE
membrane was 0.22 µm, 175 µm, 70% and 5 µm, respectively.

Figure 4.2. A schematics representation of membrane distillation-enzymatic membrane
bioreactor (MD-EMBR).

4.3.4. Experimental protocol
Initially, the MD-EMBR system was operated without the addition of enzyme and mediators
to determine the loss in TrOC concentrations due to adsorption and/or evaporation. Laccase
from T. versicolor was tested alone and then both redox-mediators, HBT and VA (at 1 mM
concentration), were added separately to investigate the improvement in the degradation of
TrOCs. Similarly, laccase from genetically modified A. oryzae was also tested with and without
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the addition of HBT and VA separately. At the start of each experiment with laccase, 1 mL and
0.1 g of A. oryzae and T. versicolor, respectively, were added to 1.5 L Milli-Q water separately
for achieving an initial enzymatic activity of 95-100 µM(DMP)/min. TrOCs were each added at
a nominal concentration of 1 mg/L. However, the actual measured concentrations of
sulfamethoxazole, diclofenac, carbamazepine, atrazine and oxybenzone were 948±90, 923±76,
873±137, 855±140, 771±210 µg/L (n=8), respectively. The difference in theoretical and
measured concentrations of TrOCs may be attributed to the purity of each compound, since the
actual purity of a compound may differ from that claimed by the manufacturer [32]. Samples
from the enzymatic bioreactor and distillate were taken at every three hours over a period of
12 hours to monitor TrOC removal and enzymatic activity. The enzymatic degradation of the
𝑚

TrOCs was determined as 𝑅(%) = 100 × (1 − 𝑚𝑡 ), where mo and mt are initial mass (0 h) and
0

mass at the time of sampling, respectively.

4.3.5. Analytical methods
4.3.5.1. Analysis of TrOCs
TrOC concentration in the enzymatic bioreactor and permeate was measured at different time
intervals using HPLC (Shimadzu, Kyoto, Japan) at the detection wavelength of 280 nm. The
HPLC system was equipped with a UV-Vis detector and C-18 column (300×4.6 mm) having a
pore size of 5 mm (Supelco Drug Discovery, Sigma Aldrich, Australia). Milli-Q water buffered
with 25 mM KH2PO4 and HPLC grade acetonitrile were used as the mobile phase for TrOC
quantification. Two eluents, namely eluent A (20% acetonitrile + 80% buffer, v/v) and eluent
B (80% acetonitrile + 20% buffer, v/v), were passed through the C-18 column at a flow rate of
0.7 mL/min for 30 min in time dependent gradients as follows: [Time (min), A (%)]: [0, 85],
[8, 40], [10, 0], [22, 0], [24, 85]. The limit of detection (LOD) for this method was
approximately 10 µg/L. Since any residual enzymatic activity in samples may interfere with
the accuracy of the results, samples were diluted (2 folds) with methanol to inactivate laccases
[15]. Before TrOC analysis, known standards of each TrOC were analyzed to determine the
time at which the peak of specific TrOC appears. After that, standards prepared from stock
solution containing the mixture of selected TrOCs were analyzed to prepare the calibration
curve (peak area vs concentration). Coefficient of determination (R2) for all the calibration
curves was greater than 0.99.
4.3.5.2. Laccase assay and ORP
Laccase activity was measured at an interval of three hours using a previously developed
method [15]. A detailed description of laccase activity assay and ORP is already given in the
Section 3.3.4.2 (Chapter 3).
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4.4. Results and discussion
4.4.1. TrOC retention by MD system
TrOC removal by an MD-EMBR system is governed by enzymatic transformation and
retention by MD membrane. In this experiment, the MD membrane achieved complete
retention (>99%) of the tested TrOCs, i.e., concentration of TrOCs in membrane permeate was
below the detection limit of 10 µg/L during all experiments. Since mass transfer in MD occurs
in vapor phase, volatility (pKH) of target pollutants controls their transport from feed to
distillate. The retention of TrOCs has been investigated recently in MD-only and MD coupled
with conventional bioreactor (MDBR) systems [19, 26], but not an enzymatic bioreactor. In
these studies, retention of volatile TrOCs (pKH <9) by MD system varied from 50-90%, while
retention of most non-volatile TrOCs (pKH >9) varied from 95-99%. Among the incompletely
removed moderately-volatile TrOCs in previous studies was oxybenzone [19, 26]. Complete
retention of all TrOCs including oxybenzone in the current experiment can be attributed to the
lower operating temperature (i.e., 30 oC vs. 40 oC) of the enzymatic bioreactor, which
consequently lowered the vapor pressure.
The MD system was also operated without the addition of laccase to quantify the loss in the
mass of tested TrOCs due to adsorption and/or evaporation. Sulfamethoxazole and diclofenac
lost approximately 4.5 and 2.5% of its initial mass, respectively, at the end of control run, while
the remaining compounds lost less than 1%. A negligible loss in the mass of TrOCs due to
adsorption and/or evaporation during the control run suggests that membrane retention and
enzymatic degradation were the main mechanisms of TrOC removal in MD-EMBR.

4.4.2. TrOC degradation vs. laccase source in MD-EMBR
Oxidation of TrOCs by laccase is principally controlled by two factors: (i) the nature of
functional groups attached to the core part of the molecule i.e., EDGs and EWGs; and (ii)
relative redox potential of laccase and TrOCs. Laccase can efficiently degrade phenolic
compounds. On the other hand, oxidation of non-phenolic compounds by laccase is possible
but it may be restricted by kinetic limitations [11, 14]. Notably, depending on the fungal
species, growth medium and level of glycosylation, the catalytic potential of laccase for TrOC
removal may be different. Thus, effect of laccase source on TrOC degradation was assessed.
In this experiment, significant enzymatic degradation of TrOCs was observed following their
complete retention by the MD membrane in MD-EMBR (Figure 4.3).
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Figure 4.3. Total mass of selected TrOCs in feed at the start (0 h) and the end (12 h) of
experiment in the enzymatic bioreactor of MD-EMBR following complete TrOC retention
(>99%) by MD. Error bars represent the standard deviation of duplicate samples. Error bars
for samples taken at t=12 h are not visible for all the selected TrOCs because the standard
deviation among those samples was less than 5%. Operating conditions: temperature of
enzymatic bioreactor and distillate was maintained at 30 and 10 °C, respectively; cross-flow
rate of water from enzymatic bioreactor and distillate was 1 L/min (corresponding to crossflow velocity of 9 cm/s); and initial laccase activity in enzymatic bioreactor was 95-100
µMDMP/min.
The fate of each compound was analyzed by developing a mass balance considering the total
input mass, mass in concentrate at the end of experiment, mass in permeate, adsorption and/or
evaporation losses, and enzymatically degraded portion (Figure 4.4). It was observed that
biodegradation was the main mechanism of TrOC removal in the enzymatic bioreactor.
Laccase from T. versicolor and A. oryzae achieved 40-80% and 45-99% TrOC degradation,
respectively (Figure 4.4). Laccase from A. oryzae demonstrated better overall performance
possibly due to its higher ORP, as discussed further later.
This is the first demonstration of a laccase-based membrane distillation – enzymatic membrane
bioreactor (MD-EMBR). Thus, the results are compared with previous UF-EMBR studies to
highlight the synergistic effect of integrating a high retention membrane with an enzymatic
bioreactor. Given the high TrOC retention by the MD membrane, depending on the level of
biodegradation, TrOC concentration in the bioreactor and the MD-permeate may be
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significantly different. By contrast, in an UF-EMBR, due to the limited TrOC retention by the
cake-layer on UF membrane, the TrOC concentration in the bioreactor and in permeate are
usually close i.e., permeate to supernatant ratio is usually within 0.8-1.0 as reported by Nguyen
et al. [13]. Therefore, for simplicity we compare overall removal by UF-EMBR
(biodegradation plus retention on membrane cake-layer) with biodegradation in MD-EMBR.
Concentrate
Adsorption and/or evaporation
Enzymatic degradation
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80

Mass distribution (%)
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Figure 4.4. The fate of TrOCs following treatment with laccases from A. oryzae (a) and T.
versicolor (b) in the bioreactor of MD-EMBR. The fate of each compound was analyzed by
developing a mass balance among the total input, mass in concentrate, enzymatic degradation,
adsorption/evaporation and permeates. MD system completely retained (>99%) all the selected
TrOCs. Operating conditions of MD-EMBR are given in the caption of Figure 4.3.
The highest degradation (80-99%) was achieved for a phenolic compound oxybenzone
containing two EDGs, namely methoxy and hydroxyl groups. Previously, Nguyen et al. [13]
also observed high overall removal (>80%) of oxybenzone in an UF-EMBR. Conversely, in
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comparison to the very low overall removal (>10%) of carbamazepine (containing a strong
EWG amide) in previous studies [13, 33], its degradation was 43% with laccase from T.
versicolor and 53% with laccase A. oryzae in the MD-EMBR. In general, diclofenac is well
removed (>60%) by laccase in UF-EMBR due to the presence of two EDGs, namely aromatic
amine and aniline functional groups, providing active sites for enzymatic attack [13, 18]. In
this experiment, degradation of diclofenac by laccases from T. versicolor and A. oryzae was
observed to be 82 and 90%, respectively.
Despite the presence of two EDGs (methyl and amine functional groups), atrazine, a nonphenolic pesticide, is resistant to laccase based treatment systems due to the steric hindrance
caused by chloride, a strong EWG [16, 34]. Enhanced degradation of atrazine by laccases from
T. versicolor (54%) and A. oryzae (67%) compared to its previously reported overall removal
of less than 5% in UF-EMBR [13] highlights the importance of complete TrOC retention for
efficient enzymatic degradation of recalcitrant TrOCs. Sulfamethoxazole, a significantly
hydrophilic compound (log D = -0.22), contains amine (EDG) and sulfonamide (EWG) groups.
Depending on the source of fungal laccase and bioreactor type, sulfamethoxazole degradation
has been reported to vary significantly (20-80%). For instance, Nguyen et al. [35] achieved less
than 20% degradation of sulfamethoxazole by laccase from A. oryzae in an UF-EMBR.
Conversely, Rodarte-Morales et al. [36] reported around 80% degradation of sulfamethoxazole
with laccases from Bjerkandera sp., Phanerochaete chrysosporium and Bjerkandera adusta in
a batch bioreactor. In this experiment, MD-EMBR achieved approximately 40 and 46%
degradation of sulfamethoxazole with laccases from T. versicolor and A. oryzae, respectively.
Integration of a DCMD system with conventional thermophilic bioreactor (MDBR) was
investigated by Wijekoon et al. [19]. As expected, the performance of MDBR and MD-EMBR
(this experiment) is comparable based on the permeate quality. However, it is indeed important
to compare the extent of biodegradation achieved in the bioreactors. The comparison of MDEMBR with MDBR [19] and UF-EMBR [13, 30] suggests better TrOC removal in the
bioreactor of MD-EMBR. For instance, degradation of diclofenac in this experiment ranges
from 80-90% (Figure 4.4), while MDBR achieved 25% degradation [19]. Similarly, while the
conventional activated sludge in MDBR achieved 10% removal of carbamazepine, its
enzymatic degradation in MD-EMBR ranged between 43 and 55%.

4.4.3. Effect of redox-mediator addition
4.4.3.1. TrOC degradation
Oxidation of phenolic and non-phenolic compounds by laccase can be possible via monoelectronic oxidation subject to their ORP. Low removal of non-phenolic compounds by laccase
is due to: (i) their higher ORP than laccase; and/or (ii) steric hindrance caused by EWGs such
as chloride and amide functional groups [37]. Several different redox-mediators such as HBT
and VA have been studied to improve the ORP of laccase, consequently improving TrOC
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degradation [13, 16]. In a laccase-mediator system, laccase reacts with redox-mediators to
produce reactive radicals that can improve the effectiveness of laccase-based treatment
systems. Moreover, effectiveness of this system depends on mediator type and concentration,
chemical structure of the substrate and ORP of laccase [38]. The efficacy of N=OH type
mediators for non-phenolic TrOC degradation is evident from literature [16, 37]. Therefore,
two N=OH type redox-mediators, namely HBT and VA, at 1 mM concentration were added
separately in the enzymatic bioreactor at the start of the experiment. Both mediators follow
hydrogen atom transfer (HAT) mechanism and produce highly reactive aminoxyl radical [14].
Regardless of the laccase source, the tested mediators achieved the highest degradation for
oxybenzone and diclofenac (Figure 4.5), probably because these compounds were already well
removed by laccase (Figure 4.4). Overall, an improvement of 5-10% in TrOC degradation was
achieved in T. versicolor-HBT system, while T. versicolor-VA yielded 10-20% improvement.
Separate addition of HBT and VA with laccase from A. oryzae improved the degradation of
TrOCs by 12-15 and 15-20%, respectively. Importantly, redox-mediator addition significantly
improved carbamazepine and atrazine removal as compared to oxybenzone that was already
well removed in the absence of any redox-mediator (Figure 4.5).
In line with the results of this experiment, degradation of oxybenzone and diclofenac in the
range of 80-99% has been reported following the addition of HBT and VA at 1 mM
concentration in batch bioreactors [16, 39]. Similarly, Nguyen et al. [13] achieved 80-85%
degradation of oxybenzone following the continuous addition of HBT at a low concentration
of 0.01 mM in an UF-EMBR. It also suggests that high concentration (e.g., 1 mM in this
experiment) of mediators may not be required to improve the degradation of those TrOCs that
are well degraded by laccase.
Improvement in the degradation of non-phenolic compounds has been observed to depend on
the type and concentration of redox-mediators [11]. Indeed, improvement in the degradation of
non-phenolic TrOCs including carbamazepine, sulfamethoxazole and atrazine was in the range
of 10-15 and 15-20% due to the addition of HBT and VA, respectively, (Figure 4.5). Based on
the overall performance of both laccase sources with VA or HBT (Figure 4.5), the laccase
from A. oryzae again outperformed that from T. versicolor.
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Figure 4.5. Enzymatic degradation of selected TrOCs in enzymatic bioreactor after 12 h of
treatment in MD-EMBR with and without the addition of redox-mediator addition. Error bars
represent the standard deviation of duplicate samples. Two mediators (HBT and SA) are added
separately at 1 mM. Operating conditions of MD-EMBR are given in the caption of Figure
4.3.
Increase in the ORP of the reaction media has been suggested as one of the reasons for
enhanced TrOC removal in laccase-mediator system [14]. In this experiment, ORP of A. oryzae
laccase was higher than T. versicolor laccase (Figure 4.6). Moreover, significant increase in
ORP was also observed following the addition of mediators, and its highest value was obtained
for VA regardless of the laccase source. Even though ORP of laccase-VA was higher than
laccase-HBT, the results (Figure 4.7) suggest slightly better degradation of sulfamethoxazole
and oxybenzone by laccase-HBT. Therefore, ORP is not the sole factor responsible for
enhanced TrOC removal.
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Figure 4.6. Oxidation reduction potential (ORP) and enzyme inactivation with and without the
addition of redox-mediators. Two mediators, namely HBT and VA, were added separately at
1 mM concentration. Operating conditions of MD-EMBR are given in the caption of Figure 1.
Time course of enzymatic activity during all experiments is given in Appendix Figure 4-1.
4.4.3.2. Impact on enzymatic activity
Gradual enzyme denaturation can occur during the operation of an EMBR due to different
physical, biological and chemical inhibitors [40]. Moreover, rapid denaturation of enzymes has
also been observed following the dosing of redox-mediators [16]. In this experiment, despite
the absence of any chemical inhibitor, a continuous drop in enzymatic activity was observed
due to hydrodynamic stress during all experiments (see Appendix Figure 4-1). Enzyme
inactivation was significantly increased with the addition of HBT and VA (Figure 4.6). Purich
[40] suggested that the substrate and charged metabolites can inactivate enzyme in a number
of ways such as: (i) substrate can block the active sites of the enzymes due to the electrostatic
interactions between enzyme and charged metabolites; and (ii) metabolites can react with
enzyme to convert it into nonproductive complexes.
The extent of inactivation in presence of mediators was different for laccase from T. versicolor
and A. oryzae. A direct relation between ORP and enzyme inactivation was observed (Figure
4.6). For example, the highest inactivation was induced by VA having the highest ORP (>0.6
V). High ORP of laccase-mediator system indicates that radicals generated due to the oxidation
of mediator by laccase can rapidly degrade TrOCs but at the same time they can inactivate
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laccase quicker. Therefore, for the development of a long-term laccase-mediator based
treatment process, mediator type, concentration and the characteristics of target compounds
need to be considered.
4.4.3.3. Impact on contact time
Besides the assessment of the final degradation efficiency at the end of each experiment (i.e.,
12 h), TrOC concentration in the enzymatic bioreactor was measured at an interval of three
hours. In absence of mediators, regardless of the laccase source, the TrOC concentrations
showed a gradual drop over the entire operation period (Figure 4.7). On the other hand, in the
presence of redox-mediators, the maximum degradation of most TrOCs was achieved within
six hours (Figure 4.7).
Only oxybenzone degradation was completed within three hours irrespective of redox-mediator
addition. Thus, not only that 10-20% improvement in TrOC degradation was achieved (Figure
4.5) but that was achieved rapidly (Figure 4.7) following the addition of redox-mediators. The
cease of TrOC oxidation after six hours was apparently due to the inactivation of the laccase
as noted in the previous section. Reactive radicals produced due to the oxidation of redoxmediators by laccase can react with the aromatic amino residues available on the outer surface
of the enzyme, resulting in the inactivation of enzyme [41]. Improved TrOC degradation at the
expense of high laccase inactivation has been reported previously in batch tests involving
laccase-mediator systems [33, 42]. The results presented in this chapter extends such
observation in case of an MD-EMBR for the first time.
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Figure 4.7. Effect of reaction time on the removal of selected TrOCs in the enzymatic
bioreactor of MD-EMBR with and without the addition of two mediators. HBT and SA were
added at 1 mM concentration separately. Operating conditions of MD-EMBR are given in the
caption of Figure 4.2.

4.4. Hydraulic performance of membrane
Temperature difference between the feed and the distillate side has major influence over the
permeate flux in MD process. Ideally, the temperature at the feed and distillate side is kept at
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>50 and 20-25ºC, respectively to produce adequate permeate flux (approximately 10 L/m 2 h)
[24]. However, thermal stability of laccase at elevated temperature should be taken in to
account before selecting the working temperature of enzymatic bioreactor in MD-EMBR. A
few studies have covered the aspect of thermal stability of laccase under different experimental
conditions. For instance, Nguyen et al. [43] observed stable laccase activity up to 40 °C when
the enzyme solution was not spiked with TrOCs (i.e., ‘non-reacting’ laccase solution).
Conversely, in presence of TrOCs, Nair et al. [44] and Kim and Nicell [45] observed rapid drop
in laccase activity beyond 30°C. Therefore, in this experiment, the temperature of the
enzymatic bioreactor and permeate was kept at 30 and 10ºC, respectively.

Figure 4.8. Average permeate flux obtained during the operation of enzymatic membrane
distillation (E-MD) with different combinations of enzymes and mediators. Numbers within
parenthesis in x-axis indicate number of data points. MD without the addition of enzyme and
mediators served as a control. Feed and distillate temperature were controlled at 30 and 10 °C,
respectively during all experiments. The cross-flow rate of both feed and distillate side was set
at 1 L/min (corresponding to a cross-flow velocity of 9 cm/s).
The stability of the permeate flux was continually monitored during all experiments (see
Appendix Figure 4-2). Permeate flux was stable during all experiments, and no significant
decline was observed. Average permeate flux of 4.61±0.24, 3.78±0.35 and 3.74±0.46 L/m2 h
was obtained for MD only (control), MD-EMBR with T. versicolor and/or mediators and MD147

EMBR with A. oryzae and/or mediators, respectively (Figure 4.8). Permeate flux depends
more on the temperature of the feed side due to the exponential effect of increase in temperature
on flux [24]. Thus, relatively low permeate flux in this experiment was expected.

4.5. Conclusion
In this chapter, removal of trace organic contaminants (TrOCs) by an integrated membrane
distillation – enzymatic bioreactor (MD-EMBR) was assessed. Experiments were performed
using laccase from two different sources, namely Trametes versicolor and genetically modified
Aspergillus oryzae to assess the impact of laccase source on TrOC degradation. Permeate flux
of MD-EMBR was stable during all experiments. A mass balance revealed that enzymatic
degradation was the major contributor in the overall removal of TrOCs. The MD system
ensured complete retention (>99%) of both enzymes and TrOCs. Of particular interest was that
the complete retention of the TrOCs resulted in improved TrOC degradation by both laccases.
Oxybenzone and diclofenac degradation in the MD-EMBR ranged between 80 and 99%.
Compared to UF-EMBR (Section 3.4.2, Chapter 3), up to 40% improvement in the removal of
resistant non-phenolic TrOCs (e.g., carbamazepine) was observed. Laccase from A. oryzae
demonstrated better TrOC degradation and enzymatic stability as compared to laccase from T.
versicolor. This could be attributed to the higher (15%) redox-potential of laccase from Laccase
from A. oryzae than laccase from T. versicolor. Performance of MD-EMBR system was further
improved with the addition of one natural (violuric acid, VA) and one synthetic (1hydrozybenzotriazole, HBT) redox-mediator at 1 mM concentration. With the addition of
redox-mediators, TrOC degradation was improved by 10-20%. Although HBT and VA both
affected laccase stability, they increased the reaction rate, which resulted in rapid degradation
of the selected compounds.
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Chapter 5: TrOC removal by a membrane
distillation – enzymatic membrane bioreactor (MDEMBR): Impacts of redox-mediator types,
concentrations and their mixtures

This chapter is based on the following publications:
Asif, M.B., Hai, F.I., Kang, J., Van De Merwe, J.P., Leusch, F.D., Price, W.E., Nghiem, L.D.
2018. Biocatalytic degradation of pharmaceuticals, personal care products, industrial
chemicals, steroid hormones and pesticides in a membrane distillation-enzymatic bioreactor.
Bioresource Technology, 247, 528-536.
Asif, M.B., Hai, F.I., Kang, J., Van De Merwe, J.P., Leusch, F.D., Yamamoto, K., Price,
W.E., Nghiem, L.D. 2017. Degradation of Trace Organic Contaminants by a Membrane
Distillation—Enzymatic Bioreactor. Applied Sciences, 7(9), 879.
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5.1. Introduction
Membrane distillation (MD) is a low temperature distillation process in contrast to
conventional distillation processes such as fractional or steam distillation. It essentially relies
on the transport of water in the vapor phase from a feed solution through a microporous
hydrophobic membrane to the permeate or distillate. Among different MD configurations,
direct contact membrane distillation (DCMD) has been predominantly studied due to the ease
of its operation [1, 2]. In DCMD, the temperature of the feed solution is maintained at 15-20
ºC higher than the permeate to create an adequate vapor pressure difference, which allows
water to pass through a microporous membrane in vapor form via diffusion [1, 3]. Since mass
transfer occurs in gaseous phase, MD can theoretically achieve complete rejection of all nonvolatile compounds [4, 5].
Due to efficient separation efficiency, low fouling propensity and potentially low energy
requirement (subject to the availability of low grade heat), stand-alone MD has been studied
for applications such as protein recovery in dairy processing [6], treatment of industrial [7] and
municipal wastewater [8, 9], as well as for the removal of trace organic contaminant (TrOCs),
such as pharmaceuticals and personal care products, pesticides and industrial chemicals, from
wastewater [5, 10]. Recently, TrOC removal has also been investigated by coupling an
activated sludge based bioreactor to MD that achieved excellent (95-99%) TrOC retention [9].
Since effective retention of TrOCs by the MD theoretically decouples organic retention time
from hydraulic retention time (HRT) of a bioreactor, the degradation of TrOCs is expected to
improve due to prolonged contact time between the recalcitrant compounds and the
microorganisms [11]. However, it was found that the biodegradation of resistant TrOCs, such
as those containing strong electron withdrawing functional groups (EWGs), by the activated
sludge in the MD-coupled bioreactor did not improve, and eventually these TrOCs accumulated
in the bioreactor [9, 12]. Hence, to realize the full potential of a combined biological – MD
process, it is necessary to find the means to improve biodegradation of TrOCs retained in the
bioreactor by the MD membrane. In this context, it is noteworthy that the oxidoreductase
enzyme laccase (EC 1.10.3.2) can degrade TrOCs that are less susceptible to degradation by
the activated sludge process [13, 14].
Laccase can catalyze the degradation of a broad spectrum of pollutants including aromatic
hydrocarbons, aliphatic amines and TrOCs by using dissolved oxygen as a co-factor [14-16].
TrOC degradation by laccase depends on several factors including pH, temperature, chemical
structure of TrOCs and laccase properties [12, 14, 17]. In general, effective laccase-catalyzed
degradation of TrOCs containing electron donating functional groups (EDGs) such as amine
(–NH2), alkoxy (–OR) or hydroxyl (–OH) was observed. On the other hand, degradation of
TrOCs containing electron withdrawing functional groups (EWGs) such as halogen (–X),
amide (–CONR2) or nitro (–NO2) has been reported to be poor or unstable [14, 18]. Degradation
of TrOCs can be improved by adding different natural and synthetic redox-mediators that are
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low molecular weight compounds capable of exchanging electrons between laccase and TrOCs
[19-21].
Larger scale application of enzymatic treatment systems is restricted by the lack of a bioreactor
system, which can prevent washout of enzymes along with treated effluent. In an attempt to
prevent enzyme washout, an enzymatic membrane bioreactor (EMBR) was developed by
coupling an ultrafiltration (UF) membrane to an enzymatic bioreactor [22, 23]. Interestingly,
during the operation of the EMBR, adsorption of some hydrophobic TrOCs (e.g., amitriptyline,
oxybenzone and octocrylene) onto the enzyme gel layer over the membrane surface resulted in
enhanced degradation of the adsorbed compounds [22]. In another study, removal of four nonphenolic TrOCs, namely atrazine, sulfamethoxazole, diclofenac and carbamazepine were
improved by 15–25% following the addition of granular activated carbon (GAC) in EMBR.
This was probably because simultaneous adsorption of laccase and TrOCs on GAC promoted
the interaction of TrOCs with the active sites of laccase [11]. Results from previous studies
indicate the complementarity of simultaneous laccase and TrOC retention within EMBR in
contrast to only laccase retention by UF membranes utilized in the previously developed
EMBRs [22, 24]. This has led to the development of high retention (HR) – EMBR. Indeed, as
demonstrated in Chapter 3, TrOC degradation by a high retention nanofiltration (NF) – EMBR
was better than those achieved by ultrafiltration (UF)-EMBRs, which retains laccase but not
TrOCs. Apparently, the effective retention of the TrOCs by the high retention NF membrane
also improved their biodegradation [25].
In a recent study, Asif et al. [24] combined an enzymatic bioreactor with the MD (MD –
enzymatic membrane bioreactor or MD-EMBR), which retained both laccase and the tested
TrOCs (carbamazepine, sulfamethoxazole, diclofenac, atrazine and oxybenzone). During a
short term (12 h) batch operation of the MD-EMBR (see Chapter 4), degradation of the
investigated TrOCs by laccase was found to improve significantly as compared to that achieved
by an activated sludge-based MD bioreactor [9, 24]. The initial observations were promising
but it is necessary to assess the performance of MD-EMBR for a wide range of TrOCs during
continuous operation. In addition, although enhanced degradation was achieved by MD-EMBR
[24], degradation of most tested TrOCs was incomplete, requiring the introduction of an
additional agent capable of TrOC oxidation. As shown in Chapter 4, two redox-mediators,
namely 1-hydrozybenzotriazole (HBT) and violuric acid (VA) were introduced separately in
the enzymatic bioreactor at a concentration of 1 mM, which improved TrOC degradation by
10-20%. However, there is a need to systematically study the impacts of redox-mediator type
and concentration as well as mediator mixtures for improving the degradation of a broad
spectrum of TrOCs.
In this chapter, the performance of a laccase-based membrane distillation – enzymatic
membrane bioreactor (MD-EMBR) is discussed for the removal of TrOCs having diverse
physicochemical properties (e.g., EDGs/EWGs, hydrophobicity and phenolic/non-phenolic
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moieties). In addition, the effect of dosing redox-mediators, separately and as a mixture, on
TrOC degradation and laccase stability is elucidated. Redox mediators can improve
degradation but may increase the toxicity of the treated effluent [26, 27], therefore, the toxicity
of the bioreactor media and MD permeate (i.e., final effluent) to bacteria was monitored to
clarify the applicability of this treatment process. Finally, during continuous operation, TrOC
retention by MD can decrease over time due to ‘membrane wetting’ or loss of hydrophobicity
[1, 3]. Accordingly, the effect of laccase and redox-mediators on the MD performance was also
investigated.

5.2. Hypothesis
▪
▪

Redox-mediator type and concentration may affect the extent of TrOC degradation,
enzyme stability
Mixture of different redox-mediators may achieve better improvement in TrOC
degradation than a single redox-mediator

5.3. Materials and methods
5.3.1. TrOCs, laccase and mediators
A synthetic wastewater containing a mixture of 30 TrOCs in Milli-Q water was prepared for
this experiment. These compounds were selected to represent different common classes of
TrOCs, viz pharmaceutical and personal care products, industrial chemicals, steroid hormones
and pesticides, which are commonly detected in different environmental systems [28]. A
complete list along with their chemical structures appears in Appendix Table 3-1. Relevant
physicochemical properties of the selected TrOCs such as hydrophobicity (log D) and volatility
(pKH) are given in Table 5.1. The list of the selected TrOCs in this chapter and in Chapter 3
are same except for oxybenzone, i.e., list of TrOCs in Cgapter 3 did not include oxybenzone.
Analytical grade TrOCs were purchased from Sigma Aldrich (Australia). A stock solution (25
mg/L) containing the mixture of 30 TrOCs was prepared in methanol and kept in dark at -18
ºC prior to use. Laccase from genetically modified Aspergillus oryzae (Novozymes Australia
Pty Ltd.) was used. Properties of laccase are already presented in Section 3.3.1 (Chapter 3).
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Table 5.1. Physicochemical properties of TrOCs selected for this experiment
TrOCs

Primidone
Ketoprofen
Naproxen
Gemfibrozil
Metronidazole
Diclofenac
Fenoprop
Ibuprofen
Ametryn
Clofibric acid
Carbamazepine
Octocrylene
Amitriptyline
Atrazine
Propoxur
Benzophenone
DEET
Enterolactone
Estriol
17α–
Ethinylestradiol
Oxybenzone
Estrone
17β–Estradiol
17β-Estradiol-17acetate
Bisphenol A
Salicylic acid
Pentachlorophenol
Triclosan
4-tert-Butylphenol
4-tert-Octylphenol

C12H14N2O
C16H14O3
C14H14O3
C15H22O3
C6H9N3O3
C14H11Cl2NO2
C9H7Cl3O3
C13H18O2
C9H17N5S
C10H11ClO3
C15H12N2O
C24H27N
C20H23N
C8H14ClN5
C11H15NO3
C13H10O
C12H17NO
C18H18O4
C18H24O3

g/mole
218.25
254.28
230.26
250.33
171.15
296.15
269.51
206.28
27.33
214.65
236.27
361.48
277.40
215.68
209.24
182.22
191.3
288.38
298.33

0.83
0.19
0.73
2.07
-0.14
1.77
-0.13
0.94
2.97
-1.06
1.89
6.89
2.28
2.64
1.54
3.21
2.42
2.53
1.89

Water
Solubility
at 25oC
mg/L
1500
554,000
435,000
263,000
29,000
20,000
230,000
928,000
140
100,000
220
0.36
83
69
800
150
1000
200
32

C20H24O2

269.40

4.11

3.9

3.74 × 10-9

9.47

C14H12O3
C18H22O2
C18H24O2

228.24
270.37
272.38

3.89
3.62
4.15

2700
5.9
3

5.26 × 10-6
1.54 × 10-8
9.82 × 10-9

9.23
9.03
8.93

C20H26O3

314.42

5.11

1.9

9.88 ×10-9

8.67

C15H16O2
C7H6O3
C6HCl5O
C12H7Cl3O2
C10H14O
C14H22O

228.29
138.12
266.34
289.54
150.22
206.32

3.64
-1.13
2.85
5.28
3.40
5.18

73
2240
4800
19
1000
62

5.34 × 10-7
8.2 × 10-5
3.49 × 10-4
3.26 ×10-5
0.0361
1.98 × 10-3

8.66
8.18
7.59
6.18
5.15
5.06

Chemical Formula

Molecular
Weight

Log D
at
pH=7

Vapor
Pressure

pKH at
pH 7

(mmHg)
6.08 × 10-11
3.32 × 10-8
3.01 × 10-7
6.13 × 10 -7
2.67 × 10-7
1.59 × 10-7
2.13 × 10-6
1.39 × 10-4
1.72 × 10-6
1.03 × 10-4
5.78 × 10-7
2.56 × 10-9
1.50 × 10-6
1.27 × 10-5
1.53 × 10-3
8.23 × 10-4
5.6 × 10-3
3.29 × 10-13
1.34 × 10-9

13.93
13.70
12.68
12.11
11.68
11.51
11.48
10.39
9.35
9.54
9.09
8.47
8.18
7.28
6.28
5.88
5.85
15.20
10.78

Two N=OH type redox-mediators, namely 1-hydroxybenzotriazole (HBT) and violuric acid
(VA), and one phenolic redox-mediator, namely syringaldehyde (SA), were used. A separate
stock solution (50 mM) of each mediator was prepared in ultrapure Milli-Q water and stored
at 4 ºC in the dark. SA and VA produce highly reactive phenoxyl and aminoxyl radicals,
respectively. They can mediate TrOC degradation by following a hydrogen atom transfer
pathway [16, 27].
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5.3.2. The MD-EMBR System
A laboratory scale MD-EMBR system was used comprising a glass enzymatic bioreactor (1.5
L) and an external direct contact membrane distillation (DCMD) module. A schematic of the
experimental setup as well as the description of the DCMD module and MD membrane are
available in Section 4.3.3 (Chapter 4).

5.3.3. Experimental protocol
5.3.3.1. Preliminary assessment with and without mediator addition
A series of preliminary short-term (12 h) experiments was carried out to evaluate the
performance of MD-EMBR for TrOC degradation. At the start of the experiment, a mixture of
the selected TrOCs (each at 20 µg/L) in Milli-Q water was added to the bioreactor. Laccase
was added to the bioreactor for achieving an initial enzymatic activity of 95–100 µM(DMP)/min.
The media from the glass enzymatic bioreactor and water from the permeate tank were
recirculated in their respective flow channels separated by the membrane. A chiller (SC100A10, Thermo Scientific, Waltham, MA, USA) was used to regulate the temperature of the
permeate tank at 10 ± 0.1 °C. The permeate tank was also placed on a precision balance (Mettler
Toledo Inc., Columbus, OH, USA) to monitor permeate flux. The recirculation flow rate of
both feed and the distillate was controlled at 1 L/min (corresponding to the cross-flow velocity
of 9 cm/s) using two rotameters.
Duplicate samples from the enzymatic bioreactor (100 mL each) and permeate tank (500 mL
each) were taken after operating the MD-EMBR for 12 h. After evaluating the laccasecatalyzed degradation of TrOCs in MD-EMBR, the possible improvement in TrOC degradation
was assessed with the addition of three redox-mediators (HBT, VA and SA) at two different
concentrations (0.25 and 0.5 mM) via separate runs. Again, duplicate samples from the
enzymatic bioreactor and permeate tank were collected for the quantification of TrOCs.
Samples collected from the enzymatic bioreactor were diluted to 500 mL with Milli-Q water
and were filtered through 0.45 µm glass fiber filter paper (Filtech, Wollongong, NSW,
Australia). The pH of samples was adjusted to 2–2.5 using 4 M H2SO4 before solid phase
extraction (SPE) and GC/MS analysis. For toxicity analysis, undiluted samples from the
enzymatic bioreactor and permeate tank were collected in 2 mL amber vials at the end of each
experiment and stored at 4 °C until analysis.
5.3.3.2. Long-term performance with and without mediator addition
A series of long-term experiments were conducted to investigate TrOC retention (by MD
membrane) and enzymatic degradation with and without the addition of redox-mediators (i.e.,
SA and VA) to assess the stability of the developed process. Laccase activity and TrOC
concentration in the enzymatic bioreactor were identical to that during preliminary short-term
experiments. It is noteworthy that laccase activity in the enzymatic bioreactors may gradually
diminish due to various physicochemical and biological inhibitors such as shear stress caused
157

by membrane filtration [29]. Hence, the laccase activity was maintained at 95-100 µM(DMP)/min
by injecting a small dose of laccase (275 and 400 µL per liter of reactor volume for laccase and
laccase-mediator, respectively) every 12 h to sustain MD-EMBR operation.
The MD-EMBR was first operated for a period of 60 h (i.e., 2× HRT) in a continuous mode
(i.e., continuous withdrawal of treated effluent) without the addition of mediators. The
enzymatic bioreactor was replenished with synthetic wastewater every time the water recovery
reached 70% (i.e., approximately around every 24 h). Samples from feed, enzymatic bioreactor
and treated effluent (i.e., MD-permeate) were collected after 30 and 60 h of MD-EMBR
operation for TrOC quantification. The effect of individual mediators and their mixture on
TrOC degradation was investigated in additional runs. A single dose of an individual redoxmediator (at 0.5 mM) or their mixture was added to the enzymatic bioreactor at the beginning
of a run. Again, two sets of feed, supernatant and permeate samples for TrOC quantification
were collected.

5.3.4. Analytical methods
5.3.4.1. TrOC analysis
TrOCs were analyzed by solid phase extraction (SPE) and quantitative determination by a
Shimadzu GC/MS (QP5000) system [9, 30]. A detailed description of this method is given in
Section 3.3.4.1 (Chapter 3). The limit of detection (LOD) for this method is compound
specific and ranged from 1-20 ng/L as listed in Appendix Table 3-1. Removal efficiency by
enzymatic bioreactor (R1) and MD-EMBR (R2) was calculated as shown in equation (1) and
(2), respectively:
𝐶𝑆𝑢
)
𝐶𝑓
𝐶𝑝
𝑅2 = 100 × (1 − )
𝐶𝑓

𝑅1 = 100 × (1 −

(1)
(2)

Where, Cf, Csu and Cp are the concentration (ng/L) of a specific TrOC in the feed, supernatant
and permeate, respectively. Mass of each TrOC degraded by laccase was calculated as follows:
Cf × Vf = (Csu × Vsu) + (Cp × Vp) + mass degraded by laccase

(3)

where, Vf, Vsu and Vp represents the volume of feed, supernatant and permeate, respectively.
5.3.4.2. Laccase activity and contact angle
See Section 3.3.4.2 and 3.3.4.3 (Chapter 3)
5.3.4.3. Permeate toxicity analysis
Samples for toxicity analysis were collected from the enzymatic bioreactor and permeate tank
at end of each experiment. Toxicity, expressed as a relative toxicity unit (rTU), was analyzed
by measuring the inhibition of luminescence in the naturally bioluminescent bacteria,
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Photobacterium leiognathi, as previously described [26, 31]. Briefly, an aliquot of a naturally
bioluminescent bacteria, Photobacterium leiognathi, was incubated with a serial dilution of the
sample extracts in a phosphate buffered saline solution. After 30 min, luminescence was
measured on a Fluostar Omega plate reader (BMG Labtech, Germany) and the inhibition of
luminescence was calculated relative to a negative control. The IC20, the concentration of the
sample required to inhibit bacterial luminescence by 20%, was then computed for each sample
by linear regression of the response between 0 and 40% inhibition. All results are presented as
a relative toxicity unit (rTU), the reciprocal of the IC20. The limit of detection of this method
was 1 rTU.

5.4. Results and discussion
5.4.1. Overall TrOC removal by MD-EMBR
Retention by the MD membrane and degradation in the enzymatic bioreactor are two major
mechanisms for TrOC removal in the MD-EMBR system. In theory, MD membranes can retain
all but the volatile organic compounds. During the preliminary experiment, the concentration
of non-volatile (pKH > 9; Table 5.1) TrOCs in the permeate of the MD-EMBR was below the
limit of detection of GC/MS. This is consistent with the observation reported previously, where
an MD membrane was coupled with an activated sludge bioreactor [9]. On the other hand, the
MD system achieved 90–99% removal (Figure 5.1) of relatively volatile TrOCs having pKH <
9. This compares favorably to their previously reported moderate to high removal (54–99%)
by a standalone MD system [5].
In order to assess the stability of the developed process for TrOC removal, the MD-EMBR was
operated separately for an extended duration of 60 h (2× HRT). The removal of TrOCs was
consistently above 94% and ranged between 94 and above 99% (Figure 5.1). Importantly,
effective TrOC removal (90->99%) was achieved after the operation of the MD-EMBR for 12
h and 60 h, indicating no deterioration in the quality of membrane permeate. These results
suggest that the coupling of enzymatic degradation process to the MD system was favorable
for achieving high TrOC removal.
The results obtained after the long-term operation of MD-EMBR indicate that TrOC
retention/removal by the MD membrane is not only governed by the vapor pressure (indicated
by Henry’s constant, H or, pKH = -log H; Table 5.1), but is controlled by both the vapor
pressure and the water partition coefficient (log D; Table 5.1) of the target TrOC. In a standalone MD system, a low (<2.5) ‘pKH /log D’ ratio suggests poor removal of the target
compound [5]. By contrast, the MD membrane coupled to an activated sludge bioreactor may
achieve high removal of the target compounds irrespective of their pKH /log D ratio. This is
because a compound with a low pKH /log D ratio tends to be adsorbed on the bioreactor
particles [9]. Although the enzymatic bioreactor was free of any suspended particles that can
potentially adsorb TrOCs, MD-EMBR still achieved 94 to over 99% removal for the 30 TrOCs
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tested (Figure 5.1). It is noteworthy that compared to their partial removal (54-70%) in a standalone MD system [5], the MD membrane in this experiment achieved over 99% removal of
some TrOCs including 4-tert-octylphenol (pKH /log D = 0.98), octocrylene (pKH /log D = 1.21),
4-tert-butylphenol (pKH /log D = 1.51), benzophenone (pKH /log D = 1.83) and oxybenzone
(pKH /log D = 2.1). This significant improvement can be attributed to the efficient degradation
of these TrOCs by laccase in MD-EMBR as discussed in the following sections.
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Figure 5.1. Overall removal (membrane retention + enzymatic degradation) of 30 TrOCs
arranged by usage category in the MD-EMBR. The data from the preliminary short-term
experiment (t = 12 h and n=2) as well as from the long-term experiment (t = 60 h and n=4)) is
presented. Error bars are not visible because the standard deviation was less than 5%. MDEMBR operating conditions: the initial TrOC concentration and laccase activity was 20 µg/L
and 95–100 µM(DMP)/min, respectively; temperature of the enzymatic bioreactor and the
permeate tank were kept at 30 and 10 °C, respectively; and cross-flow rate of media from the
enzymatic bioreactor and distillate was 1 L/min (corresponding to a cross-flow velocity of 9
cm/s).

5.4.2. Preliminary assessment of TrOC degradation in MD-EMBR
Laccase degrades a substrate via a radical-catalyzed mechanism. In this process, transfer of one
electron from a substrate to laccase occurs, and molecular oxygen is reduced to water. Laccase
can efficiently degrade phenolic pollutants i.e., substrates containing a hydroxyl (–OH) group
attached to a benzene ring. On the other hand, non-phenolic pollutants are less amenable to
laccase-catalyzed degradation [14, 16]. Therefore, degradation achieved after the preliminary
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Absolute pKH /log D ratio (pH=7)

Preliminary short-term experiment (12 h)

experiment is presented in Figure 5.2 by arranging TrOCs based on the presence of phenolic
moiety in their molecule.
After the preliminary experiment, high degradation (87–99%) of 10 out 13 phenolic TrOCs
was achieved by the MD-EMBR (Figure 5.2). These included five steroid hormones (estriol,
estrone, 17β–estradiol, 17α–ethinylestradiol and 17β-estradiol-17-acetate (95–99%)), two
industrial chemicals (4-tert-butylphenol, and 4-tert-octylphenol (87–99%)) and two personal
care products (oxybenzone and triclosan (89–98%)). On the other hand, enzymatic degradation
of some phenolic compounds, namely pentachlorophenol, enterolactone and salicylic acid,
ranged from 55 to 75%. The enzymatic degradation of 17 non-phenolic TrOCs varied from 40
to 99% (Figure 5.2). Laccase-catalyzed degradation of 13 compounds fell in the range of 40–
65%, while the degradation of the remaining four non-phenolic TrOCs ranged between 94 and
98%. The well degraded non-phenolic TrOCs include metronidazole, benzophenone,
amitriptyline and octocrylene. High laccase-catalyzed degradation (80–99%) in continuous flow
UF-EMBR has been previously reported [22, 26] for benzophenone, amitriptyline and octocrylene.
An overall degradation of only 40–65% was achieved by the MD-EMBR for a number of nonphenolic TrOCs (Figure 5.2), however, these removal efficiencies in fact compare favorably
with those reported in the literature [17, 19, 26]. For instance, laccase-catalyzed degradation of
carbamazepine, clofibric acid, fenoprop and atrazine has been reported to be less than 10% in
both batch and continuous-flow ultrafiltration based enzymatic bioreactors [19, 22, 32]. By
contrast, 40–45% degradation of these TrOCs by the MD-EMBR was observed during
preliminary assessment. Importantly, degradation of TrOCs by laccase in the MD-EMBR
seems to be governed by TrOC properties such as the presence of strong EDGs and/or EWGs.
This has been explained comprehensively in Section 5.4.2.2 that elucidates TrOC degradation
in the MD-EMBR during long-term operation.
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Figure 5.2. Preliminary performance of the MD-EMBR for the degradation of 30 TrOCs by
laccase. Error bars indicate the standard deviation of duplicate samples. Experimental
conditions are given in the caption of Figure 5.1.

5.4.3. TrOC degradation in MD-EMBR during long-term continuous operation
5.4.3.1. Degradation of phenolic TrOCs
Of the 13 phenolic TrOCs tested (Figure 5.3), laccase achieved significant degradation (9599%) of 10 compounds including five steroid hormones, three industrial chemicals (bisphenol
A, 4-tert-butylphenol and 4-tert-octylphenol) and two ingredients of personal care products
(triclosan and oxybenzone). The observation of efficient enzymatic degradation of these TrOCs
in MD-EMBR is consistent with the literature regarding previously developed enzymatic
bioreactors. For example, Lloret et al. [23] achieved 95-99% removal of two steroid hormones
(estrone and 17β–estradiol) in a batch enzymatic bioreactor. Similarly, efficient degradation
(>90%) of oxybenzone, bisphenol A, triclosan and 4-tert-butylphenol has been achieved by
both batch or continuous-flow enzymatic bioreactors [17, 26]. Notably, a reduced removal (2035%) of three natural steroid hormones such as estrone, 17β-estradiol and estriol has been
reported in continuous -low UF-EMBRs, as compared to that achieved by batch enzymatic
bioreactor [22, 23]. This was attributed to the sustained-TrOC loading in UF-EMBRs. In this
experiment, degradation of estrone, 17β-estradiol and estriol was greater than 99%, which
indicates that effective retention of these TrOCs by the MD membrane facilitated their
degradation by laccase in MD-EMBR.
Although phenolic TrOCs are especially amenable to laccase-catalyzed degradation, moderate
degradation of a few phenolic compounds has been previously attributed to the presence of
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EWG(s) in their molecular structure [33]. Due to the steric hindrance caused by the
concomitant presence of an EWG, phenolic TrOCs cannot access the active sites of laccase for
efficient degradation [26, 33]. In line with this, a moderate degradation (44-65%) was observed
for three phenolic TrOCs, namely salicylic acid, pentachlorophenol and enterolactone in this
experiment, which contain an EWG (i.e., carbonyl or halogen) in their molecule (Figure 5.3).
5.4.3.2. Degradation of non-phenolic TrOCs
Laccase can oxidize non-phenolic TrOCs, but the extent of the degradation may not be
significant [14]. In previous studies, two distinct trends were observed for the degradation of
non-phenolic TrOCs by laccase: (i) poor removal (e.g., less than 5%) of those that only contain
strong EWGs such as halogen (–X), amide (–CONR2) and carbonyl (–C=O) functional groups;
and (ii) moderate to high removal of those that contain both EWGs and EDGs such as amine
(–NH2) or alkoxy (–OR) functional group [14, 29, 34]. In this experiment, benzophenone,
octocrylene and amitriptyline were significantly degraded (>95%) by laccase. On the other
hand, a moderate degradation (45-75%) was observed for the remaining non-phenolic TrOCs
(Figure 5.3).
Of particular interest is the enhanced degradation of pharmaceuticals and pesticides (containing
strong EWGs) that were previously reported to be poorly (<10%) degraded by laccase in both
batch and continuous-flow enzymatic bioreactors [17, 26]. These TrOCs include ketoprofen
(EWG carboxylic; 52% removal), clofibric acid (EWG halogen; 55% removal), carbamazepine
(EWG amide; 62% removal), metronidazole (EWG nitro; 67% removal), atrazine (EWG
halogen; 59% removal), fenoprop (EWG halogen, 48% removal) and N, N-Diethyl-metatoluamide (DEET; EWG amide; 69% removal) (Figure 5.3). Previously, significantly
improved degradation of recalcitrant TrOCs such as carbamazepine, atrazine and diclofenac
was attributed to simultaneous adsorption of laccase and TrOCs on granular activated carbon
which allowed prolonged close contact between laccase and TrOCs [11]. Although approach
in this experiment was different, the enhanced degradation of recalcitrant TrOCs in MD-EMBR
can be ascribed to the increased contact time between laccase and TrOCs following their
complete retention (95-99% removal) by the MD membrane. It is important to critically
analyze the degradation of TrOCs after both 12 h (preliminary performance) and 60 h
experiments (long-term performance). The comparison of TrOC degradation by the MDEMBR after 12 h (Figure 5.2) and 60 h (Figure 5.3) suggests that TrOC degradation was
stable.
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Figure 5.3. Laccase-catalyzed degradation of 30 TrOCs in MD-EMBR during long-term
continuous operation of MD-EMBR (60 h; and 2×HRT). Error bars indicate the standard
deviation among four samples. Experimental conditions are given in the caption of Figure 5.1.
It is also noteworthy that TrOCs containing EDGs such as hydroxyl and amine (e.g., steroid
hormones, bisphenol A and triclosan) can act as bi-functional substrates or redox-mediators
[33, 35]. Fragments of phenoxyl radicals or oxidative coupling agents (e.g., dimers) produced
due to the oxidation of bi-functional substrates can facilitate the degradation of recalcitrant
TrOCs via enzymatic and/or non-enzymatic reactions (e.g., polymerization or agglomeration).
Indeed, Margot et al. [17] reported significantly higher diclofenac removal in presence of the
phenolic TrOC bisphenol A as compared to that observed for diclofenac as a single compound.
Similarly, Nair et al. [36] observed above 90% removal of diclofenac in a mixture containing
bisphenol A, 17α–ethinylestradiol and diclofenac as compared to its 70% removal in absence
of the phenolic TrOCs. In another study, Hachi et al. [35] demonstrated that an oxidative
coupling agent (i.e., dimer) produced due to the degradation of acetaminophen containing an
EDG (i.e., amine) formed oligomers with carbamazepine. These oligomers were more
susceptible to laccase-catalyzed oxidation than the parent compound, which led to enhanced
carbamazepine degradation [35]. Furthermore, in nature, laccase oxidizes the aromatic rings of
lignin and produce phenoxyl radical, which are responsible for the degradation of non-phenolic
components of lignin [33, 37]. Thus, there is a strong body of evidence of TrOCs containing
EDGs working as redox-mediators for enhancing degradation of non-phenolics, albeit from
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batch tests only. The synthetic wastewater used in this experiment contained a mixture of
TrOCs containing EDGs and EWGs, as would be expected in practical wastewater conditions.
These TrOCs were well retained by the MD component during the continuous operation of the
MD-EMBR (see Section 5.4.1). Therefore, it is possible that radicals or oxidative coupling
agents formed due to the oxidation of TrOCs containing hydroxyl and amine functional groups
also contributed in achieving enhanced degradation (as compared to that achieved by UFEMBRs) of resistant TrOCs containing EWGs by the MD-EMBR. A comparative performance
of a high retention – and conventional EMBR is demonstrated in Chapter 3.

5.4.4. MD-EMBR performance with mediator addition
5.4.4.1. Preliminary screening of redox-mediators during preliminary assessment
As noted in Section 5.4.2 (i.e., preliminary assessment of TrOC degradation in MD-EMBR),
of the 30 TrOCs tested, MD-EMBR achieved high degradation (85–99%) for 14 compounds
(10 phenolic and 4 non-phenolic compounds) but the degradation efficiency varied widely (40–
70%) for the rest of the compounds. To improve the degradation of the latter group, three redoxmediators, namely SA, VA and HBT, were added at 0.25 and 0.5 mM concentrations each in
separate runs. Depending on the redox-mediator type and concentration, degradation of
phenolic compounds and non-phenolic compounds by the MD-EMBR was improved by 20–
30% and 10–50%, respectively (Figure 5.4) as explained below.
To date, the impact of redox-mediator type on the improvement of TrOC degradation has been
assessed mainly in small scale and batch tests [27, 38, 39]. For instance, Ashe et al. [27]
investigated the performance of seven different redox-mediators including SA, HBT and VA
for the degradation of four resistant TrOCs, namely atrazine, naproxen, oxybenzone and
pentachlorophenol in 10 mL batch reactors. They achieved significant improvement (40–90%)
at a concentration of 1 mM. Nguyen et al. [22] achieved enhanced (10–90%) removal of TrOCs
in UF-EMBR using SA and HBT. However, this is the first experiment investigating the
efficacy of SA, VA and HBT for enhanced degradation of a broad spectrum of TrOCs by an
MD-EMBR.
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Figure 5.4. Enzymatic degradation of 30 TrOCs during the preliminary screening of three
redox-mediators, namely HBT, VA and SA (separately at 0.5 mM) in the MD-EMBR operated
for 12 h. Error bars indicate the standard deviation of duplicate samples. Operating conditions
of the MD-EMBR are given in the caption of Figure 5.1.
All the tested redox-mediators enhanced the degradation of TrOCs. However, the best overall
performance was shown by VA (Figure 5.4). In line with the findings of Nguyen et al. [26],
degradation of the phenolic TrOCs that were already highly degraded by laccase (Figure 5.2)
remained almost the same after the addition of redox-mediators. For the remaining phenolic
TrOCs, VA (at 0.5 mM), compared to HBT and SA achieved better removal for two
compounds, namely salicylic acid (80%) and pentachlorophenol (90%). Both VA and SA
achieved above 95% degradation of enterolactone, which compares favorably with 45–70%
degradation achieved in absence of mediators (Figure 5.3).
Of the 17 non-phenolic compounds, degradation of four compounds viz metronidazole,
benzophenone, amitriptyline and octocrylene, was at least 90%, regardless of the mediator type
(Figure 5.4). For the remaining compounds, VA (at 0.5 mM) achieved better degradation for
10 compounds compared to SA and HBT. SA (at 0.5 mM) performed the best for the
degradation of two compounds, namely naproxen and primidone. It is well-known that the
herbicide atrazine is resistant to laccase catalyzed degradation [22]. Compared to other redoxmediators, HBT was particularly efficient (>99%) for the degradation of atrazine. Although a
superior ability of VA compared to other mediators for the degradation of non-phenolic TrOCs
has been reported previously in a batch enzymatic bioreactor spiked with four TrOCs [27], the
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effectiveness of VA for the degradation of a broad spectrum of non-phenolic TrOCs is
demonstrated for the first time in this chapter.
5.4.4.1.1. Impact of redox-mediator concentration

Redox-mediator dose can affect TrOC degradation by changing the abundance, stability and
reversibility of the generated radicals [40]. Therefore, the impact of two mediator
concentrations (0.25 and 0.5 mM) on ORP, TrOC degradation, and enzyme stability was
investigated during preliminary screening of redox-mediators.
Concentration-dependent improvement in the degradation of 18 TrOCs (5 phenolic and 13 nonphenolic compounds, Figure 5.5) was observed in MD-EMBR. The highest improvement in
the degradation of TrOCs was achieved at 0.5 mM. Notably, increasing the concentration of
SA, HBT and VA from 0.25 to 0.5 mM improved TOC degradation by up to 7, 15 and 25%,
respectively (Figure 5.5). This corresponds well with the respective increase of 2, 5 and 15%
of the reaction media ORP (Figure 5.6). On the other hand, degradation of 8 phenolic and 4
non-phenolic TrOCs in MD-EMBR was comparable at all the tested mediator concentrations
(Appendix Figure 5-1). For instance, HBT achieved over 99% degradation of atrazine in MDEMBR irrespective of the mediator concentration. This is consistent with HBT performance
reported in case of UF-EMBR [22].
In general, the degradation of TrOCs that are easily amenable to laccase (Appendix Figure 51) does not improve significantly (less than 5% in this chapter), while the degradation of resistant
TrOCs may improve with the increase in mediator concentration and may reach a plateau beyond
a certain mediator concentration. However, the mediator concentration beyond which no
improvement occurs may depend on the type of mediators as well as the target TrOCs [38, 41].
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Figure 5.5. Impact of redox-mediator concentration (0.25 and 0.5 mM) on the degradation of
TrOCs in the MD-EMBR operated for 12 h. Error bars indicate the standard deviation of
duplicate samples. Operating conditions of the MD-EMBR are given in the caption of Figure
5.1. Only those TrOCs showing mediator concentration-dependent improvement in their
degradation are shown here. For remaining TrOCs, results are given in Appendix Figure 5-1.
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Figure 5.6. Effect of mediator type and concentration on oxidation reduction potential (ORP)
and laccase inactivation in the MD-EMBR operated for 12 h. Operating conditions of the MDEMBR are given in the caption of Figure 5.1.
5.4.4.1.2. Effect of mediators on enzyme stability

In this experiment, a gradual inactivation of laccase was observed despite the absence of any
known chemical inhibitors in the synthetic wastewater (Figure 5.6). In the absence of redoxmediators, a 37% laccase inactivation was observed over a period of 12 h. This was possibly
due to the blockage of the active enzyme sites by the charged metabolites and/or hydraulic
stress during membrane filtration [38, 42]. Since the MD membrane can conceptually retain all
non-volatile organics including the transformation products/radicals, laccase inactivation with
or without the presence of redox-mediators can be expected. The extent of laccase inactivation
increased further when the mediators were added (61, 66 and 73 for HBT, SA and VA,
respectively, each at a concentration of 0.5 mM). The highly reactive radicals generated from
mediators can enhance the degradation of TrOCs but at the same time may inactivate laccase
[43]. Purich [21] suggested that the metabolites from the oxidation of substrate and/or
mediators could react with enzyme to form non-productive complexes, thereby inactivating the
enzyme.
The extent of laccase inactivation also depends on the concentration of redox-mediators. For
instance, Khlifi-Slama et al. [43] observed a gradual increase in the inactivation of laccase from
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Trametes trogii following a stepwise increase in the concentration of HBT from 0.1–10 mM.
In another study, increasing SA concentration from 0.1–1 mM resulted in aggravated
inactivation of laccase from Trametes versicolor [39]. These results suggest that the degree of
laccase inactivation is strongly influenced by redox-mediator concentration. Indeed, loss in
laccase activity was increased by 7, 9 and 11% in MD-EMBR due to the increase in the
concentration of HBT, SA and VA, respectively, from 0.25 to 0.5 mM (Figure 5.6). Although
laccase activity was greatly affected in the presence of redox-mediators, it was compensated
by the improvement in TrOC degradation (Figure 5.5). For example, the highest drop in
laccase activity was observed in the presence of VA (Figure 5.6), but it outperformed SA and
HBT in terms of enhanced TrOC degradation (Figure 5.5).
5.4.4.2. TrOC degradation following VA and SA addition during long-term operation
During long-term operation of MD-EMBR (Section 5.4.3), efficient degradation (95-99%) by
MD-EMBR was observed for 13 out of the 30 TrOCs, while the remaining TrOCs were
moderately removed (44-75%). While these removal rates compare favorably with that in
previous reports, two naturally occurring redox-mediators, namely SA and VA, were selected
based on their performance during preliminary screening (Section 5.4.4.1). SA and VA were
added to the EMBR separately and as a mixture in an attempt to further improve removal of
the recalcitrant TrOCs.
Oxidation of VA and SA by laccase produces highly reactive aminoxyl and phenoxyl radicals,
respectively, that have higher ORP than laccase. Moreover, these radicals act as an electron
shuttle between the substrate and laccase, thereby improving the degradation of the substrate
i.e., target pollutants [27]. In a study by Weng et al. [44], addition of SA increased the ORP of
the enzyme solution, consequently improving the degradation of sulphonamide antibiotics.
Similarly, an increase in ORP was accompanied by an improved degradation of atrazine,
pentachlorophenol, naproxen and oxybenzone following the addition of VA at a concentration
of 0.5-1 mM in a batch enzymatic bioreactor [27]. In the current experiment, the ORP of
EMBR-media increased from 0.3 to 0.39 and 0.45 V following the addition of SA and VA,
respectively. This was accompanied by significant improvement in TrOC removal: an increase
of 5-54% depending on the molecular structure of TrOCs and redox-mediator type as discussed
below (Figure 5.7).
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Figure 5.7. Enzymatic degradation of 30 TrOCs following the addition of two redox-mediators
viz SA and VA separately at 0.5 mM in MD-EMBR operated for a period of 60 h (i.e., 2×HRT).
SA or VA was introduced only at the start of MD-EMBR operation. Data presented as
average±standard deviation (n=4). Operating conditions of the MD-EMBR are given in the
caption of Figure 5.1.
The performance of different mediators for enhanced TrOC degradation has been reported in
only a few batch or UF-EMBR studies [26, 27, 38]. In previous studies, a continuous supply
of redox-mediator was required to sustain UF-EMBR operation, because UF membranes
cannot retain redox-mediators [26, 39]. A uniqueness of this chapter is that it demonstrates the
effect of the single dose of mediators on TrOC degradation following the complete retention
of laccase, TrOCs and mediators by the MD membrane. SA and VA demonstrated substrate
specific improvements in the degradation of TrOC that were moderately degraded by laccaseonly (Figure 5.3). Of the 17 moderately degraded TrOCs (Figure 5.3), the laccase-VA system
achieved better degradation for six compounds namely, ketoprofen, gemfibrozil, naproxen,
primidone, carbamazepine and pentachlorophenol. By contrast, the laccase-SA system
performed best for four compounds; fenoprop, clofibric acid, propoxur and atrazine (Figure
5.7). Similar degradation efficiency was achieved by both SA and VA for the remaining TrOCs.
A comparison of TrOC fate in laccase and laccase-mediator based MD-EMBR revealed that
the molecular structures of TrOCs significantly influence the effectiveness of laccase-mediator
systems (Figure 5.8).
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Figure 5.8. Fate of TrOCs during MD-EMBR operation with and without the addition of
redox-mediators. Operating conditions of the MD-EMBR are given in the caption of Figure
5.1.
5.4.4.3. Effect of mediator mixture on TrOC degradation
Since in this experiment, SA and VA showed different patterns of TrOC-specific degradationimprovement during long-term operation of MD-EMBR (Figure 5.7), it was envisaged that a
mediator-mixture would have further beneficial effects. Degradation of the phenolic TrOCs,
which were already well removed by laccase-only, remained unaffected when a SA-VA
mixture was used. The whole set of data is provided in Appendix Figure 5-2. However,
compared to either SA-laccase or VA-laccase, the SA-VA-laccase system did not improve the
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degradation of any TrOCs (Figure 5.9). Furthermore, in comparison to TrOC degradation by
laccase-only, the SA-VA-laccase system achieved somewhat reduced degradation of six
pharmaceuticals, namely ketoprofen, naproxen, clofibric acid, primidone, carbamazepine and
ibuprofen (Figure 5.9).
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Figure 5.9. Effect of individual mediators and their mixture on the degradation of selected nonphenolic TrOCs, showing reduced performance when mediator mixture was used. Data
presented as average±standard deviation (n=4). Effect of mediator mixture (i.e., SA and VA)
on all the tested TrOCs (i.e., phenolic and non-phenolic) is shown in Appendix Figure 5-2.
The performance of mediator mixtures has rarely been studied for the removal of TrOCs.
Previously, Jeon et al. [45] observed in batch tests that vanillin and acetovanillone mixture did
not improve the degradation of pentachlorophenol, while enhanced pentachlorophenol
degradation was found by adding a mixture of 2,2'-azino-bis(3-ethylbenzothiazoline-6sulphonic acid) (ABTS) and vanillin or acetovanillone [45]. It is possible that, in mixtures,
some mediators can chemically interact with each other instead of acting as an electron shuttle
for laccase. Moreover, simultaneous addition of some mediators can reversibly inhibit laccase,
thereby inhibiting electron transfer between laccase and TrOCs [45, 46]. Indeed, laccase
inactivation was significantly increased following the addition of SA-VA mixture (Figure
5.10). The current work demonstrates for the first time through continuous operation of the
MD-EMBR that although VA and SA outcompete many other mediators tested to date [27],
using them together may be counterproductive. Further studies to screen redox-mediators and
their mixtures are recommended, but that is beyond the scope of the current experiment.
Laccase activity in enzymatic bioreactors may be affected by various physicochemical and
biological factors [21, 29]. Transformation byproducts or charged metabolites formed
following the degradation of TrOCs can block the active sites of the laccase. Moreover,
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hydraulic stress during MD-EMBR operation can also cause laccase inactivation [38].
Although some laccase inhibition was observed during continuous operation of the MD-EMBR
(Figure 5.10), a stable operation could be sustained by reinjecting as little as 275-400 µL
laccase solution per liter of reactor (working) volume every 12 h.
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Figure 5.10. Oxidation reduction potential (ORP) and laccase inactivation percentage with and
without the addition of redox-mediators. Data presented as average±standard deviation (n=2
for ORP; and n=5 for laccase inactivation). Time course of enzymatic activity during all
experiments is given in Appendix Figure 5-3.
It may be noted that the MD membrane can theoretically retain all non-volatile compounds
including redox-mediator derived highly active radicals along with laccase and TrOCs. The
radicals enhance laccase-catalyzed TrOC degradation [35], but can also instigate laccase
inactivation. It has been suggested that the highly reactive radicals produced due to the
oxidation of mediators can react with laccase, consequently converting them into nonproductive complexes [21, 38, 47]. Indeed, the extent of laccase inactivation increased during
MD-EMBR operation after mediator addition. This data is available in Appendix Figure 5-3.
The average laccase inactivation was 53±11% (no. of laccase injections, n=4) during MDEMBR operation in absence of mediators, while the loss in laccase activity was 57±11, 62±16
and 80±12% (n=4) after the addition of a single dose of VA, SA and SA-VA mixture,
respectively (Figure 5.10). To date higher laccase inactivation in presence of mediators has
mostly been reported in small scale batch enzymatic bioreactors. For instance, Nguyen yet al.
[39] reported rapid laccase inactivation following the addition of SA at the tested
concentrations of 0.1-1 mM in a batch enzymatic bioreactor. In another study, a complete loss
of enzymatic activity was observed in a batch enzymatic bioreactor by adding VA at a
concentration of 0.5 mM [27]. In the current experiment, although laccase activity was
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significantly affected in the presence of redox-mediators, it was compensated for by the
improvement in TrOC degradation (Figure 5.8).

5.4.5. Permeate toxicity
Laccase-catalyzed degradation of TrOCs, particularly in the presence of mediators, produces
reactive radicals and transformation products that may increase the toxicity of the treated
effluent [26, 48]. In this experiment, the overall bacterial toxicity of the media in the enzymatic
bioreactor and MD-permeate (i.e., final effluent) was measured at the end of each EMBR run
(Table 5.2). Of the three mediators tested during preliminary assessment, SA significantly
increased the toxicity of the solution in the enzymatic bioreactor, whereas HBT and VA showed
no effect on toxicity levels (Table 5.2). Compared to the background toxicity of the mixture of
laccase and TrOCs in the enzymatic bioreactor of MD-EMBR (<1 to 1.8 rTU; n = 2), toxicity
in the enzymatic bioreactor due to addition of HBT, VA and SA ranged from <1 to 1.7 rTU (n
= 2), 3.3 to 3.9 rTU (n = 2) and 109 to 116 rTU (n = 2), respectively.
Table 5.2. Toxicity of the bioreactor mixture and permeate following treatment of TrOCs with
different mediators in MD-EMBR, expressed as relative toxic unit (rTU). The limit of detection
of the toxicity assay was 10% inhibition of luminescence (i.e., 1 rTU). ‘NA’: not available
Reaction media

TrOCs + Laccase
TrOCs + Laccase + HBT (0.5 mM)
TrOCs + Laccase + VA (0.5 mM)
TrOCs + Laccase + SA (0.5 mM)
TrOCs + Laccase + SA (0.25 mM) + VA (0.25
mM)

Toxicity in enzymatic
bioreactor (rTU)
12 h
60 h
4.4 – 5.0
<1 – 1.8
–
<1 – 1.7
12.8
– 15
3.3 – 3.9
61.4 – 66.3
109 – 116
NA
119.4 – 136

Toxicity of the
permeate (rTU)
<1
<1
<1
<1

At the conclusion of long-term operation of MD-EMBR, the media in the enzymatic bioreactor
showed an overall toxicity of 4.5-5, 12.8-15, 61.4-66.3, and 119.4-136 rTU (n=2) in presence
of laccase, laccase-VA, laccase-SA and laccase-SA-VA, respectively. The observed increase
in toxicity due to addition of VA and SA are consistent with previous studies [26, 27], however,
the toxicity in relation to mediator mixtures is reported for the first time in this chapter. A
significantly increased toxicity following the addition of SA-VA mixture was observed.
Despite the increase of toxicity in the enzymatic bioreactor, MD-EMBR permeate toxicity was
below the limit of detection (i.e., rTU <1) during all experiments, evidencing that in addition
to laccase and TrOCs, the MD system retained reactive radicals and transformation products,
which cause bacterial toxicity. This is an added advantage of integrating a high retention
membrane with an enzymatic bioreactor.
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5.4.6. Permeate flux of MD-EMBRs
The driving force of permeate flux in MD is the difference between feed and distillate
temperature. Ideally, feed and distillate temperature is maintained at over 50 and 20–25 °C,
respectively to obtain a permeate flux of approximately 10 L/m2 h [1, 3]. In this experiment,
however, to avoid thermal inhibition of laccase [49], temperature of the enzymatic reactor and
permeate tank was kept at 30 and 10 °C, respectively. A stable permeate flux of around 4 L/m2
h was observed during all experiments (Appendix Figure 5-4 and 5-5), suggesting that
membrane fouling did not occur during the operation period. This level of flux is consistent
with the feed temperature employed. Notably, during short-term operation (12 h), the average
permeate flux for laccase only, laccase-HBT, laccase-VA and laccase-SA was 3.69 ± 0.44 L/m2
h, 3.89 ± 0.63 L/m2 h, 3.92 ± 0.62 L/m2 h and 3.86 ± 0.66 L/m2 h, respectively, confirming
negligible impact of different type of mediator addition on membrane flux (Appendix Figure
5-4). In this experiment, the mass transfer coefficient (Km) of the DCMD, which was calculated
based on the method described by Nghiem et al. [50], ranged from 1.22 to 1.28 (×10−3) L/m2 h
Pa. This value is in good agreement with that in previous studies [3, 51]. Thus, this chapter
shows both stable membrane hydraulic performance and improved enzymatic degradation of
TrOCs following their complete retention by the MD membrane.
During prolonged continuous operation, the performance of the MD process can be affected by
the loss of hydrophobicity of the MD membrane [1, 3]. Therefore, the integrity of the MD
membrane was assessed by measuring the contact angle of the membrane after each
experiment. The contact angle i.e., the hydrophobicity was found to be not significantly
affected (Figure 5.11), confirming the suitability of combining the MD membrane with the
EMBR.
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Figure 5.11. Contact angle of the membrane before and after using it for EMBR operation of
60 h. Error bars represent the standard deviation of three repeated measurements.
5.5. Conclusion
Laccase-catalyzed degradation of a broad spectrum of trace organic contaminants (TrOCs) by
a membrane distillation (MD) – enzymatic membrane bioreactor (EMBR) was investigated.
Initially, the preliminary performance of MD-EMBR was assessed in a series of 12 h
experiment. Based on permeate quality, MD-EMBR achieved 90–99% TrOC retention.
Degradation of TrOCs varied (40–99%) depending on their molecular properties such as
electron withdrawing functional groups (EWGs), and electron donating functional groups
(EDGs). High degradation (above 90%) of TrOCs containing EDGs in their chemical structure
was observed in the MD-EMBR, while those containing EWGs in their molecular structure
were moderately degraded (40–75%). During preliminary assessment, performance of three
redox-mediators, namely syringaldehyde (SA), violuric acid (VA) and 1-hydroxybenzotriazole
(HBT) was also screened. The results suggest that VA at 0.5 mM concentration was the most
effective redox-mediator for improving the degradation of phenolic and non-phenolic TrOCs.
In addition, it was observed that the degradation of non-phenolic compounds in laccasemediator system was strongly influenced by the tested concentration of the redox-mediators.
TrOC degradation in the MD-EMBR during long-term operation was also studied for assessing
the process stability. The MD component effectively retained TrOCs (94-99%) in the EMBR
during long-term operation, facilitating their continuous biocatalytic degradation. The
comparison of TrOC degradation by the MD-EMBR after 12 h and 60 h suggests that TrOC
degradation was stable. The addition of two redox-mediators, namely SA and VA, further
improved TrOC degradation. However, a mixture of redox-mediators showed a reduced
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performance for a few pharmaceuticals such as primidone, carbamazepine and ibuprofen. This
observation disapproved the hypothesis - mixture of different redox-mediators may achieve
better improvement in TrOC degradation than a single redox-mediator. Redox-mediator
addition increased the toxicity of the media in the enzymatic bioreactor, but the membrane
permeate (i.e., final effluent) was non-toxic, suggesting an added advantage of coupling MD
with EMBR. Hydraulic performance of MD-EMBR was stable during all experiments, and
membrane wetting, or fouling was not observed.
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Chapter 6: Laccase – persulfate assisted degradation
of TrOC by nanofiltration – enzymatic membrane
bioreactor (NF-EMBR)

This chapter is based on the following publication:
Asif, M.B., Van De Merwe, J.P., Leusch, F.D., Pramanik, B.K., Price, W.E., Hai, F.I. 2019.
Elucidating the performance of an integrated laccase- and persulfate-assisted process for
degradation of trace organic contaminants (TrOCs). Submitted to Environmental Science:
Water Research & Technology

182

6.1. Introduction
Laccases (EC 1.10.3.2) are copper containing oxidoreductase enzymes and can effectively
catalyse the oxidation or degradation of a wide range of aromatic pollutants such as phenols by
using molecular oxygen as a co-factor [1-3]. The active sites of laccase contain four copper
ions as per following distribution: (i) one copper ion at the Type I active site; (ii) one copper
ion at the Type II active site; and (iii) two copper ions at the Type III active site. The
degradation of a substrate occurs at the TI active site that acts as the primary electron acceptor.
The electron accepted by the Type I active site is transferred to the Type II and Type III active
sites, where molecular oxygen is reduced to water [4-6].
In the last decade, laccase-catalysed degradation of trace organic contaminants (TrOCs) such
as pharmaceuticals, ingredients of personal care products and industrial chemicals has gained
considerable attention [7, 8], because the occurrence of TrOCs in aquatic ecosystems could be
potentially harmful to aquatic life and human health [9, 10]. Notably, laccase-catalysed
degradation has been reported to be effective for a broad variety of TrOCs as compared to
conventional biological processes [11, 12]. Recent studies have also demonstrated that the
performance of the laccase-catalysed treatment system is mainly governed by the
physicochemical properties of target TrOCs such as chemical structure and hydrophobicity [7,
13]. In general, TrOCs containing a phenolic moiety or electron donating functional groups
(EDGs) are effectively degraded (70-99%) by laccase, while degradation of TrOCs containing
electron withdrawing functional groups has been reported to be unstable/poor [7, 11].
The application of laccase in continuous systems such as wastewater treatment plants remains
a challenge, since laccase is easily washed out with the treated effluent. This loss of laccase in
a continuous treatment system could be effectively controlled by integrating a membrane of
appropriate pore size with enzymatic bioreactor. Indeed, Lloret et al. [14] and Nguyen et al.
[15] developed an enzymatic membrane bioreactor (EMBR) by coupling an ultrafiltration (UF)
membrane with an enzymatic bioreactor, and reported effective retention (>99%) of laccase by
the ultrafiltration membrane. Interestingly, Nguyen et al. [13] observed the formation of an
enzyme gel-layer formed on membrane surface following the continuous permeation of
bioreactor media, which adsorbed a few hydrophobic TrOCs (log D>3) such as oxybenzone
and improved their degradation by laccase in EMBR. They attributed enhanced degradation to
the simultaneous adsorption of TrOCs and laccase on membrane surface, thus promoting the
interaction of adsorbed pollutants with laccase active sites [13]. This observation led to the
development of high retention (HR) nanofiltration (NF) - and membrane distillation (MD)EMBRs [5, 16]. During the operation of HR-EMBR, laccase and TrOCs are simultaneously
retained by the high retention membrane separation process, thereby providing a prolonged
contact time between laccase and TrOCs for enhanced degradation. In a recent study, Asif et
al. [5] compared the performance of UF- and NF-EMBR for the treatment of synthetic
wastewater containing a mixture of TrOCs including sulfamethoxazole, carbamazepine,
diclofenac, atrazine, and oxybenzone under identical operating conditions. As compared to UFEMBR, they achieved 15–30% better degradation of the selected TrOCs in NF-EMBR [5].
Despite the effective removal (92-99%) of TrOCs achieved by NF-EMBR based on the
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permeate quality, degradation of TrOCs (except for oxybenzone) by laccase in the bioreactor
ranged between 30 and 80% [5]. The partially degraded TrOCs accumulate in the bioreactor of
NF-EMBR over time, and could increase the toxicity of NF-concentrate, consequently making
the process of NF-concentrate disposal complex. Therefore, considerable efforts are required
to further improve the extent of TrOC degradation within the bioreactor of HR-EMBR.
Degradation of TrOCs in enzymatic treatment systems could be improved by introducing a
redox-mediator that is a low molecular weight phenolic compound and can act as electron
carrier between laccase and target compounds [4]. In a study by Ashe et al. [17], efficacy of
seven redox-mediators such as 1-hydrozybenzotriazole (HBT), violuric acid (VA),
syringaldehyde (SA) and 2,2'-azino-bis-3-ethylbenzothiazoline-6-sulphonic acid (ABTS) for
improving TrOC degradation was assessed in laccase-catalysed treatment system. They
observed that effectiveness of redox-mediator strongly correlated with its type and
concentration. For instance, ABTS achieved the highest degradation for phenolic TrOCs, while
HBT and VA were the best redox-mediators for non-phenolic TrOCs [17]. In another study,
performance of SA and HBT was compared and elucidated in a continuous-flow UF-EMBR.
The tested redox-mediators were found to achieve TrOC-specific improvement in their
degradation [13]. However, the feasibility of laccase-mediator based treatment systems is
severely affected due to significant laccase inactivation, elevated toxicity of treated effluent
and high replenishment costs [4].
Instead of redox-mediators, an alternative and innovative approach could be to develop an
integrated treatment system by combining an advanced oxidation process (AOPs) with laccasecatalysed degradation process in a bioreactor. AOPs can be either hydroxyl radical-based such
as ultraviolet (UV) photolysis [18], or sulphate radical-based such as activated persulfate (PS)
assisted-oxidation process [19, 20]. In recent years, sulphate radical-based AOPs has gained
significant attention due to its effectiveness for a wide range of TrOCs such as pharmaceuticals
and personal care products in various conditions [20]. To-date, a combined laccase/AOP
assisted treatment system has yet to be developed and studied.
Persulfate (PS) is stable at room temperature (i.e., 20 oC), and requires an activator such as heat
(as low as 30 oC), transition metals (e.g., iron) and UV light to generate highly reactive SO4– •
radicals. Depending on the type of activator, PS produces one (e.g., in presence of transition
metals, see Equation 1) or two (e.g., in presence of heat or UV light, see Equation 2) SO4– •
radicals [20, 21]. It is worth mentioning that phenolic compounds [22], humic substances
containing quinone functional groups [23], graphene [24], activated carbon [20],
ultrasonication [20] and sub-surface minerals [25] have also been reported to activate PS.
However, a thorough literature survey suggests that PS activation by using enzymes has not
been assessed.
𝑆2 𝑂8 2− + ℎ𝑒𝑎𝑡 𝑜𝑟 𝑈𝑉 𝑙𝑖𝑔ℎ𝑡 → 2 𝑆𝑂4 2−.

(1)

𝑆2 𝑂8 2− + 𝐹𝑒 +2 → 𝐹𝑒 +3 + 𝑆𝑂4 2−.

(2)
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PS activation, formation of reactive radicals, and identification of degradation products or
metabolites has been predominantly studied, to-date. In addition, performance of PS has been
reported for the degradation of a single TrOC at concentration significantly higher than its
environmentally relevant concentration [20, 26]. The logical step forward should be to assess
the performance of PS for a mixture of TrOCs, because the extent of degradation for a single
TrOC may change in a reaction media containing a mixture of TrOCs. Importantly, toxicity
and estrogenicity of the treated effluent should be analysed for safe disposal and reuse of the
treated effluent.
This chapter elucidates the degradation of a mixture of five TrOCs in a laccase/persulfate (PS)
oxidation-assisted nanofiltration membrane bioreactor (NFBR) for the first time. Initially,
batch experiments were performed to understand the effect of initial PS concentration and
effect of incubation time as well as possible PS activation mechanisms. While discussing the
removals achieved by batch and continuous-flow bioreactors, physicochemical properties of
TrOCs were also considered to provide an in-depth understanding. Estrogenicity and toxicity
of the bioreactor media and membrane permeate were analysed and discussed. Finally, the
hydraulic performance of NFBR is presented to confirm the stability of the developed process.

6.2. Hypothesis
▪

Integrated laccase and PS oxidation processes may synergistically facilitate TrOC
degradation

▪

The extent of degradation in laccase/PS system is governed by TrOC properties and PS
concentration
Enhanced TrOC degradation may result in reduced toxicity and estrogenic activity

▪

6.3. Materials and methods
6.3.1. Trace organic contaminants, laccase solution and persulfate
In this experiment, one industrial chemical (bisphanol A) and four pharmaceuticals and
personal care products, namely diclofenac, sulfamethoxazole, carbamazepine and oxybenzone
were selected based on their ubiquitous presence in wastewater and freshwater bodies [9]. For
both batch and continuous experiments, a synthetic wastewater containing the mixture of the
selected TrOCs each at a concentration of 500 μg/L in ultrapure Milli-Q water was prepared.
All the TrOCs were of analytical grade (purity >98%), and were procured from Sigma–Aldrich
(Sydney, NSW, Australia). A stock solution (2 g/L) was also prepared by dissolving the
mixture of the selected TrOCs in pure methanol. The TrOC stock solution was kept at –18°C
in the dark and used within one month. The main physicochemical properties of the selected
TrOCs are presented in Table 6.1.
The enzyme solution acquired from Novozymes Australia Pty. Ltd. (Sydney, NSW, Australia)
was commercially available laccase from genetically modified Aspergillus oryzae. Properties
of laccase are presented in Section 3.3.1 (Chapter 3). Reagent grade (purity ≥99%) potassium
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persulfate (PS) was purchased from Sigma-Aldrich (Sydney, NSW, Australia). A stock
solution (50 mM) of PS was prepared in ultrapure Milli-Q water and stored at 4ºC before use.
Table 6.1. Selected physicochemical properties of the selected TrOCs
Molecular
weight
(g/mole)

Water
solubility at
25 oC (mg/L)

Acid
dissociation
coefficient
(pKa)

log D at
pH=7

Bisphenol A

228.29

120

10.29

3.64

Carbamazepine

236.27

220

13.94

1.89

Sulfamethoxazole

253.28

410

5.6

–0.22

Diclofenac

296.15

30

4.18

1.77

Oxybenzone

228.24

100

7.56

3.99

TrOCs

Molecular structure

6.3.2. Performance of laccase and persulfate in batch bioreactor
The performance of laccase/PS was initially assessed in batch bioreactor at different PS
concentration (i.e., 1, 2, 5 and 10 mM) for an incubation period of 24 h. All the experiments
were conducted in 250 mL conical flasks. The concentrated laccase stock solution (70 μL) was
diluted to a final volume of 100 mL in conical flasks for maintaining an initial enzymatic
activity of 90-95 μM(DMP)/min. PS and the selected TrOC were added in conical flasks at an
initial concentration of 1-10 mM and 500 μg/L, respectively. Actual initial measured TrOC
concentrations of bisphenol A, diclofenac, sulfamethoxazole, carbamazepine and oxybenzone
were 510±15, 485±10, 525±20, 510±10 and 480±5 μg/L (n=12), respectively. The initial pH
of the reaction media was not adjusted during all experiments and was approximately 7. All
the conical flasks were incubated in an orbital shaker incubator (Model 8500, Bioline Global
Pty Ltd. Australia) at 80 rpm and 25ºC. Triplicate samples were collected at 2, 4, 8 and 24 h
for TrOC analysis. Samples for measuring the laccase activity, PS consumption, estrogenic
activity and ecotoxicity were also collected at the end of each batch experiment. To verify the
contribution of laccase and PS in TrOC degradation, ‘control’ batch tests were performed in
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parallel by studying the performance of laccase alone, PS alone, and PS-heat inactivated
laccase.

6.3.3. Continuous nanofiltration-bioreactor setup and experimental protocol
6.3.1.1. Description of experimental setup
For elucidating the performance of accase/PS in continuous-flow mode, a lab-scale cross-flow
nanofiltration (NF) setup coupled to a bioreactor (3 L working volume) was used (Figure 3.1).
A detailed description of the cross-flow NF setup is available in Section 3.3.2 (Chapter 3). A
commercially available flat-sheet NF90 membrane (Dow/Filmtec, USA) was used. It was a
thin-film composite membrane with polyamide based active layer, and its molecular weight
cut-off (MWCO) was 200 Da.
6.3.1.2. Experimental protocol
The experiment was started by compacting the membrane at an initial hydraulic pressure of 10
bar for at least 1 h or until the stabilization of permeate flow rate. The synthetic wastewater (3
L volume) containing the mixture of the selected TrOCs each at a concentration of 500 µg/L
was added in the bioreactor of NF filtration setup. Laccase and PS from their respective stock
solutions were directly added in the bioreactor to maintain an initial laccase activity of 90-95
µM(DMP)/min, and PS concentration of 5 mM. The NFBR system was then operated at a
hydraulic pressure of 8 bar and cross-flow velocity of 40 cm/s. This resulted in an initial
permeate flux of 6.8 L/m2 h bar. The synthetic wastewater containing TrOC mixture was
continuously fed to the bioreactor via a peristaltic pump (Masterflex, USA) for a period of 64
h (i.e., 4 × hydraulic retention time, HRT). Triplicate samples from the bioreactor and
membrane permeate were collected at 0, 6, 12, 24, 36, 48, 64 h for TrOCs analysis. In addition,
samples were obtained regularly every 12 h for measuring the laccase activity and PS
consumption in the bioreactor and membrane permeate. At the end of experiment, samples
from feed, bioreactor and membrane permeate were collected for the evaluation of estrogenic
activity and ecotoxicity as explained in Section 6.3.4.3. Hydraulic performance of the NF
membrane was studied by monitoring the permeate flux. At the conclusion of the experiment,
the membrane was cleaned with Milli-Q water for 1 h to check flux recovery.
Laccase activity has been observed to diminish during continuous operation due to different
physicochemical and biological inhibitors as explained previously [5, 19]. A protocol was
developed to replenish the laccase activity by adding approximately 150 µL per litre of
bioreactor volume every 24 h. Importantly, PS at a concentration of 5 mM was added only once
at the start of laccase/PS assisted NFBR operation.

6.3.4. Analytical methods
6.3.4.1. TrOC analysis
TrOC in samples collected from batch and continuous-flow bioreactors was quantified by
High-performance liquid chromatography (HPLC) (Shimadzu, Kyoto, Japan) using a method
reported previously [5]. A detail description of this method is available in Section 3.3.4.1
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(Chapter 3). Removal efficiency by laccase/PS (Rdegradation) and the membrane
(Rdegradation+membrane retention) was measured using equation (3) and (4), respectively:
Rbiodegradation = 100 × (1 – CBR/Cf)

(3)

R(degradation+membrane retention) = 100 × (1 – Cp/Cf)

(4)

where, Cf, CBR and Cp are the concentration (µg/L) of a specific TrOC in the feed, bioreactor
and membrane permeate, respectively. The mass of TrOCs degraded by laccase/PS during
continuous-flow NF-BR operation was calculated as follows:
Cf × Vf = (CBR × VBR) + (Cp × Vp) + degradation/transformation

(5)

where, Vf, VBR and Vp represents the volume of feed, bioreactor and permeate, respectively.
6.3.4.2. Laccase activity essay and PS concentration measurement
Laccase activity was measured as described in Section 3.3.4.2 (Chapter 3). PS concentration
may change following its addition in both batch and continuous-flow bioreactors. The change
in PS concentration was measured during each experiment by using a previously developed
spectrophotometric method [19, 27].
6.3.4.3. Estrogenic activity and ecotoxicity
Duplicate samples (110 mL each) collected from the batch bioreactors and triplicate samples
(110 mL each) collected each from the continuous-flow bioreactor and membrane permeate
were extracted using Oasis HLB cartridges and eluted in 5 mL methanol. This resulted in a
relative concentration factor of 22 for each sample. Estrogenic activity was analysed by
ERα-GeneBLAzer assay (Life Technologies, USA) as described previously [28, 29]. This is
an estrogen receptor-mediated reporter gene assay that measures the presence of either
estrogens or estrogen mimicking compounds. This assay was carried out in 384-well plate and
run in both antagonist and agonist modes. A Fluostar plate reader (BMG Labtech, Germany)
was used for measuring the fluorescence at wavelengths of 460 and 520 nm after excitation at
410 nm. The data from the plate reader was presented as the ratio of fluorescence obtained at
460 nm to that obtained at 520 nm. The results were compared with the concentration-effect
curve of reference standards and expressed as 17β-estadiol (agonist) and 4-hydroxytamoxifen
(antagonist) equivalent concentration. The limits of detection for agonistic activity were 0.35
and 1.4 ng/L for 17β-estradiol (E2-EQ) in batch and continuous flow-experiments,
respectively. The detection limit for anti-estrogenicity was 20 µg/L for 4-hydroxytamoxifen
(4-OHTMX-EQ) in all experiments. The method for ecotoxicity assay has already been
described in Section 5.3.4.3 (Chapter 5).
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6.4. Results and discussion
6.4.1. TrOC removal in batch experiments
6.4.1.1. Preliminary performance of integrated laccase/PS system
Laccase is particularly suitable for the degradation of phenolic compounds but can also catalyse
the degradation of non-phenolic compounds. The extent of degradation for non-phenolics is
dependent on the relative ORP of laccase and target compound [30, 31]. In this experiment, the
non-phenolic TrOCs were poorly degraded (less than 15%) by laccase (Figure 6.1). At the end
of the incubation period of 24 h, laccase achieved 7, 9 and 15% degradation of
sulfamethoxazole, carbamazepine and diclofenac, respectively. This recalcitrance of nonphenolic TrOCs could be attributed to their chemical structure. All the tested non-phenolic
TrOCs contain strong EWGs. For example, carbamazepine and sulfamethoxazole contain
amide (–NH2) functional group, and diclofenac contains both halogen (–X) and carboxylic (–
CH3) functional groups in its molecule (see Table 6.1). These EWGs make TrOCs resistant to
laccase because they can release electrons to stabilise the electron deficiency caused by the
degradation process [3, 32]. Indeed, poor or unstable removal of non-phenolics during laccasecatalysed degradation is also evident from available literature with reported removal often
ranging between 10 and 25% [3, 11, 33].
Although phenols have been recognised as a typical substrate of laccase [7, 32], their effective
removal by laccase is not always possible. Out of five tested TrOCs, two compounds
(oxybenzone and bisphenol A) contain phenolic moiety in their chemical structures, and their
degradation by laccase is TrOC-specific. Laccase achieved 57% and complete degradation for
bisphenol A and oxybenzone, respectively (Figure 6.1). Almost complete degradation of
bisphenol A by laccase in batch enzymatic bioreactors treating the mixture of bisphenol A and
diclofenac was reported previously [15]. However, in this experiment, moderate degradation
of bisphenol A could be due to the competitiveness among phenolic TrOCs for transferring an
electron to active sites of laccase for degradation.
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Figure 6.1. Degradation of the selected TrOCs by laccase and laccase/PS in batch tests after
an incubation time of 24 h. PS (potassium persulfate) was added at 5 mM concentration, while
the initial laccase activity was 90-95 µM(DMP)/min. Results presented as average ± standarddeviation (n=3). Note: performance of PS alone at 1 mM concentration was assessed in parallel,
and no TrOC removal observed.
All TrOCs (except for oxybenzone) were not effectively degraded, thus indicating the need of
improvement via supplementing the laccase-catalysed degradation process with an oxidizing
agent capable of TrOC degradation. In the current experiment, performance of the laccasecatalysed degradation process was assessed by adding 5 mM PS in batch enzymatic bioreactor
for an incubation period of 24 h. This significantly improved (15-46%) the extent of TrOC
degradation, indicating the complementarity of combining laccase and PS oxidation process.
Compared to less than 20% degradation of non-phenolics by laccase, PS achieved 24, 36 and
53% degradation of carbamazepine, diclofenac, and sulfamethoxazole, respectively (Figure
6.1). On the other hand, PS addition provided 43% improvement in the degradation of a
phenolic plasticizer bisphenol A that was moderately degraded (57%) by laccase. Notably,
following treatment with and without PS addition, oxybenzone concentration was below the
limit of detection (i.e., 10 µg/L). Performance of an integrated laccase/PS assisted oxidation
process for TrOC removal is reported for the first time in this chapter.
It is important to note that an additional agent such as transition metals, heat or UV light is
required to activate PS for the generation of SO4– • and/or OH– • radicals [20]. Despite the
absence of any known activators in reaction media, enhanced TrOC degradation by laccase/PS
process indicated that PS was activated and produced radicals in the batch laccase/PS system.
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For understanding the possible routes of PS activation, mechanism of laccase-catalysed
degradation process needs to be revisited. Oxidation of a substrate by laccase occurs following
the transfer of an electron from the substrate to the Type I active site of laccase. This is followed
by the transfer of electrons to Type II and III active sites, where reduction of the cofactor
oxygen to water molecules occurs. During the reduction of O2, formation of peroxide
intermediates has been observed [6]. The production of peroxide intermediates can activate PS
to produce reactive radicals [34]. To produce SO4– • radicals, PS needs an electron from any
source [6]. Hence, there is a possibility that both oxygen and PS may have acted as the cofactor
and may accept electron from Type II and III active sites of laccase for completing the catalytic
cycle. In the current study, the possibility of PS acting as a final electron acceptor was
investigated by removing the dissolved oxygen from reaction media via autoclaving (Figure
6.2). Dissolved oxygen in the reaction media measured using a DO meter (YSI, USA) was less
than 0.01 mg/L. In absence of oxygen, TrOC degradation occurred in laccase/PS system but
the extent of degradation of all the tested TrOCs (except for oxybenzone) reduced by 5 to 20%
as compared to that achieved by laccase/PS system in presence of oxygen. Notably, although
TrOC degradation was affected in absence of oxygen, PS activation still happened as evident
from the better TrOC degradation by laccase/PS system without oxygen as compared to laccase
alone (Figure 6.2). An additional batch run was performed by adding heat-inactivated laccase
and PS in the bioreactor for a period of 24 h. Like the performance of laccase/PS system,
degradation of TrOCs reduced significantly (5-40%) in the heat-inactivated laccase /PS system
(Figure 6.2). These results indicate that PS activation is possibly caused by the structural
components (e.g., a polypeptide chain and carbohydrate moieties) of laccase [35]. This has not
been reported in literature, to date. Notably, TrOC degradation was affected more in heatinactivated laccase/PS system as compared to that achieved by laccase/PS system in absence
of oxygen, thus indicating the significance of active laccase in an integrated laccase/PS
treatment system. Based on the above observations, PS activation may have caused by both the
structural components of laccase as well as the possibility of PS acting as a final acceptor of
electrons transferred by Type II and III active sites of laccase.
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Figure 6.2. Degradation of the selected TrOCs by laccase and laccase/PS in batch tests for
understanding the PS activation pathways. PS (potassium persulfate) was added at 5 mM
concentration, while the initial laccase activity was 90-95 µM(DMP)/min. Results presented as
average ± standard-deviation (n=3).
6.4.1.2. Effect of PS concentration
The effects of combining laccase and PS are comprehensively demonstrated in the preceding
section. For optimization, performance of PS in laccase/PS system was analysed at different
PS concentrations of 1-10 mM. In this experiment, degradation of the tested TrOC, except for
oxybenzone that was completely degraded at all the tested concentration of PS, improved by
increasing the PS concentration from 1 to 10 mM, although the extent of improvement was
compound-specific. For instance, degradation of sulfamethoxazole was 23, 36, 53 and 72% at
an initial PS concentration of 1, 2, 5 and 10 mM (Figure 6.3). Similarly, carbamazepine
degradation increased from 11% (at 1 mM PS) to 40% (at 10 mM PS). Since performance of
laccase/PS system was studied for the first time, it is not possible to compare the results of this
chapter with literature. However, the trend in the improvement of TrOCs with increasing PS
concentration seems to be consistent with available literature. According to the available
literature, TrOC degradation generally improves with the increase in PS concentration. For
instance, Ji et al. [26] reported an improvement of approximately 80% in the degradation of
the pesticide atrazine by heat-activated PS after the increase in concentration from 0.1 to 2 mM.
In another study, degradation of sulfamethoxazole increased from merely 10 to 70% following
the increase in the concentration of bicarbonate-activated PS from 1 to 10 mM [36].
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The best PS concentration for achieving the highest degradation was different for the tested
TrOCs. It was 1 mM for oxybenzone and 5 mM for bisphenol A, while 10 mM was the most
effective PS concentration for diclofenac, carbamazepine and sulfamethoxazole (Figure 6.3).
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Figure 6.3. Effect of PS concentrations on TrOC degradation in batch laccase/PS system. PS
concentration ranged from 1-10 mM, while the initial laccase activity was 90-95
µM(DMP)/min. Results presented as average ± standard-deviation (n=3).
Laccase inactivation can be a concern during TrOC degradation, requiring intermittent
replenishment of laccase. Different physicochemical (e.g., salts and heavy metals) and
biological (e.g., organic acids and humic substances) factors can cause laccase inactivation [3,
17]. In absence of any known inhibitor, laccase activity did not reduce significantly (~2%) in
this experiment. However, when PS was added in the enzymatic bioreactor, increase in laccase
inactivation was observed (Figure 6.4a). At the end of the operation of batch laccase/PS
system, laccase inactivation was 7% at 1 mM PS concentration, which increased to 16, 18, and
43% following addition of PS at 2, 5 and 10 mM, respectively (Figure 6.4a). Laccase
inactivation could also be due to the radicals produced by PS that can interact with the active
sites of laccase, thereby affecting laccase activity. Previously, redox-mediators were added in
enzymatic bioreactor for improving the degradation of TrOCs. Despite the TrOC-specific
improvement in degradation, the radicals produced by redox-mediators has been reported to
cause rapid laccase inactivation [1, 4, 37]. For instance, laccase was reported to lose 70-80%
of its initial activity following the addition of violuric acid and 1-hydrozybenzotriazole
separately at 1 mM concentration. Notably, laccase inactivation caused by PS radicals is
significantly lower than that reported in presence of redox-mediators.
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In addition to laccase inactivation, depletion of PS may occur due to the scavenging reactions
in which radicals react with other radicals or nontarget compounds. These scavenging reactions
deplete PS by converting sulphate radicals into sulphate ions [38, 39]. In this experiment, PS
depletion was insignificant (less than 2%) at a PS concentration of 1-5 mM but increased
considerably (36%) in presence of 10 mM PS in laccase/PS system after 24 h of batch
experiment (Figure 6.4b). Thus, it important to consider the concentration of PS for developing
a stable and efficient integrated laccase/PS treatment system.

Figure 6.4. Laccase inactivation (a) and depletion of PS (b) at the end of batch tests with and
without the addition PS at different concentrations. Error bars represents the standard deviation
between duplicate samples.
6.4.1.3. Effect of incubation time
Degradation efficiency of the integrated laccase/PS system was assessed at different incubation
periods (i.e., 2, 4 8 and 24 h). To facilitate the discussion, performance of the integrated systems
at 2- and 5-mM PS concentration is presented in Figure 6.5. Laccase/PS system achieved rapid
degradation of both phenolic TrOCs. Complete elimination of oxybenzone was observed after
an incubation time of 2 h (at 5 mM PS concentration) and 4 h (at 2 mM Ps concentration). On
the other hand, 5 mM PS achieved 100% degradation of bisphenol A after 8 h in laccase/PS
system (Figure 6.5). Regardless of PS concentration, the maximum degradation for nonphenolics was observed within first 8 h of incubation period, and the degradation slowed down
considerably from 8 to 24 h. These results are consistent with the available literature related to
the performance of PS for the degradation of an individual TrOC. For instance, when heatactivated PS at 0.5 mM concentration was investigated for the degradation of an antibiotic
(penicillin G), its maximum degradation occurred within first 60 min [40]. Similarly,
degradation of sulfamethoxazole by PS was not observed to increase significantly after an
incubation period of 6 h in a PS/bicarbonate system [36]. The observations related to the
incubation time are vital for designing a wastewater treatment system. This is because
incubation time is an important parameter to estimate the size of the reactor required for
effective treatment, and its overestimation may considerably increase the cost of the treatment
system.
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Figure 6.5. Effect of incubation time on TrOC degradation in batch laccase/PS system
assessed separately at 2- and 5-mM PS concentration. Initial laccase activity was 90-95
µM(DMP)/min. Results presented as average ± standard-deviation (n=3).
6.4.1.4. Ecotoxicity and Estrogenic evaluation
Toxicity cannot be estimated by quantifying the actual amount of TrOC in the treated effluent
before disposal, because the degradation of TrOCs results in the production of transformation
by-products or metabolites that could cause more toxicity than the parent compound. To predict
the risk associated with the disposal of treated effluent, bioassays have been developed and
reported for quantifying the toxicity [17, 41]. In this experiment, toxicity of the treated effluent
was evaluated by measuring the inhibition of luminescence in the naturally bioluminescent
bacteria (Photobacterium leiognathi) using the BLT-Screen [42]. Consistent with previous
studies [13, 41], toxicity following treatment with laccase alone did not increase significantly
and ranged between less than 1 and 2.3 rTU (Table 6.2). On the other hand, toxicity of reaction
media increased from 7.6 to 28.8 rTU in batch laccase/PS systems with the increase in PS
concentration (Table 6.2). This could be attributed to: the reactive radicals generated by PS;
and/or the generation of toxic transformation by-products. Reduction in toxicity following
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treatment of a single TrOC by PS has been reported previously [43, 44]. However, toxicity of
the media following degradation of one TrOC is not comparable to that obtained from the
media containing a mixture of five TrOCs. Indeed, Kortenkamp et al. [45] observed that the
toxic effects of the solution containing a mixture of compounds are often higher than the toxic
effects of individual compound.
Table 6.2. Estrogenic activity and ecotoxicity of samples collected at the end of different
treatment options. Number of samples, n = 2.
Reaction media of different treatment
4-OHTMX-EQ
Toxicity (rTU) E2-EQ (ng/L)
options
(µg/L)
TrOCs only
<1
9.7 – 13.9
<20
TrOCs – Laccase
<1 – 2.3
< 1.4
<20
Laccase – TrOCs – Persulfate (1 mM)
7.6 – 11.3
2.3 – 2.6
<20
Laccase – TrOCs – Persulfate (2 mM)
3.9 – 5.6
1.8 – 2.6
<20
Laccase – TrOCs – Persulfate (5 mM)
10.3 – 11.2
3.3 – 3.9
<20
Laccase – TrOCs – Persulfate (10 mM)
24.8 – 28.8
2 – 2.2
<20
Note: The limit of detection of the toxicity assay was 1 rTU
The limit of detection for E2-EQ and 4-OHTMX-EQ was 1.4 ng/L and 20 (µg/L), respectively.
E2-EQ stands for 17β-estradiol equivalent; and 4-OHTMX-EQ stands for 4-hydroxytamoxifen equivalent.

Estrogenic activity was analysed because the prolonged exposure to TrOCs, particularly
bisphenol A has been reported to induce endocrine disrupting effects in aquatic life and human
[41, 46]. In this experiment, the estrogenic activity before and after treatment was evaluated by
using GeneBLAzer ERα-UAS-bla GripTiteTM cells, and the results are expressed as 17βestradiol equivalent (E2-EQ) and 4-hydroxytamoxifen equivalent (4-OHTMX-EQ). E2-EQ
estrogenic activity of the influent ranged between 9.7 and 13.9 ng/L (n=2) but was observed to
reduce after the treatments with laccase alone and laccase/PS system (Table 6.2). Importantly,
laccase-catalysed degradation achieved complete elimination of E2-EQ estrogenic activity
(i.e., below the detection limit of 1.4 ng/L). Despite the increase in toxicity, reduction in E2EQ estrogenic activity in laccase/PS system (Table 6.2) demonstrate that the resultant
transformation by-products either are not capable of exhibiting estrogenicity or have lower
estrogenic activity than the parent compound. Regardless of the treatment option, the 4OHTMX-EQ (i.e., antiestrogenic activity) of the influent and the treated effluent was below
the limit of detection (i.e., less than 20 µg/L) as indicated in Table 6.2. Although laccase [41,
47] or PS [48, 49] treatments have been reported to significantly reduce estrogenic activity
caused by TrOCs, the combination of both laccase and PS is also effective in reducing
estrogenic activity.

6.4.2. Continuous TrOC removal by laccase/PS-NFBR treatment system
The laccase/PS-NFBR system was operated continuously for a period of 64 h (i.e., 4 ×HRT)
at the TrOC loading rate of 0.72 mg/L.d, and laccase activity of 90-95 µM(DMP)/min. PS
concentration of 5 mM was selected based on the performance of batch laccase/PS system, and
was added only once at the start of the experiment. Main reason for coupling a membrane with
an enzymatic bioreactor was to effectively retain laccase, thereby preventing laccase washout
with treated effluent [14, 15]. To confirm this, permeate samples were collected after regular
196

intervals for monitoring the residual laccase activity as well as PS concentration. In this
experiment, the NF membrane effectively retained laccase, and PS was also not detected in
membrane permeate (data not shown). PS concentration may deplete over time due to the
interaction of secondary radicals with sulphate radicals as explained in the Section 6.4.1.2,
requiring intermittent addition of PS. Samples were collected after every 12 h for monitoring
PS concentration in the laccase/PS bioreactor. A gradual reduction in PS concentration was
observed during the operation of the laccase/PS-NFBR system. PS was not completely depleted
by the end of continuous experiment (i.e., after 64 h), and total reduction in PS concentration
was approximately 55%. In the following section, degradation and overall removal of TrOCs
in laccase/PS-NFBR is discussed separately for elucidating the performance of the developed
treatment system.
6.4.2.1. TrOC degradation
In the continuous-flow laccase/PS-NFBR treatment system, mechanisms of TrOC removal
include degradation by laccase/PS and membrane retention (discussed in Section 6.4.2.2).
TrOC degradation by the laccase/PS during continuous treatment ranged between 56 and 100%
(Figure 6.6a) with >99% degradation achieved for one non-phenolic (diclofenac) and two
phenolic TrOCs (bisphenol A and oxybenzone). Although the comparison of data obtained
from batch and continuous experiments may not be appropriate, better degradation of TrOC
was observed in the laccase/PS-NFBR system as compared to that achieved in the batch
laccase/PS system (Figure 6.1). Difference in the degradation of TrOCs in batch enzymatic
bioreactor and continuous-flow EMBR was also reported by Nguyen et al. [13]. They reported
that the degradation of a few TrOCs such as oxybenzone and diclofenac improved significantly
by 10 to 60% in a continuous-flow EMBR as compared to the batch enzymatic bioreactor [13].
Indeed, in the current experiment, degradation of carbamazepine, sulfamethoxazole, and
diclofenac by the laccase/PS-NFBR system was 52, 60 and 100%, respectively (Figure 6.6b),
while their degradation in batch tests under an identical PS concentration of 5 mM was less
than 55% (Figure 6.1). Previously, simultaneous retention of both laccase and TrOCs has been
reported to facilitate degradation [33, 50]. In a study by Asif et al. [5], performance of an
enzymatic bioreactor coupled to either an NF or UF membrane was compared under identical
operating conditions. Compared to UF-EMBR, degradation of the selected TrOCs, namely
carbamazepine, sulfamethoxazole, diclofenac, atrazine and oxybenzone improved by 15 to30%
in NF-EMBR, and it was attributed to the prolonged contact time between laccase and TrOCs
following their complete retention by the NF membrane [5].
It is important to note that the presence of TrOCs containing a phenolic moiety can also
facilitate the degradation of non-phenolic pollutants by acting as a redox-mediator. In natural
environmental settings, laccase can only degrade the phenolic components of lignin. This
results in the formation of secondary radicals (e.g., phenoxyl radical) or cross-coupling agents
that can degrade the non-phenolic components of lignin [32]. In a recent study, the
transformation by-products of a phenolic pharmaceutical (acetaminophen) was reported to
directly oxidize another pharmaceutical carbamazepine [51]. It is possible that the phenolic
TrOCs (oxybenzone and bisphenol A) that were effectively eliminated (~100%) may have
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contributed in the degradation of non-phenolic TrOCs. This phenomenon may not be apparent
in batch experiments probably because the abundance of oxidative cross coupling agents or
secondary radicals was not high enough as compared to that in the continuous-flow laccase/PSNFBR system. Since the NF membrane can achieve effective retention of laccase, PS and
TrOCs, the transformation by-products will also stay in the bioreactor of the continuous-flow
laccase/PS-NFBR system to contribute in TrOC degradation via catalytic and non-catalytic
pathways.
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Figure 6.6. Performance of the laccase/PS-NFBR treatment system for the degradation of the
selected TrOCs. Overall TrOC degradation (a) as well as time course of TrOC degradation (b)
is shown here. PS (potassium persulfate) was added at 5 mM concentration, while the initial
laccase activity was 90-95 µM(DMP)/min. The laccase/PS-NF treatment system was operated at
a TrOC loading rate of 0.72 mg/L.d and HRT of 16 h. Results presented as average ± standarddeviation calculated based on the triplicate samples that were collected at 24, 36, 48 and 64 h.
The performance of the laccase/PS-NFBR system was regularly monitored over the course of
its operation for assessing the stability of the developed process. The time course of TrOC
degradation during continuous operation as presented in Figure 6.6(b) indicates that the
degradation of both phenolic TrOCs (bisphenol A and oxybenzone) stabilised after an
operating time of 12 h, while steady state of diclofenac degradation was achieved after 18 h.
Degradation of sulfamethoxazole and carbamazepine increased up until 36 h, and remained
almost constant during the operating time of 36-64 h. Thus, it could be concluded that the
developed system was stable, achieving steady-state TrOC degradation.
6.4.2.2. Overall TrOC removal
The benefits of integrating the laccase/PS system with a high retention NF membrane can only
be realised by assessing the overall TrOC removal (i.e., degradation + membrane retention).
Despite the appreciable TrOC degradation, sulfamethoxazole and carbamazepine were
resistant to laccase/PS system and were moderately degraded (52-60%). The NF membrane
effectively retained the TrOCs not completely degraded by laccase/PS, producing a TrOC-free
stream with >95% overall removal (Figure 6.7). The NF membrane can effectively retain a
wide range of TrOCs via a combination of removal mechanisms. TrOC with molecular weight
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above 200 g/mol has been reported to be effectively retained (above 90%) by size exclusion.
On the other hand, mechanism of removal for hydrophobic (log D>3) and charged (e.g.,
diclofenac) TrOCs is adsorption on membrane surface and charge repulsion, respectively [52,
53]. In a previous study, the NF membrane coupled to an enzymatic bioreactor achieved an
overall removal of 92 to99% [5]. In this study, overall removal of the selected TrOCs ranged
between 95 and 100%. Since molecular weight of all the selected TrOCs was above 200 g/mol
(see Table 6.1), size exclusion appears to be the dominant mechanism of TrOC retention by
the NF membrane.
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Figure 6.7. Overall removal (degradation + membrane retention) of TrOCs by the laccase/PSNFBR system. Error bars represents the standard deviation (n=12). Experimental conditions
are presented in the caption of Figure 6.6.
As demonstrated above in section 6.4.1.4, toxicity of the treated effluent increased after the
batch laccase/PS treatment. In a previous study, a high retention membrane distillation process
coupled to an enzymatic bioreactor was reported to reject TrOCs and their transformation
products, thus producing a non-toxic permeate [50]. However, toxicity of the NF permeate has
not been evaluated to date. To confirm this, samples were collected at the end of continuous
operation, and their toxicity was analysed. Although the toxicity of the bioreactor media was
96.2 ± 6.7 rTU (n=3), NF permeate samples were non-toxic (i.e., less than 1 rTU). This
confirmed that the high retention NF membrane not only retained TrOCs but can also retain
the transformation by-products that may exhibit toxicity.
Estrogenic activity is another important parameter to evaluate the safety of treated effluent for
disposal and reuse [29, 54]. The samples collected from laccase/PS bioreactor at the end of
experiment showed an estrogenic activity of 0.6 ± 0.2 ng/L EE2-EQ, while no estrogenic
activity was found in NF permeate (i.e., blow the detection limit of 0.35 ng/L EE2-EQ).
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Importantly, the antiestrogenic activity expressed as 4-OHTMX-EQ in both the laccase/PS
bioreactor and NF permeate was below the detection limit of 20 µg/L.

6.4.3. Hydraulic performance of the laccase/PS-NFBR

Normalized flux [-]

Permeate flux was monitored regularly for analysing the hydraulic performance of the NF
membrane. By the end of the experiment, permeate flux of the NF membrane reduced by almost
20% (Figure 6.8). The permeate flux reduced by 10% within the first 2 h of operation due to
the adsorption of the reaction media consisting of TrOCs, laccase and PS. Similar trend was
observed previously when an enzymatic bioreactor was integrated with the NF membrane [5,
55]. Notably, the reduction in permeate flux can also be attributed to concentration polarization
that is caused by the accumulation of the bioreactor media on or near the surface membrane
[55, 56]. At the end of operation, cleaning the NF membrane with milli-Q water was effective
to recover the flux by almost 95%. This indicates that the reduction in flux caused due to the
adsorption of reaction media and/or concentration polarization is reversible.
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Figure 6.8. Hydraulic performance of the NF membrane expressed as normalised flux during
the operation of the laccase/PS-NFBR treatment system.

6.5. Conclusion
Performance of an integrated laccase and persulfate (PS) oxidation process in batch and
continuous modes was systematically investigated for the degradation of five trace organic
contaminants (TrOCs), namely diclofenac, sulfamethoxazole, carbamazepine, bisphenol A and
oxybenzone. Degradation of the selected TrOCs by laccase alone in batch experiments ranged
between 7 (for sulfamethoxazole) and 100% (for oxybenzone) and was governed by the
physicochemical properties such as chemical structure. Addition of PS at different
concentration (1-10 mM) in the batch enzymatic bioreactor achieved TrOC-specific
improvement in degradation, exhibiting the benefits of combining both oxidation processes.
Among the tested PS concentrations (1-10 mM), the best performance was achieved at 5 mM
concentration that achieved 100% degradation for two phenolics (bisphenol A and
oxybenzone) and 25-53% degradation for three non-phenolic (diclofenac, sulfamethoxazole,
and carbamazepine) TrOCs without significantly causing laccase inactivation and PS
depletion. However, addition of PS increased the toxicity of the treated effluent to 7.6-28.8
rTU as compared to the toxicity of <1-2.3 rTU obtained after treatment with laccase alone. All
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treatment options with and without PS reduced the estrogenic activity measured as 17βestradiol equivalent, while antiestrogenic activity (expressed as 4-hydroxytamoxifen
equivalent) was below the detection limit of 20 µg/L. A treatment system by coupling a
nanofiltration (NF) membrane with laccase/PS (5 mM) system was also developed, which
allowed continuous removal of TrOCs without laccase and PS washout. The continuous
laccase/PS-NFBR treatment system produced a high quality permeate stream due to effective
TrOC removal (95-100%). In addition, the enhanced degradation (10-65%) of non-phenolic
was also achieved in laccase/PS-NFBR as compared to that obtained in the batch laccase/PS
system. On the other hand, degradation of both bisphenol A and oxybenzone remained below
the limit of detection in the laccase/PS-NFBR system. Although the toxicity of the bioreactor
reaction media increased, the membrane permeate was non-toxic. The evaluation of the data
obtained from estrogenic activity assay indicated a reduction in the estrogenic activity of the
reaction media. Because the NF membrane can reject the residual estrogenic activity, the
membrane permeate was deemed safe for disposal and reuse. Hydraulic performance of the NF
membrane was monitored, which showed a reduction of approximately 20% in the permeate
flux at the end of the experiment. Cleaning the membrane with Milli-Q water helped to recover
permeate flux by 95%.
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Chapter 7: Simultaneous removal of TrOCs and
metals by a PS-assisted membrane distillation
reactor
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7.1. Introduction
Acid mine drainage (AMD) originating from different mining activities (such as coal and gold
mining) has gained global attention in the last decade due to its adverse environmental impacts
on soil, freshwater and aquatic ecosystem [1, 2]. AMD is generated due to the oxidation of
sulfides ores during a wide range of mining activities. Among different types of sulfide ores,
pyrite ore (FeS2) has been recognized as the main mineral ore for AMD generation, because its
exposure to oxygen and water can easily oxidize the pyrite ore as shown in Equation (1-3) [1,
3]. Composition of AMD is diverse and is commonly characterized by high concentrations of
sulphate and iron (II) as well as other trace elements such as calcium and lithium. AMD flows
into freshwater bodies and can promote the release of different toxic metals following its
interaction with underground rocks [1, 4, 5]. Thus, an efficient process for the treatment of
AMD-impacted water is required for maintaining high water quality.
7

𝐹𝑒𝑆2 + 2 𝑂2 + 𝐻2 𝑂 → 𝐹𝑒 2+ + 2SO4 2− + 2H +
1
1
𝐹𝑒 2+ + 𝑂2 + H + → 𝐹𝑒 3+ + 𝐻2 𝑂
4
2
𝐹𝑒 3+ + 3𝐻2 𝑂 → 𝐹𝑒(𝑂𝐻)3 + 3H +

Eq. (1)
Eq. (2)
Eq. (3)

Technologies for the treatment of AMD-impacted water can be divided into two categories,
namely active and passive treatment processes. The conventional active treatment process
includes the application of alkaline chemicals (e.g., lime) to precipitate metals by raising the
pH [6]. However, this process generates toxic sludge that contains high concentrations of
amorphous ferric oxyhydroxide, and the treated effluent requires additional treatment for
meeting the water quality guidelines [1, 6]. Bioreactors and wetlands are the passive processes,
which use natural processes for the treatment AMD-impacted water. For instance, during
treatment with bioreactors, naturally occurring iron and sulfate reducing bacteria are cultured
to convert sulfate into hydrogen sulfide, but the pH of AMD-impacted water should be above
3 for effective metabolization of iron and sulfate ions [7]. During treatment with wetlands,
natural attenuation processes, lime dosing, and long hydraulic retention time (HRT) allow all
the solids including heavy metals to settle down [8]. Although conventional active and passive
processes are effective, large area requirement; large quantities of reagents for neutralization;
and long HRT as well as process sensitivity to changes in influent chemistry (such as pH and
temperature) are the major drawbacks [9-11]. Hence, a compact and robust treatment process
is required for the treatment of AMD-impacted water.
In addition to AMD contamination, trace organic contamination (TrOCs) such as
pharmaceuticals and pesticides have been reported to be detected in sewage-impacted
freshwater bodies [12-14]. This raises significant concern due to their potential harmful impact
on aquatic organisms and even humans in the case of prolonged ingestion, thus requiring a
treatment process for effective removal of both the metals and TrOCs. Recently membrane
distillation (MD) has gained significant attention as an effective separation process [15, 16].
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MD is a thermally driven membrane separation process; however, it requires a lower operating
temperature than conventional distillation processes such as fractional distillation. During the
MD process, water in vapor form moves via diffusion through a microporous hydrophobic
membrane from a higher temperature feed solution to a lower temperature permeate solution.
This occurs due to the vapor pressure gradient developed by the temperature difference
between the sides of the membrane [17, 18]. Since the water moves across the membrane in
vapor form, MD can theoretically provide complete removal of non-volatile pollutants [15, 19].
Furthermore, the compatibility of the MD process with low-grade waste heat and solar thermal
energy [17] makes its application attractive in various fields, including water desalination and
wastewater treatment.
The MD process has been predominantly assessed for the desalination of sea and brackish
water, particularly for hyper-saline feed, because, being a thermally driven process, water flux
in MD is negligibly affected by the feed osmotic pressure as compared to the pressure-driven
membrane desalination processes (e.g., RO and NF) [16, 20, 21]. In addition, as compared to
RO and NF membranes, superior performance of MD for the removal of a range of pollutants
such as pharmaceuticals and metal salts has been reported [22-25]. Despite the potential to
date, the performance of MD for the removal of TrOCs and metals has been mostly assessed
separately only in a few short-term batch studies. For instance, Wijekoon et al. [15] investigated
the removal of TrOCs including pesticides and pharmaceuticals by MD operated in batch mode
for 24h. They observed TrOCs removal to be governed by their volatility and hydrophobicity.
In another short-term study by Han et al. [22], MD achieved 90-95% removal of a nonsteroidal
anti-inflammatory drug ibuprofen from synthetic wastewaters mimicking surface water or
reverse-osmosis concentrate. Hull and Zodrow [26] investigated the removal of AMD
constituents including iron, aluminum and zinc from synthetic by using an MD process. They
achieved above 99% removal of AMD constituents by MD after a short-term experiment of
12-24 h [26]. Although these studies provide useful insights, it is important to note that a
continuous-flow operation is required to analyze and understand process stability. To date, only
a handful of studies have assessed TrOC removal in continuous-flow mode [16, 27]. The
authors reported 70 to 99% removal of the investigated TrOCs depending on their
physicochemical properties. Two particular aspects highlighted in these studies were: (a)
membrane fouling, significantly reducing permeate flux; and (b) additional requirement of
treatment and disposal of membrane-concentrate rich in TrOCs as well as other organic and
inorganic impurities. Notably, a continuous-flow MD process for the treatment of AMDimpacted water is yet to be studied.
Accumulation of organic pollutants, particularly TrOCs in MD-concentrate could be reduced
by integrating either a laccase or a persulfate (PS) oxidation process with the MD process. This
integration will simultaneously degrade bulk organics and TrOCs, reducing their accumulation
in MD-concentrate and potentially mitigating membrane fouling. Efficacy of laccase-catalyzed
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degradation process and PS-assisted oxidation processes for TrOC removal has already been
discussed in Chapter 6.
In this chapter, the performance of a direct-contact MD process is discussed for simultaneous
removal of metal salts and TrOCs from sewage- and AMD-impacted water. For this purpose,
a synthetic wastewater was prepared, which contains a mixture of 12 TrOCs at an
environmentally relevant concentration of 5 µg/L, as well as a mixture of four metal ions (iron,
calcium, magnesium and lithium each at 10 and 100 mg/L concentration). The performance of
laccase and PS for the degradation of TrOCs was systematically analyzed, and the oxidation
process showing better stability and TrOC removal was selected for integration with the MD.
Basic water quality parameters such as total organic carbon (TOC) and total nitrogen (TN) as
well as membrane water productivity was thoroughly evaluated to determine the fouling
behavior. At the end of operation, MD membranes were characterized by scanning electron
microscopy (SEM) - energy dispersion spectrometry (EDS) to gain an in-depth understanding
of the fouling mitigation.

7.2. Hypothesis
▪
▪

▪

The direct-contact MD process can achieve effective removal of TrOCs and metal salts
from sewage- and AMD-impacted water
Accumulation of organic and inorganic impurities (such as metal ions) in membraneconcentrate may affect the hydraulic performance of the MD process by causing
membrane fouling
Integration of an oxidation process with MD may achieve TOC and TrOC degradation
as well as membrane fouling control

7.3. Materials and methods
7.3.1. Chemicals
Potassium persulfate (PS) was purchased from Sigma-Aldrich (Australia). The stock solution
(100 mM) of PS was prepared in ultrapure Milli-Q water and stored at 4ºC before use. HPLC
grade acetonitrile, methanol, dichloromethane and formic acid were used for quantification of
TrOCs as explained in Section 7.3.4.2. As noted in Section 7.3.3.2, analytical grade glucose,
peptone, urea, monopotassium phosphate, magnesium sulphate, ferrous sulphate, and sodium
acetate were used to make the synthetic wastewater for MBR. In this experiment, metal salts
and TrOCs were added in the MBR permeate for making the synthetic wastewater. MBR
permeate was used to mimic sewage-impacted water.
Properties of the selected TrOCs including three pesticides and nine PPCPs are presented in
Table 7.1, and their chemical structures are given in Appendix Table 7-1. These were selected
based on their widespread occurrence in municipal wastewater and sewage-impacted water
[12]. These chemicals were also purchased from Sigma-Aldrich (Australia). A combined stock
solution of TrOCs was prepared in pure methanol and stored at −18ºC in dark. Analytical grade
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iron sulfate, lithium chloride, magnesium chloride and calcium chloride were purchased from
Sigma-Aldrich (Australia), and a concentrated stock solution containing the mixture of each
metal salt was prepared in 100 mL Milli-Q ultrapure water. Laccase from genetically modified
Aspergillus oryzae obtained from Novozymes Pty Ltd (Australia) was used in this experiment.
Properties of laccase are presented in Section 3.3.1 (Chapter 3).
Table 7.1. Physicochemical properties of the selected TrOCs
Molecular
log D @
pKH @
Charge
weight a
pKa a
pH=7 a
pH=7 b at pH=7
(g/mol)
Pharmaceuticals Acetaminophen
152
0.46
0.52
8.3
and personal
Bezafibrate
362
-0.93
3.29
Negative
care products
Diclofenac
296
1.77
4.18
11.51
(PPCPs)
Sulfamethoxazole
253
-0.96
5.18
11.81
Amitriptyline
277
2.28
9.18
8.18
Carbamazepine
236
1.89
13.94
9.09
Primidone
218
0.83
12.26
13.93
Neutral
Triclosan
290
5.28
7.8
6.18
Trimethoprim
290
0.27
7.04
13.62
Atrazine
216
2.64
2.27
7.28
Negative
Pesticide
Linuron
249
3.12
12.13
8.71
Pentachlorophenol
266
2.85
4.68
7.59
Neutral
a
molecular weight, log D (water partition coefficient) and pka (acid dissociation coefficient) were
obtained from the SciFinder Scholar database
b
pKH = - log10 H, where H is Henry’s law constant and defined as vapour pressure×molecular
weight/water solubility.
“−”: not available
Type

Name

7.3.2. Experimental setup
A laboratory-scale direct contact membrane distillation (DCMD) system was used for the
treatment of synthetic sewage- and AMD-impacted water (Figure 7.1), due to the ease of
operation as compared to other MD configurations, e.g., air gap MD [17]. In Chapter 4 and
5, the MD setup was operated in concentration mode, and is different from that used in this
experiment. Hence, a brief description of the continuous-flow MD setup is provided here. The
DCMD setup consisted of a 3 L glass reactor (hereafter referred to as MD feed tank), a
membrane module, a glass distillate tank (5 L) and two circulation gear pumps (Micropump
Inc., Vancouver, WA, USA). Operated via a water level controller, a peristaltic pump (ColeParmer, Vernon Hills, IL, USA) supplied wastewater from a storage tank to the MD feed tank.
The temperature of the MD feed tank, which was covered, was maintained at 40 ± 1.5ºC by
using a heating immersion circulator (Julabo, Seelbach, Germany), while a chiller (Thermo
Scientific, Waltham, MA, USA) was used to keep the temperature of the distillate tank at 20 ±
0.5ºC.
The MD membrane module was made of acrylic plastic. It was comprised of two identical
cells, each engraved with flow channels 145 mm long, 95 mm wide and 3 mm deep as described
previously [28]. A hydrophobic polytetrafluoroethylene (PTFE) membrane with a thickness,
nominal pore size, and porosity of 60 μm, 0.2 μm, and 80%, respectively, was purchased from
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Ningbo Porous Membrane Technology (Ningbo, China). The media from the MD feed tank
and the distillate tank were passed through the opposite membrane cells at a recirculation
flowrate of 1 L/min (corresponding to a cross flow velocity of 9 cm/s) using two rotameters.
The partial vapor pressure gradient developed due to difference in temperature allows water to
move across the membrane as vapor, consequently increasing the volume of water in distillate
tank. This tank was placed on a precision balance (Mettler-Toledo, Kings Park, NSW,
Australia). Change in the weight of distillate water was recorded in a computer via BalanceLink
software (Mettler Toledo) to determine the MD water flux.

Figure 7.1. Schematic representation of the laboratory-scale DCMD setup

7.3.3. Experimental protocols
7.3.3.1. MD process characterization
The MD process was characterized by calculating the mass transfer coefficient (Km) using a
procedure previously described by Duong et al. [18]. Briefly, the MD system was operated in
batch mode at different feed temperatures (i.e., 40, 45 and 50 ºC) for 1 h with ultrapure Milli
Q water. Distillate temperature was kept constant at 20 ºC, and recirculation flow rate of both
feed and distillate was maintained at 1 L/min. The permeate flux was recorded every 5 min for
1 h. Permeate flux of MD can be theoretically calculated using Equation 4 as given below:
𝐽 = 𝐾𝑚 × (𝑃𝑓𝑒𝑒𝑑 − 𝑃𝑑𝑖𝑠𝑡𝑖𝑙𝑙𝑎𝑡𝑒 )

Eq. (4)

where J is the permeate flux (L/m2 h) of DCMD, Km is the mass transfer coefficient (L/m2 h
Pa), Pfeed is the vapor pressure of water in MD feed, and Pdistillate is the vapor pressure of water
in MD distillate. Pfeed and Pdistillate can be determined by using Equation 5 [29]:
𝑃 = 𝑥𝑤𝑎𝑡𝑒𝑟 × 𝛼𝑤𝑎𝑡𝑒𝑟 × 𝑃𝑜

Eq. (5)

where xwater and αwater are the molar fraction and activity of water, respectively, and Po is the
vapor pressure of water in MD feed and distillate. Since DCMD was characterised with
ultrapure Milli-Q water, value of both xwater and αwater is equal to 1. Vapor pressure of water in
MD feed and distillate can be calculated by using Antoine’s Equation [18, 29] as given below:
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3816.44
)
𝑇 − 46.13

𝑃𝑜 = exp(23.1964 −

Eq. (6)

where T is the absolute temperature of the feed or distillate streams.
7.3.3.2. Performance of a stand-alone MD process
In the first part of this experiment, removal of both the TrOCs and metalions from four different
compositions of synthetic wastewater was studied by operating the stand-alone MD in a
continuous-flow mode for a period of 5 d, i.e., 6×HRT (Table 7.2). The main aim was to
understand the interaction of different pollutants on their rejection as well to understand the
performance governing factors.
Table 7.2. Description of different wastewater compositions treated by the stand-alone MD
Run ID
Milli-Q water MBR permeate
TrOCs
Metal salts
Control run
✓
✓
✓
–
MD-WW0
✓
✓
–
–
MD-WW10
✓
✓
✓
–
MD-WW100
✓
✓
✓
–
Note: TrOC concentration was kept at 5 µg/L during all experiments.
The numbers in the sub-script of the run ID indicate the concentration of each metals salt. For
example, MD-WW0 represents the run with no metal salts, while MD-WW10 indicates that the
concentration of each salt during this experiment was 10 mg/L.

As mentioned above, permeate from a lab-scale MBR was collected to make a synthetic
wastewater mimicking the properties of sewage- and AMD-impacted water. The MBR was
operated for around one year, while it was continuously fed with synthetic wastewater
containing 400 mg/L glucose, 100 mg/L peptone, 35 mg/L urea, 17.5 mg/L monopotassium
phosphate, 17.5 mg/L magnesium sulphate, 10 mg/L ferrous sulphate, and 225 mg/L sodium
acetate. The wastewater had a chemical oxygen demand (COD), total organic carbon (TOC),
total nitrogen (TN) and PO43--P concentrations of 650, 175, 25, and 15 mg/L, respectively. The
hydraulic retention time and solids retention time of the MBR was 12 h and 10 d, respectively.
Characteristics of MBR permeate are given in Table 7.3.
Table 7.3. Characteristics of MBR permeate used for making the different compositions of
wastewater to be treated by MD
Parameter
pH
Conductivity
Total organic carbon (TOC)
Total nitrogen (TN)
NH4+-N
PO43--P

Unit
µS/cm
mg/L
mg/L
mg/L
mg/L

Value (minimum – maximum)
6.9 – 7.2
190 – 220
8.5 – 16
6.4 – 7.9
2.4 – 2.9
3.4 – 6.1

Prior to the commencement of this experiment, the MBR-treated effluent was spiked with the
selected pharmaceuticals and pesticides (at 5 µg/L each) as well as metal salts at either 10 or
100 mg/L each as illustrated in Table 7.2. Duplicate samples from MD feed tank and distillate
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tank were collected after every 3×HRT for the quantification of TrOCs and metal ions. In
addition, samples were collected on daily basis to measure TOC and TN removal by the MD.
At the start of each run, 1.5 L of Milli-Q was added in the distillate tank that served as the
initial distillate. Thus, the concentrations of TOC, TN, TrOCs and metals in MD permeate were
corrected for dilution by considering the initial working volume of the distillate tank. At the
end of MD operation, MD membranes were collected and characterized by SEM-EDS to gain
an in-depth understanding of the fouling constituents.
7.3.3.3. Performance of an integrated MD process
To choose an oxidation process to be integrated with MD, performance and stability of both
laccase and PS was assessed in batch experiments. The batch reactors (250 mL) containing the
wastewater prepared by adding the mixture of TrOCs and iron salt in MBR permeate were
incubated for a period of 24 h at 20 and 40 °C in separate runs. Initial laccase activity and PS
concentration was maintained at 95-100 µM/min and 1 mM, respectively. Samples were
collected at the end for TrOC quantification, laccase activity and residual PS concentration.
Based on the results achieved (see Section 7.4.3.1), PS exhibited better TrOC removal and
stability in batch experiments as compared to laccase. Thus, PS-assisted oxidation process was
selected for integration with MD. PS was directly added to the feed media at a concentration
of 1 mM after every 2×HRT. Concentration of PS was selected based on a comprehensive
literature survey [30, 31]. The spiked secondary treated wastewater was treated by PS-assisted
MD system with (PS-MD-WW10) and without (PS-MD-WW0) the addition of metal salts in
continuous-flow mode for a period of 5 d (i.e., 6×HRT).
Duplicate samples from MD feed tank and distillate tank were collected after every 3×HRT for
the determination of TrOCs and metals. In addition, samples were collected on daily basis to
measure TOC and TN removal by PS-assisted MD with and without the addition of metal salts.
Similar to the stand-alone MD, membranes at the end of PS-assisted MD systems were
collected and characterized by SEM-EDS to gain an in-depth understanding of the fouling
control achieved by PS.

7.3.4. Analytical methods
7.3.4.1. Analysis of basic quality parameters
Samples from MD feed tank and distillate tank were collected on daily basis for analysis. TOC
and TN concentrations were measured using a TOC/TN-VCSH analyser (Shimadzu, Japan).
TOC and TN removal efficiency by the stand-alone and PS-assisted MD were calculated based
on the method described in Section 7.3.4.2. The pH and conductivity were measured using an
Orion 4 Star Plus portable pH/conductivity meter (Thermo Scientific, Waltham, MA, USA)
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7.3.4.2. Analysis of TrOCs and metals
TrOCs were analysed using a Shimadzu LC-MS system (LC-MS 2020) after solid phase
extraction (SPE). A detailed description of this method is available elsewhere [32]. Briefly,
TrOCs were extracted using 6 mL Oasis HLB cartridges (Waters, Milford, MA, USA). The
HLB cartridges were first pre-conditioned with 5 mL dichloromethane and methanol solution
(1:1 v/v), 5 mL methanol and 5 mL Milli-Q water. The pH of the samples was adjusted to 2-3
using 2 M H2SO4, and then loaded onto the cartridges at a flow rate of 1–4 mL/min. The
cartridges were dried for 30 min under gentle stream of nitrogen. The extracted samples were
eluted using 7 mL methanol and 7 mL dichloromethane and were dried in a water bath at 40ºC
for 3-4 h. The residues were redissolved in 400 µL methanol for quantification by LC-MS.
The LC-MS system was equipped with an electrospray ionization (ESI) interface, and a
Phenomenex Kinetex C8 chromatography column (50 × 4.6 mm) was used for the separation
of TrOCs. Milli-Q water buffered with 0.1% (v/v) formic acid, and HPLC grade acetonitrile
was used as the mobile phase during the analysis. Mobile phase flow rate and sample injection
volume were 0.5 mL/min and 10 µL, respectively. Quantification of acetaminophen,
primidone, trimethoprim, sulfamethoxazole, carbamazepine, bezafibrate, atrazine, linuron, and
amitriptyline was performed under ESI positive ionization [M+H]+ mode, while ESI negative
ionization [M-H]− mode was adopted for pentachlorophenol, diclofenac and triclosan [32].
During the analysis, detector voltage, desolvation line temperature and heating block
temperature were kept constant at 0.9 kV, 250ºC, and 200ºC, respectively. The analysis was
conducted in gradient elution mode as shown in Appendix Table 7-2. High purity nitrogen
that acted as both the nebulizing and drying gas was supplied continuously at a flow rate of 1.5
and 10 L/min, respectively. The calibration curves were prepared by analyzing the known
concentrations of analytes that ranged between 0.1 and 20 µg/L. The correlation coefficient of
all the calibration curves was above 0.99.
Removal of TrOCs by PS/laccase (R1) and MD (R2) was calculated by using Equation (7) and
(8), respectively:
𝑅1 = 100 × (1 −

𝐶𝑆𝑢
)
𝐶𝑓

Eq. (7)

𝑅2 = 100 × (1 −

𝐶𝑝
)
𝐶𝑓

Eq. (8)

where, Cf, Csu and Cp are the concentration (ng/L) of a specific pollutant in MD storage tank
(Figure 7.1), MD feed and MD permeate, respectively.
The mass of a TrOCs degraded by PS during PS-assisted MD operation was calculated as
follows:
Cf × Vf = (Csu × Vsu) + (Cp × Vp) + Mass degraded by PS
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Eq. (9)

where, Vf, Vsu and Vp represents the volume of wastewater, MD feed and permeate,
respectively.
Concentrations of iron (II), calcium, magnesium and lithium were determined by inductively
coupled plasma-optical emission spectroscopy (ICP-OES, 7500CS, Agilent Technologies,
USA). A sample dilution was prepared out with 5% nitric acid. The linear regression
coefficients for all calibration curves were higher than 0.99 for both elements. Prior to each
batch of analyses, the ICP-OES was tuned by a using multi-element tuning solution.
7.3.4.3. Membrane characterization and toxicity of MD permeate
At the end of DCMD operation with and without PS dosing, MD membranes were collected
and air-dried in a desiccator. MD membranes were then coated with an ultra-thin gold layer
with a sputter coater (SPI Module, West Chester, PA, USA), and were characterized with a
scanning electron microscopy (SEM) coupled with energy dispersion spectrometry (EDS)
(JCM-600, JEOL, Tokyo, Japan). The method for toxicity assay has already been described in
Section 5.3.4.3 (Chapter 5).
7.3.4.4. PS concentration and laccase activity
The change in PS concentration following its addition to the reaction media was monitored
during batch experiments as well as during the operation of PS-assisted MD by using a
previously developed spectrophotometric method [33]. Briefly, two solutions were prepared
before measuring PS concentration. Solution-1 was the PS stock solution (100 mM). Solution2 was prepared by dissolving 0.2 g NaHCO3 and 4 g KI in 40 mL Milli-Q water, mixed well
and allowed to equilibrate for 15 min. Portions of Solution-1 (i.e., 0.1, 0.2, 0.4, 2 and 4 mL)
were separately added to Solution-2 to achieve final PS concentration of 0.25, 0.5, 1, 5 and 10
mM. The standard solutions were incubated on a rotary shaker at 80 rpm for 2 h. Absorbance
of the standard solutions was measured at a wavelength of 352 nm in 1 cm quartz cuvettes
using a UV-visible spectrophotometer (DR6000, Hach, Loveland, CO, USA). The coefficient
of determination (R2) obtained by drawing the calibration curve was >0.98. For determining
the concentration of PS during the operation of PS-assisted DCMD, 20 mL sample collected
from MD feed was added to 40 mL Solution-2, and the resulting solution was incubated for 2
h before measuring its absorbance at 352 nm using a UV-visible spectrophotometer as
described above. The concentration of the PS was corrected by multiplying it with the dilution
factor of 3. Laccase activity was measured as described in Section 3.3.4.2 (Chapter 3).

7.4. Results and discussions
7.4.1. Mass transfer coefficient (Km) of MD
The mass transfer coefficient (Km) of the MD system in the current experiment was determined
experimentally using ultrapure Milli-Q water as feed following Equations 4−6. Mass transfer
(denoted by Km value) during MD operation can be affected by concentration and temperature
polarization. Since concentration of salts in Milli-Q water is negligible, the effect of
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concentration polarization on Km could be ignored. Temperature polarization effect has been
incorporated in Equations 4−6 for the determination of Km. The significance of temperature
polarization effect can be assessed by comparing Km values at different feed temperatures [17,
18]. Despite the increase in permeate flux (Figure 7.2a), Km reduced with the increase of MD
feed temperature from 40 to 50ºC (Figure 7.2). This indicates that temperature polarization
effects become severe at high feed temperature, which is consistent with the available literature
[18, 34, 35]. Therefore, we operated the DCMD system at a feed temperature of 40ºC, resulting
a Km value 2.7 L/m2.h.Pa.
(a) Experimentally measured permeate flux
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Figure 7.2. Permeate flux (a) and mass transfer coefficient (b) of the MD system determined
experimentally with Milli-Q water as feed at a temperature of 40, 45 and 50 ºC. Temperature
of the distillate reservoir was kept at 20 ºC, while the cross-flow velocity was maintained at 1
L/min.

7.4.2. Performance of a stand-alone MD system
7.4.2.1. Removal of TrOCs
Overall removal of the selected TrOCs by the standalone MD system in absence of metal salts
is presented in Figure 7.3. In a stand-alone MD process, membrane retention is the only
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mechanism of TrOC removal. Because water moves across an MD membrane in vapor form,
the extent of TrOC removal by the membrane is influenced by the water partition coefficient
(log D) and vapor pressure of the target pollutant [25]. Noting that pKH = -log10 H (where, H
is the Henry’s Law constant and is equal to vapor pressure × MW/water solubility), in general,
TrOCs with a low ‘pKH / log D’ ratio (e.g., less than 2.5) are partially removed by the MD
membrane in a stand-alone MD system [15, 28]. In the current experiment, TrOC removal from
two different compositions of wastewater (control and MD-WW0) by MD was initially
assessed. The stand-alone MD achieved TrOC-specific removal that ranged between 86 and
100% (Figure 7.3). During the control run, out of the 12 selected TrOCs, removal of six
including four PPCPs (amitriptyline, acetaminophen, trimethoprim and triclosan) and two
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pesticides (pentachlorophenol and linuron) was between 90 and 98%, while removal of four
PPCPs (primidone, bezafibrate, carbamazepine and sulfamethoxazole) was greater than 98%
(Figure 7.3). For the remaining two TrOCs, removal of the pesticide atrazine and the
nonsteroidal anti-inflammatory diclofenac was 85%.

A

Figure 7.3. Performance of the stand-alone MD for the removal of the selected TrOCs arranged
based on pKH /log. Two different compositions of the synthetic wastewater were prepared to
assess the performance of the stand-alone MD. For the control run, synthetic wastewater was
prepared by adding a mixture of TrOCs in ultrapure Milli-Q water. For the MD-WW0 run,
synthetic wastewater was prepared by dosing MBR permeate with TrOC mixture. Operating
conditions: the initial TrOC concentration was 5 µg/L; temperature of the MD feed and the
distillate (permeate) tank was kept at 40 and 20 ºC, repectivley; and cross-flow rate was 1
L/min (corresponding to cross-flow velocity of 9 cm/s). Mean removal efficiency and standard
deviation (n=4 for control run, and n=10 for MD-WW0 run) are presented.
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During the MD-WW0 run for the treatment of wastewater prepared by dosing MBR permeate
with TrOC mixture, six including four PPCPs (carbamazepine, trimethoprim, bezafibrate,
primidone and acetaminophen) and three pesticide (pentachlorophenol) exhibited removal
greater than 98% (Figure 7.3). For the remaining TrOCs, MD achieved a removal of 86% for
atrazine, 91% for triclosan, 92% for amitriptyline, 94% for diclofenac, 95% for
sulfamethoxazole, and 96% for linuron (Figure 7.3). Previously, Song et al. [27] investigated
the performance of a stand-alone MD system for the treatment of anaerobic-MBR permeate
containing a mixture of TrOCs. Consistent with the results of the current experiment, they also
reported good but incomplete removal (80-95%) of a few TrOCs such as atrazine, diclofenac,
sulfamethoxazole, linuron and triclosan [27]. Due to the adsorption of a few TrOCs onto the
residual organics present in MBR permeate, TrOC removal from MBR permeate could be
better than that achieved from milli-Q water [15]. Indeed, comparison of the results indicates
that removal of two TrOCs (diclofenac and sulfamethoxazole) by the stand-alone MD was
significantly better (up to 10%) during the MD-WW0 run as compared to that during control
run (Figure 7.3).
When the salts of iron, calcium, magnesium and lithium were added at either 10 or 100 mg/L
in the MBR-permeate, no apparent change in the extent of TrOC removal by the stand-alone
MD system was observed. TrOC removal ranged from 84 to 100% at a salt concentration of 10
mg/L each, and 82 to 100% at a salt concentration of 100 mg/L each (Figure 7.4). Comparison
of the results obtained from this experiment could not be compared with the available literature
due to unviability of the studies on removal of TrOCs in presence of metal salts. These results
suggest that the stand-alone MD can achieve effective TrOC removal even in presence of metal
salts.
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Figure 7.4. Performance of the stand-alone MD for the removal of the selected TrOCs arranged
based on pKH /log in presence of metal salts at 10 (MD-WW10) and 100 mg/L (MD-WW100).
Mean removal efficiency and standard deviation (n=4) are presented. Operating conditions are
presented in the caption of Figure 7.3.
7.4.2.2. Removal of TOC, TN and metal ions
Overall removal of bulk organics was monitored via TOC and TN concentration in the MD
permeate (distillate) for different wastewater compositions (Table 7.4). TN and TOC removal
by the stand-alone MD was consistently above 95% and 98%, respectively, as shown in Table
7.4, thus ensuring high quality treated effluent. However, effective retention of TOC and TN
during continuous feeding also means their accumulation in MD feed tank (i.e,, MD reactor),
which may cause severe membrane fouling [27]. This aspect is more comprehensively
discussed in Section 7.4.4.
Table 7.4. Removal of different pollutants during the treatment of wastewater by the standalone MD system
Parameters
TOC
TN
Conductivity
Iron (II)
Magnesium
Calcium
Lithium

Control
–
–
99
100
99
99
99

Removal efficiency (%)
MD-WW0
MD-WW10
99
98
96
98
99
99
–
99
–
99
–
100
–
100
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MD-WW100
99
98
99
99
100
99
100

n=5 for TOC and TN, and n=4 for metal ions. Standard deviation during all analysis was below
5%. ‘–‘ indicates that metal ions were not added during that run. TrOC concentration was kept at
5 µg/L during all experiments.
The numbers in the sub-script of the run ID indicate the concentration of each metals salt. For
example, MD-WW0 represents the run with no metal salts, while MD-WW10 indicates that the
concentration of each salt during this experiment was 10 mg/L.

Composition of AMD-impacted water is diverse and is commonly characterized by high
concentrations of iron (II) as well as other trace elements such as calcium and lithium [1, 4, 5].
The MD performance was assessed for the removal of metal ions at different concentration to
check process stability. According to the results presented in Table 7.4, removal of all metal
ions was greater than 99% during all experiments. Since the water moves across the membrane
in vapor form, MD can provide effective removal of non-volatile metal ions [15, 19]. However,
high concentrations of metal ions can cause severe scaling, affecting membrane permeability
[36] as discussed in Section 7.4.4.

7.4.3. Performance of an integrated MD system
7.4.3.1. Degradation of TrOCs in batch tests
To choose an oxidation process to be integrated with MD, performance and stability of both
laccase and PS was assessed in batch experiments. The batch reactors (250 mL) containing the
wastewater prepared by adding the mixture of TrOCs and iron salt in MBR permeate were
incubated for a period of 24 h at 20 and 40 °C in separate runs. Oxidation of TrOCs by laccase
is principally controlled by two factors: (i) the nature of functional groups attached to the core
part of the molecule; and (ii) relative redox potential of laccase and TrOCs. Laccase can
efficiently degrade phenolic compound, but the oxidation of non-phenolic compounds may be
restricted by kinetic limitations [37, 38]. In this experiment, all the tested TrOCs except
triclosan, pentachlorophenol and acetaminophen were non-phenolic, and their degradation by
laccase ranged from 6 to 75% at 20°C, and 6 to 90% at 40°C (Figure 7.5). Out the 12 tested
TrOCs, degradation of one non-phenolic compound (bezafibrate) and two phenolic TrOCs
(triclosan, and acetaminophen) was above 75% and 90%, respectively. When the temperature
of the bioreactor was increased from 20 to 40°C to assess laccase performance at the operating
temperature of MD feed, degradation of three trimethoprim, diclofenac, triclosan,
pentachlorophenol and acetaminophen improved significantly by 10-25%. This is because the
increase in temperature can increase the rate of TrOC oxidation [39].
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Figure 7.5. Performance of laccase and persulfate (PS) for degradation of the selected TrOCs
in batch experiments. The performance of both laccase (95-100 µM/min) and PS (1 mM) was
assessed for an incubation period of 24 h in presence of iron salt (10 mg/L) at 20 and 40 °C.
Mean removal efficiency and standard deviation (n=2) are presented.
PS is stable at room temperature, but can be activated by various agents such as transition
metals (e.g., iron), heat, and ultraviolet (UV) light to form one or more sulphate radicals (SO4–
•
), which are highly reactive [30]. PS activation by heat and UV light produce two SO4– •
radicals (Equation 10), while only one SO4– • radical is generated following activation by
transition metals such as Fe2+ (Equation 11). This indicates that activation by heat or UV light
may provide more efficient treatment compared to activation by a transition metal [30, 40].
𝑆2 𝑂8 2− + ℎ𝑒𝑎𝑡 𝑜𝑟 𝑈𝑉 𝑙𝑖𝑔ℎ𝑡 → 2 𝑆𝑂4 2−.

Eq. (10)

𝑆2 𝑂8 2− + 𝐹𝑒 +2 → 𝐹𝑒 +3 + 𝑆𝑂4 2−.

Eq. (11)

In this experiment, ability of PS for TrOC degradation studied at 20 and 40°C to show that both
heat and iron (II) can activate PS. Previously, a combined peroxymonosulfate (50 µM) – Fe2+
(50 µM) process achieved above 99% degradation of atrazine, outperforming atrazine removal
by coagulation [41]. Heat-activated PS has been also reported to achieve 40-100% removal of
a few investigated TrOCs such as atrazine, aniline, monochlorobenzene and
2,4-dichlorophenol [30]. In the current experiment, degradation of 10-85% was achieved by
Fe-activated PS at 20°C (Figure 7.5), and the degradation of nine out of 12 TrOCs was less
than 50%. This indicates that iron can cause activation because PS is stable at room temperature
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of 20°C [30]. Notably, at 40°C, the spectrum of significantly degraded TrOC broadened as the
degradation of 10 out of the 12 tested TrOCs was above 60% (Figure 7.5). Compared to
laccase, performance of activated-PS was superior for eight TrOCs, while the degradation of
three TrOCs (acetaminophen, diclofenac and bezafibrate) by both laccase and activated-PS was
comparable. Notably, degradation of a phenolic PPCP triclosan by laccase was almost 20-30%
higher than activated-PS (Figure 7.5).
Increasing the temperature from 20 to 40°C caused laccase inhibition. The initial laccase
activity reduced by less than 5% at 20°C, while a reduction of 45% in laccase activity was
observed at 40°C. On the other hand, depletion of PS was 2% at 20°C and 12% at 40°C. Thus,
PS-assisted oxidation process was selected for integration with MD.
7.4.3.2. Degradation of TrOCs by PS-assisted MD system
In a stand-alone MD, TrOCs accumulate within the feed following their retention by the MD
membrane. Over time, this may affect TrOC retention. This also requires additional intensive
treatment of MD-concentrate that needs to be periodically purged from the system. Thus,
intermittent PS dosing was investigated for TrOC degradation to reduce their accumulation in
feed (with and without metal salts) during MD operation.
Following the absorption of heat, breaking of the peroxide bond (O–O) that bridges the sulphur
atoms in persulfate occurs, resulting in the formation of two SO4–

•

radicals as shown in

Equation 10 [30]. Depending on wastewater characteristics, persulfate or SO4–• radicals may
react with water and/or organics to form secondary radicals that can also contribute to
degradation of organic impurities [30, 42]. SO4–• radicals can react with water to form hydroxyl
(OH–•) radicals, but the abundance of the SO4–• and OH–• radicals is governed by the pH of
reaction media (Equation 12 and 13). Under acidic conditions (pH<7), SO4–• radicals are the
dominant species, while OH–• is the primary reactive species under basic conditions (pH>7).
At neutral pH, both SO4–• and OH–• radicals contribute equally to pollutant degradation [43].
Since the pH of the secondary treated effluent in this experiment ranged between 6.9 and 7.2,
both SO4–• and OH–• radicals were responsible for the degradation of TrOCs.
𝑆𝑂4 2−. + 𝐻2 𝑂 → 𝑆𝑂4 2− + 𝑂𝐻 . + 𝐻 +
𝑆𝑂4 2−. + 𝑂𝐻 − → 𝑆𝑂4 2− + 𝑂𝐻 .

(𝑝𝐻 < 7)
(𝑝𝐻 > 7)

Eq. (12)
Eq. (13)

A mass balance (Equation 9) reveals that heat-activated PS achieved 25-100% degradation of
the TrOCs (Figure 7.6) and above 99% overall removal (i.e., degradation+membrane
retention). During treatment without the addition of metal salts (MD-WW0), degradation of
TrOCs can be divided into three categories: (i) 90-100% degradation of four PPCPs, namely
amitriptyline, trimethoprim, bezafibrate and acetaminophen; (ii) 60-90% degradation of three
pesticides (atrazine, linuron and pentachlorophenol) and four PPCPs (carbamazepine, triclosan,
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sulfamethoxazole and primidone); and (iii) less than 25% degradation of the pharmaceutical
compound diclofenac (Figure 7.6). Similar to biodegradation [37, 38, 44], degradation of
TrOCs by the heat-activated PS appears to be governed by their chemical structure (e.g.,
presence of EWGs and/or EDGs). For instance, TrOCs such as amitriptyline, trimethoprim and
bezafibrate that contain amine (– NH2), alkyl (–R) or acyl (– COR) EDGs were readily
degraded (Figure 7.6). This is because sulphate radicals are electrophilic and can achieve faster
degradation of pollutants containing strong EDGs [45]. However, even some of the compounds
with strong EWGs underwent significant degradation. Of particular interest was the
significantly higher PS-mediated degradation of pesticides, particularly atrazine and linuron,
compared to biodegradation by conventional activated sludge and fungal enzymes [37, 38, 44].
Literature on the degradation of TrOCs by heat-activated PS is scarce, and to date has been
generally focused on PS activation routes in the presence of a single TrOCs. For instance, Deng
et al. [46] reported only 12% degradation of carbamazepine following 2 h treatment with heatactivated-PS at a PS concentration and operating temperature of 1 mM and 40ºC, respectively.
In a study by Ji et al. [47], PS (1 mM) activated by heat at 40ºC achieved 20% atrazine
degradation after an incubation time of 120 h. Ji et al. [48] observed complete degradation of
the antibiotic sulfamethoxazole within 8 h at 50ºC. These previous experiments were done in
batch mode. Instead of a single TrOCs, this chapter presents the performance of activated PS
for the degradation of a dozen of TrOCs in their mixture for the first time. Furthermore, this is
the first set of data from a reactor operated in continuous-feeding mode. Although a direct
comparison with previous data [46, 47] is not recommended due to the differences in
experimental setup, higher degradation efficiencies observed in the current experiment are
worth noting.
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Figure 7.6. Degradation of the selected TrOCs by PS (1 mM)-assisted MD system during the
treatment of wastewater with (MD-WW10) and without (MD-WW0) the addition metal salts.
Data is presented as average ± standard deviation (n=4 for MD-WW10 and n=10 for MD-WW0).
Operating conditions are presented in the caption of Figure 7.3.
Notably, when metals salts each at 10 mg/L were added in MBR-permeate (MD-WW10), the
extent of degradation of the selected TrOC was comparable to that achieved in absence of metal
salts. Importantly, degradation of a nonsteroidal anti-inflammatory drug diclofenac was
increased from 25 to 52% (Figure 7.6). Compared to an integrated activated sludge-MD
system, degradation of a few TrOCs in the PS-assisted MD system was more efficient. For
instance, Wijekoon [49] reported less than 30% removal for diclofenac, atrazine and
carbamazepine in an activated sludge-MD system. In the current experiment, PS-assisted MD
system achieved 55-64% degradation of carbamazepine, and 76-85% degradation of atrazine
(Figure 7.6). Future studies are recommended to systematically compare biodegradation vs.
advanced oxidation-assisted MD process. However, that is beyond the scope of this chapter.
The concentration of the PS added to the MD reactor was monitored to determine if recurrent
dosing of PS was required. Only a few studies have investigated the depletion of sulphate
radicals during TrOC degradation [42, 50-52]. The radicals (e.g., SO4–

•

and OH•) formed

following PS activation by heat and/or iron (II) not only can react with the target pollutants but
can also react with other radicals and non-target pollutants. The scavenging reactions (i.e.,
radical-radical and radical-nontarget) produce secondary radicals that can take part in the
degradation process. However, scavenging reactions deplete PS by converting the SO4–
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•

radicals into sulphate ions [42, 45]. Depletion of PS necessitates its intermittent dosing to
maintain the performance of the oxidation process. In this experiment, the concentration of
persulfate was observed to be reduced by 50-70% over a period of 2×HRT. Thus, intermittent
dosing of PS after every 2×HRT was applied to reinstate PS concentration to 1 mM and
maintain PS-mediated degradation. Although the addition of PS would increase the operating
cost of the treatment system, it is compensated generously by: (i) achieving improved TrOC
removal in MD; (ii) reducing the accumulation of organic impurities in the feed of MD (See
Section 7.4.3.3); and (iii) significantly mitigating membrane fouling (See section 7.4.4).
7.4.3.3. TOC and TN degradation by PS-assisted MD system
Overall removal of bulk organics was monitored via TOC and TN concentration in the PSassisted MD feed and permeate (distillate). Removal of TOC, TN and metal ions by the PSassisted MD was consistently above 99% as shown in Table 7.5, thus ensuring high quality
treated effluent. However, effective retention of TOC and TN during continuous feeding also
means their accumulation in MD feed tank (i.e., MD reactor), which may cause severe
membrane fouling [27].
Table 7.5. Removal of pollutants during the treatment of wastewater by the PS-assisted MD
system
Parameters

MD-WW0
Degradation
Overall
(%)
removal (%)
TOC
66±4
99±0.5
TN
39±2
99±1
Iron (II)
–
100±0
Magnesium
–
100±0
Calcium
–
99±1
Lithium
–
99±2
n=5 for TOC and TN, and n=4 for metal ions.

MD-WW10
Overall removal
Degradation (%)
(%)
71±7
99±0.5
51±3
99±0.5
–
99±1
–
100±0
–
100±0
–
99±1

Persulfate and SO4–• radicals can directly react with organic impurities (e.g., humic substances)
to either degrade them or form organic radicals. The complex combination of SO4–• chain
propagation and termination reactions govern the overall degradation of organic impurities [30,
53, 54]. In a previous study, dissolved organic carbon removal by UV-activated PS (0.6 mM)
was reported to be 80% after an irradiation time of 3 h [55]. Depending on the dose of PS,
Deng and Ezyske [56] achieved chemical oxygen demand and ammonia-nitrogen removal of
up to 95 and 80%, respectively, from landfill leachate. Consistent with previous studies, this
chapter shows significant TOC and TN removal by activated-PS.
Following effective retention by MD membrane in this chapter, up to 66-71% and 39-51%
degradation of TN and TOC, respectively, was achieved by the PS-assisted MD with and
without the presence of metal salts (Table 7.5). This significantly reduced the accumulation of
these impurities in the MD reactor. The advantages of combining PS oxidation with the MD
process is demonstrated for the first time in this chapter. Particularly, operating the MD system
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in a continuous flow (i.e., continuous feeding) mode helped demonstrate the effectiveness of
PS in significantly reducing the accumulation of organics within the reactor.

7.4.4. Hydraulic performance of the stand-alone and PS-assisted MD
Permeate flux of the stand-alone MD system during treatment of different wastewater
compositions was monitored continuously throughout their operation in continuous-flow mode
(Figure 7.7). Permeate flux of the stand-alone MD reduced during all experiments and was
dependent on the composition of the wastewater. During the control run (Milli-Q water, 5 µg/L
TrOCs and 100 mg/L metal salts), the permeate flux reduced gradually at a rate of 1.5 L/m2.h/d,
dropping to 55% of the initial flux within 5 days (i.e., 6×HRT) of operation. On the hand,
addition of metal salts each at 100 mg/L and TrOCs each at 5 µg/L in MBR-permeate (i.e.,
MD-WW100) significantly affected the permeability of the MD membrane by reducing the
permeate flux by 76% of the initial flux (Figure 7.7). Based on the comparison of the permeate
flux achieved by the MD membrane for different wastewater compositions, it can be concluded
that the presence of metal salts affected the membrane permeability during treatment in
presence of metal salts as compared to that in absence of metal salts. For instance, reduction in
permeate flux was only 20% during treatment of MD-permeate without metal salts, while metal
salts at 100 mg/L concentrations reduced permeate flux by 76%, respectively (Figure 7.7).
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MD-WW10

MD-WW100

PS-MD-WW0

PS-MD-WW10

16

2

Permeate flux (L/m .h)

14
12
10
8
6
4
2
0
0

1

2
3
Time (d)

4

5

Figure 7.7. Variations in the permeate flux of the stand-alone and PS-assisted MD systems as
a function of time. TrOC retention by MD during each experiment was TrOC-specific and
ranged from 85 to 98% and 95 to 99% for standalone MD and integrated MD systems,
respectively. Operating conditions are given in the caption of Figure 7.3.
Reduction in permeate flux during the stand-alone MD operation can be attributed to scaling
and membrane fouling. A fouling layer formed on the membrane surface can significantly
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affect permeate flux by reducing the active area of membrane surface for effective mass transfer
[27, 57]. The comparatively lower flux reduction for the PS-assisted MD system can be
attributed to the degradation of TOC (up to 70%, Table 7.5) achieved by activated PS, which
reduced TOC accumulation in the feed of the PS-assisted MD system.
To derive deeper insights into the fouling phenomenon, the fouling layer formed on the
membrane surface was characterized by SEM-EDS. As shown in Figure 7.8, during the
standalone MD operation for the treatment without metal salts, a dense fouling layer formed
on the membrane that almost uniformly covered the surface. On the other hand, during the PSassisted MD operation without salt addition, the fouling layer on the membrane was distributed
unevenly and covered a significantly smaller surface area (Figure 7.8).

Figure 7.8. SEM images and EDS spectra of pristine MD membrane (a) and fouled membrane
collected at the end of experiment with the stand-alone MD (b) and PS-assisted MD (c)
systems. The membranes were used for the treatment of wastewater without the addition of
metal salts.
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The EDS spectra revealed that the fouling layers were mainly composed of carbon, oxygen,
iron and calcium. However, the comparison of EDS spectra suggests that the abundance of
carbon and oxygen (main constituents of organic impurities) was significantly higher (almost
double) in the fouling layer of the membrane collected from the standalone MD system. A
similar composition of fouling layer was reported when a standalone MD was operated for the
treatment of anaerobic-MBR permeate [27]. Song et al. [27] additionally observed the
deposition of phosphorous on the MD membrane. However, in this experiment, phosphorous
was not detected in the membrane fouling layer. This can be due to the low concentration (i.e.,
3.4 – 6.1 mg PO43--P/L) of phosphorous in wastewater used in the current experiment as
compared to that reported for anaerobically treated effluent in the study by Song et al. [27],
i.e., approximately 200 mg PO43--P/L.
MD membrane flux reduction can be also caused by accumulation of salts leading to
concentration polarization and membrane scaling [17]. However, in this experiment, at the end
of the operation, the conductivity of the feed increased from 200 to 2050 µS/cm in case of the
standalone MD system in absence of additional metal salts, which is comparable to the increase
observed for the PS-assisted MD system (i.e., from 190 to 2940 µS/cm), and did not affect
permeate flux during MD-WW0 and PS-MD-WW0 run. However, when metal salts were added
at different concentrations, the composition of fouling layer completely changed (Figure 7.9).
The EDS spectra revealed that the fouling layers were mainly composed of carbon, oxygen,
iron and calcium, but the percentage of iron is significantly higher than other components of
the fouling layer. It is evident that under the operating conditions of this experiment, salt
accumulation affected the permeate flux when additional metal salts were added to the MD
feed. Notably, membrane pore wetting phenomenon did not occur for any of the membranes,
which is evident from the effective conductivity removal (above 99%) by MD membrane in all
experiments.
It is noteworthy that the fouling layer on the membrane could potentially influence the degree
of removal of dissolved constituents including TrOCs. For example, for nanofiltration,
membrane fouling may cause different changes in hydrophobicity, surface charge, and
effective pore size of the membrane, which may lead to reduced rejection depending on the
membrane evaluated and the charge of the compound [58]. Also, in the presence of a fouling
layer, polymeric forward osmosis membranes may swell due to elevated electroneutrality,
reducing rejection of hydrophilic non-ionic TrOCs [59]. However, results shows that despite
significant fouling, removal of TrOCs, TOC, TN and metal ions by the MD membrane was
stable throughout the operation period (Figure7.3 and Table 7.4 and 7.5).
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Figure 7.9. SEM images and EDS spectra of the MD membrane. (a) PS-assisted MD
membrane at the end of MD-WW10 run; (b) MD membrane at the end of MD-WW10 run (c)
MD membrane at the end of MD-WW100 run; and (d) MD membrane at the end of control run.

7.4.5. Toxicity of treated effluent
The bioluminescent bacteria Photobacterium leiognathi was used to monitor effluent toxicity.
Our analysis indicates that the reactor media toxicity for both the stand-alone and PS-assisted
MD slightly increased at the end of their operation (Table 7.6), and that the toxicity of the PSassisted MD reactor media in absence of metal salts (6.3-6.5 rTU, n=2) was higher than that of
the stand-alone MD (3.4-3.9 rTU, n=2). This suggests that PS itself and/or the transformation
products originating from PS-mediated degradation of the organics present in the feed (i.e.,
effluent organic matter and spiked TrOCs) was slightly more toxic than the feed. Whatever
those compounds (whether PS, or intermediate TrOC transformation products) were, they did
not pass into the permeate, and the MD permeate (i.e., the final effluent) was not toxic to
bacteria (below the assay limit of detection, <1 rTU) (Table 7.6).
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Table 7.6. Toxicity, expressed as relative toxic unit (rTU), of different samples. The limit of
detection of the toxicity assay was 1 rTU. Number of samples, n = 2.
Sample description

Toxicity (rTU)

MD feed (i.e., Secondary treated effluent + TrOCs)

<1 – 2.4

Reactor media of the stand-alone MD system

3.4 – 3.9

Reactor media of the PS-assisted MD system

6.3 – 6.5

MD permeate

<1

7.5. Conclusions
This chapter aims to elucidate the performance of a direct-contact MD process for simultaneous
removal of metals and TrOCs from sewage- and AMD-impacted water. The results in this
chapter indicate that the stand-alone MD can achieve effective retention of both TrOCs (80100%) and metal ions (>99%). Notably, addition of metal salts did not affect the removal of
TrOCs and metal ions but caused significant fouling due to the accumulation of organic and
inorganic impurities in the MD reactor. To reduce the accumulation of bulk organics and
TrOCs, performance of laccase and persulfate (PS) was assessed. Based on the results of this
chapter, PS exhibited better TrOC removal and stability in batch experiments as compared to
laccase. Thus, PS-assisted oxidation process was selected for integration with MD. Depending
on the molecular structure and hydrophobicity of the TrOCs, PS dosing at a concentration of 1
mM achieved 25 to >99% TrOC degradation with and without the addition of metal salts. This
led to the consistent removal of above 99% for all the TrOCs from the MD permeate (i.e., final
effluent), without the production of toxic transformation products in the MD permeate.
Activated PS degraded other organic impurities, along with TrOCs present in MD feed.
Accordingly, during continuous operation of the PS-assisted MD system, organics
accumulation in the reactor media was significantly reduced. This in turn helped minimize
membrane fouling to some extent. However, when metal salts were added, performance of MD
membrane was still affected due to the formation of scaling layer.
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Chapter 8: Conclusions and recommendations for
future work
8.1. Conclusions
This thesis systematically investigates the performance of a novel high retention (HR) –
enzymatic membrane bioreactor (EMBR) for effective degradation of a broad spectrum of trace
organic contaminants (TrOCs) ubiquitously detected either in sewage-impacted water or in
wastewater treatment plant effluent. In nutshell, two different configurations of HR-EMBRs
viz nanofiltration (NF)-EMBR and membrane distillation (MD)-EMBR are developed and
explored for the first time. The impacts of (i) laccase source; and (ii) redox-mediator (low
molecular weight chemicals added to improve laccase-catalyzed degradation) type and
concentration on membrane retention, TrOC degradation and effluent ecotoxicity are
systematically analyzed and elucidated. In addition to redox-mediator dosing, a combined
laccase/persulfate (PS)-assisted oxidation process is envisaged, and its efficacy for TrOC
degradation as well as estrogenicity and ecotoxicity reduction is assessed for understanding the
stability of the developed process. Simultaneous removal of both TrOCs and the metal ions by
a high retention MD process is comprehensively studied by assessing the effects of organic and
inorganic impurities on membrane retention and fouling.
In Chapter 3, integration of an enzymatic bioreactor (3 L) with a high retention NF membrane
(0.2 kDa), which will retain both laccase and TrOCs, and a conventional UF membrane (30
kDa), which will only retain laccase but not TrOCs, was investigated to assess the fate of a
diverse set of 29 TrOCs. The operation of both EMBRs under full recirculation mode
confirmed effective retention (95% for UF membrane and 100% for NF membrane) of a
commercially available laccase from genetically modified Aspergillus oryzae. However,
during the operation of EMBRs, laccase activity may diminish due to various physical,
chemical and biological inhibitors such as shear stress caused by membrane filtration. The
laccase activity was maintained by re-injecting a small dose of laccase (250 µL per litre of
bioreactor media). The continuous-flow NF-EMBR was observed to produce high quality
effluent due to effective TrOC retention (90-99%). NF-EMBR achieved TrOC-specific
improvement in the extent of degradation (up to 65%) as compared to that achieved by UFEMBR. It is noteworthy that membrane retention and laccase-catalyzed degradation were the
removal mechanism, and their contribution was dependent on TrOC properties. For instance,
laccase-catalyzed degradation was the main mechanism of removal for TrOCs containing
strong electron donating functional groups (EDGs), while TrOCs containing strong electron
withdrawing functional groups (EWGs) were mainly removed via membrane retention
mechanism. Although degradation is the only expected mechanism of removal in UF-EMBR,
anionic and hydrophobic (log D>3) TrOCs were partially retained by the UF membrane via
charge repulsion by UF membrane and adsorption on the enzyme gel-layer visible to the naked
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eye. Change in membrane properties due to laccase adsorption along with concentration
polarization reduced the permeate flux of the UF and NF membrane, but the flux can be
recovered effectively by cleaning the membrane with water.
In Chapter 4, MD, which is another format of the high retention membrane separation process
with a completely different working principle as compared to the pressure-driven NF, was
integrated with an enzymatic bioreactor. Degradation of TrOCs by two commercially laccases
from: (i) genetically modified Aspergillus oryzae; and (ii) Trametes versicolor was examined
and elucidated. The MD system ensured complete retention (>99%) of both laccases and
selected TrOCs. Laccase from T. versicolor and A. oryzae achieved 40-80% and 45-99% TrOC
degradation, respectively. Laccase from A. oryzae demonstrated better overall performance
possibly due to its higher redox-potential (up to 15%). Notably, during MD-EMBR operation,
degradation of TrOCs was achieved within first 9 h regardless of laccase type. Cease of TrOC
oxidation at the later end was apparently due to laccase inactivation. Hydraulic performance of
MD-EMBR monitored by recording the permeate flux was stable during all experiments.
Importantly, like NF-EMBR, the complete retention of the TrOCs resulted in improved TrOC
degradation by both laccases as compared to previously developed UF-EMBRs. In addition to
the prolonged contact time ensured by the MD process, TrOCs containing phenolic moiety
such as oxybenzone and bisphenol A can improve laccase-catalyzed degradation by acting as
redox-mediators. The secondary radicals or coupling agents, which are formed following the
oxidation of phenolic TrOCs, are highly reactive and could directly oxidize or polymerize other
TrOCs.
Chapter 5 elucidates the factors governing the performance of redox-mediators following their
addition in the enzymatic bioreactor of MD-EMBR. Two N=OH type redox-mediators, namely
1-hydroxybenzotriazole (HBT) and violuric acid (VA), and one phenolic redox-mediator,
namely syringaldehyde (SA), were assessed at different concentrations. The selected redoxmediators can improve TrOC degradation by following a hydrogen atom transfer pathway.
Degradation of phenolic compounds and non-phenolic compounds by the MD-EMBR was
improved by 20–30% and 10–50%, respectively, following the addition of redox-mediators.
Improved TrOC degradation after the addition of redox-mediators is possibly due to the
generation of aminoxyl and phenoxyl radicals that have significantly higher redox-potential
than that of laccase only. Since SA and VA showed different patterns of TrOC-specific
degradation-improvement during MD-EMBR, it was envisaged that a mediator-mixture would
have further beneficial effects. Instead of inducing a synergistic effect, degradation of at least
six pharmaceutically active TrOCs reduced in presence of SA-VA mixture. This is because, in
mixtures, some mediators can: (i) chemically interact with each other instead of acting as an
electron shuttle for laccase; and/or (ii) reversibly inhibit laccase, thereby inhibiting electron
transfer between laccase and TrOCs. Indeed, laccase activity reduced by up to 80% in laccasemediator system, indicating frequent replenishment of laccase. Mediator addition increased the
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toxicity of the reaction media, but MD permeate remained non-toxic. This is an added
advantage of coupling an enzymatic bioreactor with a high retention MD membrane.
Chapter 6 details the performance of an integrated laccase- and persulfate (PS)- assisted
oxidation process for the first time. To date, only redox-mediators have been assessed to
improve the extent of laccase-catalyzed degradation. However, they achieve TrOC degradation
at the expense of laccase activity and could increase the toxicity of the treated effluent. Thus,
PS-assisted oxidation process was studied as an alternative to the redox-mediators. A series of
batch tests were performed at different PS concentrations ranging from 1 to 10 mM to
investigate the impact of PS concentration and incubation time on TrOC degradation. Among
the tested PS concentrations (1-10 mM), the best performance was achieved at 5 mM
concentration. PS at 5 mM achieved 100% degradation for two phenolics (bisphenol A and
oxybenzone) and 25-53% degradation for three non-phenolic (diclofenac, sulfamethoxazole,
and carbamazepine) TrOCs. A continuous treatment system developed by integrating a
nanofiltration (NF) membrane with laccase/PS process was hydraulically stable and achieved
steady-state degradation within 24 h for all TrOCs. Importantly, degradation of non-phenolics
further improved by 10 to 65% in laccase/PS-NFBR system as compared to laccase only. This
could be attributed to the prolonged contact time between laccase/PS and TrOCs; as well as
the contribution of oxidative coupling agents in degradation. The NF membrane not only
retained the moderately degraded carbamazepine and sulfamethoxazole effectively but was
also effective for the removal of the toxic transformation by-products and residual estrogenic
activity as evaluated by ecotoxicity and estrogenicity assays, respectively.
Chapter 7 reports the performance of a direct-contact MD process for simultaneous removal
of metal ions and TrOCs from sewage- and AMD-impacted water for a period of 6×HRT (i.e.,
5 d). For this purpose, different compositions of wastewater was prepared by adding a mixture
of structurally diverse TrOCs as well as a mixture of four metal ions (iron, calcium, magnesium
and lithium each at 10 and 100 mg/L concentration). The stand-alone MD process achieved
80-100% and >99% removal (via membrane retention) for the selected TrOCs and the metals,
respectively. Based on the performance achieved by the MD membrane, addition of salts did
not affect the extent of pollutant removal. Effective retention of bulk organics, TrOCs and
metal ions during continuous feeding also means their accumulation in MD feed tank (i.e., MD
reactor). This caused severe membrane fouling as evident from flux reduction. Accumulation
of bulk organics could be reduced by combining a laccase or activated-PS oxidation process
with the MD system. The integration of PS-assisted oxidation process reduced the
accumulation of bulk organics and TrOCs, but a gradual decline in permeate flux was still
observed due to membrane scaling mainly caused by iron. Nevertheless, the MD membrane
effectively retained all impurities, and consistently produced a high-quality effluent during all
experiments.
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Two different configurations of HR-EMBR are assessed for enhanced degradation of TrOCs
in this thesis. Both NF- and MD-EMBRs achieved TrOC-specific improvement in degradation
by laccase, but it is not appropriate to compare their performances due to difference in their
working principles (temperature gradient-driven vs. pressure-driven) and operating conditions
such as temperature and operating mode (concentration mode in MD and continuous-flow
mode in NF). Both EMBR configurations have its own pros and cons. For instance, MD-EMBR
achieved better extent of TrOC degradation, while laccase showed significantly better stability
in NF-EMBR.

8.2. Recommendations for future research
This thesis provides an in-depth understanding of the TrOC removal in HR-EMBRs by
elucidating the performance of laccase-catalyzed degradation, role of membrane removal
mechanism, synergistic impacts of the combined laccase/mediators- and laccase/PS systems.
However, few new research questions emerged during the course of this research and are worth
exploring in future.
In this study, two different configurations of HR-EMBR, namely NF-EMBR and MD-EMBR
are examined for improved degradation of TrOCs. Forward osmosis (FO) is another format of
high retention membrane separation process and is recommended to be integrated with an
enzymatic bioreactor. During the development and assessment of FO-EMBR performance,
preliminary focus could be on the selection of a suitable draw solute that will not inhibit
laccase. In addition, FO permeate is saline, and the selection of an appropriate process for the
treatment saline product water will be critical.
TrOCs containing phenolic moiety can improve laccase-catalyzed degradation by acting as
redox-mediators. The secondary radicals or coupling agents, which are formed following the
oxidation of phenolic TrOCs, are highly reactive and could directly oxidize or polymerize other
TrOCs. To date, only two TrOCs, namely bisphenol A and acetaminophen were demonstrated
to act as redox-mediators. More phenolic TrOCs with the ability to facilitate degradation are
required to be identified and examined in future studies.
Since intermittent replenishment is required to maintain enzymatic activity, use of crude
enzymes can reduce the cost of the treatment system if renewable waste products such as
agricultural residues are used for fungal growth. Because crude enzyme extract may contain a
cocktail of enzymes and natural redox-mediators, their use can enhance the spectrum of
significantly degradable TrOCs. The presence of unspent growth media in enzyme solution can
increase organic loading in enzymatic treatment systems. Simple and robust enzyme
purification processes should be developed in future studies.
For full-scale applications of HR-EMBRs for real wastewater treatment, laccase stability needs
to be improved. One approach could be to use stabilizers. For instance, polyvinyl alcohol,
polyethylene glycol (PEG), polythene and polysaccharide (e.g., Ficoll) were able to improve
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the stability of laccase during the treatment of bisphenol A. However, effluent toxicity may
increase in the presence of PEG. Another option is to use encapsulation or carrier materials to
improve laccase stability. In this regard, inert carrier materials may be preferred to avoid
adsorption of denaturants. Efficacy of stabilizers and carriers needs to be assessed
systematically in future studies in HR-EMBR.
Fungal species secrete different organic compounds (e.g., oxalates) that can protect them from
metal-induced toxicity, their presence in the crude enzyme preparation may enhance the
stability of ligninolytic enzymes. However, there is a dearth of information regarding this.
Toxicity of the reaction media, particularly following the addition of redox-mediators increase
significantly, indicating that transformation by-products are more toxic than the parent
compound. It is recommended to identify and elucidate the formation of transformation byproducts during laccase only and/or laccase/mediator treatment process. This will explain the
quantitative and qualitative difference between the transformation by-products formed in
laccase-catalyzed degradation process and laccase/mediator process.
Combining laccase with a PS-assisted oxidation was observed to improve TrOC degradation
without significantly inactivating laccase. Combination of other advanced oxidation processes
such as photolysis and ozonation should be explored in future studies.
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Table 3-1. Physicochemical properties of the selected trace organic contaminants (TrOCs)

Compound
Category

(Formula)
(CAS number)

Limit of
detection
(ng/L)b

Molecular
weight
(g/mol)

Log KOW

206.28

3.50 ± 0.23

20

230.26

2.88 ± 0.24

1

254.28

2.91 ± 0.33

20

296.15

4.55 ± 0.57

5

218.25

0.83 ± 0.50

10

236.27

1.89 ± 0.59

10

138.12

2.01 ± 0.25

1

171.15

-0.14 ± 0.30

20

a

Ibuprofen
(C13H18O2)
(5687-27-1)
Naproxen
(C14H14O3)
(22204-53-1)
Ketoprofen
(C16H14O3)
(22071-15-4)

Diclofenac

Pharmaceuticals

(C14H11Cl2NO2)
(15307-86-5)

Primidone
(C12H14N2O2)
(125-33-7)

Carbamazepine
(C15H12N2O)
(298-46-4)
Salicylic acid
(C7H6O3)
(69-72-7)
Metronidazole
(C6H9N3O3)
(443-48-1)
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Chemical structure

Gemfibrozil
(C15H22O3)

250.33

4.30 ± 0.32

1

277.40

4.40±0.26

1

289.54

5.34 ± 0.79

1

182.22

3.21 ± 0.29

5

228.24

3.99±0.36

5

361.48

6.89±0.33

10

269.51

3.45 ± 0.37

20

266.34

5.12 ± 0.36

1

(25812-30-0)

Amitriptyline
C20 H23 N
(50-48-6)

Triclosan
(C12H7Cl3O2)
(3380-34-5)

Benzophenone

Personal care products

C13 H10O
(119-61-9)

Oxybenzone
C14 H12 O3
(131-57-7)

Octocrylene
C24 H27 N O2
(6197-30-4)

Fenoprop
(C9H7Cl3O3)

Pesticides

(93-72-1)

Pentachlorophenol
(C6HCl5O)
(87-86-5)
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Atrazine
(C8H14ClN5)

215.68

2.636±0.205

10

209.24

1.538±0.229

1

2.967± 0.12

10

214.65

2.425±0.273

1

191.27

2.42 ± 0.23

1

150.22

3.39 ± 0.21

1

206.32

5.18 ± 0.20

1

228.29

3.64 ± 0.23

1

(1912-24-9)

Propoxur
(C11H15NO3)
(114-26-1)

Ametryn
(C9H17N5S)

227.33

(843-12-8)

Clofibric acid
(C10H11ClO3)
(882-09-7)

DEET
(C12H17NO)
(134-62-3)

4-tert-butylphenol
(C10H14O)

Industrial chemicals

(98-54-4)
4-tert-octylphenol
(C14H22O)
(140-66-9)
Bisphenol A
(C15H16O2)
(80-05-7)
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Estrone
(C18H22O2)

270.37

3.62 ± 0.37

5

272.38

4.15 ± 0.26

5

314.42

5.11 ± 0.28

5

269.40

4.10 ± 0.31

10

288.38

2.53 ± 0.28

10

298.33

1.89± 0.37

10

(53-16-7)

17β-estradiol
(C18H24O2)

Steroid hormones

(50-28-2)

17β-estradiol 17–
acetate
(C20H26O3)
(1743-60-8)

17α - ethinylestradiol
(C20H24O2)
(57-63-6)

Estriol (E3)
(C18H24O3)

Phytoestrogens

(50-27-1)

Enterolactone
C18 H18 O4
(78473-71-9)

a

Source: SciFinder database https://scifinder.cas.org/scifinder/view/scifinder/scifinderExplore.jsf
Log D is logarithm of the distribution coefficient which is the ratio of the sum of concentrations of all forms of
the compound (ionised and unionised) in octanol and water at a given pH.
b

Limit of detection (LOD) of the compounds during GC-MS analysis as described in Section 2.5.2. LOD is
defined as the concentration of an analyte giving a signal to noise (S/N) ratio greater than 3. The limit of
reporting was determined using an S/N ration of greater than 10.
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Figure 3-1. Lab-scale enzymatic membrane bioreactor
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Figure 3-3. Laccase activity profiles in UF-EMBR (a) and NF-EMBR (b). Laccase activity was
maintained by re-injecting a small dose of laccase (250 µL per litre of bioreactor volume) every 24 h.
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Figure 3-4. Enzyme-gel layer formed on the active side of the UF and NF membrane during
the operation of UF- and NF-EMBRs.

Figure 3-5. Rejection of TrOCs by the UF and NF membrane during the operation of EMBRs
in full recirculation mode. Error bars show average± standard deviation (n=8).
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Figure 3-6. Confirmation of effective laccase retention by the NF and UF membrane. Laccase
retention of >99% and 95% was achieved by the NF and UF membrane respectively. UF/NF-EMBR
were operated for a period of 24 h in full recirculation mode without the addition of TrOCs.
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Figure 3-7. Removal of TrOC by the NF membrane to confirm their effective retention. NF-EMBR
were operated for a period of 32 h in continuous mode without the addition of laccase. The UF-EMBR
was not operated because the UF membrane was not expected to retain TrOCs. Data presented as
average ± standard deviation (n=2).
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Figure 3-8. Impact of VA concentration on the oxidation reduction potential of media in NF-EMBR

T. Versicolor
Novozym+HBT

Novozym
T. Versicolor+HBT
T. Versicolor+VA
Novozym+VA

110
100

Enzymatic Activity (M(DMP)/min)

90
80
70
60
50
40
30
20
10
0
0

3

6

9

12

Time (h)
Figure 4-1. Enzymatic Activity profiles with and without the addition of redox mediator(s) in
enzymatic membrane distillation system. Two N–OH type redox mediators namely, 1hydrozybenzotriazole (HBT) and violuric acid (VA), were added separately at 1mM concentration.
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Figure 4-2. Variations in permeate flux during the operation of MD and MD-EMR systems. Feed and
distillate temperature were controlled at 30 and 10 °C, respectively. The cross-flow rate of both feed
and distillate side was set at 1 L/min (corresponding to a cross-flow velocity of 9 cm/s). Concentration
of both HBT and VA was 1 mM.
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Figure 5-1. Impact of mediator concentration (0.25 and 0.5 mM) on the degradation of after an

incubation time of 12 h in the MD-EMBR. Error bars indicate the standard deviation of
duplicate samples. Degradation of these TrOCs did not improve by increasing mediator
concentration
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Figure 5-2. Comparison of the degradation capacity of laccase, SA, VA and SA-VA mixture in MDEMBR operated for a period of 60 h.
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Figure 5-3. Enzymatic activity profiles with and without the addition of redox mediator(s) in
EMBR during long-term operation (60 h) of MD-EMBR
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Figure 5-4. Permeate flux obtained during the preliminary operation (12 h) of enzymatic
membrane distillation (MD-EMBR) with and without the addition of redox mediators. Feed
and distillate temperature were controlled at 30 and 10 °C, respectively during all experiments.
The cross-flow rate of both feed and distillate side was set at 1 L/min (corresponding to a crossflow velocity of 9 cm/s).
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Figure 5-5. Permeate flux obtained during the long-term operation (60 h) of enzymatic
membrane distillation (MD-EMR) with and without the addition of mediators. Feed and
distillate temperature were controlled at 30 and 10 °C, respectively during all experiments. The
cross-flow rate of both feed and distillate side was set at 1 L/min (corresponding to a crossflow velocity of 9 cm/s).
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Table 7-1. Chemical formula and structures of the selected micropollutants
Type
Pharmaceuticals
and personal care
products (PPCPs)

Name

Chemical Formula

MW (g/mol)

C8H9NO2

152

C19H20ClNO4

362

C14H11Cl2NO2

296

C10H11N3O3S

253

C20 H23 N

277

Carbamazepine

C15H12N2O

236

Primidone

C12H14N2O2

218

Triclosan

C12H7Cl3O2

290

Acetaminophen

Bezafibrate

Chemical structure

Diclofenac

Sulfamethoxazole

Amitriptyline

NH2

CH3
O

N

O

N

Trimethoprim

C14H18N4O3

290

H2N

O

Pesticide

Atrazine

C8H14ClN5

216

254

CH3

CH3

Cl

Linuron

C9H10Cl2N2O2

249

Cl

NH
O

Pentachlorophenol

C6HCl5O

266

255

N
O

CH3
CH3

Table 7-2: LC-MS analysis eluent gradient time program. adapted from (Xie et al., 2013)

*

Time (min)

Eluent B proportion (%)*

0

10

6

10

8

23

15

23

16

45

25

45

26

85

30

85

31

10

35

10

Eluent A contains 0.1% (v/v) formic acid in Milli-Q water; eluent B is acetonitrile.
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